User Image Cart Icon 0 Search Image
  • Home > Blog > Corticotropin Releasing Factor

Corticotropin Releasing Factor

  1. Stress, CORTICOTROPIN โ€“RELEASING FACTOR , and behavior
  2. Chemical and biological characterization of CORTICOTROPIN RELEASING FACTOR
  3. Psychiatric implications of basic and clinical studies with CORTICOTROPIN โ€“RELEASING FACTOR
  4. CORTICOTROPIN โ€“RELEASING FACTOR has an anxiogenic action in the social interaction test
  5. Effects of CORTICOTROPIN โ€“RELEASING FACTOR and growth hormone-RELEASING FACTOR on sleep and activity in rats
  6. Influence of CORTICOTROPIN โ€“RELEASING FACTOR on reproductive functions in the rat
  7. Behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR : localization and characterization of central effects
  8. Isolation and sequence analysis of the human CORTICOTROPIN โ€RELEASING FACTOR precursor gene.
  9. CORTICOTROPIN โ€“RELEASING FACTOR : actions on the sympathetic nervous system and metabolism
  10. Stress-induced inhibition of reproductive functions: role of endogenous CORTICOTROPIN โ€“RELEASING FACTOR
  11. Characterization of rat hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  12. Primary structure of CORTICOTROPIN โ€“RELEASING FACTOR from ovine hypothalamus
  13. CORTICOTROPIN RELEASING FACTOR decreases postburst hyperpolarizations and excites hippocampal neurons
  14. Interleukin-1 stimulates the secretion of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  15. CORTICOTROPIN RELEASING FACTOR produces behavioural activation in rats
  16. CORTICOTROPIN โ€“RELEASING FACTOR -producing neurons in the rat activated by interleukin-1
  17. Elevated concentrations of CSF CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in depressed patients
  18. Intraventricular CORTICOTROPIN โ€“RELEASING FACTOR enhances behavioral effects of novelty
  19. CORTICOTROPIN โ€“RELEASING FACTOR receptors are widely distributed within the rat central nervous system: an autoradiographic study
  20. The role of CORTICOTROPIN โ€“RELEASING FACTOR in the pathogenesis of major depression
  21. Immunocytochemical localization of CORTICOTROPIN โ€RELEASING FACTOR (CRF) in the rat brain
  22. In vivo CORTICOTROPIN โ€“RELEASING FACTOR -induced secretion of adrenoCORTICOTROPIN , ฮฒ-endorphin, and corticosterone
  23. Mediation by CORTICOTROPIN RELEASING FACTOR (CRF) of adenohypophysial hormone secretion
  24. [38] Assay of CORTICOTROPIN RELEASING FACTOR
  25. CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study
  26. CORTICOTROPIN โ€“RELEASING FACTOR : effects on the autonomic nervous system and visceral systems.
  27. Hypothalamic control of adrenoCORTICOTROPIN secretion: advances since the discovery of 41-residue CORTICOTROPIN โ€“RELEASING FACTOR
  28. Mechanisms of action of CORTICOTROPIN โ€“RELEASING FACTOR and other regulators of CORTICOTROPIN release in rat pituitary cells.
  29. CORTICOTROPIN โ€“RELEASING FACTOR receptors in the rat central nervous system: characterization and regional distribution
  30. CSF CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in depression and schizophrenia.
  31. CORTICOTROPIN โ€“RELEASING FACTOR directly mediates colonic responses to stress
  32. Catecholaminergic modulation of CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN secretion
  33. Reduced CORTICOTROPIN RELEASING FACTOR binding sites in the frontal cortex of suicide victims
  34. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR in rat brain.
  35. Organization of ovine CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive cells and fibers in the rat brain: an immunohistochemical study
  36. Clinical applications of CORTICOTROPIN โ€“RELEASING FACTOR
  37. Interaction of CORTICOTROPIN โ€“RELEASING FACTOR and Arginine Vasopressin on AdrenoCORTICOTROPIN Secretion in Vivo
  38. Physiological and behavioral responses to CORTICOTROPIN โ€“RELEASING FACTOR administration: is CRF a mediator of anxiety or stress responses?
  39. CORTICOTROPIN โ€“RELEASING FACTOR : effects on the sympathetic nervous system and oxygen consumption
  40. Synthetic competitive antagonists of CORTICOTROPIN โ€“RELEASING FACTOR : effect on ACTH secretion in the rat
  41. CORTICOTROPIN โ€“RELEASING FACTOR as the mediator of stress responses
  42. The CORTICOTROPIN โ€“RELEASING FACTOR stimulation test: an aid in the evaluation of patients with Cushingโ€™s syndrome
  43. CORTICOTROPIN โ€“RELEASING FACTOR potentiates acoustic startle in rats: blockade by chlordiazepoxide
  44. Effects of CORTICOTROPIN RELEASING FACTOR on locomotor activity in hypophysectomized rats
  45. CORTICOTROPIN โ€“RELEASING FACTOR activates noradrenergic neurons of the locus coeruleus
  46. Distribution and efferent projections of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the rat amygdaloid complex
  47. CORTICOTROPIN RELEASING FACTOR produces increases in brain excitability and convulsive seizures in rats
  48. Potentiation by vasopressin of CORTICOTROPIN release induced by CORTICOTROPIN โ€“RELEASING FACTOR
  49. Alterations in CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in discrete rat brain regions after acute and chronic stress
  50. Co-expression of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat
  51. Chlordiazepoxide attenuates response suppression induced by CORTICOTROPIN โ€“RELEASING FACTOR in the conflict test
  52. CORTICOTROPIN โ€“RELEASING FACTOR modulates defensive-withdrawal and exploratory behavior in rats.
  53. Central nervous system effects of CORTICOTROPIN โ€“RELEASING FACTOR on gastrointestinal transit in the rat
  54. CORTICOTROPIN โ€“RELEASING FACTOR decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-RELEASING hormone release into hypophysial โ€ฆ
  55. Localization, colocalization, and plasticity of CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in rat brain.
  56. Anorexia induced by interleukin 1: involvement of CORTICOTROPIN โ€“RELEASING FACTOR
  57. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF).
  58. CORTICOTROPIN RELEASING FACTOR (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution
  59. Modulation of stress-induced ACTH release by CORTICOTROPIN โ€“RELEASING FACTOR , catecholamines and vasopressin
  60. CORTICOTROPIN RELEASING FACTOR induction of leukocyte-derived immunoreactive ACTH and endorphins
  61. CORTICOTROPIN โ€“RELEASING FACTOR : evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress
  62. CORTICOTROPIN โ€“RELEASING FACTOR
  63. CORTICOTROPIN RELEASING FACTOR (CRF): immunoreactive neurones and fibers in rat hypothalamus
  64. Chronic administration of CORTICOTROPIN โ€“RELEASING FACTOR increases pituitary corticotroph number
  65. Evidence for local stimulation of ACTH secretion by CORTICOTROPIN โ€“RELEASING FACTOR in human placenta
  66. Comparison of the biologic actions of CORTICOTROPIN โ€“RELEASING FACTOR and sauvagine
  67. CORTICOTROPIN โ€“RELEASING FACTOR and gonadotropin-RELEASING hormone pulse generator activity in the rhesus monkey
  68. Distribution and characterization of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in human tissues
  69. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of CORTICOTROPIN โ€“RELEASING FACTOR
  70. Stimulation of hypothalamic ฮฒ-endorphin and dynorphin release by CORTICOTROPIN โ€“RELEASING FACTOR (in vitro)
  71. CORTICOTROPIN โ€“RELEASING FACTOR produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus
  72. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous CORTICOTROPIN โ€“RELEASING FACTOR
  73. Central nervous system action of CORTICOTROPIN โ€“RELEASING FACTOR to inhibit gastric emptying in rats
  74. CORTICOTROPIN โ€“RELEASING FACTOR -like activity in human placental extracts
  75. Presence op CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in hypophysial portal blood
  76. CORTICOTROPIN โ€“RELEASING FACTOR is a potent inhibitor of sexual receptivity in the female rat
  77. Ectopic secretion of CORTICOTROPIN โ€“RELEASING FACTOR as a cause of Cushingโ€™s syndrome: a clinical, morphologic, and biochemical study
  78. The distribution of CORTICOTROPIN RELEASING FACTOR -like immunoreactive neurons in rat brain
  79. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on food intake and brown adipose tissue thermogenesis in rats
  80. CORTICOTROPIN RELEASING FACTOR โ€like immunoreactivity in the rat brain as revealed by a modified cobaltโ€glucose oxidaseโ€diaminobenzidine method
  81. CORTICOTROPIN โ€“RELEASING FACTOR : endocrine and autonomic integration of responses to stress
  82. GnRH release from the mediobasal hypothalamus: in vitro inhibition by CORTICOTROPIN โ€“RELEASING FACTOR
  83. Interleukin-1 stimulates ACTH release by an indirect action which requires endogenous CORTICOTROPIN RELEASING FACTOR
  84. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR receptors in primate brain
  85. CORTICOTROPIN RELEASING FACTOR (CRF) receptor antagonist blocks activating and โ€˜anxiogenicโ€™actions of CRF in the rat
  86. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the anorexia induced by exercise
  87. Stimulant and anxiogenic effects of CORTICOTROPIN RELEASING FACTOR .
  88. CORTICOTROPIN โ€“RELEASING FACTOR antagonist blocks stress-induced fighting in rats
  89. Studies of the nature of the interaction between vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR on adrenoCORTICOTROPIN release in the rat
  90. Immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in human plasma.
  91. CORTICOTROPIN โ€“RELEASING FACTOR receptors and pituitary adrenal responses during immobilization stress
  92. Cloning and sequence analysis of cDNA for rat CORTICOTROPIN โ€RELEASING FACTOR precursor
  93. CORTICOTROPIN โ€“RELEASING FACTOR receptors in rat forebrain: autoradiographic identification
  94. CORTICOTROPIN โ€“RELEASING FACTOR : a physiologic regulator of adrenal epinephrine secretion
  95. Effects of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR , glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic โ€ฆ
  96. CORTICOTROPIN โ€“RELEASING FACTOR (CRF): central effects on mean arterial pressure and heart rate in rats.
  97. Arginine vasopressin potentiates adrenoCORTICOTROPIN release induced by ovine CORTICOTROPIN โ€“RELEASING FACTOR .
  98. Interleukin-1 stimulates CORTICOTROPIN โ€“RELEASING FACTOR gene expression in rat hypothalamus
  99. Co-localization of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin in median eminence neurosecretory vesicles
  100. Neurochemical and behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR in the ventral tegmental area of the rat.
  101. Studies of the secretion of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep
  102. Neurotransmitters and peptides modulate the release of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR from cultured human placental cells
  103. Cocaine stimulates adrenoCORTICOTROPIN (ACTH) secretion through a CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-mediated mechanism
  104. Central and peripheral distribution of CORTICOTROPIN โ€“RELEASING FACTOR .
  105. CORTICOTROPIN โ€“RELEASING FACTOR administered intraventricularly to rhesus monkeys
  106. Effect of centrally administered CORTICOTROPIN RELEASING FACTOR (CRF) on multiple feeding paradigms
  107. Effect of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR . Dose response of plasma adrenoCORTICOTROPIN and cortisol.
  108. The Effects of CORTICOTROPIN โ€“RELEASING FACTOR on AdrenoCORTICOTROPIN Secretion from Perifused Pituitaries in vitro: Rapid Inhibition by Glucocorticoids
  109. CORTICOTROPIN RELEASING FACTOR : central nervous system sites of action
  110. CORTICOTROPIN โ€“RELEASING FACTOR (ovine) and vasopressin exert a synergistic effect on adrenoCORTICOTROPIN release in man
  111. The role of pituitary beta-endorphin in mediating CORTICOTROPIN โ€“RELEASING FACTOR -induced antinociception
  112. CORTICOTROPIN โ€“RELEASING FACTOR administration elicits a stress-like activation of cerebral catecholaminergic systems
  113. Central nervous system effects of CORTICOTROPIN RELEASING FACTOR in the dog
  114. Properties and regulation of high-affinity pituitary receptors for CORTICOTROPIN โ€“RELEASING FACTOR
  115. Co-localization of CORTICOTROPIN RELEASING FACTOR and vasopressin mRNA in neurones after adrenalectomy
  116. Electrophysiological actions of CORTICOTROPIN โ€“RELEASING FACTOR in the central nervous system.
  117. Human CORTICOTROPIN โ€“RELEASING FACTOR in man: pharmacokinetic properties and dose-response of plasma adrenoCORTICOTROPIN and cortisol secretion
  118. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in human brain
  119. Gastrointestinal motor effects of CORTICOTROPIN โ€“RELEASING FACTOR in mice
  120. CORTICOTROPIN โ€“RELEASING FACTOR disrupts sensory responses of brain noradrenergic neurons
  121. A comparison of the effects of CORTICOTROPIN RELEASING FACTOR and sauvagine on food intake
  122. Neurotransmitter modulation of CORTICOTROPIN RELEASING FACTOR secretion into the hypophysial-portal circulation
  123. A CORTICOTROPIN โ€“RELEASING FACTOR antagonist reverses the stress-induced changes of exploratory behavior in mice
  124. CORTICOTROPIN โ€“RELEASING FACTOR (CRF): mechanism to elevate mean arterial pressure and heart rate
  125. Facilitation of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central โ€ฆ
  126. Evidence for differential regulation of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related โ€ฆ
  127. CORTICOTROPIN RELEASING FACTOR : immunocytochemical localization in rat brain
  128. Quantitative in situ hybridization histochemistry reveals increased levels of CORTICOTROPIN โ€“RELEASING FACTOR mRNA after adrenalectomy in rats
  129. Immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR is present in human maternal plasma during the third trimester of pregnancy
  130. Intra-amygdala injections of CORTICOTROPIN RELEASING FACTOR facilitate inhibitory avoidance learning and reduce exploratory behavior in rats
  131. Effects of CORTICOTROPIN โ€“RELEASING FACTOR , neurohypophyseal peptides, and catecholamines on pituitary function.
  132. Cloning and sequence analysis of cDNA for ovine CORTICOTROPIN โ€“RELEASING FACTOR precursor
  133. CORTICOTROPIN โ€“RELEASING FACTOR : pharmacokinetics in man
  134. CORTICOTROPIN โ€“RELEASING FACTOR
  135. CORTICOTROPIN โ€“RELEASING FACTOR attenuates interleukin 1-induced sleep and fever in rabbits
  136. Synaptic interaction of serotonergic axons and CORTICOTROPIN RELEASING FACTOR (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat
  137. Inhibition of gastric acid secretion in rats by intracerebral injection of CORTICOTROPIN โ€“RELEASING FACTOR
  138. CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy
  139. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) inhibits gonadotropin-RELEASING hormone (GnRH) release from superfused rat hypothalami in vitro
  140. Evidence for CORTICOTROPIN โ€RELEASING FACTOR , neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus
  141. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on energy balance in rats are sex dependent
  142. CORTICOTROPIN โ€RELEASING FACTOR receptors: Distribution and regulation in brain, pituitary, and peripheral tissues
  143. Reciprocal changes in CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimerโ€™s disease
  144. Dexamethasone inhibits CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the rat paraventricular nucleus
  145. โ€ฆ of lordosis behaviour in the female rat by CORTICOTROPIN โ€“RELEASING FACTOR , ฮฒ-endorphin/CORTICOTROPIN and luteinizing hormone-RELEASING hormone neuronal systems in the โ€ฆ
  146. CORTICOTROPIN โ€“RELEASING FACTOR Stimulation of AdrenoCORTICOTROPIN and ฮฒ-Endorphin Release: Effects of Acute and Chronic Stress
  147. Activating and โ€˜anxiogenicโ€™effects of CORTICOTROPIN RELEASING FACTOR are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
  148. Differential behavioral actions of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  149. The effects of intracerebroventricularly injected CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on the central nervous system: behavioural and biochemical studies
  150. Anatomy of the CORTICOTROPIN โ€“RELEASING FACTOR and opiomelanocortin systems of the brain.
  151. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) produces analgesia in humans and rats
  152. CORTICOTROPIN โ€“RELEASING FACTOR regulates proopiomelanocortin messenger ribonucleic acid levels in vivo
  153. Influence of steroids on the hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR and preproenkephalin mRNA responses to stress
  154. PITUITARY MICROADENOMAS CAUSING CUSHING/S DISEASE RESPOND TO CORTICOTROPIN โ€“RELEASING FACTOR
  155. CORTICOTROPIN โ€“RELEASING FACTOR stimulates accumulation of adenosine 3โ€ฒ, 5โ€ฒ-monophosphate in rat pituitary corticotrophs
  156. Immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF) in the rat spinal cord
  157. CORTICOTROPIN โ€“RELEASING FACTOR in the adrenal medulla.
  158. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)โ€”a review
  159. CORTICOTROPIN RELEASING FACTOR (CRF) has a peripheral site of action for antinociception
  160. Potentiation of acoustic startle by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and by fear are both reversed by! a-helical CRF (9-41).
  161. CORTICOTROPIN โ€“RELEASING FACTOR receptors and actions in rat Leydig cells
  162. Opioid inhibition of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR secretion into the hypophysial-portal circulation of rats
  163. Heterogeneity of chandelier neurons in monkey neocortex: CORTICOTROPIN โ€RELEASING FACTOR โ€and parvalbuminโ€immunoreactive populations
  164. Adrenergic innervation of CORTICOTROPIN RELEASING FACTOR (CRF)โ€”synthesizing neurons in the hypothalamic paraventricular nucleus of the rat
  165. Propranolol antagonizes the enhanced conditioned fear produced by CORTICOTROPIN RELEASING FACTOR .
  166. Thyrotropic activity of the ovine CORTICOTROPIN โ€“RELEASING FACTOR in the chick embryo
  167. Vasopressin coexists in half of the CORTICOTROPIN โ€“RELEASING FACTOR axons present in the external zone of the median eminence in normal rats
  168. CORTICOTROPIN โ€“RELEASING FACTOR : co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the โ€ฆ
  169. Effects of purified hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR and other substances on the secretion of adrenoCORTICOTROPIN and ฮฒ-endorphin-like immunoactivities in โ€ฆ
  170. Regulation of the messenger ribonucleic acid for CORTICOTROPIN โ€“RELEASING FACTOR in the paraventricular nucleus and other brain sites of the rat
  171. NEUROTRANSMITTER REGULATION OF CORTICOTROPIN โ€RELEASING FACTOR IN VITRO
  172. CORTICOTROPIN โ€“RELEASING FACTOR inhibits thermal injury.
  173. Effect of the serotonin reuptake inhibitor fluoxetine on CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin secretion into hypophysial portal blood
  174. CORTICOTROPIN โ€“RELEASING FACTOR is produced by rat Leydig cells and has a major local antireproductive role in the testis
  175. Neuropeptide-Y and ACTH-immunoreactive innervation of CORTICOTROPIN RELEASING FACTOR (CRF)-synthesizing neurons in the hypothalamus of the rat
  176. Immunoreactive CORTICOTROPIN and CORTICOTROPIN RELEASING FACTOR in human hypothalamus, adrenal, lung cancer, and pheochromocytoma
  177. Sympathetic nervous system mediates central CORTICOTROPIN โ€“RELEASING FACTOR induced suppression of natural killer cytotoxicity.
  178. Inhibitory influence of CORTICOTROPIN RELEASING FACTOR on components of sexual behaviour in the male rat
  179. Stimulation of cyclic AMP accumulation and CORTICOTROPIN release by synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR in rat anterior pituitary cells: site of glucocorticoid โ€ฆ
  180. CORTICOTROPIN RELEASING FACTOR receptor-mediated stimulation of adenylate cyclase activity in the rat brain
  181. Augmentation of acth-RELEASING activity op synthetic CORTICOTROPIN RELEASING FACTOR (crf) by vasopressin in women
  182. CORTICOTROPIN RELEASING FACTOR : basic studies and clinical applications
  183. Continuous administration of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR in man. Physiological and pathophysiological implications.
  184. Acute effects of alprazolam and adinazolam on the concentrations of CORTICOTROPIN โ€RELEASING FACTOR in the rat brain
  185. Central administration of CORTICOTROPIN โ€“RELEASING FACTOR modulates oxytocin secretion in the rat
  186. Functional CORTICOTROPIN RELEASING FACTOR receptors in the primate peripheral sympathetic nervous system
  187. CORTICOTROPIN โ€“RELEASING FACTOR as a transmitter in the human olivocerebellar pathway
  188. Cushingโ€™s syndrome due to ectopic production of CORTICOTROPIN โ€“RELEASING FACTOR
  189. Hemorrhage-induced secretion of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids
  190. Effects of CORTICOTROPIN โ€“RELEASING FACTOR , CORTICOTROPIN and cortisol on gastrointestinal motility in dogs
  191. Effect of angiotensin II on ACTH release in vivo: role of CORTICOTROPIN โ€“RELEASING FACTOR
  192. Endogenous opioid peptides modulate the effect of CORTICOTROPIN โ€“RELEASING FACTOR on gonadotropin release in the primate
  193. Quantification of Morphological Changes in Pituitary Corticotropes Produced by in Vivo CORTICOTROPIN โ€“RELEASING FACTOR Stimulation and Adrenalectomy
  194. Extrapituitary effects of CORTICOTROPIN โ€“RELEASING FACTOR .
  195. Characterization of CORTICOTROPIN โ€RELEASING FACTOR receptorโ€mediated adenylate cyclase activity in the rat central nervous system
  196. Ontogeny of expression of the CORTICOTROPIN โ€“RELEASING FACTOR gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary
  197. Brain and pituitary receptors for CORTICOTROPIN RELEASING FACTOR : localization and differential regulation after adrenalectomy
  198. Effects of CORTICOTROPIN RELEASING FACTOR on genetically obese (fatty) rats
  199. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by CORTICOTROPIN โ€“RELEASING FACTOR
  200. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonist: effects on the autonomic nervous system and cardiovascular function
  201. CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in human gastrointestinal tract
  202. Effects of CORTICOTROPIN RELEASING FACTOR and sauvagine on social behavior of isolated mice
  203. Immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR and CORTICOTROPIN during pregnancy, labor and puerperium
  204. Desensitization of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  205. The ontogeny of brain receptors for CORTICOTROPIN โ€“RELEASING FACTOR and the development of their functional association with adenylate cyclase
  206. CORTICOTROPIN โ€“RELEASING FACTOR elicits naloxone sensitive stress-like alterations in exploratory behavior in mice
  207. Clinical studies with CORTICOTROPIN RELEASING FACTOR : implications for the diagnosis and pathophysiology of depression, Cushingโ€™s disease, and adrenal insufficiency
  208. Central CORTICOTROPIN โ€“RELEASING FACTOR mediates the suppressive effect of stress on natural killer cytotoxicity
  209. Central administration of CORTICOTROPIN RELEASING FACTOR alters rat pup isolation calls
  210. Release of CORTICOTROPIN โ€“RELEASING FACTOR from Rat Brain Regions in Vitro
  211. A novel mechanism of action of CORTICOTROPIN RELEASING FACTOR in rat Leydig cells.
  212. Central CORTICOTROPIN โ€“RELEASING FACTOR suppresses natural killer cytotoxicity
  213. Binding of [125I] CORTICOTROPIN RELEASING FACTOR to blood immunocytes and its reduction in Alzheimerโ€™s disease
  214. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR and somatostatin in stress-induced inhibition of growth hormone secretion in the rat
  215. Stimulation of rat Bโ€lymphocyte proliferation by CORTICOTROPIN โ€RELEASING FACTOR
  216. Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by CORTICOTROPIN โ€“RELEASING FACTOR
  217. CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in senile dementia of the Alzheimer type: reduced cortical and striatal concentrations
  218. Neuromodulatory effects of CORTICOTROPIN RELEASING FACTOR on cerebellar Purkinje cells: an in vivo study in the cat
  219. Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of CORTICOTROPIN โ€“RELEASING FACTOR and sympathetic activation of brown adipose tissue
  220. CORTICOTROPIN โ€“RELEASING FACTOR synapses within the paraventricular nucleus of the hypothalamus
  221. Cholecystokininโ€, galaninโ€, and CORTICOTROPIN โ€RELEASING FACTOR โ€like immunoreactive projections from the nucleus of the solitary tract to the parabrachial nucleus in the โ€ฆ
  222. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected CORTICOTROPIN โ€“RELEASING FACTOR in anesthetized rats
  223. The paraventriculo-infundibular CORTICOTROPIN RELEASING FACTOR (CRF) pathway as revealed by immunocytochemistry in long-term hypophysectomized or โ€ฆ
  224. Differential regulation of brain and pituitary CORTICOTROPIN โ€“RELEASING FACTOR receptors by corticosterone
  225. Increase of CORTICOTROPIN โ€“RELEASING FACTOR staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline
  226. Comparative immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF-41) and neurohypophysial peptides in the brain of Brattleboro and Long-Evans โ€ฆ
  227. Receptor-mediated actions of CORTICOTROPIN โ€“RELEASING FACTOR in pituitary gland and nervous system
  228. The CORTICOTROPIN โ€“RELEASING FACTOR release in rat hypophysial portal blood is mediated by brain catecholamines
  229. Evidence for the presence of tumor peptides with CORTICOTROPIN โ€“RELEASING โ€“FACTOR -like activity in the ectopic ACTH syndrome
  230. CORTICOTROPIN โ€“RELEASING FACTOR test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders
  231. Induction of ฮฒ-endorphin secretion by lymphocytes after subcutaneous administration of CORTICOTROPIN โ€“RELEASING FACTOR
  232. Inhibition of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback
  233. Lactation inhibits stress-mediated secretion of corticosterone and oxytocin and hypothalamic accumulation of CORTICOTROPIN โ€“RELEASING FACTOR and enkephalin messenger โ€ฆ
  234. Central CORTICOTROPIN โ€“RELEASING FACTOR administration prevents the excessive body weight gain of genetically obese (fa/fa) rats
  235. Immunohistochemical study of neurons containing CORTICOTROPIN โ€RELEASING FACTOR in Alzheimerโ€™s disease
  236. Cloning and sequence analysis of cDNA for CORTICOTROPIN โ€“RELEASING FACTOR precursor from the teleost fish Catostomus commersoni
  237. CORTICOTROPIN โ€“RELEASING FACTOR in humans
  238. Behavioral effects of ovine CORTICOTROPIN โ€“RELEASING FACTOR administered to rhesus monkeys.
  239. Effects of adrenalectomy and dexamethasone administration on the level of prepro-CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid (mRNA) in the โ€ฆ
  240. CORTICOTROPIN โ€“RELEASING FACTOR and parturition: plasma and amniotic fluid levels and placental binding sites.
  241. Gonadal regulation of CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in hypothalamus
  242. ACTH, cortisol, and corticosterone output after ovine CORTICOTROPIN โ€“RELEASING FACTOR challenge during depression and after recovery
  243. New hypothalamic hormone, CORTICOTROPIN โ€“RELEASING FACTOR , specifically stimulates the release of adrenocorticotropic hormone and cortisol in man
  244. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and CORTICOTROPIN โ€“RELEASING FACTOR
  245. Chronic cocaine administration alters CORTICOTROPIN โ€“RELEASING FACTOR receptors in the rat brain
  246. Presence of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in rat testis
  247. Modulation of basal and CORTICOTROPIN โ€“RELEASING FACTOR -stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary
  248. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of CORTICOTROPIN โ€“RELEASING FACTOR , arginine vasopressin, and oxytocin โ€ฆ
  249. Reductions in CORTICOTROPIN RELEASING FACTOR โ€like immunoreactivity in cerebral cortex in Alzheimerโ€™s disease, Parkinsonโ€™s disease, and progressive supranuclear palsy
  250. Effect of the long-term administration of CORTICOTROPIN โ€“RELEASING FACTOR on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
  251. Mechanism of action of interleukin-1ฮฒ in increasing CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN hormone release from cultured human placental cells
  252. CORTICOTROPIN โ€“RELEASING FACTOR stimulates the release of adrenoCORTICOTROPIN from domestic fowl pituitary cells
  253. Stress-induced secretion of adrenoCORTICOTROPIN in rats is inhibited by administration of antisera to ovine CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin
  254. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) immunoreactivity in the dorsolateral pontine tegmentum: further studies on the micturition reflex system
  255. Ovine CORTICOTROPIN โ€“RELEASING FACTOR administration in normal men
  256. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine CORTICOTROPIN โ€“RELEASING FACTOR
  257. CORTICOTROPIN โ€RELEASING FACTOR immunoreactivity in monkey neocortex: An immunohistochemical analysis
  258. CORTICOTROPIN โ€RELEASING FACTOR mRNA in the hypothalamus is affected differently by drinking saline and by dehydration
  259. Alcohol reverses the proconflict effect of CORTICOTROPIN โ€“RELEASING FACTOR
  260. The role of IL-1 in the CORTICOTROPIN โ€“RELEASING FACTOR and arginine-vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood โ€ฆ
  261. CORTICOTROPIN โ€“RELEASING FACTOR inhibits neurogenic plasma extravasation in the rat paw.
  262. [38] CORTICOTROPIN โ€“RELEASING FACTOR receptors in the pituitary gland and central nervous system: Methods and overview
  263. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) acts centrally to inhibit growth hormone secretion in the rat
  264. CORTICOTROPIN โ€“RELEASING FACTOR in the olivocerebellar tract of rats: demonstration by light-and electron-microscopic immunohistochemistry and in situ hybridization โ€ฆ
  265. Effect of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR : prolonged duration of action and biphasic response of plasma adrenoCORTICOTROPIN and cortisol
  266. Demonstration of distinct CORTICOTROPIN RELEASING FACTOR โ€”containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic โ€ฆ
  267. Different epileptogenic activities of murine and ovine CORTICOTROPIN โ€“RELEASING FACTOR
  268. CORTICOTROPIN RELEASING FACTOR : a new tool for the differential diagnosis of Cushingโ€™s syndrome
  269. CORTICOTROPIN โ€“RELEASING FACTOR receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages
  270. The involvement of central noradrenergic systems and CORTICOTROPIN โ€“RELEASING FACTOR in defensive-withdrawal behavior in rats.
  271. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the vertebrate endocrine pancreas
  272. In vitro study of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR release from the rat hypothalamus
  273. CORTICOTROPIN โ€“RELEASING FACTOR receptors in rat pituitary gland: autoradiographic localization
  274. Central autonomic modulation of cardiac baroreflex by CORTICOTROPIN โ€“RELEASING FACTOR
  275. Insulin-induced hypoglycemia stimulates CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained โ€ฆ
  276. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin โ€ฆ
  277. CORTICOTROPIN โ€“RELEASING FACTOR , sauvagine, and urotensin I: effects on blood flow
  278. Single or repeated mild stress increases synthesis and release of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  279. Monoamine metabolites, CORTICOTROPIN RELEASING FACTOR and somatostatin as CSF markers in depressed patients
  280. CORTICOTROPIN RELEASING FACTOR distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals
  281. CORTICOTROPIN โ€“RELEASING FACTOR binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides
  282. Combined administration of human CORTICOTROPIN โ€“RELEASING FACTOR and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects
  283. The status of the CORTICOTROPIN RELEASING FACTOR (CRF)
  284. CORTICOTROPIN โ€“RELEASING FACTOR stimulates secretion of melanocyte-stimulating hormone from the rat pituitary
  285. Evidence for the involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the gastrointestinal disturbances induced by acoustic and cold stress in mice
  286. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing CORTICOTROPIN RELEASING FACTOR (CRF)
  287. Isolation and amino acid sequence of CORTICOTROPIN โ€“RELEASING FACTOR from pig hypothalami
  288. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses
  289. Inhibitory effect of adrenoCORTICOTROPIN on CORTICOTROPIN โ€“RELEASING FACTOR release from rat hypothalamus in vitro
  290. Starvation-induced changes in rat brain CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and putuitary-adrenocortical response
  291. Modulation of central nervous system actions of CORTICOTROPIN โ€“RELEASING FACTOR by dynorphin-related peptides
  292. Modulation of lordosis behaviour in the female rat by CORTICOTROPIN RELEASING FACTOR , ฮฒ-endorphin and gonadotropin RELEASING hormone in the mesencephalic central โ€ฆ
  293. Angiotensin II and ACTH release: site of action and potency relative to CORTICOTROPIN RELEASING FACTOR and vasopressin
  294. Rat preprocarboxypeptidase H: Cloning, characterization, and sequence of the cDNA and regulation of the mRNA by CORTICOTROPIN โ€“RELEASING FACTOR
  295. โ€ฆ -and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin neurons
  296. CORTICOTROPIN RELEASING FACTOR administered into the ventricular CSF stimulates the pituitary-adrenal axis
  297. A new cytotoxin specific for the target cells of CORTICOTROPIN โ€“RELEASING FACTOR
  298. Evidence for a role of endogenous CORTICOTROPIN โ€“RELEASING FACTOR in cold, ether, immobilization, and traumatic stress
  299. Demonstration of glucocorticoid receptorโ€like immunoreactivity in glucocorticoidโ€sensitive vasopressin and CORTICOTROPIN โ€RELEASING FACTOR neurons in the hypothalamic โ€ฆ
  300. Surface properties of an amphiphilic peptide hormone and of its analog: CORTICOTROPIN โ€“RELEASING FACTOR and sauvagine
  301. Purification of hypothalamic CORTICOTROPIN RELEASING FACTOR .
  302. Neuropeptide Y administration acutely increases hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity: lack of effect in other rat brain regions
  303. Iontophoretic mapping of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) sensitive neurons in the rat forebrain
  304. Acetylcholine and Norepinephrine Stimulate the Release of CORTICOTROPIN โ€“RELEASING FACTOR -41 from the Rat Hypothalamus in Vitro
  305. Inhibition of gastric acid secretion in rats and in dogs by CORTICOTROPIN โ€“RELEASING FACTOR
  306. CORTICOTROPIN โ€“RELEASING FACTOR : central action to influence gastric secretion.
  307. ACTH and multisteroid responses to CORTICOTROPIN โ€“RELEASING FACTOR in depressive illness: relationship to multisteroid responses after ACTH stimulation and โ€ฆ
  308. Characterization and biological activity of a rat monoclonal antibody to rat/human CORTICOTROPIN โ€“RELEASING FACTOR
  309. Role of cholecystokinin in CORTICOTROPIN release: coexistence with vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR in cells of the rat hypothalamic paraventricular nucleus
  310. Inhibition of CORTICOTROPIN release during hypothermia: the role of CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin, and oxytocin
  311. CSF CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in Alzheimerโ€™s disease: its relationship to severity of dementia and monoamine metabolites
  312. Characterization of immunoreactive CORTICOTROPIN and CORTICOTROPIN โ€“RELEASING FACTOR in human adrenal and ovarian tumours
  313. Localization of urotensin I-and CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the central nervous system of Catostomus commersoni
  314. Plasma adrenoCORTICOTROPIN , cortisol, and aldosterone responses to CORTICOTROPIN โ€“RELEASING FACTOR : modulatory effect of basal cortisol levels
  315. Ethanol Exposure Decreases Pituitary CORTICOTROPIN โ€“RELEASING FACTOR Binding, Adenylate Cyclase Activity, Proopiomelanocortin Biosynthesis, and Plasma ฮฒ โ€ฆ
  316. CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in sensory ganglia and capsaicin sensitive neurons of the rat central nervous system: colocalization with other โ€ฆ
  317. CORTICOTROPIN โ€“RELEASING FACTOR in the dog adrenal medulla is secreted in response to hemorrhage
  318. Effect of paraventricular lesions on CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenoCORTICOTROPIN โ€ฆ
  319. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat
  320. Coexistence of peptides (CORTICOTROPIN RELEASING FACTOR /neurotensin and substance P/somatostatin) in the bed nucleus of the stria terminalis and central amygdaloid โ€ฆ
  321. Influence of the frequency of ovine CORTICOTROPIN โ€“RELEASING FACTOR administration on adrenoCORTICOTROPIN and corticosterone secretion in the rat
  322. Adrenal modulation of the inhibitory effect of CORTICOTROPIN RELEASING FACTOR on feeding
  323. In vitro potentiation of the activity of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR by arginine vasopressin
  324. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR secretion in vitro by glucose
  325. Distribution and coexistence of CORTICOTROPIN โ€“RELEASING FACTOR -, neurotensin-, enkephalin-, cholecystokinin-, galanin-and vasoactive intestinal polypeptide/peptide โ€ฆ
  326. Structural homology of CORTICOTROPIN โ€“RELEASING FACTOR , sauvagine, and urotensin I: circular dichroism and prediction studies
  327. Stress and CORTICOTROPIN โ€“RELEASING FACTOR potentiate center region activity of mice in an open field
  328. Vasopressin stimulation of adrenoCORTICOTROPIN hormone (ACTH) in humans. In vivo bioassay of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) which provides evidence for CRF โ€ฆ
  329. Effects of intracerebroventricular administration of growth hormone-RELEASING FACTOR and CORTICOTROPIN โ€“RELEASING FACTOR on somatostatin secretion into rat hypophysial โ€ฆ
  330. Localization of CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the brain of the domestic fowl
  331. Distribution of CORTICOTROPIN โ€RELEASING FACTOR in the cerebellum and precerebellar nuclei of the cat
  332. Structural characterization and localization of CORTICOTROPIN โ€“RELEASING FACTOR in testis
  333. Dementia of the Alzheimer type and hypothalamusโ€pituitaryโ€adrenocortical axis: changes in cerebrospinal fluid CORTICOTROPIN RELEASING FACTOR and plasma cortisol โ€ฆ
  334. Ovine CORTICOTROPIN โ€“RELEASING FACTOR stimulates somatostatin secretion from cultured brain cells
  335. Regional hemodynamic responses to central administration of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  336. Distribution of CORTICOTROPIN โ€RELEASING โ€FACTOR โ€like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): An โ€ฆ
  337. Glucocorticoids Inhibit CORTICOTROPIN โ€“RELEASING FACTOR -Induced Production of Adenosine 3โ€ฒ,5โ€ฒ-Monophosphate in Cultured Anterior Pituitary Cells
  338. Presence of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in human corebrospinal fluid
  339. Isolation and characterization of caprine CORTICOTROPIN โ€“RELEASING FACTOR
  340. Evidence for local CORTICOTROPIN RELEASING FACTOR (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus
  341. โ€ฆ (PHI-27)/CORTICOTROPIN โ€“RELEASING FACTOR /enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, CORTICOTROPIN โ€ฆ
  342. ฮฒ-Lipotropinโ€”ฮฒ-Endorphin Response to Low-Dose Ovine CORTICOTROPIN RELEASING FACTOR in Endogenous Depression: Preliminary Studies
  343. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats
  344. CORTICOTROPIN RELEASING FACTOR (CRF) immunoreactivity in hypothalamic and extrahypothalamic nuclei of sheep brain
  345. Influence of the central nucleus of the amygdala on the content of CORTICOTROPIN โ€“RELEASING FACTOR in the median eminence
  346. Distribution of CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in the rat brain by immunohistochemistry and radioimmunoassay: comparison and characterization of โ€ฆ
  347. Immunocytochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the human hypothalamus
  348. Ontogeny of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressein in the rat
  349. Role of CORTICOTROPIN โ€“RELEASING FACTOR in mediating the expression of defensive behavior.
  350. Neuropeptide Y-induced effects on hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR content and release are dependent on noradrenergic/adrenergic neurotransmission
  351. Abnormal ACTH and cortisol responses to ovine CORTICOTROPIN RELEASING FACTOR in patients with primary affective disorder
  352. Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by CORTICOTROPIN โ€“RELEASING FACTOR
  353. Stimulation of adrenoCORTICOTROPIN /ฮฒ-endorphin release by synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR in vitro
  354. AdrenoCORTICOTROPIN , ฮฒ-lipotropin, ฮฒ-endorphin, and CORTICOTROPIN โ€“RELEASING FACTOR -like activity in an adrenoCORTICOTROPIN -producing nephroblastoma
  355. The CORTICOTROPIN RELEASING FACTOR (CRF) neurosecretory system in intact, adrenalectomized, and adrenalectomized-dexamethasone treated rats
  356. The hippocampus and amygdala mediate the locomotor stimulating effects of CORTICOTROPIN โ€“RELEASING FACTOR in mice
  357. CORTICOTROPIN RELEASING FACTOR stimulates adrenoCORTICOTROPIN and ฮฒ-endorphin release from AtT-20 mouse pituitary tumor cells
  358. Co-localization of the immunoreactivities of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasotocin in the brain and pituitary system of the teleost Catostomus โ€ฆ
  359. Coexistence of CORTICOTROPIN โ€RELEASING FACTOR and enkephalin in the paraventricular nucleus of the rat
  360. Immunoreactive dynorphin-(1-8) and CORTICOTROPIN โ€“RELEASING FACTOR in subpopulation of hypothalamic neurons
  361. Glutamic acid decarboxylase-and ฮณ-aminobutyric acid-like immunoreactivities in CORTICOTROPIN โ€“RELEASING FACTOR -containing parvocellular neurons of the hypothalamic โ€ฆ
  362. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the adrenal medulla
  363. Isolation and characterization of the bovine hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  364. Effects of intraventricular infusion of CORTICOTROPIN โ€“RELEASING FACTOR on VMH-lesioned obese rats
  365. Selective facilitation of putative CORTICOTROPIN โ€“RELEASING FACTOR -secreting neurones by interleukin-1
  366. CORTICOTROPIN RELEASING FACTOR increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells.
  367. CORTICOTROPIN RELEASING FACTOR (CRF) and age-related differences in behavior of mice
  368. Induction of fos-Like Immunoreactivity in Hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR Neurons after Adrenalectomy in the Rat
  369. Insulin-induced hypoglycemia increases CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid levels in rat hypothalamus
  370. Heterogeneity between brain and pituitary CORTICOTROPIN โ€“RELEASING FACTOR receptors is due to differential glycosylation
  371. CORTICOTROPIN โ€“RELEASING FACTOR receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides
  372. Alcohol exposure in utero results in diminished Tโ€cell function and alterations in brain CORTICOTROPIN โ€RELEASING FACTOR and ACTH content
  373. Corticosterone-induced changes in hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) content after stress
  374. Hypoglycemia enhances turnover of CORTICOTROPIN โ€“RELEASING FACTOR and of vasopressin in the zona externa of the rat median eminence
  375. Immunohistochemical localization and radioimmunoassay of CORTICOTROPIN โ€“RELEASING FACTOR in the forebrain and hypophysis of the frog Rana ridibunda
  376. Release from inflamed tissue of a substance with properties similar to CORTICOTROPIN โ€“RELEASING FACTOR
  377. Nucleotide sequence of the gene coding for ovine CORTICOTROPIN โ€“RELEASING FACTOR and regulation of its mRNA levels by glucocorticoids
  378. Stress mediated changes in hypothalamic CORTICOTROPIN RELEASING FACTOR -like immunoreactivity
  379. CORTICOTROPIN โ€“RELEASING FACTOR in cerebellar afferent systems: a combined immunohistochemistry and retrograde transport study
  380. CORTICOTROPIN RELEASING FACTOR and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test
  381. Hypercorticosteronuria and diminished pituitary responsiveness to CORTICOTROPIN โ€“RELEASING FACTOR in obese Zucker rats
  382. Intrahypothalamic CORTICOTROPIN โ€“RELEASING FACTOR elevates gastric bicarbonate and inhibits stress ulcers in rats
  383. Suppression by glucocorticoid of the immunoreactivity of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin in the paraventricular nucleus of rat hypothalamus
  384. Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of CORTICOTROPIN โ€“RELEASING FACTOR
  385. CORTICOTROPIN โ€“RELEASING FACTOR inhibits gastric emptying in dogs
  386. CORTICOTROPIN โ€“RELEASING FACTOR and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function
  387. Behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR
  388. Central modulation of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR secretion by arginine vasopressin
  389. Secretion of CORTICOTROPIN RELEASING FACTOR (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams
  390. Regulation of duodenal bicarbonate secretion during stress by CORTICOTROPIN โ€“RELEASING FACTOR and beta-endorphin
  391. Radioautographic study of binding and internalization of CORTICOTROPIN โ€“RELEASING FACTOR by rat anterior pituitary corticotrophs
  392. Effects of serotonin, cyproheptadine and reserpine on CORTICOTROPIN โ€“RELEASING FACTOR release from the rat hypothalamus in vitro
  393. Evidence for the involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the inhibition of gonadotropin release induced by hyperprolactinemia
  394. Effects of intravenous and intraventricular injection of antisera directed against CORTICOTROPIN โ€“RELEASING FACTOR on the secretion of anterior pituitary hormones
  395. Assays for CORTICOTROPIN โ€“RELEASING FACTOR (CRF) using rats treated with morphine, chlorpromazine, dexamethasone and nembutal
  396. Cardiovascular responses to exercise in the rat: role of CORTICOTROPIN โ€“RELEASING FACTOR
  397. CORTICOTROPIN โ€“RELEASING FACTOR receptors in human pituitary gland: autoradiographic localization
  398. Effects of opioid peptides on immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR release from the rat hypothalamus in vitro
  399. Stress-induced alterations in neurotensin, somatostatin and CORTICOTROPIN โ€“RELEASING FACTOR in mesotelencephalic dopamine system regions
  400. Clinical studies with synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR .
  401. CORTICOTROPIN RELEASING FACTOR (CRF): immunocytochemical localization and radioimmunoassay (RIA)
  402. Immunocytochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF)-like immunoreactivity in the thalamus of the rat
  403. Pituitary and adrenocortical responses to CORTICOTROPIN โ€“RELEASING FACTOR in pigs.
  404. Immunoelectron microscopic localization of CORTICOTROPIN โ€“RELEASING FACTOR in the rat hypothalamus
  405. Effect of CORTICOTROPIN โ€“RELEASING FACTOR , Dexamethasone and Actinomycin D on the Release of ACTH from Rat Pituitaries in Vivo and in Vitro
  406. Vasopressin potentiates cyclic AMP accumulation and ACTH release induced by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rat anterior pituitary cells in culture
  407. The hormonal actions of CORTICOTROPIN โ€“RELEASING FACTOR in sheep: effect of intravenous and intracerebroventricular injection
  408. Handling in infancy: increased levels of the hypothalamic CORTICOTROPIN RELEASING FACTOR (CRF) following exposure to a novel situation
  409. Inhibition of rat CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN secretion by an osmotic stimulus
  410. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and CORTICOTROPIN RELEASING FACTOR (CRF) in the rat
  411. Diurnal rhythm of plasma immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in normal subjects
  412. Coexistence of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity and vasotocin in perikarya of the preoptic nucleus in the eel
  413. CORTICOTROPIN โ€“RELEASING FACTOR -induced adrenoCORTICOTROPIN hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein โ€ฆ
  414. CORTICOTROPIN โ€“RELEASING FACTOR . Mechanisms to inhibit gastric acid secretion in conscious dogs.
  415. Additive effects of epinephrine and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on adrenoCORTICOTROPIN release in rat anterior pituitary cells
  416. Brain CORTICOTROPIN โ€“RELEASING FACTOR acts as inhibitor of stress-induced gastric erosion in rats
  417. CORTICOTROPIN โ€“RELEASING FACTOR -like activity in ACTH producing tumors
  418. Secretion of CORTICOTROPIN โ€“RELEASING FACTOR from cultured rat hypothalamic cells: effects of catecholamines
  419. Ultrastructural characteristics of immunolabelled, CORTICOTROPIN RELEASING FACTOR (CRF)-synthesizing neurons in the rat brain
  420. CORTICOTROPIN โ€“RELEASING FACTOR is contained within perikarya and nerve fibres of rat duodenum
  421. Widespread expression of CORTICOTROPIN โ€“RELEASING FACTOR messenger RNA and immunoreactivity in the rat olFACTOR y bulb
  422. CORTICOTROPIN โ€“RELEASING FACTOR receptors: autoradiographic identification.
  423. Effects of CORTICOTROPIN RELEASING FACTOR , desipramine and haloperidol on a DRL schedule of reinforcement
  424. Epidermal growth FACTOR acts as a CORTICOTROPIN โ€“RELEASING FACTOR in chronically catheterized fetal lambs.
  425. CORTICOTROPIN RELEASING FACTOR (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus
  426. CORTICOTROPIN โ€“RELEASING FACTOR as a possible cause of comorbidity in anxiety and depressive disorders.
  427. Involvement of vasopressin in the down-regulation of pituitary CORTICOTROPIN โ€“RELEASING FACTOR receptors after adrenalectomy
  428. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR in ovine brain determined by radioimmunoassay
  429. Glucocorticoids regulate ovine hypophysial portal levels of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin in a stress-specific manner
  430. Comparative effects of CORTICOTROPIN โ€“RELEASING FACTOR , arginine vasopressin, and related neuropeptides on the secretion of ACTH and ฮฑ-MSH by frog anterior pituitary โ€ฆ
  431. Inhibition by Dexamethasone of the in Vivo Pituitary Response to CORTICOTROPIN โ€“RELEASING FACTOR (CRF)1
  432. Vasopressin and CORTICOTROPIN โ€RELEASING FACTOR : an axonal pathway to portal capillaries in the zona externa of the median eminence containing vasopressin and its โ€ฆ
  433. Behavioral investigation of the coexistence of substance P, CORTICOTROPIN RELEASING FACTOR , and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the โ€ฆ
  434. Low doses of CORTICOTROPIN โ€“RELEASING FACTOR potentiate amphetamine-induced stereotyped behavior
  435. Predominant release of vasopressin vs. CORTICOTROPIN โ€“RELEASING FACTOR from the isolated median eminence after adrenalectomy
  436. EEG stability following CORTICOTROPIN RELEASING FACTOR in rats
  437. CORTICOTROPIN โ€“RELEASING FACTOR binding to peripheral tissue and activation of the adenylate cyclase-adenosine 3โ€ฒ, 5โ€ฒ-monophosphate system
  438. Active clearance of CORTICOTROPIN โ€“RELEASING FACTOR from the cerebrospinal fluid
  439. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and interleukin-1 (IL-1) receptors in the brain-pituitary-immune axis.
  440. CORTICOTROPIN โ€RELEASING FACTOR is altered in brains of animals with high preference for ethanol
  441. Immunohistochemical demonstration of the localization of CORTICOTROPIN RELEASING FACTOR -containing neurons in the hypothalamus of mammals including primates
  442. Intrahypothalamic microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR inhibits gastric acid secretion but increases secretion volume in rats
  443. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the gastro-entero-pancreatic endocrine system
  444. Associated endocrine, physiological and behavioral changes in rhesus monkeys after intravenous CORTICOTROPIN โ€“RELEASING FACTOR administration
  445. Responsiveness of the hypophyseal-adrenocortical axis to CORTICOTROPIN โ€“RELEASING FACTOR in pituitary-dependent Cushingโ€™s disease
  446. CORTICOTROPIN โ€“RELEASING FACTOR in Humans
  447. Hypothalamic organization of CORTICOTROPIN RELEASING FACTOR (CRF) producing structures
  448. CORTICOTROPIN โ€“RELEASING FACTOR -induced stimulation of immune functions
  449. Immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in rat plasma
  450. Autonomic and cardiovascular effects of CORTICOTROPIN โ€“RELEASING FACTOR in the spontaneously hypertensive rat
  451. Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR in man
  452. Ovine CORTICOTROPIN โ€“RELEASING FACTOR and dexamethasone responses in hyperandrogenic women
  453. CORTICOTROPIN โ€RELEASING FACTOR : isolation and chemical properties
  454. CORTICOTROPIN โ€“RELEASING FACTOR : putative neurotransmitter in the noradrenergic nucleus locus ceruleus.
  455. Antagonistic effect of somatostatin on CORTICOTROPIN โ€“RELEASING FACTOR -induced anorexia in the rat
  456. Binding sites for CORTICOTROPIN RELEASING FACTOR in sensory areas of the rat hindbrain and spinal cord
  457. Optokinetic stimulation increases CORTICOTROPIN โ€“RELEASING FACTOR mRNA in inferior olivary neurons of rabbits
  458. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by CORTICOTROPIN โ€“RELEASING FACTOR .
  459. Effects of cyproheptadine, reserpine, and synthetic CORTICOTROPIN โ€“RELEASING FACTOR on pituitary glands from patients with Cushingโ€™s disease
  460. Paradoxical responsiveness of growth hormone to CORTICOTROPIN โ€“RELEASING FACTOR in acromegaly
  461. Central nervous system actions of CORTICOTROPIN โ€“RELEASING FACTOR on cardiovascular function in the absence of locomotor activity
  462. CORTICOTROPIN โ€“RELEASING FACTOR acts centrally to suppress stimulated gastric contractility in the rat
  463. The CORTICOTROPIN โ€“RELEASING FACTOR test in the differential diagnosis of Cushingโ€™s syndrome: a comparison with the lysine-vasopressin test
  464. Further studies on CORTICOTROPIN RELEASING FACTOR (CRF); CORTICOTROPIN RELEASING activity of synthetic peptides
  465. Effects of catecholamine-depleting medullary knife cuts on CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin immunoreactivity in the hypothalamus of normal and steroid โ€ฆ
  466. Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central CORTICOTROPIN โ€“RELEASING FACTOR in conscious male rats
  467. CORTICOTROPIN โ€“RELEASING FACTOR desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin
  468. Effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and opiates on amphibian locomotion
  469. Immunohistochemical identification of neurons containing CORTICOTROPIN โ€“RELEASING FACTOR in the rat hypothalamus
  470. โ€ฆ secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin
  471. Distribution and characterization of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin in rat hypothalamic nuclei
  472. Central CORTICOTROPIN RELEASING FACTOR reduces natural cytotoxicity. Time course of action.
  473. Functional CORTICOTROPIN โ€“RELEASING FACTOR receptors in neonatal rat spinal cord
  474. Identification and characterization of a pituitary CORTICOTROPIN โ€“RELEASING FACTOR binding protein by chemical cross-linking.
  475. Chronic ethanol exposure potentiates the locomotor-activating effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rats
  476. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of CORTICOTROPIN โ€“RELEASING FACTOR on cyclic AMP production in rat anterior pituitary cells โ€ฆ
  477. CORTICOTROPIN โ€“RELEASING FACTOR stimulates adenylate cyclase activity in the anterior pituitary gland
  478. CORTICOTROPIN โ€“RELEASING FACTOR concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: differential sensitivity to โ€ฆ
  479. Pituitary receptors for CORTICOTROPIN โ€“RELEASING FACTOR : no effect of vasopressin on binding or activation of adenylate cyclase
  480. CORTICOTROPIN โ€“RELEASING FACTOR acts via a third ventricle site to reduce exploratory behavior in rats
  481. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Induces Desensitization of the Rat Pituitary CRF Receptor Adenylate Cyclase Complex
  482. Cytochemical studies of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl โ€ฆ
  483. CORTICOTROPIN โ€“RELEASING FACTOR : central nervous system effects on baroreflex control of heart rate
  484. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein is a glycoprotein
  485. Evidence for basal and stress-induced release of CORTICOTROPIN RELEASING FACTOR in the push-pull cannulated median eminence of conscious free-moving rats
  486. Protective actions of CORTICOTROPIN โ€“RELEASING FACTOR on thermal injury to rat pawskin.
  487. CORTICOTROPIN โ€“RELEASING FACTOR inhibits gastric emptying in dogs: studies on its mechanism of action
  488. Distribution of CORTICOTROPIN RELEASING FACTOR (s) activity in neural and extraneural tissues of the rat
  489. CORTICOTROPIN RELEASING FACTOR -like peptides produce selective dilatation of the dog mesenteric circulation
  490. Immediate and delayed alterations of adrenoCORTICOTROPIN and cortisol nyctohemeral profiles after CORTICOTROPIN โ€“RELEASING FACTOR in normal man
  491. โ€ฆ of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by CORTICOTROPIN RELEASING FACTOR , isoproterenol, and forskolin.
  492. Brain CORTICOTROPIN RELEASING FACTOR in the spontaneously hypertensive rat.
  493. Inhibition of protein exudation from the trachea by CORTICOTROPIN โ€“RELEASING FACTOR
  494. CORTICOTROPIN โ€“RELEASING FACTOR stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo โ€ฆ
  495. CORTICOTROPIN โ€“RELEASING FACTOR : a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm
  496. Secretion of ACTH by isolated anterior pituitary cells: kinetics of stimulation by CORTICOTROPIN โ€“RELEASING FACTOR and of inhibition by corticosterone
  497. The preferential release of beta-endorphin from the anterior pituitary lobe by CORTICOTROPIN RELEASING FACTOR (CRF)
  498. Angiotensin II and adrenoCORTICOTROPIN release: mediation by endogenous CORTICOTROPIN โ€“RELEASING FACTOR
  499. Capsaicin depletes CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactive neurons in the rat spinal cord and medulla oblongata
  500. CORTICOTROPIN โ€“RELEASING FACTOR differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and โ€ฆ
  501. Dynamic training and circulating levels of CORTICOTROPIN โ€“RELEASING FACTOR , beta-lipotropin and beta-endorphin in rheumatoid arthritis
  502. Improved fixation and cobalt-glucose oxidase-diaminobenzidine intensification for immunohistochemical demonstration of CORTICOTROPIN โ€“RELEASING FACTOR in rat brain.
  503. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on the release and synthesis of prolactin
  504. Cloning and distribution of expression of the rat CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene
  505. Central administration of CORTICOTROPIN RELEASING FACTOR in the pig: effects on operant feeding, drinking and plasma cortisol
  506. CORTICOTROPIN RELEASING FACTOR โ€containing afferents to the lateral septum of the rat brain
  507. Effects of bilateral adrenalectomy on immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in the rat median eminence and intermediate-posterior pituitary
  508. Role of central epinephrine on the regulation of CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN secretion
  509. Ovine CORTICOTROPIN โ€“RELEASING FACTOR stimulates the concomitant secretion of CORTICOTROPIN , ฮฒ-lipotropin, ฮฒ-endorphin and ฮณ-melanotropin by the bovine adenohypophysis โ€ฆ
  510. CORTICOTROPIN โ€“RELEASING FACTOR secretion increases in rat hypophysial portal blood during insulin-induced hypoglycemia
  511. CORTICOTROPIN โ€“RELEASING FACTOR levels in the peripheral plasma and hypothalamus of the rat vary in parallel with changes in the pituitary-adrenal axis
  512. CORTICOTROPIN RELEASING FACTOR activity of CRF 41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin
  513. CORTICOTROPIN โ€“RELEASING FACTOR stimulates phospholipid methylation and CORTICOTROPIN secretion in mouse pituitary tumor cells
  514. Thyrotropin-RELEASING FACTOR -induced adrenoCORTICOTROPIN secretion is mediated by CORTICOTROPIN โ€“RELEASING FACTOR .
  515. High molecular weight peptide with CORTICOTROPIN โ€“RELEASING FACTOR activity from porcine hypothalami
  516. Immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders
  517. Edinger-Westphal nucleus: cells that project to spinal cord contain CORTICOTROPIN โ€“RELEASING FACTOR
  518. โ€ฆ in vivo release of opioid peptides and luteinizing hormone-RELEASING hormone from the hypothalamus following blockade of receptors for CORTICOTROPIN โ€“RELEASING FACTOR
  519. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in intermediate lobe of the pituitary: biochemical characterization and autoradiographic localization
  520. AdrenoCORTICOTROPIN responses to CORTICOTROPIN RELEASING FACTOR and vasopressin in spontaneously hypertensive rats.
  521. Segmental distribution of CORTICOTROPIN โ€“RELEASING FACTOR -like and vasoactive intestinal peptide-like immunoreactivities in presumptive sympathetic preganglionic โ€ฆ
  522. โ€ฆ intestinal polypeptideimmunoreactive neurons in the central nervous system with special reference to their relation to CORTICOTROPIN RELEASING FACTOR -and enkephalin-like โ€ฆ
  523. Sequence analysis of rat hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR with the o-phthalaldehyde strategy
  524. AdrenoCORTICOTROPIN and cortisol responses to ovine CORTICOTROPIN โ€“RELEASING FACTOR in alcohol dependence disorder
  525. Immunohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR -and arginine vasotocin-like immunoreactivities in the brain and pituitary of the American bullfrog โ€ฆ
  526. Effect of pharmacological adrenalectomy on CORTICOTROPIN โ€“RELEASING FACTOR -like and arginine vasotocin immunoreactivities in the brain and pituitary of the eel โ€ฆ
  527. Immimohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR in selected brain areas of the European starling (Sturnus vulgaris) and the song sparrow (Melospiza โ€ฆ
  528. CORTICOTROPIN RELEASING FACTOR -like immunoreactive neurons in the rat retina
  529. Distribution of CORTICOTROPIN โ€RELEASING FACTOR in the cerebellum and precerbellar nuclei of the opossum: A study utilizing immunohistochemistry, In situ hybridization โ€ฆ
  530. Coesxistence of CORTICOTROPIN RELEASING FACTOR and enkephalin in cerebellar afferent systems
  531. Functional CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in mouse spleen: evidence from adenylate cyclase studies
  532. CORTICOTROPIN โ€“RELEASING FACTOR inhibits the response of trigeminal neurons to noxious heat
  533. Pituitary-adrenal responses to ovine CORTICOTROPIN โ€“RELEASING FACTOR in polycystic ovary syndrome and in other hyperandrogenic patients
  534. Stimulation of CORTICOTROPIN release by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) or by vasopressin following intrapituitary infusions in unanesthetized dogs: inhibition of the โ€ฆ
  535. On the Presence in Hog Hypothalamus of (ฮฒ-CORTICOTROPIN RELEASING FACTOR , ฮฑ- and (ฮฒ-Melanocyte Stimulating Hormones, AdrenoCORTICOTROPIN , Lysine-Vasopressin โ€ฆ
  536. Immunoreactive CORTICOTROPIN RELEASING FACTOR (CRF) and vasopressin are colocalized in a subpopulation of the immunoreactive vasopressin cells in the โ€ฆ
  537. Effect of dexamethasone on immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in the rat median eminence and intermediate-posterior pituitary
  538. Dissociation of locus coeruleus activity and blood pressure: effects of clonidine and CORTICOTROPIN โ€“RELEASING FACTOR
  539. Molecular mechanisms of CORTICOTROPIN โ€“RELEASING FACTOR stimulation of calcium mobilization and adrenoCORTICOTROPIN release from anterior pituitary tumor cells.
  540. The antagonistic effect of CORTICOTROPIN โ€“RELEASING FACTOR on pentobarbital in rats
  541. Inhibition of gastric motor function by circulating CORTICOTROPIN โ€RELEASING FACTOR in anesthetized rats
  542. Coexistence of CORTICOTROPIN RELEASING FACTOR and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat
  543. Assays and dynamics of CORTICOTROPIN โ€“RELEASING FACTOR activity in rat hypothalamus.
  544. Re-evaluation of a technique of pituitary incubation in vitro as an assay for CORTICOTROPIN RELEASING FACTOR
  545. Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by CORTICOTROPIN โ€“RELEASING FACTOR
  546. Circadian rhythm of CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in rat hypothalamus
  547. CORTICOTROPIN โ€“RELEASING FACTOR mRNA is expressed in the inferior olives of rodents and primates
  548. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on plasma motilin and somatostatin levels and gastrointestinal motility in dogs
  549. โ€ฆ and ฮฒ-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR
  550. CORTICOTROPIN โ€RELEASING FACTOR (CRF) stimulates locomotor activity in intact and hypophysectomized newts (Amphibia)
  551. CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive neurons persist throughout the brain in Alzheimerโ€™s disease
  552. Increased CORTICOTROPIN โ€“RELEASING FACTOR receptors in rat cerebral cortex following chronic atropine treatment
  553. Effects of adrenergic blockers on CORTICOTROPIN โ€“RELEASING FACTOR -induced behavioral changes in rats
  554. CORTICOTROPIN RELEASING FACTOR (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis
  555. CORTICOTROPIN โ€“RELEASING FACTOR : its action on the islets of Langerhans
  556. Sauvagine-like and CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the brain of the bullfrog (Rana catesbeiana)
  557. Synergism between systemic CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin on adrenoCORTICOTROPIN release in vivo varies as a function of gestational age in โ€ฆ
  558. The effect of ovine CORTICOTROPIN โ€“RELEASING FACTOR on catecholamine, vasopressin, and aldosterone secretion in normal man
  559. Isolation and Amino Acid Sequence of ฮฑ2-CORTICOTROPIN โ€“RELEASING FACTOR (ฮฑ2-CRF) from Hog Pituitary Glands
  560. CORTICOTROPIN โ€“RELEASING FACTOR in olivocerebellar climbing-fiber system of monkey (Saimiri sciureus and Macaca fascicularis): parasagittal and regional organization โ€ฆ
  561. Immunocytochemical localization and spatial relation to the adenohypophysis of a somatostatin-like and a CORTICOTROPIN โ€“RELEASING FACTOR -like peptide in the brain of four โ€ฆ
  562. Co-localization of CORTICOTROPIN โ€“RELEASING FACTOR -and enkephalin-like immunoreactivities in nerve cells of the rat hypothalamus and adjacent areas
  563. Presence of CORTICOTROPIN โ€RELEASING FACTOR โ€like immunoreactivity in human tumors
  564. The effects of adrenalectomy, CORTICOTROPIN RELEASING FACTOR and vasopressin on the sympathetic firing rate of nerves to interscapular brown adipose tissue in the Zucker โ€ฆ
  565. Immunohistochemical localization of urotensin I/CORTICOTROPIN โ€RELEASING FACTOR , urotensin II, and serotonin immunoreactivities in the caudal spinal cord of nonteleost โ€ฆ
  566. Differential regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptors in anterior and intermediate lobes of pituitary and in brain following adrenalectomy in rats
  567. Effect of axonal transport blockade on CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship โ€ฆ
  568. Concentration of CORTICOTROPIN RELEASING FACTOR by chromatography on carboxymethylcellulose
  569. Reduction in brain immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in spontaneously hypertensive rats
  570. Protein kinase C potentiates CORTICOTROPIN RELEASING FACTOR stimulated cyclic AMP in pituitary
  571. Dissociation of the adrenoCORTICOTROPIN secretory responses to CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and vasopressin or oxytocin by using a specific cytotoxic analog of โ€ฆ
  572. CORTICOTROPIN RELEASING FACTOR increases the adrenocortical responsiveness to adrenoCORTICOTROPIN
  573. CORTICOTROPIN โ€“RELEASING FACTOR in the amacrine cells of the chicken retina.
  574. The effects of CORTICOTROPIN RELEASING FACTOR on the anterior pituitary function of stalk-sectioned cynomdlgus macaques: Dose response of cortisol secretion
  575. Synthetic CORTICOTROPIN โ€“RELEASING FACTOR stimulates secretion of immunoreactive ฮฒ-endorphin/ฮฒ-lipotropin and ACTH by human fetal pituitaries in vitro
  576. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on central respiratory activity
  577. โ€ฆ specificity for stimulation of CORTICOTROPIN secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and CORTICOTROPIN โ€“RELEASING FACTOR
  578. Inhibitory effect of norepinephrine on immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR release from the rat hypothalamus in vitro
  579. Pituitary-adrenal responses to CORTICOTROPIN โ€“RELEASING FACTOR in late onset 21-hydroxylase deficiency
  580. CORTICOTROPIN โ€“RELEASING FACTOR and adrenal function in major depression
  581. Metabolic clearance rate and plasma half-life of radioiodinated CORTICOTROPIN RELEASING FACTOR in a primate
  582. Does CORTICOTROPIN RELEASING FACTOR act via a calcium-dependent mechanism?
  583. โ€ฆ ADENOMAS THAT CAUSED CUSHINCโ€™S DISEASE OR NELSONโ€™S SYNDROME ARE NOT RESPONSIVE TO OVINE CORTICOTROPIN โ€“RELEASING FACTOR IN โ€ฆ
  584. Stimulatory effect of acetylcholine on immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR release from the rat hypothalamus in vitro
  585. Arginine vasopressin, but not CORTICOTROPIN RELEASING FACTOR , is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment
  586. Effects and pharmacokinetic properties of the rat/human CORTICOTROPIN โ€“RELEASING FACTOR in rhesus monkeys
  587. Effects of CORTICOTROPIN โ€“RELEASING FACTOR and Other Materials on AdrenoCORTICOTROPIN Secretion from Pituitary Glands of Patients with Cushingโ€™s Disease in Vitro
  588. Brain CORTICOTROPIN โ€“RELEASING FACTOR and development
  589. Cord blood levels of CORTICOTROPIN โ€“RELEASING FACTOR
  590. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered CORTICOTROPIN โ€“RELEASING FACTOR in mice.
  591. CORTICOTROPIN RELEASING FACTOR receptors: characterization and actions in the anterior pituitary gland
  592. Effect of atrial natriuretic peptide on acethylcholine-induced release of CORTICOTROPIN โ€“RELEASING FACTOR from rat hypothalamus in vitro
  593. Interaction of vasoactive intestinal peptide (VIP) and growth hormone RELEASING FACTOR (GRF) with CORTICOTROPIN RELEASING FACTOR (CRF) on CORTICOTROPIN secretion in vitro
  594. A system of CORTICOTROPIN RELEASING FACTOR -containing amacrine cells in the rat retina
  595. CORTICOTROPIN โ€“RELEASING FACTOR differentially regulates proopiomelanocortin messenger ribonucleic acid levels in anterior as compared to intermediate pituitary lobes of โ€ฆ
  596. Immunohistochemical identification of CORTICOTROPIN RELEASING FACTOR -containing neurons projecting to the stalk-median eminence of the rat
  597. Repetitive and continuous administration of human CORTICOTROPIN RELEASING FACTOR to human subjects
  598. Identification of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF
  599. The brain CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor is of lower apparent molecular weight than the CRF receptor in anterior pituitary. Evidence from chemical cross โ€ฆ
  600. The Role of CORTICOTROPIN โ€RELEASING FACTOR in Rat Gastric Ulcerogenesis
  601. CORTICOTROPIN โ€“RELEASING FACTOR and forskolin increase proopiomelanocortin messenger RNA levels in rat anterior and intermediate cells in vitro
  602. Neonatal peptides affect developing rats: ฮฒ-endorphin alters nociception and opiate receptors, CORTICOTROPIN โ€“RELEASING FACTOR alters corticosterone
  603. CORTICOTROPIN โ€“RELEASING FACTOR release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine
  604. An in vitro assay for CORTICOTROPIN RELEASING FACTOR (s) using suspensions of isolated pituitary cells
  605. Medroxyprogesterone acetate lowers plasma CORTICOTROPIN and cortisol but does not suppress anterior pituitary responsiveness to human CORTICOTROPIN RELEASING FACTOR
  606. Multiple endocrine neoplasia with Cushingโ€™s syndrome due to paraganglioma producing CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN
  607. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on the electrical and mechanical activities of the guinea-pig ventricular myocardium.
  608. Interaction of synthetic ovine CORTICOTROPIN RELEASING FACTOR and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats
  609. Identification of a CORTICOTROPIN โ€“RELEASING FACTOR -binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone
  610. CORTICOTROPIN โ€“RELEASING FACTOR antagonist attenuates defensive-withdrawal behavior elicited by odors of stressed conspecifics.
  611. Characterization and modulation of CORTICOTROPIN โ€“RELEASING FACTOR in the neurointermediate pituitary gland
  612. Effect of Histamine, Hog Vasopressin, and CORTICOTROPIN โ€“RELEASING FACTOR (GRF) on AGTH Release in vitro
  613. Amacrine and ganglion cells with CORTICOTROPIN โ€RELEASING โ€FACTOR โ€like immunoreactivity in the turtle retina
  614. The Effect of Various CORTICOTROPIN โ€“RELEASING FACTOR Trains on the Release of AdrenoCORTICOTROPIN , ฮฒ-Endorphin, and ฮฒ-Lipotropin from Perifused Ovine Pituitary โ€ฆ
  615. Electrical Properties of Cultured Human AdrenoCORTICOTROPIN -Secreting Adenoma Cells: Effects of High K+, CORTICOTROPIN โ€“RELEASING FACTOR , and Angiotensin II
  616. Acute inflammatory response of the rat pawskin to acid injury is attenuated by CORTICOTROPIN โ€“RELEASING FACTOR
  617. CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in post-mortem brain from depressed suicides
  618. Stress-related behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR
  619. Modulation by CORTICOTROPIN โ€“RELEASING FACTOR of monoamine metabolism in the lateral hypothalamus
  620. Vasopressin-containing and vasopressin-deficient subpopulations of CORTICOTROPIN โ€“RELEASING FACTOR axons are differentially affected by adrenalectomy
  621. Ontogenetic development of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-containing neural elements in the brain of the chicken during incubation and after hatching
  622. Development of the hypothalamic-pituitary-axis in the ovine fetus: ontogeny of action of ovine CORTICOTROPIN โ€“RELEASING FACTOR .
  623. Immunocytochemical detection of CORTICOTROPIN โ€“RELEASING FACTOR : multiple cross-reactions of a widely used carboxy-terminally directed CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  624. Gastrointestinal secretory, motor and circulatory effects of CORTICOTROPIN RELEASING FACTOR (CRF)
  625. Comparative localization of neurons containing ovine CORTICOTROPIN RELEASING FACTOR (CRF)โ€like and neurophysinโ€like immunoreactivity in the diencephalon of the โ€ฆ
  626. โ€ฆ corticoliberin hypothalamic neuroglandular system: comparative immunocytochemical study with anti-rat and anti-ovine CORTICOTROPIN โ€“RELEASING FACTOR sera in the early โ€ฆ
  627. Role of CORTICOTROPIN โ€“RELEASING FACTOR in neuropsychiatric disorders and neurodegenerative diseases
  628. Acute and chronic effects of CORTICOTROPIN โ€“RELEASING FACTOR on schedule-controlled responding and neurochemistry of pigeons.
  629. Oxytocin: major CORTICOTROPIN โ€“RELEASING FACTOR secreted from diabetes insipidus rat posterior pituitary in vitro
  630. High-performance liquid chromatographic purification of peptide hormones: ovine hypothalamic amunine (CORTICOTROPIN RELEASING FACTOR )
  631. The intestinal peptide PHI-27 potentiates the action of CORTICOTROPIN โ€“RELEASING FACTOR on ACTH release from rat pituitary fragments in vitro.
  632. Control of ACTH secretion by CORTICOTROPIN โ€“RELEASING FACTOR (s)
  633. Convulsant peptides related to CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  634. CORTICOTROPIN RELEASING FACTOR stimulation of protein carboxylmethylation in mouse pituitary tumor cells
  635. Effects of synthetic CORTICOTROPIN โ€“RELEASING FACTOR and dopamine on the release of immunoreactive ฮฒ-endorphin/ฮฒ-lipotropin and ฮฑ-melanocyte-stimulating hormone โ€ฆ
  636. Catecholaminergic innervation of neurons containing CORTICOTROPIN โ€“RELEASING FACTOR in the paraventricular nucleus of the rat hypothalamus
  637. Vasopressin responses to CORTICOTROPIN RELEASING FACTOR and hyperosmolality in conscious dogs
  638. Organization of ovine CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive neurons in the canine hypothalamo-pituitary system
  639. Immunohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-containing neurons in the hypothalamus of the Japanese quail, Coturnix coturnix
  640. Physiological concentrations of atrial natriuretic FACTOR s with intact N-terminal sequences inhibit CORTICOTROPIN โ€“RELEASING FACTOR -stimulated adrenoCORTICOTROPIN secretion โ€ฆ
  641. Ovine CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin: antibody-quenching studies on hypothalamic extracts of normal and Brattleboro rats
  642. Immunoelectron microscopic study of CORTICOTROPIN โ€“RELEASING FACTOR in the human hypothalamus and pituitary gland
  643. Plasma adrenoCORTICOTROPIN and cortisol responses to ovine CORTICOTROPIN โ€“RELEASING FACTOR in patients with adrenocortical insufficiency due to hypothalamic and pituitary โ€ฆ
  644. Characterization of CORTICOTROPIN โ€“RELEASING FACTOR receptors in dissociated brain cell cultures
  645. Assessment of CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin and somatostatin secretion by fetal hypothalamic neurons in culture
  646. Plasma adrenoCORTICOTROPIN , cortisol, and dehydroepiandrosterone response to CORTICOTROPIN โ€“RELEASING FACTOR in normal children during pubertal development
  647. Regulation of hypothalamic-endorphin and dynorphin release by CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  648. Immunocytochemical ultrastructural study of hypothalamic neurons containing CORTICOTROPIN โ€“RELEASING FACTOR in normal and adrenalectomized rats
  649. CORTICOTROPIN โ€“RELEASING FACTOR , stress and arousal
  650. Stimulation of ฮฒ-endorphin secretion by CORTICOTROPIN โ€“RELEASING FACTOR in primary rat leydig cell cultures
  651. Behavioral pharmacology of stress: Focus on CNS CORTICOTROPIN โ€“RELEASING FACTOR
  652. Differential influences of CORTICOTROPIN โ€“RELEASING FACTOR on memory retention of aversive learning and appetitive learning in rats
  653. Arginine vasopressin and CORTICOTROPIN RELEASING FACTOR : binding to ovine anterior pituitary membranes
  654. CORTICOTROPIN โ€“RELEASING FACTOR antagonist blocks microwave-induced decreases in high-affinity choline uptake in the rat brain
  655. Dynamic changes in the hypothalamic content of CORTICOTROPIN RELEASING FACTOR following noxious stimuli: delayed response in early neonates in comparison with โ€ฆ
  656. Increased ACTH response to CORTICOTROPIN โ€“RELEASING FACTOR in cold-adapted rats in vivo
  657. Immunocytochemical observations of CORTICOTROPIN โ€“RELEASING โ€“FACTOR -containing neurons in the rat hypothalamus with special reference to neuronal communication
  658. CORTICOTROPIN โ€“RELEASING FACTOR can stimulate gonadotropin secretion by human fetal pituitaries in superfusion
  659. The action of hypothalamic and placental CORTICOTROPIN RELEASING FACTOR on the corticotrope
  660. Ultrastructural alterations of the paraventriculo-infundibular CORTICOTROPIN RELEASING FACTOR (CRF)-immunoreactive neuronal system in long term adrenalectomized rats
  661. CORTICOTROPIN โ€“RELEASING FACTOR -induced adrenocorticotropic hormone release in the sheep fetus: blockade by cortisol
  662. Immunohistochemical demonstration of CORTICOTROPIN RELEASING FACTOR containing nerve fibers in the median eminence of the rat and monkey
  663. Synthesis and biological properties of ovine CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  664. CORTICOTROPIN โ€“RELEASING FACTOR neurons innervate dopamine neurons in the periventricular hypothalamus of juvenile macaques
  665. Comparative immunoelectron microscopic localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF-41) and oxytocin in the rat median eminence
  666. Posttranslational processing of CORTICOTROPIN โ€“RELEASING FACTOR in the ovine tuberoinfundibular system and pituitary.
  667. Quantitative immunocytochemistry of CORTICOTROPIN โ€“RELEASING FACTOR (CRF). Studies on nonbiological models and on hypothalamic tissues of rats after hypophysectomy โ€ฆ
  668. Decreased CORTICOTROPIN โ€“RELEASING FACTOR -Like Immunoreactivity in Rat Intermediate and Posterior Pituitary after Stalk Secretion
  669. The Effect of Serotonin Agonist 1-(Trifluoromethylphenly)-piperazine on CORTICOTROPIN RELEASING FACTOR and Arginine Vasopressin in Rat Hypothalamic Nuclei
  670. Desensitization of Superfused Isolated Ovine Anterior Pituitary Cells to Human CORTICOTROPIN โ€RELEASING FACTOR
  671. Brain noradrenergic neurons, CORTICOTROPIN โ€“RELEASING FACTOR , and stress
  672. Evidence for CORTICOTROPIN RELEASING FACTOR and Leu-enkephalin in the neural projection from the lateral parabrachial nucleus to the median preoptic nucleus: a โ€ฆ
  673. Cerebrospinal fluid concentrations of neurotensin and CORTICOTROPIN โ€“RELEASING FACTOR in pediatric patients
  674. Brain CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and catecholamine responses in acutely stressed rats
  675. CORTICOTROPIN โ€“RELEASING FACTOR immunostaining in the rat spinal cord and medulla oblongata: an unexpected form of cross-reactivity with substance P
  676. Intravenous application of ovine and human CORTICOTROPIN RELEASING FACTOR (CRF): ACTH, cortisol and CRF levels
  677. Effects of morphine on hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF), norepinephrine and dopamine in non-stressed and stressed rats.
  678. Plasma corticosterone and restraint induced gastric pathology: age-related differences after administration of CORTICOTROPIN RELEASING FACTOR
  679. Nigrostriatal dopamine mediates the stimulatory effects of CORTICOTROPIN RELEASING FACTOR on methionine-enkephalin and dynorphin release from the rat neostriatum
  680. In vivo potentiation of CORTICOTROPIN RELEASING FACTOR activity by vasopressin analogues
  681. CORTICOTROPIN RELEASING FACTOR (CRF): Diagnostic implications
  682. Circulating CORTICOTROPIN โ€“RELEASING FACTOR in pregnancy
  683. Calcium-Independent and Calcium-Dependent Mechanisms; Regulate CORTICOTROPIN โ€“RELEASING FACTOR -Stimulated Proopiomelanocortin Peptide Secretion and โ€ฆ
  684. Purification and characterization of peptides with CORTICOTROPIN โ€“RELEASING FACTOR activity from porcine hypothalami
  685. Solid phase synthesis of ovine CORTICOTROPIN RELEASING FACTOR
  686. โ€ฆ ฮฒ-endorphin-immunoreactivity from rat pituitary and hypothalamus in vitro: Effects of isoproterenol, dopamine, CORTICOTROPIN โ€“RELEASING FACTOR and agrinine8-vasopressin
  687. Plasma ACTH-response to the CORTICOTROPIN RELEASING FACTOR in patients with Cushingโ€™s disease. Comparison with the lysine-vasopressin test
  688. CORTICOTROPIN โ€“RELEASING FACTOR : Central nervous system effects on the sympathetic nervous system and cardiovascular regulation
  689. Central effects of CORTICOTROPIN RELEASING FACTOR (CRF): evidence for similar interactions with environmental novelty and with caffeine
  690. Role of cyclic AMP in CORTICOTROPIN RELEASING FACTOR mediated ACTH release
  691. Site of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) RELEASING elements: effect of lesions on ACTH release and adenohypophysial blood flow
  692. CORTICOTROPIN โ€“RELEASING FACTOR -containing afferents to the inferior colliculus of the rat brain
  693. Interactions of CORTICOTROPIN โ€“RELEASING FACTOR with antidepressant and anxiolytic drugs: behavioral studies with pigeons
  694. โ€ฆ -C in the adrenoCORTICOTROPIN secretory response to arginine vasopressin (AVP) and the synergistic response to AVP and CORTICOTROPIN โ€“RELEASING FACTOR by perifused rat โ€ฆ
  695. โ€ฆ in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic CORTICOTROPIN RELEASING FACTOR (CRF โ€ฆ
  696. Some endorphin derivatives and hydrocortisone prevent EEG limbic seizures induced by CORTICOTROPIN โ€RELEASING FACTOR in rabbits
  697. Lack of correlation between immunoreactive CORTICOTROPIN โ€RELEASING FACTOR concentration profiles in hypophysialโ€portal and peripheral plasma
  698. CORTICOTROPIN โ€“RELEASING FACTOR (CRF): stimulation in normal controls and in patients with Cushingโ€™s syndrome
  699. CORTICOTROPIN โ€“RELEASING FACTOR receptors in the rabbit brain visualized by in vitro autoradiography
  700. The coexistence of oxytocin and CORTICOTROPIN โ€“RELEASING FACTOR in the hypothalamus: an immunocytochemical study in the rat, sheep and hedgehog
  701. CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity, arginine vasopressin-like immunoreactivity and ACTH-RELEASING bioactivity in hypothalamic tissue from fetal and โ€ฆ
  702. Effects of CORTICOTROPIN RELEASING FACTOR and Growth Hormone RELEASING FACTOR on Pituitary Hormone Secretion in Patients with Congenital Thyrotropin Deficiency.
  703. Pseudo-Cushingโ€™s syndrome: an example of alcohol-induced central disorder in CORTICOTROPIN โ€“RELEASING FACTOR -ACTH release?
  704. In pregnancy, CORTICOTROPIN โ€“RELEASING โ€“FACTOR in maternal blood and amniotic fluid correlates with the gestational age.
  705. Immunohistochemical localization of CORTICOTROPIN RELEASING FACTOR (CRF) in the hypothalamus of the squirrel monkey, Saimiri sciureus
  706. CORTICOTROPIN โ€“RELEASING FACTOR inhibits insulin release from perfused rat pancreas
  707. Immunoreactive CORTICOTROPIN RELEASING FACTOR in adult and developing rat cerebellum: its presence in climbing and mossy fibres.
  708. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and neurotransmitters modulate melanotropic peptide release from rat neurointermediate pituitary in vitro
  709. Rat hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) content remains constant despite marked acute or chronic changes in ACTH secretion
  710. Vagal mediation of CORTICOTROPIN โ€“RELEASING โ€“FACTOR -induced increase in insulinemia in lean and genetically obese fa/fa rats
  711. โ€ฆ of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  712. The role of calcium in the mechanism of CORTICOTROPIN RELEASING FACTOR mediated ACTH release
  713. The effects of cortisol, vasopressin (AVP), and CORTICOTROPIN โ€“RELEASING FACTOR administration on pulsatile adrenoCORTICOTROPIN , ฮฑ-melanocyte-stimulating hormone, and โ€ฆ
  714. Site of calcium requirement for stimulation of ACTH release in rat anterior pituitary cells in culture by synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR
  715. Osmotic stimulation affects neurohypophysial CORTICOTROPIN RELEASING FACTOR -41 content: effect of dexamethasone
  716. CORTICOTROPIN โ€“RELEASING FACTOR acts on the brain to reduce gastric contractility
  717. Immunohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the hypothalamus of the newt, Triturus cristatus
  718. Effect of passive immunization against CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on the postadrenalectomy changes of CRF binding sites in the rat anterior pituitary gland
  719. Uptake of a monoclonal antibody to CORTICOTROPIN โ€“RELEASING FACTOR (CRF) into rat hypothalamic neurons
  720. Coexistence of urotensin I/CORTICOTROPIN โ€“RELEASING FACTOR and urotensin II immunoreactivities in cells of the caudal neurosecretory system of a teleost and an โ€ฆ
  721. Immunohistochemical localization of urotensin I/CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in neurosecretory neurons in the caudal spinal cord of fish
  722. CORTICOTROPIN โ€“RELEASING FACTOR activates tyrosine hydroxylase in rat and mouse striatal homogenates
  723. Cytological responses of the pituitary (rostral pars distalis) and immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the goldfish treated with dopamine antagonists
  724. Histogenesis of CORTICOTROPIN RELEASING FACTOR -like immunoreactive amacrine cells in the rat retina
  725. A model of the distribution and metabolism of CORTICOTROPIN โ€“RELEASING FACTOR
  726. Characterization of PGE2 inhibition of CORTICOTROPIN RELEASING FACTOR -mediated ACTH release
  727. Cerebrospinal fluid CORTICOTROPIN โ€RELEASING FACTOR levels and stimulation test in dementia of the Alzheimer type
  728. Effects of endorphin derivatives on the EEG alterations induced by CORTICOTROPIN RELEASING FACTOR in the rabbit hippocampus
  729. Effects of angiotensin II blockade on the responses of the pituitary-adrenal axis to CORTICOTROPIN โ€“RELEASING FACTOR in humans.
  730. Circulating CORTICOTROPIN RELEASING FACTOR -like activity in man
  731. Acetylcholine stimulates the secretion of CORTICOTROPIN โ€“RELEASING FACTOR from primary dissociated cell cultures of the rat telencephalon and diencephalon
  732. Fluorescent and cytotoxic analogs of CORTICOTROPIN โ€“RELEASING FACTOR : probes for studying target cells in heterogeneous populations
  733. Levels of CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in mammalian hypothalamic and extrahypothalamic brain tissue as determined with a monoclonal โ€ฆ
  734. Comparison of CORTICOTROPIN โ€“RELEASING FACTOR and acetylcholine on catecholamine secretion in dogs
  735. Normal pattern of labeling of cerebral cortical CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in Alzheimerโ€™s disease: evidence from chemical cross-linking studies
  736. Reduced lumbar cerebrospinal fluid CORTICOTROPIN RELEASING FACTOR (CRF) levels in amyotrophic lateral sclerosis
  737. Presence of CORTICOTROPIN โ€RELEASING FACTOR โ€Stimulated Adenylate Cyclase Activity in Rat Retina
  738. Synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR stimulates adrenoCORTICOTROPIN release in the ovine fetus over the last fifth of gestation
  739. Colocalization of peptide histidine isoleucine amine and CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in neurons of the rat hypothalamus: a surprising artefact
  740. CORTICOTROPIN โ€“RELEASING FACTOR : Immunohistochemical co-localization with adrenoCORTICOTROPIN and ฮฒ-endorphin, but not with Met-enkephalin, in subpopulations of โ€ฆ
  741. Atrial natriuretic peptide does not affect CORTICOTROPIN โ€“RELEASING FACTOR -, arginine vasopressin-and angiotensin II-induced adrenocorticotropic hormone release in vivo or โ€ฆ
  742. Antidepressants modulate the CNS effects of CORTICOTROPIN RELEASING FACTOR in rats.
  743. Intrahypothalamic microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR elevates blood glucose and free fatty acids in rats
  744. Localization of CORTICOTROPIN โ€RELEASING FACTOR , somatostatin, and vasoactive intestinal polypeptide in the parabrachial nuclei of the human brain
  745. Lack of effect of CORTICOTROPIN RELEASING FACTOR on hypothalamic dopamine and serotonin synthesis turnover rates in rats
  746. Postnatal development of CORTICOTROPIN RELEASING FACTOR -like immunoreactive amacrine cells in the rat retina
  747. Effects of intracerebroventricular administration of ovine CORTICOTROPIN โ€“RELEASING FACTOR (CRF 1โ€“41) on passive avoidance behaviour: lack of influence on monoamine โ€ฆ
  748. Distribution, biosynthesis, and physiological role of CORTICOTROPIN โ€“RELEASING FACTOR in the human: an overview.
  749. Glucocorticoid modulation of CORTICOTROPIN โ€“RELEASING FACTOR desensitization in cultured rat anterior pituitary cells
  750. CORTICOTROPIN RELEASING FACTOR
  751. CORTICOTROPIN RELEASING FACTOR OF DIABETES INSIPIDUS RATS: EFFECTS OF PARAVENTICULAR NUCLEI LESIONS
  752. Stimulus-induced CORTICOTROPIN โ€“RELEASING FACTOR content and adrenoCORTICOTROPIN release are augmented after unilateral adrenalectomy, independently of circulating โ€ฆ
  753. Effect of ovine CORTICOTROPIN RELEASING FACTOR and arginine vasopressin on ACTH and aldosterone secretion in sheep
  754. Demonstration of CORTICOTROPIN โ€“RELEASING FACTOR binding sites on human and rat erythrocyte membranes and their modulation by chronic ethanol treatment in rats
  755. Stimulation of insulin secretion by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in anesthetized rats
  756. Phorbol esters and CORTICOTROPIN RELEASING FACTOR stimulate calcium influx in the anterior pituitary tumor cell line, AtT-20, through different intracellular sites of action.
  757. Endocytosis of the vasopressin receptor by anterior pituitary cells is increased by CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  758. Peripheral acid inhibitory action of CORTICOTROPIN RELEASING FACTOR : mediation by nongastric mechanisms
  759. Pituitary and adrenal responses to pulsatile ovine CORTICOTROPIN โ€“RELEASING FACTOR administered to fetal sheep
  760. Abnormal response of adrenoCORTICOTROPIN to CORTICOTROPIN RELEASING FACTOR in spontaneously hypertensive rats
  761. The origin and ultrastructural characteristics of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-immunoreactive nerve fibers in the posterior pituitary of the rat
  762. Solidโ€phase synthesis and some biological properties of ovine CORTICOTROPIN โ€RELEASING FACTOR
  763. Colocalization of CORTICOTROPIN โ€“RELEASING FACTOR /urotensin I and urotensin 2 in the caudal neurosecretory neurons in the carp, Cyprinus carpio (Communication)
  764. Synergistic interaction of CORTICOTROPIN RELEASING FACTOR and arginine vasopressin on adrenoCORTICOTROPIN and cortisol secretion in Macaca fuscata.
  765. Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonist
  766. Responses of plasma adrenoCORTICOTROPIN and cortisol to intravenous injection of synthetic ovine CORTICOTROPIN RELEASING FACTOR in the morning and early evening in โ€ฆ
  767. Conversion of high molecular weight CRF (CORTICOTROPIN โ€“RELEASING FACTOR ) or PRF (prolactin-RELEASING FACTOR ) into lower molecular weight forms by boiling at low pH
  768. Solubilization of high affinity CORTICOTROPIN โ€“RELEASING FACTOR receptors from rat brain: characterization of an active digitonin-solubilized receptor complex
  769. Effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF), tuftsin and dermorphin on behavior of squirrel monkeys maintained by different events
  770. Immunohistochemical identification of the CORTICOTROPIN RELEASING FACTOR (CRF)-containing nerve fibers in the pig hypophysis, with special reference to the relationship โ€ฆ
  771. Somatostatin Inhibits CORTICOTROPIN โ€“RELEASING FACTOR -Stimulated Adrenocorticoropin Release, Adenylate Cyclase, and Activation of Adenosine 3โ€ฒ, 5 โ€ฆ
  772. CORTICOTROPIN โ€“RELEASING FACTOR receptors in the brain and pituitary: their role in the stress response
  773. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on adrenal DBH and PNMT activity
  774. Perinatal thiouracil exposure depresses CORTICOTROPIN โ€“RELEASING FACTOR activity in 15 day old rats
  775. Effects of Synthetic CORTICOTROPIN โ€RELEASING FACTOR in Normal Individuals and in Patients with Hypothalamicโ€pituitaryโ€adrenocortical Disorders
  776. Evidence for CORTICOTROPIN RELEASING FACTOR (CRF) synthesis in the preoptic nucleus of Xenopus laevis tadpoles
  777. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-immunoreactive neurons in the mammillary body of the rat
  778. Effect of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR on growth hormone secretion in patients with acromegaly
  779. Immunological detection of proโ€CORTICOTROPIN RELEASING FACTOR (CRF) in rat hypothalamus and pancreatic extracts: Evidence for in vitro conversion into CRF
  780. On thein vitro CORTICOTROPIN RELEASING FACTOR (CRF) activity of the heptapeptide: Methionyl-glutaminyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycine
  781. Plasma ACTH, cortisol and aldosterone concentrations in chronically cannulated ovine fetuses and in lambs injected with ovine CORTICOTROPIN RELEASING FACTOR .
  782. Effect of morphine on hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and pituitary-adrenocortical activity
  783. Effect of angiotensin II, catecholamines and glucocorticoid on CORTICOTROPIN RELEASING FACTOR (CRF)-induced ACTH release in pituitary cell cultures.
  784. On the subcellular localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the rat median eminence
  785. Preclinical and clinical evidence for the involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the pathogenesis of depression
  786. The Paraventriculo-Infundibular CORTICOTROPIN RELEASING FACTOR (CRF)โ€”Immunoreactive System of the Ratโ€”I. Morphological Aspects
  787. Studies on the tissue distribution and stability of โ€œbigโ€ CRF (CORTICOTROPIN โ€“RELEASING FACTOR )
  788. Gamma-melanotropin response to ovine CORTICOTROPIN RELEASING FACTOR in normal humans
  789. CORTICOTROPIN โ€“RELEASING FACTOR potentiates the contractile response of rabbit airway smooth muscle to electrical field stimulation but not to acetylcholine
  790. Effect of hypophysectomy on the hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neuronal system in the eel: immunocytochemical study
  791. โ€ฆ delta sleep-inducing peptide secretion from mouse dissociated, anterior pituitary cells: Regulation by CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin
  792. Effects of bromocriptine and cyproheptadine on basal and CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced ACTH release in a patient with Nelsonโ€™s syndrome
  793. Stimulation of synaptosomal dopamine synthesis by CORTICOTROPIN โ€“RELEASING FACTOR in rat striatum: role of Ca2+-dependent mechanisms
  794. Neuropeptides and neurotransmitters involved in regulation of CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the rat
  795. Evidence for the existence of a CORTICOTROPIN โ€“RELEASING FACTOR in the pigeon hypothalamus
  796. โ€ฆ adrenoCORTICOTROPIN , ฮฒ-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic CORTICOTROPIN โ€“RELEASING FACTOR and lysine vasopressin
  797. Demonstration that CORTICOTROPIN โ€“RELEASING FACTOR binding to rat peripheral tissues is modulated by glucocorticoid treatment in vivo and in vitro
  798. Characterization of CORTICOTROPIN RELEASING FACTOR (CRF) and arginine vasopressin in median eminence extracts on sephadex gel-filtration
  799. Human CORTICOTROPIN โ€“RELEASING FACTOR plus lysine vasopressin test during glucocorticoid therapy.
  800. Preclinical and clinical investigations of CORTICOTROPIN โ€“RELEASING FACTOR : Assessment of its role in depressive disorders
  801. CORTICOTROPIN โ€“RELEASING FACTOR : central regulation of autonomic nervous and visceral function
  802. Interactions between tumor necrosis FACTOR -ฮฑ, hypothalamic CORTICOTROPIN โ€“RELEASING hormone, and adrenoCORTICOTROPIN secretion in the rat
  803. Ultrashort-loop positive feedback of CORTICOTROPIN (ACTH)-RELEASING FACTOR to enhance ACTH release in stress
  804. Biological and immunological studies of bovine hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR .
  805. Immunohistochemical evidence against the coexistence of a CORTICOTROPIN โ€“RELEASING FACTOR and oxytocin or vasopressin in the rat paraventricular nucleus
  806. โ€ฆ of rat hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR by reversed-phase, high-performance liquid chromatography with synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR as a โ€ฆ
  807. Distribution and metabolism of CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  808. Synthesis, purification and biological evaluation of porcine CORTICOTROPIN โ€“RELEASING FACTOR
  809. Studies on Peptides. CLIII. Application of the Hard-Acid Deprotecting Procedure to the Synthesis of Ovine CORTICOTROPIN RELEASING FACTOR (oCRF)
  810. Regional Responses of the Pituitary to CORTICOTROPIN โ€”RELEASING FACTOR (CRF) and Ammonium Ions1
  811. Increase of ฮฒ-endorphin serum levels by human CORTICOTROPIN โ€“RELEASING FACTOR does not affect beta-cell function in normalweight men
  812. Anatomical Localization of CORTICOTROPIN โ€RELEASING FACTOR and Arginine Vasopressin in the Human Hypothalamus; the Effect of Corticosteroids on their โ€ฆ
  813. Possible role of neurohypophysial CORTICOTROPIN RELEASING FACTOR (NH-CRF) in the regulation of the pituitary-adrenal axis
  814. A different distribution of CORTICOTROPIN RELEASING FACTOR and arginine vasopressin contents in the hypothalamic nuclei after estrogen administration.
  815. CORTICOTROPIN RELEASING FACTOR (CRF)-like immunoreactivity in the hypothalamus and posterior pituitary of the goat, bovine, rat, monkey and human
  816. Adrenal insufficiency secondary to hypothalamic CORTICOTROPIN RELEASING FACTOR (CRF) insufficiency with hyperpigmentation: a case report
  817. The effects of verapamil on the locomotor-activating properties of CORTICOTROPIN RELEASING FACTOR (CRF) in the rat
  818. Stability of rat (human) CORTICOTROPIN โ€“RELEASING FACTOR in serum, urine and tissue incubation medium.
  819. Inconsistent stimulation of plasma ACTH through CORTICOTROPIN โ€“RELEASING FACTOR in a patient with central Cushingโ€™s disease due to pituitary adenoma
  820. Arginine8 Vasopressin Potentiates the ฮฒ-Endorphin-RELEASING Activity of Ovine CORTICOTROPIN โ€“RELEASING FACTOR (oCRF) in Vitro
  821. Adrenocortical responses to CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  822. Studies on Peptides. CXXIII. Preparations of Nine Peptide Fragments for the Synthesis of Human CORTICOTROPIN RELEASING FACTOR (hCRF)
  823. Synergistical effects of ovine CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by โ€ฆ
  824. Micro-Sequence Analysis of Ovine Hypothalamic CORTICOTROPIN RELEASING FACTOR
  825. Effects of ATP synthesis inhibitors, temperature, 8-bromo c-AMP, and calcium omission on release of CORTICOTROPIN RELEASING FACTOR from superfused rat hypothalami
  826. Activation of protein kinase C differentially regulates CORTICOTROPIN โ€“RELEASING FACTOR -stimulated peptide secretion and cyclic AMP formation of intermediate and anterior โ€ฆ
  827. Differential effects of dithiothreitol and iodoacetamide on CORTICOTROPIN โ€“RELEASING FACTOR (CRF) activity of bovine hypothalamic CRFs and vasopressin
  828. Hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity is reduced during induction of pituitary tumors by chronic estrogen treatment
  829. Monensin inhibition of CORTICOTROPIN RELEASING FACTOR mediated ACTH release
  830. Fine structures of nerve fibers with CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the rat lateral septum
  831. CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin production in the rat pituitary tumor 7315a: Biochemical and immunohistochemical studies
  832. Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and CORTICOTROPIN โ€“RELEASING FACTOR
  833. CORTICOTROPIN RELEASING FACTOR (CRF) activity in rat plasma
  834. Modulatory effects of CORTICOTROPIN โ€“RELEASING FACTOR on the delayed corticosteroid feedback in humans: Implications of feedback sites
  835. Specificity of cultured anterior pituitary cells in detecting CORTICOTROPIN RELEASING FACTOR (s): the effect of biologically active peptides and neurotransmitter substances on โ€ฆ
  836. In vivo and in vitro ACTH Response to Ovine CORTICOTROPIN โ€“RELEASING FACTOR in a Bronchial Carcinoid from a Patient with Ectopic ACTH Syndrom
  837. Effects of ovine CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin on plasma ฮฒ-endorphin, cortisol and behavior after minor surgery in sheep
  838. Effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism
  839. Acute and Long-Term Suppression of Stress-Induced ACTH Secretion by a Rat Monoclonal Antibody to CORTICOTROPIN RELEASING FACTOR
  840. Pituitary and adrenal responses to ovine CORTICOTROPIN RELEASING FACTOR and vasopressin injected into young and adult guinea-pigs.
  841. Weight gain and food intake in CORTICOTROPIN RELEASING FACTOR immunized Zucker rats
  842. CORTICOTROPIN โ€“RELEASING FACTOR and intraocular pressure
  843. CORTICOTROPIN โ€“RELEASING FACTOR reverses the effect of pentobarbital through a ฮฒ-noradrenergic mechanism in rats
  844. Reproductive functions in the adult male rats after prolonged intraventricular administration of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  845. โ€ฆ Peptides. CXXIV. Solution Synthesis of the Hentetracontapeptide Amide Corresponding to the Entire Amino Acid Sequence of Human CORTICOTROPIN RELEASING FACTOR โ€ฆ
  846. Subcellular distribution of CORTICOTROPIN โ€“RELEASING FACTOR in the medio-basal hypothalamus of the rat
  847. CORTICOTROPIN โ€“RELEASING FACTOR in depression and suicide
  848. CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactive nerve fibers in the rat superior cervical ganglion and their fine structures
  849. Studies on the secretion of CORTICOTROPIN โ€“RELEASING FACTOR into hypophysial portal blood
  850. Neonatal Monosodium Glutamate Abolishes CORTICOTROPIN โ€RELEASING FACTOR โ€Induced Epileptogenic Activity in Rats
  851. Interaction of arginine vasopressin and CORTICOTROPIN RELEASING FACTOR demonstrated with an improved bioassay
  852. Effect of chronic intracerebroventricular infusion of CORTICOTROPIN โ€“RELEASING FACTOR on circadian corticosterone rhythm in the rat
  853. Negative Feedback by Corticosterone is the Major Mechanism Responsible for CORTICOTROPIN โ€RELEASING FACTOR โ€Induced Desensitization
  854. Effect of a specific dopaminergic blocking agent, pimozide, on hypothalamic CORTICOTROPIN โ€“RELEASING โ€“FACTOR activity in rats: Clinical correlates
  855. Differential alpha-1 and alpha-2 adrenergic effects on hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR and plasma adrenoCORTICOTROPIN
  856. CORTICOTROPIN โ€“RELEASING FACTOR Stimulation Test
  857. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) stimulation test in normal subjects and patients with Cushingโ€™s syndrome
  858. The CORTICOTROPIN โ€“RELEASING FACTOR test in the diagnosis of ectopic ACTH secretion.
  859. Effects of human CORTICOTROPIN RELEASING FACTOR (CRF) on gastric and pancreatic secretion in vivo and in vitro
  860. CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN stimulate ciliary motility in rabbit tracheal epithelium
  861. Stress, hypothalamic-pituitary-adrenal function, and aging: focus on CORTICOTROPIN โ€“RELEASING FACTOR
  862. Plasma concentrations of adrenoCORTICOTROPIN -related peptides in lambs injected with ovine CORTICOTROPIN RELEASING FACTOR or vasopressin.
  863. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and vasopressin concentration in major brain regions after adrenalectomy and their involvement in adrenalectomy-induced ACTH โ€ฆ
  864. Tyrosine hydroxylase-and CORTICOTROPIN RELEASING FACTOR -immunoreactivity in the olFACTOR y bulb of the opossum (Didelphis virgianina).
  865. Studies for clinical application of ovine CORTICOTROPIN โ€“RELEASING FACTOR
  866. CORTICOTROPIN โ€“RELEASING FACTOR : The elusive hormone
  867. Alzheimerโ€™s disease and CORTICOTROPIN โ€“RELEASING FACTOR
  868. CORTICOTROPIN RELEASING FACTOR (Hormone): Physiological and Clinical Implications
  869. Human CORTICOTROPIN โ€“RELEASING FACTOR (hCRF) is a potent respiratory analeptic
  870. Release of CORTICOTROPIN โ€RELEASING FACTOR from Rat Brain in Vitro
  871. Fluctuated changes in the rat hypothalamic content of CORTICOTROPIN RELEASING FACTOR around the peak of the circadian rhythm
  872. The development of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (IR-CRF) in the hypothalamus, pancreas and gastrointestinal tract of immature rats
  873. Involvement of dopaminergic receptors in action of CORTICOTROPIN RELEASING FACTOR (CRF) under in vitro conditions.
  874. The Paraventriculo-Infundibular CORTICOTROPIN RELEASING FACTOR (CRF)-System II. Functional Aspects
  875. Ultrastructural studies of peptide coexistence in CORTICOTROPIN โ€“RELEASING FACTOR -and arginine-vasopressin-containing neurons
  876. The co-localization of neurohypophysis peptides and the CORTICOTROPIN โ€“RELEASING FACTOR in the rat brain. Contribution of morphometric analyses
  877. Synthesis of a hentetracontapeptide amide corresponding to the entire amino acid sequence of human CORTICOTROPIN RELEASING FACTOR (hCRF)
  878. Dissociated effects of CORTICOTROPIN โ€“RELEASING FACTOR on acid secretion and blood flow
  879. Influence of the Neurohormones: Human CORTICOTROPIN RELEASING FACTOR (hCRF), Thyrotropin RELEASING Hormone (TRH), Adrenocorticotropic Hormone (ACTH) on โ€ฆ
  880. CORTICOTROPIN RELEASING FACTOR stimulates cAMP formation in pituitary corticotropic tumor cells
  881. hpGRF-44-NH2, lot no. 92-81-5G-41-47, is (human) growth hormone-RELEASING FACTOR containing no trace of (ovine) CORTICOTROPIN โ€“RELEASING FACTOR
  882. Effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on Aldosterone and 18-Hydroxycorticosterone Secretion
  883. CORTICOTROPIN -and growth hormone-RELEASING FACTOR (CRF and GRF) in the diagnosis of hypothalamo-pituitary diseases
  884. Ontogeny and afferent connections of CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in the rat neocortex
  885. Studies on hypothalamo-pituitary corticoliberin system. II. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and neurophysin (NP) immunoreactive neurocytes in the hamster.
  886. Evidence for the synthesis of pro-CRF (CORTICOTROPIN โ€“RELEASING FACTOR ) in cultured fetal pancreatic islets of rats
  887. Application of avidin-biotinized peroxidase (ABC) method for immunocytochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rat hypothalamus
  888. Dual Control of ACTH Secretion by Hypothalamic and Placental CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in Late Pregnancy
  889. COEXISTENCE OF CORTICOTROPIN RELEASING FACTOR AND NEUROTENSIN IN THE OVAL NUCLEUS OF THE BED NUCLEI OF THE STRIA TERMINALIS IN โ€ฆ
  890. Self-association and solubility of peptides. A solvent titration study of the 28-31 segment of CORTICOTROPIN RELEASING FACTOR .
  891. Studies on hypothalamo-pituitary corticoliberin system. I. Localization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-and neurophysin-immunoreactive neurons in the โ€ฆ
  892. Development of radioimmunological measurements of neuropeptides-CORTICOTROPIN RELEASING FACTOR , growth hormone RELEASING FACTOR and ฮฒ-endorphin
  893. CORTICOTROPIN RELEASING FACTOR , the Amygdaloid Complex, and Depression: A Hypothetical Interrelationship
  894. Study on the development of the radioimmunoassay of the CORTICOTROPIN RELEASING FACTOR (CRF)
  895. In vitro Expression and Mutagenesis of a Gene for CORTICOTROPIN RELEASING FACTOR
  896. 164 HUMAN CORTICOTROPIN โ€“RELEASING FACTOR (CRF) ARO ACTH TEST IN PREMATURE PUBARCHE (PP)
  897. CORTICOTROPIN RELEASING FACTOR as an aid in the diagnosis of Cushing syndrome
  898. A different distribution of CORTICOTROPIN RELEASING FACTOR and arginine vasopressin
  899. Neuroendocrine Effects of Intravenous Ovine CORTICOTROPIN โ€“RELEASING FACTOR and Human Growth Hormone-RELEASING FACTOR in Affective Disorder Patients and Normal โ€ฆ
  900. REGULATION OF HYPOTHALAMIC B-ENDORPHIN AND DYNORPHIN RELEASE BY CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  901. Characterization of CORTICOTROPIN โ€“RELEASING FACTOR activity from sheep hypothalamic extracts
  902. Effects of ketanserin on hemodynamic changes after intracerebroventricular CORTICOTROPIN RELEASING FACTOR administration in rats
  903. the Antidiuretic, Pressor and Oxytocic Properties of CORTICOTROPIN โ€“RELEASING FACTOR (CRF).
  904. Analysis of dynamics of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) activity in the rat hypothalamus under stress
  905. CORTICOTROPIN โ€“RELEASING FACTOR and dopamine in the central amygdaloid nucleus of the rat: Localization and interactions
  906. STUDIES ON CORTICOTROPIN RELEASING FACTOR (CRF) IN THE CENTRAL NERVOUS SYSTEM (HYPOTHALAMUS, CEREBELLUM).
  907. Effects of synthetic ovine CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on ACTH release in vitro
  908. Vasopressin: a major CORTICOTROPIN RELEASING FACTOR released from the rat median eminence in vitro
  909. Functional maturation of the human CORTICOTROPIN RELEASING FACTOR -adrenocorticotropic hormone system during intrauterine life. An in vitro study
  910. โ€ฆ OF STIMULATED-ACTH SECRETION BY GLUCOCORTICOIDS IN VITRO: A NOVEL GLUCOCORTICOID ACTION (CORTICOTROPIN RELEASING FACTOR ).
  911. Characterization and modulation of anterior pituitary binding sites for rat CORTICOTROPIN RELEASING FACTOR (r-CRF)
  912. Cytochemical Studies of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptors in Anterior Lobe Corticotropes: Binding,โ€ฆ
  913. Ultrastructural changes in adrenocortical cells following injection of CORTICOTROPIN RELEASING FACTOR (CRF) in fetal rats.
  914. 136 THE DEVELOPMENT OF IMMUNOREACTIVE CORTICOTROPIN โ€“RELEASING FACTOR (IR-CRF) IN THE HYPOTHALAMUS, PANCREAS AND โ€ฆ
  915. COEXISTENCE OF CORTICOTROPIN RELEASING FACTOR AND NEUROTENSIN IN THE OVAL NUCLEUS OF THE BED NUCLEI OF THE STRIA TERMINALIS IN โ€ฆ
  916. โ€ฆ OF TWO HYPOTHALAMIC POLYPEPTIDES: CORTICOTROPIN RELEASING FACTOR AND SIALOGEN, A FACTOR THAT STIMULATES SALIVARY โ€ฆ
  917. 1. Brain CORTICOTROPIN RELEASINGFACTOR (CRF) and catecholamine responses in acutely stressed rats. 2. Effects of morphine on hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  918. CORTICOTROPIN RELEASING activity of a pepsin labile FACTOR in the hypothalamus.
  919. Pituitary response to thyrotropin, CORTICOTROPIN and gonadotropin RELEASING FACTOR in lactating cows treated for a fourth consecutive lactation with a prolonged release โ€ฆ
  920. Physiology and pharmacology of CORTICOTROPIN โ€“RELEASING FACTOR .
  921. The role of CORTICOTROPIN โ€“RELEASING FACTOR in depression and anxiety disorders.
  922. Expression cloning of a human CORTICOTROPIN โ€“RELEASING โ€“FACTOR receptor
  923. CORTICOTROPIN โ€“RELEASING FACTOR , norepinephrine, and stress
  924. CORTICOTROPIN RELEASING FACTOR receptors and their ligand family
  925. CORTICOTROPIN RELEASING FACTOR , stress and behavior
  926. The role of CORTICOTROPIN โ€“RELEASING FACTOR in pain and analgesia
  927. Stress, CORTICOTROPIN โ€RELEASING FACTOR , and drug addiction
  928. CP-154,526: a potent and selective nonpeptide antagonist of CORTICOTROPIN RELEASING FACTOR receptors
  929. CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y: role in emotional integration
  930. Elevated CSF CORTICOTROPIN โ€“RELEASING FACTOR concentrations in posttraumatic stress disorder
  931. Identification of a second CORTICOTROPIN โ€“RELEASING FACTOR receptor gene and characterization of a cDNA expressed in heart.
  932. Overproduction of CORTICOTROPIN โ€“RELEASING FACTOR in transgenic mice: a genetic model of anxiogenic behavior
  933. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on brain serotonergic activity
  934. CORTICOTROPIN โ€“RELEASING FACTOR in antinociception and inflammation
  935. A role for CORTICOTROPIN RELEASING FACTOR and urocortin in behavioral responses to stressors
  936. Displacement of CORTICOTROPIN RELEASING FACTOR from its binding protein as a possible treatment for Alzheimerโ€™s disease
  937. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor mRNA expression in the rat brain and pituitary
  938. The amygdala: CORTICOTROPIN โ€“RELEASING FACTOR , steroids, and stress
  939. Persistent changes in CORTICOTROPIN โ€“RELEASING FACTOR neuronal systems induced by maternal deprivation
  940. Identification of a seven transmembrane helix receptor for CORTICOTROPIN โ€“RELEASING FACTOR and sauvagine in mammalian brain
  941. CORTICOTROPIN โ€“RELEASING FACTOR receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
  942. Cloning and functional expression of a rat brain CORTICOTROPIN RELEASING FACTOR (CRF) receptor
  943. CORTICOTROPIN โ€“RELEASING FACTOR CRF1, but not CRF2, receptors mediate anxiogenic-like behavior
  944. Characterization of a novel and potent CORTICOTROPIN โ€“RELEASING FACTOR antagonist in rats.
  945. Differential regulation of CORTICOTROPIN โ€“RELEASING FACTOR mRNA in rat brain regions by glucocorticoids and stress
  946. The role of CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1 in the regulation of neurons controlling reproductive functions
  947. Cyclic vomiting syndrome: the CORTICOTROPIN โ€“RELEASING โ€“FACTOR hypothesis.
  948. Interleukin 1 beta and CORTICOTROPIN โ€“RELEASING FACTOR inhibit pain by RELEASING opioids from immune cells in inflamed tissue
  949. Cloning and characterization of the cDNAs for human and rat CORTICOTROPIN RELEASING FACTOR -binding proteins
  950. Role of nitric oxide in interleukin 2-induced CORTICOTROPIN โ€“RELEASING FACTOR release from incubated hypothalami.
  951. A sauvagine/CORTICOTROPIN โ€“RELEASING FACTOR receptor expressed in heart and skeletal muscle
  952. CORTICOTROPIN โ€“RELEASING FACTOR and the brain-gut motor response to stress
  953. Molecular Identification and Analysis of a Novel Human CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptor: The CRF2ฮณ Receptor
  954. Differential distribution of urocortin-and CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivities in the rat brain
  955. Cloning and characterization of a functionally distinct CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype from rat brain
  956. The role of CORTICOTROPIN RELEASING FACTOR in depressive illness: a critical review
  957. Activation of CORTICOTROPIN โ€“RELEASING FACTOR in the limbic system during cannabinoid withdrawal
  958. Development of Cushingโ€™s syndrome in CORTICOTROPIN โ€“RELEASING FACTOR transgenic mice.
  959. A new functional isoform of the human CRF2 receptor for CORTICOTROPIN โ€“RELEASING FACTOR
  960. CORTICOTROPIN โ€“RELEASING FACTOR innervation of the locus coeruleus region: distribution of fibers and sources of input
  961. New vistas in neuropeptide research in neuropsychiatry: focus on CORTICOTROPIN โ€“RELEASING FACTOR .
  962. Ligand requirements of the human CORTICOTROPIN โ€“RELEASING FACTOR -binding protein
  963. Regulation of the stress response by CORTICOTROPIN โ€“RELEASING FACTOR receptors
  964. Autoradiographic and in situ hybridization localization of CORTICOTROPIN โ€RELEASING FACTOR 1 and 2 receptors in nonhuman primate brain
  965. Role of CORTICOTROPIN โ€RELEASING FACTOR receptorโ€1 in opiate withdrawal
  966. CORTICOTROPIN โ€RELEASING FACTOR : An antireproductive hormone of the testis
  967. CORTICOTROPIN โ€“RELEASING FACTOR receptors: an overview
  968. CORTICOTROPIN RELEASING FACTOR receptor 1โ€“deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
  969. Plasma CORTICOTROPIN โ€“RELEASING FACTOR in depressive disorders
  970. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on neuronal activity in the serotonergic dorsal raphe nucleus
  971. The role of CORTICOTROPIN โ€“RELEASING FACTOR โ€“norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine โ€ฆ
  972. Evolution and physiology of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of neuropeptides in vertebrates
  973. Cloning and characterization of the human CORTICOTROPIN โ€“RELEASING FACTOR -2 receptor complementary deoxyribonucleic acid
  974. The role of CORTICOTROPIN โ€RELEASING FACTOR in the anxiogenic effects of ethanol withdrawal
  975. Reduced anxiety-like and cognitive performance in mice lacking the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1
  976. Modulation of learning and anxiety by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and stress: differential roles of CRF receptors 1 and 2
  977. Characterization of CORTICOTROPIN โ€RELEASING FACTOR Receptor Subtypesa
  978. Depression and anxiety: role of the locus coeruleus and CORTICOTROPIN โ€“RELEASING FACTOR
  979. Urocortin, a mammalian neuropeptide related to fish urotensin I and to CORTICOTROPIN โ€“RELEASING FACTOR
  980. The Locus Coeruleus as a Site for Integrating CORTICOTROPIN โ€RELEASING FACTOR and Noradrenergic Mediation of Stress Responses a
  981. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central CORTICOTROPIN โ€“RELEASING FACTOR system
  982. Localization of novel CORTICOTROPIN โ€“RELEASING FACTOR receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA โ€ฆ
  983. Learning impairment in transgenic mice with central overexpression of CORTICOTROPIN โ€“RELEASING FACTOR
  984. Receptor-mediated immunomodulation by CORTICOTROPIN โ€“RELEASING FACTOR
  985. The behavioural effects of CORTICOTROPIN โ€“RELEASING FACTOR -related peptides in rats
  986. Potent, structurally constrained agonists and competitive antagonists of CORTICOTROPIN โ€“RELEASING FACTOR
  987. CORTICOTROPIN โ€“RELEASING FACTOR in the paraventricular nucleus modulates feeding induced by neuropeptide Y
  988. CORTICOTROPIN โ€“RELEASING FACTOR antagonist reduces emotionality in socially defeated rats via direct neurotropic action
  989. Peripheral CORTICOTROPIN โ€“RELEASING FACTOR and stress-stimulated colonic motor activity involve type 1 receptor in rats
  990. The Role of Early Adverse Life Events in the Etiology of Depression and Posttraumatic Stress Disorder: Focus on CORTICOTROPIN โ€RELEASING FACTOR a
  991. The central distribution of a CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-binding protein predicts multiple sites and modes of interaction with CRF.
  992. โ€ฆ stress-induced activation of CORTICOTROPIN โ€“RELEASING FACTOR neurons enhances vasopressin stores and colocalization with CORTICOTROPIN โ€“RELEASING FACTOR in the median โ€ฆ
  993. CORTICOTROPIN โ€“RELEASING FACTOR modulates the immune response to stress in the rat
  994. CORTICOTROPIN RELEASING FACTOR (CRF) receptor modulators: progress and opportunities for new therapeutic agents
  995. The role of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin in the modulation of ingestive behavior
  996. Effects of prenatal stress on defensive withdrawal behavior and CORTICOTROPIN RELEASING FACTOR systems in rat brain
  997. Brain CORTICOTROPIN โ€“RELEASING FACTOR mediates โ€˜anxiety-likeโ€™behavior induced by cocaine withdrawal in rats
  998. CORTICOTROPIN โ€“RELEASING FACTOR : long-lasting facilitation of the acoustic startle reflex
  999. Abnormalities in the regulation of vasopressin and CORTICOTROPIN RELEASING FACTOR secretion in obsessive-compulsive disorder
  1000. CORTICOTROPIN โ€“RELEASING FACTOR , but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
  1001. Previous stress alters CORTICOTROPIN โ€“RELEASING FACTOR neurotransmission in the locus coeruleus
  1002. The central CORTICOTROPIN โ€“RELEASING FACTOR and glucagon-like peptide-1 in food intake of the neonatal chick
  1003. CORTICOTROPIN RELEASING FACTOR (CRF) binding protein: a novel regulator of CRF and related peptides
  1004. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR in chronic stress regulation of the brain noradrenergic system
  1005. Differential actions of CORTICOTROPIN RELEASING FACTOR on basolateral and central amygdaloid neurones, in vitro
  1006. Amygdaloid CORTICOTROPIN โ€RELEASING FACTOR targets locus coeruleus dendrites: substrate for the coโ€ordination of emotional and cognitive limbs of the stress response
  1007. Urocortin, a member of the CORTICOTROPIN โ€“RELEASING FACTOR family, in normal and diseased heart
  1008. Structural requirements for peptidic antagonists of the CORTICOTROPIN โ€“RELEASING FACTOR receptor (CRFR): development of CRFR2ฮฒ-selective antisauvagine-30
  1009. Urocortin and CORTICOTROPIN โ€“RELEASING FACTOR receptor expression in the human colonic mucosa
  1010. Conditioned emotional response in rats enhances colonic motility through the central release of CORTICOTROPIN โ€“RELEASING FACTOR
  1011. Persistent elevations of cerebrospinal fluid concentrations of CORTICOTROPIN โ€“RELEASING FACTOR in adult nonhuman primates exposed to early-life stressors: implications for โ€ฆ
  1012. Anti-stress action of a CORTICOTROPIN โ€“RELEASING FACTOR antagonist on behavioral reactivity to stressors of varying type and intensity
  1013. Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in the anorexic syndrome induced by CRF
  1014. Early, postnatal experience alters hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats
  1015. Suppression of CORTICOTROPIN โ€“RELEASING FACTOR in the amygdala attenuates aversive consequences of morphine withdrawal.
  1016. Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) as a food intake regulator in goldfish
  1017. The role of CORTICOTROPIN โ€“RELEASING FACTOR and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats
  1018. Attenuation of stress-induced behavior by antagonism of CORTICOTROPIN โ€“RELEASING FACTOR receptors in the central amygdala in the rat
  1019. Acute stress causes mucin release from rat colon: role of CORTICOTROPIN RELEASING FACTOR and mast cells
  1020. CORTICOTROPIN โ€“RELEASING FACTOR plays a permissive role in cerebellar long-term depression
  1021. Putative role of placental CORTICOTROPIN โ€“RELEASING FACTOR in the mechanisms of human parturition
  1022. Corticosterone delivery to the amygdala increases CORTICOTROPIN โ€“RELEASING FACTOR mRNA in the central amygdaloid nucleus and anxiety-like behavior
  1023. Persistent changes in CORTICOTROPIN โ€“RELEASING FACTOR systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress โ€ฆ
  1024. Long-term regulation of locus ceruleus sensitivity to CORTICOTROPIN โ€“RELEASING FACTOR by swim stress
  1025. Stimulation of interleukin-6 production by CORTICOTROPIN โ€“RELEASING FACTOR
  1026. Stress-induced increase in vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR expression in hypophysiotrophic paraventricular neurons
  1027. Prenatal stress increases CORTICOTROPIN โ€“RELEASING FACTOR (CRF) content and release in rat amygdala minces
  1028. Gender, sex steroids, CORTICOTROPIN โ€“RELEASING FACTOR , nitric oxide, and the HPA response to stress
  1029. CORTICOTROPIN โ€“RELEASING FACTOR and adrenocorticotrophic hormone as potential central mediators of OB effects
  1030. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of CORTICOTROPIN โ€“RELEASING FACTOR
  1031. Expression of CORTICOTROPIN โ€“RELEASING FACTOR in inflamed tissue is required for intrinsic peripheral opioid analgesia
  1032. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein is produced by human placenta and intrauterine tissues
  1033. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides
  1034. Chronic social stress alters levels of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin mRNA in rat brain
  1035. Water-avoidance stress-inducedc-fos expression in the rat brain and stimulation of fecal output: role of CORTICOTROPIN โ€“RELEASING FACTOR
  1036. Effect of desipramine on cerebrospinal fluid concentrations of CORTICOTROPIN โ€“RELEASING FACTOR in human subjects
  1037. Anti-sexual and anxiogenic behavioral consequences of CORTICOTROPIN โ€“RELEASING FACTOR overexpression are centrally mediated
  1038. Psychological stress-induced accelerated colonic transit in rats involves hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  1039. Microinjection of a CORTICOTROPIN โ€“RELEASING FACTOR antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
  1040. Placental CORTICOTROPIN โ€RELEASING FACTOR An Update
  1041. Repeated stress enhances vasopressin synthesis in CORTICOTROPIN RELEASING FACTOR neurons in the paraventricular nucleus
  1042. Pharmacological comparison of two CORTICOTROPIN โ€“RELEASING FACTOR antagonists: in vivo and in vitro studies.
  1043. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide CORTICOTROPIN โ€“RELEASING FACTOR subtype 1 receptor antagonists CRA1000 and CRA1001
  1044. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1045. Role of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin within the basolateral amygdala of rats in anxiety and panic responses
  1046. CORTICOTROPIN โ€“RELEASING FACTOR Increases In VitroFiring Rates of Serotonergic Neurons in the Rat Dorsal Raphe Nucleus: Evidence for Activation of a Topographically โ€ฆ
  1047. Cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR concentrations in patients with anxiety disorders and normal comparison subjects
  1048. Role of CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin and the autonomic nervous system in learning and memory
  1049. Increase of extracellular CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as โ€ฆ
  1050. Neurobiology of CORTICOTROPIN RELEASING FACTOR (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders.
  1051. CORTICOTROPIN โ€“RELEASING FACTOR induces a place aversion independent of its neuroendocrine role
  1052. Physiological and behavioral effects of chronic intracerebroventricular infusion of CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  1053. โ–  REVIEW: CORTICOTROPIN โ€“RELEASING FACTOR , Stress, and Depression
  1054. Locus coeruleus activation by colon distention: role of CORTICOTROPIN โ€“RELEASING FACTOR and excitatory amino acids
  1055. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of CORTICOTROPIN โ€“RELEASING FACTOR during endotoxemia
  1056. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of CORTICOTROPIN โ€“RELEASING FACTOR on stress-induced reinstatement of cocaine โ€ฆ
  1057. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats
  1058. CORTICOTROPIN โ€“RELEASING FACTOR mRNA in rat thymus and spleen
  1059. Differential roles of CORTICOTROPIN โ€RELEASING FACTOR receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence
  1060. Acute alcohol administration stimulates the activity of hypothalamic neurons that express CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin
  1061. The role of CRF2 receptors in CORTICOTROPIN โ€“RELEASING FACTOR -and urocortin-induced anorexia
  1062. Central administration of CORTICOTROPIN RELEASING FACTOR induces long-term sensitization to D-amphetamine
  1063. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR : effects on discharge rate, cortical โ€ฆ
  1064. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rats
  1065. Localization of agonist-and antagonist-binding domains of human CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1066. Understanding CORTICOTROPIN RELEASING FACTOR neurobiology: contributions from mutant mice.
  1067. CORTICOTROPIN โ€“RELEASING FACTOR decreases vasogenic brain edema
  1068. Central injection of a new CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonist, astressin, blocks CRF-and stress-related alterations of gastric and colonic motor function
  1069. CORTICOTROPIN โ€“RELEASING FACTOR and type 1 CORTICOTROPIN โ€“RELEASING FACTOR receptor messenger RNAs in rat brain and pituitary duringโ€ bingeโ€-pattern cocaine โ€ฆ
  1070. Intracerebroventricular administration of CORTICOTROPIN โ€“RELEASING FACTOR inducesc-fos mRNA expression in brain regions related to stress responses: comparison with โ€ฆ
  1071. CORTICOTROPIN โ€“RELEASING FACTOR in the locus coeruleus mediates EEG activation associated with hypotensive stress
  1072. The role of CORTICOTROPIN โ€“RELEASING FACTOR in behavioural responses to stress
  1073. CORTICOTROPIN โ€“RELEASING FACTOR and its binding protein in human plasma
  1074. Expression of c-fos in regions of the basal limbic forebrain following intra-cerebroventricular CORTICOTROPIN โ€“RELEASING FACTOR in unstressed or stressed male rats
  1075. Paradoxical activational effects of a CORTICOTROPIN โ€“RELEASING FACTOR -binding protein โ€œligand inhibitorโ€ in rat brain
  1076. Human umbilical vein endothelial cells: a new source and potential target for CORTICOTROPIN โ€“RELEASING FACTOR
  1077. CORTICOTROPIN โ€“RELEASING FACTOR activates c-fos, NGFI-B, and CORTICOTROPIN โ€“RELEASING FACTOR gene expression within the paraventricular nucleus of the rat hypothalamus.
  1078. CORTICOTROPIN RELEASING FACTOR decidualizes human endometrial stromal cells in vitro. Interaction with progestin
  1079. Increased CORTICOTROPIN โ€“RELEASING FACTOR concentrations in the bed nucleus of the stria terminalis of anhedonic rats
  1080. Neuropeptide Y increases the CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid level in the rat hypothalamus
  1081. Characterization of native CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 (cRFR1) in the rat and mouse central nervous system
  1082. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates CORTICOTROPIN โ€“RELEASING FACTOR gene expression in conscious rats
  1083. CORTICOTROPIN โ€RELEASING FACTOR stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis
  1084. Alanine series of ovine CORTICOTROPIN RELEASING FACTOR (oCRF): a structure-activity relationship study
  1085. CORTICOTROPIN โ€“RELEASING FACTOR and its binding protein: maternal serum levels in term and preterm deliveries
  1086. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 mediates stress-induced relapse to opiate dependence in rats
  1087. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for CORTICOTROPIN โ€“RELEASING FACTOR
  1088. Relationship between CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-2: evolutionary evidence
  1089. Evidence of a thyrotropin-RELEASING activity of ovine CORTICOTROPIN โ€“RELEASING FACTOR in the domestic fowl (Gallus domesticus)
  1090. Stress-induced activation of neuronal activity and CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats.
  1091. Constrained CORTICOTROPIN RELEASING FACTOR antagonists (astressin analogues) with long duration of action in the rat
  1092. A Variant of the Human CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptor: Cloning, Expression, and Pharmacology
  1093. The role of limbic and hypothalamic CORTICOTROPIN โ€RELEASING FACTOR in behavioral responses to stress
  1094. Effects of the CORTICOTROPIN โ€RELEASING FACTOR (CRF) on rectal afferent nerves in humans
  1095. Spontaneous and CORTICOTROPIN โ€“RELEASING FACTOR -induced cytosolic calcium transients in corticotrophs
  1096. CORTICOTROPIN โ€“RELEASING FACTOR antagonist attenuates the โ€œanxiogenic-likeโ€ effect in the defensive burying paradigm but not in the elevated plus-maze following chronic โ€ฆ
  1097. CORTICOTROPIN โ€“RELEASING FACTOR up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus
  1098. Conformationally restricted competitive antagonists of human/rat CORTICOTROPIN โ€“RELEASING FACTOR
  1099. Involvement of CORTICOTROPIN โ€RELEASING FACTOR in the control of food intake and energy expenditure
  1100. CORTICOTROPIN RELEASING FACTOR (CRF): studies in alcohol preferring and non-preferring rats
  1101. โ€ฆ oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, CORTICOTROPIN โ€“RELEASING FACTOR , CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 โ€ฆ
  1102. Direct projection from the suprachiasmatic nucleus to hypophysiotrophic CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive cells in the paraventricular nucleus of the โ€ฆ
  1103. Evidence That CORTICOTROPIN โ€RELEASING Hormone Acts as a Growth Hormoneโ€RELEASING FACTOR in a Primitive Teleost, the European Eel (Anguilla anguilla)
  1104. Neuropeptide Y blocks anxiogenic-like behavioral action of CORTICOTROPIN โ€“RELEASING FACTOR in an operant conflict test and elevated plus maze
  1105. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on CORTICOTROPIN โ€“RELEASING FACTOR and urocortin neuronal systems
  1106. Expression of CORTICOTROPIN โ€“RELEASING FACTOR and its receptors in the brain of lean and obese Zucker rats
  1107. Postmortem and Cerebrospinal Fluid Studies of CORTICOTROPIN โ€RELEASING FACTOR in Humansa
  1108. The first extracellular domain of CORTICOTROPIN RELEASING FACTOR -R1 contains major binding determinants for urocortin and astressin
  1109. Colocalization of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin in the paraventricular nucleus of the human hypothalamus
  1110. Ultraviolet B stimulates production of CORTICOTROPIN RELEASING FACTOR (CRF) by human melanocytes
  1111. Interleukin-2 (IL-2) induces CORTICOTROPIN โ€“RELEASING FACTOR (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the โ€ฆ
  1112. The effect of acute exercise on the secretion of CORTICOTROPIN โ€“RELEASING FACTOR , arginine vasopressin, and adrenoCORTICOTROPIN as measured in pituitary venous blood โ€ฆ
  1113. Hair cycleโ€dependent expression of CORTICOTROPIN โ€RELEASING FACTOR (CRF) and CRF receptors in murine skin
  1114. Chronic administration of the selective CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat
  1115. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonist [D-Phe12, Nle21, 38, C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid โ€ฆ
  1116. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human CORTICOTROPIN โ€“RELEASING FACTOR 2 alpha receptors.
  1117. Chronic psychosocial stress enhances vasopressin, but not CORTICOTROPIN โ€“RELEASING FACTOR , in the external zone of the median eminence of male rats: relationship to โ€ฆ
  1118. Constitutive activation of tethered-peptide/CORTICOTROPIN โ€“RELEASING FACTOR receptor chimeras
  1119. Microinfusion of CORTICOTROPIN RELEASING FACTOR into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats
  1120. โ€ฆ -induced inhibition of gonadotropin-RELEASING hormone pulse generator activity in the rhesus monkey: roles of vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR
  1121. Early induction of c-fos precedes increased expression of CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid in the paraventricular nucleus after immobilization โ€ฆ
  1122. The effect of caffeine on food intake in rats: Involvement of CORTICOTROPIN โ€“RELEASING FACTOR and the sympatho-adrenal system
  1123. Extracellular Cysteines of the CORTICOTROPIN โ€“RELEASING FACTOR Receptor Are Critical for Ligand Interactionโ€ 
  1124. Effect of corticosterone on the enhancement of the acoustic startle reflex by CORTICOTROPIN RELEASING FACTOR (CRF)
  1125. Interleukin 1ฮฒ inhibits gastric emptying in rats: mediation through prostaglandin and CORTICOTROPIN โ€“RELEASING FACTOR
  1126. Differential expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and urotensin I precursor genes, and evidence of CRF gene expression regulated by cortisol in goldfish โ€ฆ
  1127. The Protooncogene c-fos Is Induced by CORTICOTROPIN โ€“RELEASING FACTOR and Stimulates Proopiomelanocortin Gene Transcription in Pituitary Cells
  1128. Angiotensin II increases the CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid level in the rat hypothalamus
  1129. Localization of ligand-binding domains of human CORTICOTROPIN โ€“RELEASING FACTOR receptor: a chimeric receptor approach
  1130. Neuroprotection by CORTICOTROPIN RELEASING FACTOR during hypoxia in rat brain.
  1131. Cocaine-amphetamine-regulated transcript (CART) acts in the central nervous system to inhibit gastric acid secretion via brain CORTICOTROPIN โ€“RELEASING FACTOR system
  1132. CORTICOTROPIN โ€“RELEASING FACTOR antagonists in affective disorders
  1133. CORTICOTROPIN RELEASING FACTOR mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute โ€ฆ
  1134. Physiological and neurochemical aspects of CORTICOTROPIN โ€“RELEASING FACTOR actions in the brain: the role of the locus coeruleus
  1135. CORTICOTROPIN RELEASING FACTOR antagonist reduces ischemic hippocampal neuronal injury
  1136. โ€ฆ relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the CORTICOTROPIN โ€“RELEASING FACTOR /arginine-vasopressin test โ€ฆ
  1137. Isolation and pharmacological characterization of two functional splice variants of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor from Tupaia belangeri.
  1138. Endogenous CORTICOTROPIN โ€“RELEASING FACTOR modulates feeding induced by neuropeptide Y or a tail-pinch stressor
  1139. Prenatal stress enhances stress-and CORTICOTROPIN โ€“RELEASING FACTOR -induced stimulation of hippocampal acetylcholine release in adult rats
  1140. Discrete local application of CORTICOTROPIN โ€RELEASING FACTOR increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus
  1141. Allopregnanolone and dehydroepiandrosterone response to CORTICOTROPIN โ€“RELEASING FACTOR in patients suffering from Alzheimerโ€™s disease and vascular dementia
  1142. The genomic organization of the human CORTICOTROPIN โ€“RELEASING FACTOR type-1 receptor
  1143. A non peptidic CORTICOTROPIN RELEASING FACTOR receptor antagonist attenuates fever and exhibits anxiolytic-like activity
  1144. CORTICOTROPIN โ€“RELEASING FACTOR suppresses the afterhyperpolarization in cerebellar Purkinje neurons
  1145. Modulation of urocortin-induced hypophagia and weight loss by CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 deficiency in mice
  1146. Modulation of the inflammatory response by CORTICOTROPIN โ€“RELEASING FACTOR
  1147. Paradoxical responses of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial โ€ฆ
  1148. โ€ฆ central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of CORTICOTROPIN โ€“RELEASING FACTOR on the acoustic โ€ฆ
  1149. Regulation of a putative neurotransmitter effect of CORTICOTROPIN โ€“RELEASING FACTOR : effects of adrenalectomy
  1150. Identification of amino acids in the Nโ€terminal domain of CORTICOTROPIN โ€RELEASING FACTOR receptor 1 that are important determinants of highโ€affinity ligand binding
  1151. CORTICOTROPIN โ€RELEASING FACTOR โ€containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of โ€ฆ
  1152. C-fos mRNA pattern and CORTICOTROPIN โ€“RELEASING FACTOR neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type
  1153. The amygdaloid complex, CORTICOTROPIN RELEASING FACTOR and stress-induced gastric ulcerogenesis in rats
  1154. Effects of pretreatment with CORTICOTROPIN โ€“RELEASING FACTOR on the electrophysiological responsivity of the locus coeruleus to subsequent CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  1155. Altered pituitary sensitivity to CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin participates in the stress hyporesponsiveness of lactation in the rat.
  1156. Brain CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behaviour
  1157. Both CORTICOTROPIN RELEASING FACTOR and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats
  1158. Autonomic and behavioral effects of centrally administered CORTICOTROPIN โ€“RELEASING FACTOR in rats
  1159. Fluoxetine induces the transcription of genes encoding c-fos, CORTICOTROPIN โ€“RELEASING FACTOR and its type 1 receptor in rat brain
  1160. Functional characterization of CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor endogenously expressed in human embryonic kidney 293 cells
  1161. Effects of Leptin on CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Synthesis and CRF Neuron Activation in the Paraventricular Hypothalamic Nucleus of Obese (ob/ob) Mice
  1162. Identification of Two CORTICOTROPIN โ€RELEASING FACTOR Receptors from Xenopus laevis with High Ligand Selectivity: Unusual Pharmacology of the Type 1 Receptor
  1163. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF messenger โ€ฆ
  1164. Characterization of the genomic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians.
  1165. An interleukin-1ฮฒ-induced noradrenaline release in the spleen is mediated by brain CORTICOTROPIN โ€“RELEASING FACTOR : an in vivo microdialysis study in conscious rats
  1166. Involvement of Arachidonic Acid Cascade Pathways in lnterleukin-6-Stimulated CORTICOTROPIN โ€“RELEASING FACTOR Release in vitro
  1167. CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 from Tupaia belangeri Cloning, functional expression and tissue distribution
  1168. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain CORTICOTROPIN โ€“RELEASING FACTOR
  1169. In vitro excitatory actions of CORTICOTROPIN โ€“RELEASING FACTOR on rat colonic motility.
  1170. CORTICOTROPIN โ€“RELEASING FACTOR
  1171. The developmental profile of the CORTICOTROPIN RELEASING FACTOR receptor (CRF2) in rat brain predicts distinct age-specific functions
  1172. The effects of alprazolam on CORTICOTROPIN โ€“RELEASING FACTOR neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
  1173. An inhibitory effect of interleukin-la on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a CORTICOTROPIN โ€“RELEASING FACTOR antagonist
  1174. Interleukin 1 beta mediates stress-induced immunosuppression via CORTICOTROPIN โ€“RELEASING FACTOR .
  1175. Both conditioned taste preference and aversion induced by CORTICOTROPIN โ€“RELEASING FACTOR
  1176. Cellular localization of CORTICOTROPIN RELEASING FACTOR receptors in the adult mouse cerebellum
  1177. The CRF1 receptor mediates the excitatory actions of CORTICOTROPIN RELEASING FACTOR (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non โ€ฆ
  1178. CORTICOTROPIN RELEASING FACTOR and its binding protein
  1179. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on isolated rat heart activity
  1180. Effects of chronic ethanol exposure on neurophysiological responses to CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y
  1181. CSF CORTICOTROPIN โ€“RELEASING FACTOR is not affected in panic disorder.
  1182. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR secretion from Leydig cells by serotonin.
  1183. CORTICOTROPIN โ€“RELEASING FACTOR binding sites in cortex of depressed suicides
  1184. Hippocampal norepinephrine-like voltammetric responses following infusion of CORTICOTROPIN โ€“RELEASING FACTOR into the locus coeruleus
  1185. Transneuronal labeling from the rat distal colon: anatomic evidence for regulation of distal colon function by a pontine CORTICOTROPIN โ€RELEASING FACTOR system
  1186. CORTICOTROPIN โ€“RELEASING FACTOR administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex
  1187. Ultrastructural localization and afferent sources of CORTICOTROPIN โ€RELEASING FACTOR in the rat rostral ventrolateral medulla: Implications for central cardiovascular โ€ฆ
  1188. CORTICOTROPIN โ€“RELEASING FACTOR stimulates metamorphosis and increases thyroid hormone concentration in prometamorphic Rana perezi larvae
  1189. Effects of chronic stress on anterior pituitary and brain CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1190. Differential regulation of the expression of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 (CRF2) in hypothalamus and amygdala of the immature rat by sensory input โ€ฆ
  1191. Major role of 3โ€ฒ, 5โ€ฒ-cyclic adenosine monophosphate-dependent protein kinase A pathway in CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the rat hypothalamus in โ€ฆ
  1192. The genomic structure of the rat CORTICOTROPIN RELEASING FACTOR receptor: a member of the class II G protein-coupled receptors
  1193. Differential modulation of Purkinje cell activity by enkephalin and CORTICOTROPIN RELEASING FACTOR
  1194. Relaxing actions of CORTICOTROPIN โ€RELEASING FACTOR on rat resistance arteries
  1195. Conditioned release of corticosterone by contextual stimuli associated with cocaine is mediated by CORTICOTROPIN โ€“RELEASING FACTOR
  1196. Astressin analogues (CORTICOTROPIN โ€“RELEASING FACTOR antagonists) with extended duration of action in the rat
  1197. Stress-induced sleep deprivation modifies CORTICOTROPIN RELEASING FACTOR (CRF) levels and CRF binding in rat brain and pituitary
  1198. Neurobiology of Stress and Cocaine Addiction: Studies on CORTICOTROPIN โ€RELEASING FACTOR in Rats, Monkeys, and Humansa
  1199. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by CORTICOTROPIN โ€“RELEASING FACTOR
  1200. Effect of acetylcholine on CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the hypothalamic paraventricular nucleus of conscious rats
  1201. Activation of noradrenergic neurons in the locus coeruleus by CORTICOTROPIN โ€“RELEASING FACTOR
  1202. Noradrenergic mediation of the memory-enhancing effect of CORTICOTROPIN โ€“RELEASING FACTOR in the locus coeruleus of rats
  1203. โ€ฆ and biological activity of oxo-7H-benzo [e] perimidine-4-carboxylic acid derivatives as potent, nonpeptide CORTICOTROPIN RELEASING FACTOR (CRF) receptor antagonists
  1204. CORTICOTROPIN โ€“RELEASING FACTOR release from the mediobasal hypothalamus of the rat as measured by microdialysis
  1205. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF
  1206. Protein synthesis in the hippocampus associated with memory facilitation by CORTICOTROPIN โ€“RELEASING FACTOR in rats
  1207. Molecular cloning of a type A chicken CORTICOTROPIN โ€“RELEASING FACTOR receptor with high affinity for urotensin I
  1208. Direct secretagogue effect of CORTICOTROPIN โ€“RELEASING FACTOR on the rat adrenal cortex: the involvement of the zona medullaris
  1209. Fine structure and possible origins of nerve fibers with CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in the rat central amygdaloid nucleus
  1210. Serotonin stimulates CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the hypothalamic paraventricular nucleus of conscious rats
  1211. Characterization of the relaxant action of urocortin, a new peptide related to CORTICOTROPIN โ€RELEASING FACTOR in the rat isolated basilar artery
  1212. Alterations of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in different brain regions after acute cocaine administration in rats
  1213. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the antinociception produced by interleukin-1 in mice
  1214. Alcohol increases the expression of type 1, but not type 2ฮฑ CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor messenger ribonucleic acid in the rat hypothalamus
  1215. Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of CORTICOTROPIN โ€“RELEASING FACTOR does not affect the behavioral response to โ€ฆ
  1216. A single-point slight alteration set as a tool for structureโˆ’ activity relationship studies of ovine CORTICOTROPIN RELEASING FACTOR
  1217. Neuroimmune Mechanisms of Intestinal Responses to Stress: Role of CORTICOTROPIN โ€RELEASING FACTOR and Neurotensin
  1218. Chronic stress enhances vasopressin but not CORTICOTROPIN โ€“RELEASING FACTOR secretion during hypoglycemia
  1219. CORTICOTROPIN RELEASING FACTOR binding protein (CRF-BP) is expressed in neuronal and astrocytic cells
  1220. Plasma CORTICOTROPIN โ€“RELEASING FACTOR concentrations in the baboon during pregnancy
  1221. Central regulation of gastric emptying of solid nutrient meals by CORTICOTROPIN RELEASING FACTOR
  1222. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells
  1223. CORTICOTROPIN โ€“RELEASING FACTOR enhances brain-derived neurotrophic FACTOR gene expression to facilitate memory retention in rats
  1224. A phase I trial of human CORTICOTROPIN โ€“RELEASING FACTOR (hCRF) in patients with peritumoral brain edema
  1225. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell โ€ฆ
  1226. Constrained CORTICOTROPIN โ€“RELEASING FACTOR Antagonists with i-(i + 3) Gluโˆ’Lys Bridges
  1227. CORTICOTROPIN โ€“RELEASING FACTOR neurotransmission in locus coeruleus: a possible site of antidepressant action
  1228. Cerebrospinal fluid prostaglandins and CORTICOTROPIN RELEASING FACTOR in schizophrenics and controls: relationship to sleep architecture
  1229. Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and CORTICOTROPIN โ€“RELEASING FACTOR in the juvenile rat
  1230. Sensitization of cocaine-stimulated increase in extracellular levels of CORTICOTROPIN โ€“RELEASING FACTOR from the rat amygdala after repeated administration as determined โ€ฆ
  1231. CORTICOTROPIN โ€“RELEASING FACTOR produces a protein synthesisโ€“dependent long-lasting potentiation in dentate gyrus neurons
  1232. The modulatory role of estrogens on CORTICOTROPIN โ€RELEASING FACTOR gene expression in the hypothalamic paraventricular nucleus of ovariectomized rats: Role of the โ€ฆ
  1233. CORTICOTROPIN โ€“RELEASING FACTOR modulates dietary preference in nutritionally and physically stressed rats
  1234. Peripheral CORTICOTROPIN โ€“RELEASING FACTOR mediates the elevation of plasma IL-6 by immobilization stress in rats
  1235. Single point D-substituted CORTICOTROPIN โ€“RELEASING FACTOR analogs: effects on potency and physicochemical characteristics
  1236. CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin, and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local โ€ฆ
  1237. Stress and autoimmunity: the neuropeptides CORTICOTROPIN โ€“RELEASING FACTOR and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary โ€ฆ
  1238. CORTICOTROPIN โ€“RELEASING FACTOR upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes
  1239. Mutation and expression analysis of CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor in adrenoCORTICOTROPIN -secreting pituitary adenomas
  1240. Pulsatile fluctuations of plasmaโ€gonadotropinโ€RELEASING hormone and CORTICOTROPIN โ€RELEASING FACTOR levels in healthy pregnant women
  1241. Urocortin, a CORTICOTROPIN โ€“RELEASING FACTOR -related mammalian peptide, inhibits edema due to thermal injury in rats
  1242. Physiological role of CORTICOTROPIN โ€“RELEASING FACTOR in the control of adrenoCORTICOTROPIN -mediated corticosterone release from the rat adrenal gland.
  1243. CORTICOTROPIN โ€RELEASING FACTOR in the caudal pontine reticular nucleus mediates the expression of fearโ€potentiated startle in the rat
  1244. Ultrastructural localization of the CORTICOTROPIN โ€RELEASING FACTOR โ€“binding protein in rat brain and pituitary
  1245. Microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR into the nucleus accumbens shell results in increased behavioral arousal and oral motor activity
  1246. Mediation of osmoregulatory influences on neuroendocrine CORTICOTROPIN โ€“RELEASING FACTOR expression by the ventral lamina terminalis
  1247. Functional impairment of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR neurons with immunotargeted toxins enhances food intake induced by neuropeptide Y
  1248. Localization of CORTICOTROPIN โ€“RELEASING FACTOR in primary and secondary lymphoid organs of the rat
  1249. Astressin, a CORTICOTROPIN RELEASING FACTOR antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala
  1250. Effects of single and repeated immobilization stress on CORTICOTROPIN โ€“RELEASING FACTOR concentrations in discrete rat brain regions
  1251. Immunohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR in the brain and CORTICOTROPIN โ€“RELEASING FACTOR and thyrotropin-stimulating hormone in the pituitary of โ€ฆ
  1252. Role of CORTICOTROPIN โ€“RELEASING FACTOR and substance P in pressor responses of nuclei controlling emotion and stress
  1253. Chronic treatment with CP-55,940 regulates CORTICOTROPIN RELEASING FACTOR and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat
  1254. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR mRNA and immunoreactivity in the central auditory system of the rat
  1255. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฒ messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines
  1256. Structureโ€“function relationship of different domains of the rat CORTICOTROPIN โ€“RELEASING FACTOR receptor
  1257. Mechanisms underlying the anti-inflammatory actions of central CORTICOTROPIN โ€“RELEASING FACTOR
  1258. CORTICOTROPIN RELEASING FACTOR stimulation test in obsessive compulsive disorder.
  1259. Characterization of a sheep brain CORTICOTROPIN RELEASING FACTOR binding protein
  1260. Expression of genes encoding CORTICOTROPIN โ€“RELEASING FACTOR (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human โ€ฆ
  1261. Involvement of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR neurons in behavioral responses to novelty in rats
  1262. Reduced CORTICOTROPIN โ€“RELEASING FACTOR and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction
  1263. Role for brain CORTICOTROPIN โ€“RELEASING FACTOR in the weight-reducing effects of chronic fenfluramine treatment in rats
  1264. Cloning and characterization of a short variant of the CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype from rat amygdala
  1265. Effect of uteroplacental insufficiency upon brain neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR gene expression and concentrations
  1266. Local tetrodotoxin blocks chronic stress effects on CORTICOTROPIN โ€RELEASING FACTOR and vasopressin messenger ribonucleic acids in hypophysiotropic neurons
  1267. Chlordiazepoxide attenuates stress-induced activation of neurons, CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene transcription and CRF biosynthesis in the paraventricular โ€ฆ
  1268. Evidence for a role of nitric oxide in the CORTICOTROPIN โ€“RELEASING FACTOR release induced by interleukin-1ฮฒ
  1269. Differentiated hemodynamic responses to central versus peripheral administration of CORTICOTROPIN โ€“RELEASING FACTOR in conscious rats
  1270. Modulatory Actions of CORTICOTROPIN โ€RELEASING FACTOR โ€“binding Proteina
  1271. CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin mRNA levels in roman high-and low-avoidance rats: response to open-field exposure
  1272. Effects of third intracerebroventricular injections of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on ethanol drinking and food intake
  1273. CORTICOTROPIN RELEASING FACTOR in the brain of the gymnotiform fish, Apteronotus leptorhynchus: immunohistochemical studies combined with neuronal tract tracing
  1274. CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1 receptors in the brain-endocrine-immune axis. Role in stress response and infection.
  1275. Anti-neoplastic properties of human CORTICOTROPIN RELEASING FACTOR : involvement of the nitric oxide pathway.
  1276. Cellular localization of CORTICOTROPIN RELEASING FACTOR mRNA in the ovine brain
  1277. Assignment of disulfide bonds in CORTICOTROPIN โ€“RELEASING FACTOR -binding protein.
  1278. Potential CORTICOTROPIN โ€RELEASING FACTOR pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the โ€ฆ
  1279. Interferon-ฮฑ and transforming growth FACTOR -ฮฒ1 regulate CORTICOTROPIN โ€“RELEASING FACTOR release from the amygdala: Comparison with the hypothalamic response
  1280. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein: origins and possible functions
  1281. Urocortin, a newly identified CORTICOTROPIN โ€“RELEASING FACTOR -related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from โ€ฆ
  1282. In vivo effects of CORTICOTROPIN โ€“RELEASING FACTOR in pregnant rats
  1283. Signaling properties of mouse and human CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors: decreased coupling efficiency of human type II CRF receptor
  1284. CORTICOTROPIN โ€RELEASING FACTOR (CRF), CRFโ€binding protein (CRFโ€BP), and CRF/CRFโ€BP complex in Alzheimerโ€™s disease and control postmortem human brain
  1285. Enhancement of performance in multiple learning tasks by CORTICOTROPIN โ€“RELEASING FACTOR -binding protein ligand inhibitors
  1286. CORTICOTROPIN โ€RELEASING FACTOR Administered Centrally, but Not Peripherally, Stimulates Hippocampal Acetylcholine Release
  1287. CORTICOTROPIN โ€“RELEASING FACTOR antagonists
  1288. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR in the retrieval process of fear-conditioned ultrasonic vocalization in rats
  1289. Chronic imipramine, L-sulpiride and mianserin decrease CORTICOTROPIN RELEASING FACTOR levels in the rat brain
  1290. Critical role of endogenous CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the mediation of the behavioral action of cocaine in rats
  1291. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats
  1292. Human placenta, chorion, amnion and decidua express different variants of CORTICOTROPIN โ€“RELEASING FACTOR receptor messenger RNA
  1293. Structure and function of the ovine type 1 CORTICOTROPIN RELEASING FACTOR receptor (CRF1) and a carboxyl-terminal variant
  1294. CORTICOTROPIN RELEASING FACTOR neurons are innervated by calcitonin gene-related peptide terminals in the rat central amygdaloid nucleus
  1295. CORTICOTROPIN โ€“RELEASING FACTOR : an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury
  1296. Antisense oligonucleotides to CORTICOTROPIN โ€“RELEASING FACTOR impair memory retention and increase exploration in rats
  1297. Secretion of immunoreactive CORTICOTROPIN RELEASING FACTOR and adrenocorticotropic hormone by T-and B-lymphocytes in response to cellular stress FACTOR s
  1298. Recent progress in CORTICOTROPIN โ€“RELEASING FACTOR receptor agents
  1299. โ€ฆ endotoxin increases steady-state gene expression of hypothalamic nitric oxide synthase: comparison with CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin gene โ€ฆ
  1300. Neuroendocrine suppression of female courtship in a wild passerine: CORTICOTROPIN โ€RELEASING FACTOR and endogenous opioids
  1301. Behavioral and physiological consequences of repeated daily intracerebroventricular injection of CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  1302. CORTICOTROPIN โ€“RELEASING FACTOR modulation of Ca2+ influx in rat pancreatic beta-cells.
  1303. Activin A, CORTICOTROPIN โ€“RELEASING FACTOR and prostaglandin F2ฮฑ increase immunoreactive oxytocin release from cultured human placental cells
  1304. CORTICOTROPIN โ€“RELEASING FACTOR enhances locomotion and medullary neuronal firing in an amphibian
  1305. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal
  1306. Mouse strain differences in the behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and the CRF antagonist ฮฑ-helical CRF9โ€“41
  1307. Distribution of CORTICOTROPIN โ€RELEASING FACTOR โ€like immunoreactivity in squirrel monkey (Saimiri sciureus) amygdala
  1308. Sites of origin of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactive projection fibers to the paraventricular thalamic nucleus in the rat
  1309. CORTICOTROPIN โ€“RELEASING FACTOR type 1 and type 2ฮฑ receptors regulate phosphorylation of calcium/cyclic adenosine 3โ€ฒ, 5โ€ฒ-monophosphate response element-binding โ€ฆ
  1310. Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR receptors in the locus coeruleus attenuates shock-induced freezing in rats
  1311. Effect of CORTICOTROPIN โ€“RELEASING FACTOR antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats
  1312. Role of regional neurotransmitter receptors in CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-mediated modulation of fear conditioning
  1313. Transcriptional activation of the macrophage migration-inhibitory FACTOR gene by the CORTICOTROPIN โ€“RELEASING FACTOR is mediated by the cyclic adenosine 3โ€ฒ, 5 โ€ฆ
  1314. Central administration of saikosaponin-d increases CORTICOTROPIN โ€“RELEASING FACTOR mRNA levels in the rat hypothalamus
  1315. CORTICOTROPIN โ€“RELEASING FACTOR , stress, and animal behavior.
  1316. Pituitary adenylate cyclase-activating peptide gene expression in CORTICOTROPIN โ€“RELEASING FACTOR -containing parvicellular neurons of the rat hypothalamic paraventricular โ€ฆ
  1317. Solution structure of human CORTICOTROPIN RELEASING FACTOR by 1H NMR and distance geometry with restrained molecular dynamics
  1318. Expression of ionotropic glutamate receptor subunit mRNAs by paraventricular CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurons
  1319. Differential effects of two CORTICOTROPIN โ€“RELEASING FACTOR antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus)
  1320. Regional binding to CORTICOTROPIN RELEASING FACTOR receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal
  1321. Changes in brain CORTICOTROPIN โ€“RELEASING FACTOR messenger RNA expression in aged Fischer 344 rats
  1322. Hypertensive rats exhibit heightened expression of CORTICOTROPIN โ€“RELEASING FACTOR in activated central neurons in response to restraint stress
  1323. The role of the fourth extracellular domain of the rat CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 in ligand binding
  1324. CORTICOTROPIN โ€“RELEASING FACTOR activates the noradrenergic neuron system in the rat brain
  1325. Nifedipine and verapamil block the memory-facilitating effect of CORTICOTROPIN โ€“RELEASING FACTOR in rats
  1326. Stress-induced genetic expression of a selective CORTICOTROPIN โ€“RELEASING FACTOR -receptor subtype within the rat ovaries: an effect dependent on the ovulatory cycle
  1327. Role of endogenous CORTICOTROPIN RELEASING FACTOR in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats
  1328. Effects of peripherally administered CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and a CRF antagonist: Does peripheral CRF activity mediate behavior of guinea pig pups โ€ฆ
  1329. The role of CORTICOTROPIN โ€“RELEASING FACTOR in the pathophysiology of psychiatric disorders
  1330. Suppression of in vitro antibody production by CORTICOTROPIN โ€“RELEASING FACTOR neurohormone
  1331. CORTICOTROPIN โ€“RELEASING FACTOR modulation of the ultrasonic vocalization rate of isolated rat pups
  1332. Peripheral injection of a new CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonist, astressin, blocks peripheral CRF-and abdominal surgery-induced delayed gastric โ€ฆ
  1333. Role of arginine vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR in mediating alcohol-induced adrenoCORTICOTROPIN and vasopressin secretion in male rats bearing โ€ฆ
  1334. Stimulation by CORTICOTROPIN โ€“RELEASING FACTOR of the release of immunoreactive dynorphin A from mouse spinal cords in vitro
  1335. Increased CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in select brain sites following kainate-elicited seizures
  1336. ฮฑ1-Adrenergic and dopaminergic receptors are involved in the anoretic effect of CORTICOTROPIN โ€“RELEASING FACTOR in goldfish
  1337. Synthesis, CORTICOTROPIN โ€“RELEASING FACTOR receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and-pyridines
  1338. Urocortin interaction with CORTICOTROPIN โ€“RELEASING FACTOR (CRF) binding protein (CRF-BP): a novel mechanism for elevating โ€˜freeโ€™CRF levels in human brain
  1339. Expression of CORTICOTROPIN โ€“RELEASING FACTOR mRNA in response to stress
  1340. CORTICOTROPIN โ€“RELEASING FACTOR binding protein dimerizes after association with ligand
  1341. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonist suppresses stress-induced locomotor activity in an amphibian
  1342. Reciprocal cross-desensitization of locus coeruleus electrophysiological responsivity to CORTICOTROPIN โ€“RELEASING FACTOR and stress
  1343. Immuno-reactive and bioactive CORTICOTROPIN โ€“RELEASING FACTOR in rat thymus
  1344. Carbon monoxide modulates secretion of CORTICOTROPIN โ€“RELEASING FACTOR from rat hypothalamic cell cultures
  1345. Human interleukin 1ฮฒ: CORTICOTROPIN RELEASING FACTOR and ACTH RELEASING and gene expression in the male rat: In vivo and in vitro studies
  1346. Immortalization of a fetal rat brain cell line that expresses CORTICOTROPIN โ€“RELEASING FACTOR mRNA
  1347. Effect of central CORTICOTROPIN โ€“RELEASING FACTOR on carbon tetrachloride-induced acute liver injury in rats
  1348. Chlordiazepoxide attenuates stress-induced accumulation of CORTICOTROPIN โ€“RELEASING FACTOR mRNA in the paraventricular nucleus
  1349. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor messenger ribonucleic acid in rat anterior pituitary
  1350. The distribution of CORTICOTROPIN โ€“RELEASING FACTOR (CRF), CRF binding sites and CRF1 receptor mRNA in the mouse cerebellum
  1351. Antidepressant interactions with CORTICOTROPIN โ€“RELEASING FACTOR in the noradrenergic nucleus locus coeruleus.
  1352. Role of CORTICOTROPIN โ€“RELEASING FACTOR in forced swimming test
  1353. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR mRNA in neuroendocrine and autonomic neurons by osmotic stimulation and volume loading
  1354. CORTICOTROPIN โ€“RELEASING FACTOR -induced immunosuppression in human and invertebrate immunocytes
  1355. Effects of generalized convulsive seizures on CORTICOTROPIN โ€“RELEASING FACTOR neuronal systems
  1356. Functional CORTICOTROPIN โ€“RELEASING FACTOR receptors in human neuroblastoma cells
  1357. Central actions of CORTICOTROPIN โ€“RELEASING FACTOR on autonomic nervous activity and cardiovascular functioning
  1358. High levels of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy โ€ฆ
  1359. CORTICOTROPIN โ€“RELEASING FACTOR mediated muscle atonia in pons and medulla
  1360. Hypophysiotropic role and hypothalamic gene expression of CORTICOTROPIN โ€RELEASING FACTOR and vasopressin in rats injected with interleukinโ€1ฮฒ systemically or into the โ€ฆ
  1361. Structure of equine CORTICOTROPIN RELEASING FACTOR
  1362. Peripheral blood CORTICOTROPIN โ€“RELEASING FACTOR , adrenocorticotropic hormone and cytokine (interleukin beta, interleukin 6, tumor necrosis FACTOR alpha) levels after high โ€ฆ
  1363. Pregnane steroid alphaxalone attenuates anxiogenic behavioral effects of CORTICOTROPIN RELEASING FACTOR and stress
  1364. Amygdala-kindled seizures increase the expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus
  1365. Antagonism of morphine antinociception by intrathecally administered CORTICOTROPIN โ€“RELEASING FACTOR in mice.
  1366. The effect of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on the gonadotropin hormone RELEASING hormone (GnRH) hypothalamic neuronal system during preovulatory period โ€ฆ
  1367. โ€ฆ of 5-HT2A receptors in the paraventricular hypothalamus attenuates neuropeptide Y-induced hyperphagia through activation of CORTICOTROPIN RELEASING FACTOR
  1368. CORTICOTROPIN โ€“RELEASING FACTOR stimulates Ca2+ influx in cultured rat astrocytes
  1369. CORTICOTROPIN โ€“RELEASING FACTOR antagonists, binding-protein and receptors: implications for central nervous system disorders
  1370. Alterations in CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and โ€ฆ
  1371. Stimulation of the amygdala by glutamate facilitates CORTICOTROPIN โ€“RELEASING FACTOR release from the median eminence and activation of the hypothalamic-pituitary โ€ฆ
  1372. Origins of cerebellar mossy and climbing fibers immunoreactive for CORTICOTROPIN โ€RELEASING FACTOR in the rabbit
  1373. Regional neuropeptide pathology in Alzheimerโ€™s disease: CORTICOTROPIN โ€“RELEASING FACTOR and somatostatin
  1374. Regulation of CORTICOTROPIN โ€RELEASING FACTOR receptor function in human Yโ€79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged โ€ฆ
  1375. CORTICOTROPIN โ€“RELEASING FACTOR and schedule-induced polydipsia
  1376. Ovulatory cycle influences the stimulatory effect of stress on the expression of CORTICOTROPIN โ€“RELEASING FACTOR receptor messenger ribonucleic acid in the paraventricular โ€ฆ
  1377. Age-related alterations in emotional behaviors and amygdalar CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein expression in aged Fischer 344 rats
  1378. Mapping of the ligand-selective domain of the Xenopus laevis CORTICOTROPIN โ€“RELEASING FACTOR receptor 1: implications for the ligand-binding site
  1379. The alternatively spliced type II CORTICOTROPIN โ€“RELEASING FACTOR receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein (s)
  1380. The ligandโ€selective domains of CORTICOTROPIN โ€RELEASING FACTOR type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors โ€ฆ
  1381. Endotoxin decreases CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 messenger ribonucleic acid levels in the rat pituitary
  1382. Transcriptional regulation of human placental CORTICOTROPIN โ€“RELEASING FACTOR by prostaglandins and estradiol
  1383. Expression of CORTICOTROPIN โ€“RELEASING FACTOR in the peripheral nervous system of the rat
  1384. CORTICOTROPIN โ€“RELEASING FACTOR increases dihydropyridine-and neurotoxin-resistant calcium currents in neurons of the central amygdala
  1385. Lactation abolishes CORTICOTROPIN โ€“RELEASING FACTOR -induced oxytocin secretion in the conscious rat
  1386. Interaction between CORTICOTROPIN โ€“RELEASING FACTOR and nitric oxide in mediating the response of the rat hypothalamus to immune and non-immune stimuli
  1387. CORTICOTROPIN โ€“RELEASING FACTOR enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis.
  1388. Effect of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in โ€ฆ
  1389. โ€ฆ anabolic steroid, nandrolone decanoate, on adrenoCORTICOTROPIN hormone, corticosterone and proopiomelanocortin, CORTICOTROPIN RELEASING FACTOR (CRF) and CRF โ€ฆ
  1390. Downregulation of CORTICOTROPIN โ€“RELEASING FACTOR mRNA, but not vasopressin mRNA, in the paraventricular hypothalamic nucleus of rats following nutritional stress
  1391. Expression of receptors for CORTICOTROPIN โ€“RELEASING FACTOR in the vasculature of pregnant rats
  1392. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage
  1393. Intracerebroventricular administration of CORTICOTROPIN โ€“RELEASING FACTOR antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress
  1394. CORTICOTROPIN โ€“RELEASING FACTOR alone, but not arginine vasopressin alone, stimulates the release of adrenoCORTICOTROPIN in the conscious intact sheep
  1395. Characterization and regulation of CORTICOTROPIN โ€“RELEASING FACTOR in the human hepatoma NPLC-KC cell line
  1396. Dilatory and inotropic effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on the isolated heart
  1397. CORTICOTROPIN โ€“RELEASING FACTOR and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of โ€ฆ
  1398. Studies of the secretion of CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central โ€ฆ
  1399. Stimulation of adrenoCORTICOTROPIN secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not CORTICOTROPIN โ€“RELEASING FACTOR .
  1400. Cushingโ€™s syndrome caused by Ewingโ€™s sarcoma secreting CORTICOTROPIN RELEASING FACTOR -like peptide
  1401. CORTICOTROPIN RELEASING FACTOR inhibits proliferation of AtT-20 cells
  1402. Intracerebroventricular CORTICOTROPIN โ€“RELEASING FACTOR decreases food intake in white-crowned sparrows
  1403. Early development of cerebellar afferent systems that contain CORTICOTROPIN โ€RELEASING FACTOR
  1404. Growth hormone response to clonidine in adversely reared young adult primates: relationship to serial cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR concentrations
  1405. Evidence that CORTICOTROPIN โ€“RELEASING FACTOR within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat
  1406. CORTICOTROPIN RELEASING FACTOR Receptor Type II (CRF2) Messenger Ribonucleic Acid Levels in the Hypothalamic Ventromedial Nucleus of the Infant Rat Are โ€ฆ
  1407. Inactivation of early glucocorticoid feedback by CORTICOTROPIN โ€“RELEASING FACTOR in vitro.
  1408. Adrenocorticotropic hormone and cortisol response to CORTICOTROPIN โ€“RELEASING FACTOR and lysine vasopressin in pigs
  1409. Effect of CORTICOTROPIN RELEASING FACTOR receptor 1 antagonist on extracellular norepinephrine, dopamine and serotonin in hippocampus and prefrontal cortex of rats in โ€ฆ
  1410. CORTICOTROPIN โ€“RELEASING FACTOR antagonists as novel psychotherapeutics
  1411. Time-dependent alterations in CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in different brain regions after acute cocaine administration to rats
  1412. CORTICOTROPIN โ€“RELEASING FACTOR -like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells
  1413. Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in anxiety.
  1414. N-methyl-D-aspartate (NMDA)-mediated CORTICOTROPIN โ€“RELEASING FACTOR (CRF) release in cultured rat amygdala neurons
  1415. The CORTICOTROPIN RELEASING FACTOR stimulation test in patients with major depression: relationship to dexamethasone suppression test results
  1416. Effect of adrenalectomy and stress on interleukin-1ฮฒ-mediated activation of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR mRNA
  1417. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1
  1418. Glutamate and Nโ€Methylโ€Dโ€Aspartate Stimulate Rat Hypothalamic CORTICOTROPIN โ€RELEASING FACTOR Secretion in vitro
  1419. CORTICOTROPIN RELEASING FACTOR induces proliferation of cerebellar astrocytes
  1420. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine CORTICOTROPIN โ€“RELEASING FACTOR in the brain of โ€ฆ
  1421. Effect of acute CORTICOTROPIN RELEASING FACTOR on pituitary-adrenocortical responsiveness in elderly women and men
  1422. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene family in the brain of the teleost fish Catostomus commersoni (white sucker): molecular analysis predicts distinct precursors โ€ฆ
  1423. CORTICOTROPIN RELEASING FACTOR in the embryonic mouse cerebellum
  1424. Steady-state methadone in rats does not change mRNA levels of CORTICOTROPIN โ€“RELEASING FACTOR , its pituitary receptor or proopiomelanocortin
  1425. Synthesis and characterization of a photoactivatable analog of CORTICOTROPIN โ€“RELEASING FACTOR for specific receptor labeling
  1426. Intracerebroventricularly administered CORTICOTROPIN โ€RELEASING FACTOR inhibits food intake and produces anxietyโ€like behaviour at very low doses in mice
  1427. Shortโ€and longโ€term consequences of CORTICOTROPIN โ€RELEASING FACTOR in early development
  1428. Role of arachidonic acid metabolism on CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-release induced by interleukin-1 from superfused rat hypothalami
  1429. The effects of alprazolam on CORTICOTROPIN โ€“RELEASING FACTOR neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders
  1430. Local injections of CORTICOTROPIN RELEASING FACTOR reduce doxorubicin-induced acute inflammation in the eyelid.
  1431. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures
  1432. A radioimmunoassay of CORTICOTROPIN RELEASING FACTOR of hypothalamus in Ochotona curzoniae
  1433. Evaluation of CORTICOTROPIN RELEASING FACTOR stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients
  1434. Further characterization of the behavioral effects of peripherally administered CORTICOTROPIN โ€“RELEASING FACTOR in guinea pigs
  1435. CORTICOTROPIN โ€“RELEASING FACTOR gene expression
  1436. CORTICOTROPIN โ€“RELEASING FACTOR Up-Regulates Its Own Receptor Gene Expression in Corticotropic Adenoma Cells in Vitro
  1437. โ€ฆ neuropeptide Y messenger ribonucleic acid levels in preโ€obese and genetically obese (fa/fa) rats; potential regulation thereof by CORTICOTROPIN โ€RELEASING FACTOR
  1438. CORTICOTROPIN โ€“RELEASING FACTOR inhibits luteinizing hormone-stimulated P450c17 gene expression and androgen production by isolated thecal cells of human ovarian โ€ฆ
  1439. โ€ฆ -induced adrenoCORTICOTROPIN secretion in the developing rat through a central mechanism independent from CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin
  1440. Endothelium-dependent and-independent mechanisms of vasorelaxation by CORTICOTROPIN โ€“RELEASING FACTOR in pregnant rat uterine artery
  1441. Cord plasma CORTICOTROPIN โ€“RELEASING FACTOR -binding protein (CRF-BP) in term and preterm labour
  1442. Effects of intravenous administration of interleukin-1-beta on the release of prostaglandin E2, CORTICOTROPIN โ€“RELEASING FACTOR , and arginine vasopressin in several โ€ฆ
  1443. Antagonism by pivagabine of stress-induced changes in GABAA receptor function and CORTICOTROPIN โ€“RELEASING FACTOR concentrations in rat brain
  1444. The effect of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on autonomic and behavioral responses during shock-prod burying test in rats
  1445. Developmental expression of CORTICOTROPIN โ€“RELEASING FACTOR in the postnatal murine cerebellum
  1446. The role of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin in hypoglycemia-induced proopiomelanocortin gene expression in the rat anterior pituitary gland
  1447. In situ hybridization of CORTICOTROPIN โ€“RELEASING FACTOR -encoding messenger RNA in the hypothalamus of the white sucker, Catostomus commersoni
  1448. Synaptic associations between oxytocin-containing magnocellular neurons and neurons containing CORTICOTROPIN โ€“RELEASING FACTOR in the rat magnocellular โ€ฆ
  1449. Role of brain, pituitary and spleen CORTICOTROPIN โ€“RELEASING FACTOR receptors in the stress response.
  1450. Noradrenergic inhibition of canine gallbladder contraction and murine pancreatic secretion during stress by CORTICOTROPIN โ€“RELEASING FACTOR .
  1451. CORTICOTROPIN โ€“RELEASING FACTOR -induced production of cyclic AMP by human peripheral blood immunocytes
  1452. Beta-endorphin inhibits hypoglycemia-induced gene expression of CORTICOTROPIN โ€“RELEASING FACTOR in the rat hypothalamus.
  1453. D-Fenfluramine induces serotonin-mediated Fos expression in CORTICOTROPIN โ€“RELEASING FACTOR and oxytocin neurons of the hypothalamus, and serotonin-independent โ€ฆ
  1454. The relaxation responses to CORTICOTROPIN โ€“RELEASING FACTOR in rat aorta are endothelium dependent and gestationally regulated
  1455. CORTICOTROPIN โ€“RELEASING FACTOR inhibition of substance P-induced vascular leakage in rats: possible sites of action
  1456. Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and CORTICOTROPIN โ€“RELEASING FACTOR -induced colonic motor โ€ฆ
  1457. CORTICOTROPIN โ€RELEASING FACTOR Binding Sites Undergo Axonal Transport in the Rat Vagus Nerve
  1458. Permissive role of CORTICOTROPIN โ€“RELEASING FACTOR in the acute stress-induced prolactin release in female rats
  1459. Localization of CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in the brain of the teleost Sparus aurata
  1460. CORTICOTROPIN โ€“RELEASING FACTOR and anorexia nervosa: reactions of the hypothalamus-pituitary-adrenal axis to neurotropic stress
  1461. CORTICOTROPIN โ€RELEASING FACTOR accelerates metamorphosis in Bufo arenarum: Effect on pituitary ACTH and TSH cells
  1462. CORTICOTROPIN โ€“RELEASING FACTOR โ€“immunolabeled fibers in brain regions with localized kainate neurotoxicity
  1463. Nonโ€adrenoCORTICOTROPIN mediated effects of endogenous CORTICOTROPIN โ€RELEASING FACTOR on the adrenocortical activity in the rat
  1464. Ontogeny of hypothalamic CORTICOTROPIN โ€RELEASING FACTOR and anterior pituitary proโ€opiomelanocortin expression in male and female offspring of alcoholโ€exposed and โ€ฆ
  1465. CORTICOTROPIN โ€“RELEASING FACTOR modulates basal and stress-induced excitatory amino acid release in the locus coeruleus of conscious rats
  1466. Effects of CORTICOTROPIN RELEASING FACTOR on the production of adrenocorticotropic hormone by leukocyte populations
  1467. The presence of CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the โ€ฆ
  1468. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on prostaglandin synthesis in endothelial cells and fibroblasts
  1469. Activation of CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the paraventricular nucleus of the hypothalamus by interleukin-1 in the rat
  1470. Buspirone inhibits CORTICOTROPIN โ€“RELEASING FACTOR and stress-induced cecal motor response in rats by acung through 5-HT1A receptors
  1471. Activation of L-type calcium channels induces CORTICOTROPIN โ€“RELEASING FACTOR secretion from human placental trophoblasts
  1472. The acute effects of CORTICOTROPIN โ€“RELEASING FACTOR on energy expenditure in lean and obese women.
  1473. Fourth ventricle injection of CORTICOTROPIN โ€“RELEASING FACTOR and gastric emptying of glucose during gastric fill
  1474. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein expression in amygdalar neuronal cultures
  1475. Effect of chronic active immunization anti-CORTICOTROPIN โ€“RELEASING FACTOR on the pituitary-adrenal function in the sheep.
  1476. โ€ฆ โ€“RELEASING Hormone, ฮฑ-Melanocyte-Stimulating Hormone, Naloxone, Dexamethasone and Indomethacin on lnterleukin-2-lnduced CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  1477. Immunocytochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR in the brain of the turtle, Mauremys caspica
  1478. Cleavage of recombinant human CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-binding protein produces a 27-kilodalton fragment capable of binding CRF
  1479. Immunosuppressive phenotype of CORTICOTROPIN โ€“RELEASING FACTOR transgenic mice is reversed by adrenalectomy
  1480. Coordinate and divergent regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line
  1481. Pavlovian conditioning of CORTICOTROPIN โ€RELEASING FACTOR โ€induced increase of blood pressure and corticosterone secretion in the rat
  1482. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive neurons in the brain of the tigerfrog, Rana tigrina
  1483. Anorectic action of bombesin requires receptor for CORTICOTROPIN โ€“RELEASING FACTOR but not for oxytocin
  1484. CORTICOTROPIN โ€“RELEASING FACTOR enhances sodium and water intake/excretion in rabbits
  1485. Functional, endogenously expressed CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH โ€ฆ
  1486. Existence of mutual synaptic relations between CORTICOTROPIN โ€“RELEASING FACTOR -containing and somatostatin-containing neurons in the rat hypothalamus
  1487. CORTICOTROPIN โ€“RELEASING FACTOR receptor blockade enhances conditioned aversive properties of cocaine in rats
  1488. Effect of 6-hydroxydopamine on neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR expression in rat amygdala
  1489. CORTICOTROPIN โ€“RELEASING FACTOR induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in โ€ฆ
  1490. Saireito (a Chinese herbal drug)-stimulated secretion and synthesis of pituitary ACTH are mediated by hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  1491. CORTICOTROPIN โ€“RELEASING FACTOR inhibits the acute inflammatory response of rat pawskin to cold injury
  1492. Trans-acting FACTOR s dictate the species-specific placental expression of CORTICOTROPIN โ€“RELEASING FACTOR genes in choriocarcinoma cell lines
  1493. Intracisternal sauvagine is more potent than CORTICOTROPIN โ€“RELEASING FACTOR to decrease gastric vagal efferent activity in ratsโ˜†
  1494. Characterization of neuropeptide Y-mediated CORTICOTROPIN โ€“RELEASING FACTOR synthesis and release from human placental trophoblasts
  1495. Comparative localization of CORTICOTROPIN and CORTICOTROPIN RELEASING FACTOR -like peptides in the brain and hypophysis of a primitive vertebrate, the sturgeonAcipenser โ€ฆ
  1496. โ€ฆ stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the rat โ€ฆ
  1497. CORTICOTROPIN RELEASING FACTOR -like immunoreactivity in afferent projections to the sacral spinal cord of the cat
  1498. Repeated stress, like vasopressin, sensitizes the excitatory effects of CORTICOTROPIN RELEASING FACTOR on the acoustic startle reflex
  1499. Central neuropeptide Y and the sigma ligand, JO 1784, reverse CORTICOTROPIN โ€RELEASING FACTOR โ€induced inhibition of gastric acid secretion in rats
  1500. Luteinizing hormone secretion and CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis โ€ฆ
  1501. Epinephrine-induced pulmonary oedema in rats is inhibited by CORTICOTROPIN โ€“RELEASING FACTOR
  1502. Constrained CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Agonists and Antagonists with iโˆ’(i+3) Glu-Xaa-dXbb-Lys Bridges
  1503. Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1 alpha in the primate
  1504. Homologous desensitization of human CORTICOTROPIN โ€“RELEASING FACTOR , receptor in stable transfected mouse fibroblast cells
  1505. The effect of CORTICOTROPIN โ€“RELEASING FACTOR and pro-opiomelanocortin-derived peptides on the phagocytosis of molluscan hemocytes
  1506. Cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR increases following haloperidol withdrawal in chronic schizophrenia
  1507. The effect of acute immobilization stress on the abundance of CORTICOTROPIN โ€“RELEASING FACTOR receptor in lymphoid organs
  1508. โ€ฆ produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and CORTICOTROPIN RELEASING FACTOR gene expression in the hypothalamus โ€ฆ
  1509. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and CORTICOTROPIN โ€“RELEASING FACTOR in rats
  1510. Peripheral administration of a CORTICOTROPIN โ€“RELEASING FACTOR antagonist increases the vocalizing and locomotor activity of isolated guinea pig pups
  1511. Alteration of CORTICOTROPIN โ€RELEASING FACTOR immunoreactivity in MPTPโ€treated rats
  1512. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR and calcitonin generelated peptide in the developing mouse cerebellum
  1513. Involvement of endogenous CORTICOTROPIN โ€“RELEASING FACTOR in mediation of neuroendocrine and behavioral effects to alpha-melanocyte-stimulating hormone
  1514. Differential regulation of CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic โ€ฆ
  1515. Minimal-Size, Constrained CORTICOTROPIN โ€“RELEASING FACTOR Agonists with iโˆ’(i+3) Gluโˆ’Lys and Lysโˆ’Glu Bridges
  1516. The distribution of CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive neurons and nerve fibers in the brain of the snake, Natrix maura
  1517. Ontogeny and molecular weight of immunoreactive arginine vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR in the ovine fetal hypothalamus
  1518. โ€ฆ of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR
  1519. Subcellular distribution of CORTICOTROPIN โ€“RELEASING โ€“FACTOR -like immunoreactivity in rat central nervous system
  1520. CORTICOTROPIN RELEASING FACTOR and substance P mediate the nucleus amygdaloideus centralis-nucleus ventromedialis-nucleus dorsomedialis pressor system
  1521. Structureโ€“activity studies on 4-substituted-2-anilinopyrimidine CORTICOTROPIN RELEASING FACTOR (CRF) antagonists
  1522. Localization of CORTICOTROPIN โ€RELEASING FACTOR โ€like immunoreactivity in monkey olFACTOR y bulb and secondary olFACTOR y areas
  1523. Differential effect of low doses of intracerebroventricular CORTICOTROPIN โ€“RELEASING FACTOR in forced swimming test
  1524. Modulation of acute morphine tolerance by CORTICOTROPIN โ€“RELEASING FACTOR and dynorphin A in the mouse spinal cord
  1525. Age-related decreases in CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in rat brain and anterior pituitary gland
  1526. Locus coeruleus electrophysiological activity and responsivity to CORTICOTROPIN โ€“RELEASING FACTOR in inbred hypertensive and normotensive rats
  1527. Postnatal development of regional binding of CORTICOTROPIN โ€“RELEASING FACTOR and adenylate cyclase activity in the rat brain
  1528. The effects of atrial natriuretic peptide (ANP1โ€“28) on CORTICOTROPIN RELEASING FACTOR in brain of rats
  1529. Heterogeneity of CORTICOTROPIN RELEASING FACTOR receptors: multiple targets for the treatment of CNS and inflammatory disorders
  1530. Changes in amniotic fluid immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein levels in pregnant women at term and during labor
  1531. Early glucocorticoid induction of calmodulin and its suppression by CORTICOTROPIN โ€“RELEASING FACTOR in pituitary corticotrope tumor (AtT20) cells
  1532. Influence of CORTICOTROPIN โ€“RELEASING FACTOR on the in vitro thyroxine and thyrotropin secretion in newly hatched fowl
  1533. The effects of brain and C-type natriuretic peptides on CORTICOTROPIN โ€“RELEASING FACTOR in brain of rats
  1534. Measurement of CORTICOTROPIN โ€“RELEASING FACTOR (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in human plasma by two-site enzyme-linked โ€ฆ
  1535. Neuroanatomical connections between CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and somatostatin (SRIF) nerve endings and thyrotropin-RELEASING hormone (TRH) neurons โ€ฆ
  1536. The human neuroblastoma cell line, IMR-32, expresses functional CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1537. Cardiovascular activation by serotonergic stimulation: role of CORTICOTROPIN โ€“RELEASING FACTOR
  1538. Modulation of endothelial prostaglandin synthesis by CORTICOTROPIN RELEASING FACTOR and antagonists
  1539. CORTICOTROPIN โ€“RELEASING FACTOR but not urocortin is involved in adrenalectomy-induced adrenoCORTICOTROPIN release.
  1540. CORTICOTROPIN โ€“RELEASING FACTOR reduces lipopolysaccharide-induced pulmonary vascular leak
  1541. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR messenger RNA by nicotine in an immortalized amygdalar cell line
  1542. Cholecystokinin, neurotensin and CORTICOTROPIN โ€“RELEASING FACTOR , three important anorexic peptides
  1543. Quantitative analysis of tuberoinfundibular tyrosine hydroxylase-and CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive neurons in monkeys raised with differential rearing โ€ฆ
  1544. CORTICOTROPIN โ€“RELEASING FACTOR inhibits antigen-induced plasma extravasation in airways
  1545. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein expression in cultured rat astrocytes.
  1546. Correlation of neuroendocrine and anti-edema activities of alanine-CORTICOTROPIN โ€“RELEASING FACTOR analogs
  1547. CORTICOTROPIN โ€“RELEASING FACTOR in the ovine fetus and pregnant ewe: role of placenta
  1548. CORTICOTROPIN โ€“RELEASING FACTOR receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data
  1549. Regulation of beta-endorphin secretion by CORTICOTROPIN โ€“RELEASING FACTOR in the intact rat testis.
  1550. Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of CORTICOTROPIN RELEASING FACTOR : block by adrenalectomy, by โ€ฆ
  1551. Interactions between CORTICOTROPIN โ€“RELEASING FACTOR and endogenous opiates on the cardioaccelerator, hypothermic, and corticoid responses to restraint in the rat
  1552. CORTICOTROPIN RELEASING FACTOR (CRF) increases postโ€prandial duodenal motor activity in humans
  1553. Second messenger regulation of mRNA for CORTICOTROPIN โ€“RELEASING FACTOR
  1554. The discovery of 4-(3-pentylamino)-2, 7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1, 5-a]-pyrimidine: a CORTICOTROPIN โ€“RELEASING FACTOR (hCRF1) antagonist
  1555. Effects of cocaine and CORTICOTROPIN โ€“RELEASING FACTOR on pulsatile ACTH and cortisol release in ovariectomized rhesus monkeys
  1556. Alpha-Melanocyte-Stimulating Hormone Abolishes IL-1-and IL-6-lnduced CORTICOTROPIN โ€“RELEASING FACTOR Release from the Hypothalamus in vitro
  1557. Regulation of CORTICOTROPIN โ€RELEASING FACTOR Secretion and Synthesis in the Human Neuroblastoma Clonesโ€BE (2)โ€M17 and BE (2)โ€C
  1558. ICV administration of anti-CORTICOTROPIN โ€“RELEASING FACTOR antisense oligonucleotide: effects on feeding behavior and body weight
  1559. Enhanced hippocampal CORTICOTROPIN โ€“RELEASING FACTOR gene expression associated with memory consolidation and memory storage in rats.
  1560. Ovine CORTICOTROPIN โ€“RELEASING FACTOR Increases Endocrine and Immunologic Activity of Avian Leukocytes In Vitro
  1561. Effects of centrally administered CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and ฮฑ-helical CRF on the vocalizations of isolated guinea pig pups
  1562. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on neurons in the hypothalamic paraventricular nucleus in vitro
  1563. Elevated neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR in the brain of a novel epileptic mutant rat: Noda epileptic rat
  1564. Stimulation by CORTICOTROPIN โ€“RELEASING FACTOR of atrial natriuretic peptide and brain natriuretic peptide secretions from cultured neonatal rat cardiomyocytes
  1565. Thyroxine Modulates CORTICOTROPIN โ€RELEASING FACTOR but not Arginine Vasopressin Gene Expression in the Hypothalamic Paraventricular Nucleus of the Developing โ€ฆ
  1566. Central CORTICOTROPIN โ€“RELEASING FACTOR and benzodiazepine receptor systems are involved in the social isolation stress-induced decrease in ethanol sleep in mice
  1567. Cloning and characterization of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin in Syrian hamster (Mesocricetus auratus)
  1568. Interleukin-1 regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF), glucocorticoid receptor, c-fos and c-jun messenger RNA in the NPLC-KC cell line
  1569. Alpha-helical CRF blocks differential influence of CORTICOTROPIN RELEASING FACTOR (CRF) on appetitive and aversive memory retrieval in rats
  1570. Intracerebroventricular administration of ฮฒ-endorphin increases the expression of c-fos and of CORTICOTROPIN โ€“RELEASING FACTOR messenger ribonucleic acid in the โ€ฆ
  1571. CORTICOTROPIN โ€“RELEASING FACTOR and vasoactive intestinal polypeptide activate gene transcription through the cAMP signaling pathway in a catecholaminergic โ€ฆ
  1572. Psychomotor stimulant sensitization: The CORTICOTROPIN โ€“RELEASING FACTOR -steroid connection: Commentary on Wise and Leebโ€ Psychomotor-stimulant sensitization: A โ€ฆ
  1573. CORTICOTROPIN โ€“RELEASING FACTOR increases [Ca2+] i via receptor-mediated Ca2+ channels in human epidermoid A-431 cells
  1574. Effect of CORTICOTROPIN RELEASING FACTOR (CRF) injected into the median eminence on LH secretion in male rats
  1575. Distribution and cerebellar projections of cholinergic and CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the caudal vestibular nuclear complex and adjacent โ€ฆ
  1576. Effects of repeated administration of CORTICOTROPIN โ€“RELEASING FACTOR on schedule-controlled behavior in rats
  1577. Depolarization-induced release of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in primary neuronal cultures of the amygdala
  1578. Effects of metyrapone infusion on CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin secretion into the hypophysial portal blood of conscious, unrestrained rams
  1579. Attenuation of CORTICOTROPIN RELEASING FACTOR -induced hypotension in anesthetized rats with the CRF antagonist, ฮฑ-helical CRF9โ€“41; Comparison with effect on ACTH โ€ฆ
  1580. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and its role in the central nervous system
  1581. โ€ฆ CORTICOTROPIN levels in Addisonโ€™s disease are not associated with increased plasma arginine vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR concentrations in peripheral โ€ฆ
  1582. Interleukin-1ฮฒ and calcitonin, but not CORTICOTROPIN โ€“RELEASING FACTOR , alter sleep cycles when injected into the rat hypothalamic lateral paraventricular area
  1583. Release of CORTICOTROPIN โ€“RELEASING FACTOR from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism
  1584. Plasma levels of luteinizing hormone during hyperprolactinemia: response to central administration of antagonists of CORTICOTROPIN โ€“RELEASING FACTOR
  1585. Optokinetically evoked expression of CORTICOTROPIN โ€“RELEASING FACTOR in inferior olivary neurons of rabbits
  1586. Alterations in food intake and thyroid tissue content by CORTICOTROPIN โ€“RELEASING FACTOR in Tinca tinca.
  1587. โ€ฆ implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of CORTICOTROPIN โ€“RELEASING FACTOR following neural stimuli
  1588. CORTICOTROPIN โ€“RELEASING FACTOR treatment upregulates interleukin-1 receptors in the mouse pituitary: reversal by dexamethasone
  1589. Stimulation of neuropeptide Y overflow in the rat paraventricular nucleus by CORTICOTROPIN โ€RELEASING FACTOR
  1590. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in infant rhesus monkey brain and pituitary gland: biochemical characterization and autoradiographic localization
  1591. The BE (2)-M17 neuroblastoma cell line synthesizes and secretes CORTICOTROPIN โ€“RELEASING FACTOR
  1592. Microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR into the locus coeruleus/subcoeruleus nuclei inhibits gastric acid secretion via spinal pathways in the rat
  1593. Transcriptional regulation of human CORTICOTROPIN RELEASING FACTOR gene expression by cyclic adenosine 3โ€ฒ, 5โ€ฒ-monophosphate: differential effects at proximal and distal โ€ฆ
  1594. Upregulation of interleukin-1 receptors in mouse AtT-20 pituitary tumor cells following treatment with CORTICOTROPIN โ€“RELEASING FACTOR
  1595. Estrogens decrease expression of the CORTICOTROPIN โ€“RELEASING FACTOR gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in the โ€ฆ
  1596. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) binding sites in the opossum cerebellum
  1597. In vivo microdialysis of CORTICOTROPIN RELEASING FACTOR (CRF): calcium dependence of depolarization-induced neurosecretion of CRF
  1598. Rapid communication: molecular cloning of the porcine CORTICOTROPIN โ€“RELEASING FACTOR gene
  1599. Changes of immunoreactive neuropeptide Y, somatostatin and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the brain of a novel epileptic mutant rat, Iharaโ€™s genetically โ€ฆ
  1600. Colocalization of enkephalin-, glucagon-, and CORTICOTROPIN โ€“RELEASING FACTOR -like immunoreactivity in GABAergic amacrine cells in turtle retina
  1601. Immunohistochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR ,[arginine8]-vasopressin and oxytocin neurons in the goat hypothalamus
  1602. CORTICOTROPIN RELEASING FACTOR (CRF) Agonists with Reduced Amide Bonds and Ser7 Substitutions
  1603. CORTICOTROPIN RELEASING FACTOR and ACTH-related fragments modulate the phagocytic activity of human monocytes
  1604. The role of CORTICOTROPIN โ€“RELEASING FACTOR and its receptors in the central nervous system.
  1605. Effect of immobilization stress on transcriptional activity of inducible immediateโ€early genes, CORTICOTROPIN โ€RELEASING FACTOR , its type 1 receptor, and enkephalin in the โ€ฆ
  1606. CORTICOTROPIN โ€“RELEASING FACTOR , but not arginine vasopressin, stimulates concentration-dependent increases in ACTH secretion from a single corticotrope โ€ฆ
  1607. Heterogeneity of the human CORTICOTROPIN โ€“RELEASING FACTOR -binding protein
  1608. Prolonged inflammatory pain modifies CORTICOTROPIN โ€“RELEASING FACTOR -induced opioid peptide release in the hypothalamus
  1609. Peritoneal fluid levels of immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women
  1610. Effect of CORTICOTROPIN RELEASING FACTOR on atrial natriuretic peptide release from the isolated perfused rat heart.
  1611. Biochemical, pharmacological, and autoradiographic methods to study CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1612. Intracerebroventricularly administered CORTICOTROPIN โ€RELEASING FACTOR releases somatostatin through a cholinergic, vagal pathway in freely fed rats
  1613. CORTICOTROPIN โ€“RELEASING FACTOR and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type โ€ฆ
  1614. Cโ€Fos expression as a molecular marker in CORTICOTROPIN โ€RELEASING FACTOR โ€induced seizures
  1615. The degradation of CORTICOTROPIN โ€“RELEASING FACTOR by enzymes of the rat brain studied by liquid chromatographyโ€“mass spectrometry
  1616. CORTICOTROPIN and cortisol responses to CORTICOTROPIN โ€“RELEASING FACTOR in the chronically hypoxemic ovine fetus
  1617. Selective CORTICOTROPIN โ€RELEASING FACTOR Type 1 Receptor Antagonist Blocks Conditioned Fearโ€Induced Release of Noradrenaline in the Hypothalamic โ€ฆ
  1618. Responses of the rat pituitary-adrenal axis to hypotensive infusions of CORTICOTROPIN โ€“RELEASING FACTOR , vasoactive intestinal peptide and other depressor agents
  1619. Benzodiazepine suppression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced beta-endorphin release from rat neurointermediate pituitary
  1620. CORTICOTROPIN โ€“RELEASING FACTOR induces phosphorylation of phospholipase C-ฮณ at tyrosine residues via its receptor 2ฮฒ in human epidermoid A-431 cells
  1621. IL-1ฮฑ BUT NOT IL-1ฮฒ-INDUCED PROSTAGLANDIN SYNTHESIS IS INHIBITED BY CORTICOTROPIN โ€“RELEASING FACTOR
  1622. CORTICOTROPIN โ€“RELEASING FACTOR and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress
  1623. Evidence that endogenous CORTICOTROPIN โ€RELEASING FACTOR suppresses behavioral responses of guinea pig pups to brief isolation in novel surroundings
  1624. CORTICOTROPIN โ€“RELEASING FACTOR stimulates cyclic AMP, arachidonic acid release, and growth of lung cancer cells
  1625. Interleukin-1ฮฒ induces CORTICOTROPIN โ€“RELEASING FACTOR -41 release from cultured hypothalamic cells through protein kinase C and cAMP-dependent protein kinase โ€ฆ
  1626. Effect of CORTICOTROPIN RELEASING FACTOR (CRF) in the median eminence on gonadotropins in ovariectomized rats with or without steroid priming: dose-response study
  1627. CORTICOTROPIN โ€“RELEASING FACTOR increases protein kinase C activity by elevating membrane-bound alpha and beta isoforms.
  1628. Stimulation by interleukin-1 (IL-1) of the release of rat CORTICOTROPIN โ€“RELEASING FACTOR (CRF), which is independent of the cholinergic mechanism, from superfused rat โ€ฆ
  1629. CORTICOTROPIN RELEASING FACTOR and galanin-containing neurons projecting to the median eminence of the rat
  1630. CORTICOTROPIN โ€“RELEASING FACTOR mRNA increases in the inferior olivary complex during harmaline-induced tremor
  1631. Responses of brain and pituitary immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR in surgically interrenalectomized eels: Immunocytochemical study
  1632. Alphaxalone, a steroid anesthetic, inhibits the startle-enhancing effects of CORTICOTROPIN RELEASING FACTOR , but not strychnine
  1633. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) stimulates 45Ca2+ uptake in the mouse corticotroph cell line AtT-20
  1634. The Zucker fatty (fa) gene is not a mutation of CORTICOTROPIN โ€“RELEASING FACTOR
  1635. Colorimetric assay for rapid screening of CORTICOTROPIN RELEASING FACTOR receptor ligands
  1636. Reciprocal modulation of CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1 receptors following ether-laparotomy stress in the mouse
  1637. Involvement of Central CORTICOTROPIN โ€RELEASING FACTOR (CRF) in Sucklingโ€Induced Inhibition of Luteinizing Hormone Secretion in Lactating Rats
  1638. Enhancement of tachykinin-induced contractions of guinea pig isolated bronchus by CORTICOTROPIN โ€“RELEASING FACTOR
  1639. Stress-induced upregulation of pituitary interleukin-1 receptors is mediated by CORTICOTROPIN RELEASING FACTOR
  1640. Interleukin-1 (IL-1) stimulates the release of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) from superfused rat hypothalamo-neurohypophyseal complexes (HNC) independently โ€ฆ
  1641. Clonidine prevents CORTICOTROPIN RELEASING FACTOR โ€induced epileptogenic activity in rats
  1642. CORTICOTROPIN RELEASING FACTOR modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: receptor binding and effects of antagonists
  1643. Urocortin: slower dissociation than CORTICOTROPIN RELEASING FACTOR from the CRF binding protein
  1644. The distribution of CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive neurons and nerve fibres in the brain of Gambusia affinis and Salmo trutta
  1645. Immunocytochemical distribution of CORTICOTROPIN โ€“RELEASING FACTOR in the brain and hypophysis of larval Bufo arenarum; effect of KClO4 during early development
  1646. Special folding pathway to tetramer only through the micelle state of the CORTICOTROPIN โ€“RELEASING FACTOR
  1647. CORTICOTROPIN โ€“RELEASING FACTOR receptor expression in the pituitary of fetal sheep after lesion of the hypothalamic paraventricular nucleus
  1648. Central administration of ฮฑ-melanocyte-stimulating hormone inhibits CORTICOTROPIN โ€“RELEASING FACTOR release in adrenalectomized rats
  1649. [d-Pro5] CORTICOTROPIN โ€“RELEASING FACTOR analogs as selective agonists at CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1650. Heterogeneity of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  1651. Hemilabyrinthectomy causes both an increase and a decrease in CORTICOTROPIN RELEASING FACTOR mRNA in rat inferior olive
  1652. Studies of the mechanisms of action of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and arginine vasopressin (AVP) in the ovine anterior pituitary: evidence that CRF and AVP โ€ฆ
  1653. Is Vasopressin Preferentially Released from CORTICOTROPIN โ€RELEASING FACTOR and Vasopressin Containing Nerve Terminals in the Median Eminence of โ€ฆ
  1654. Bipolar-shape response of human neutrophils to CORTICOTROPIN โ€“RELEASING FACTOR
  1655. Diurnal variation of CORTICOTROPIN โ€“RELEASING FACTOR binding sites in the rat brain and pituitary
  1656. Central actions of CORTICOTROPIN RELEASING FACTOR on sensori-autonomic processing in normotensive and hypertensive rats
  1657. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on circadian locomotor rhythm in the golden hamster
  1658. Corticosterone response to the serotonergic agonist D-fenfluramine may be independent from CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  1659. CORTICOTROPIN โ€“RELEASING FACTOR induction in rat piriform cortex following kainate-elicited seizures
  1660. Actions of CORTICOTROPIN โ€“RELEASING FACTOR or cortisol on follicle-stimulating hormone secretion by isolated pig pituitary cells
  1661. Exposure to an Antisense Oligonucleotide Decreases CORTICOTROPIN โ€RELEASING FACTOR Receptor Binding in Rat Pituitary Cultures
  1662. Effects of long term treatment with CORTICOTROPIN RELEASING FACTOR on corticotropic tumor cells in vitro
  1663. Effect of endotoxin and interleukin-1beta on CORTICOTROPIN โ€“RELEASING โ€“FACTOR and prostaglandin release by rat brainstem slices.
  1664. CORTICOTROPIN โ€“RELEASING FACTOR injected into the lateral septum improves memory function in rats.
  1665. CORTICOTROPIN โ€“RELEASING FACTOR receptors: inhibitors, subtypes, pharmacology, localization, and their role in central nervous system function
  1666. Estrous cycle-and acute stress-related changes of rat ovarian immunoreactive CORTICOTROPIN โ€“RELEASING FACTOR
  1667. Tyrosine pretreatment alleviates suppression of schedule-controlled responding produced by CORTICOTROPIN RELEASING FACTOR (CRF) in rats
  1668. Study on the relationship between cadmium immunotoxicity and CORTICOTROPIN โ€“RELEASING FACTOR
  1669. Effect of intratesticular administration of antiโ€CORTICOTROPIN โ€RELEASING FACTOR antiserum (aโ€CRF) on testicular function in neonatal rats
  1670. โ€ฆ of Stressโ€Induced AdrenoCORTICOTROPIN Release by Intracerebral Administration of a Monoclonal Antibody to Rat CORTICOTROPIN โ€RELEASING FACTOR Together with Ricin A โ€ฆ
  1671. Cortisol up-regulates CORTICOTROPIN RELEASING FACTOR gene expression in the fetal ovine brainstem at 0.70 gestation
  1672. Interaction of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and alpha-helical CRF on rat neurointermediate lobes: in vitro studies
  1673. Norepinephrine but not epinephrine stimulates the release of CORTICOTROPIN โ€RELEASING FACTOR from in vitro superfused rat hypothalamus
  1674. CORTICOTROPIN โ€“RELEASING hormone is not the sole FACTOR mediating exercise-induced adrenoCORTICOTROPIN release in humans
  1675. Injections of CORTICOTROPIN โ€“RELEASING FACTOR into the periaqueductal gray enhance Pavlovian fear conditioning
  1676. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on feeding and pancreatic polypeptide response in the dog
  1677. Brainstem origin of CORTICOTROPIN โ€“RELEASING FACTOR afferents to the nucleus interpositus anterior of the cat
  1678. Neuronal mechanisms contribute to CORTICOTROPIN โ€“RELEASING FACTOR -induced anti-oedema effect in the rat hind paw
  1679. โ€ฆ bilateral blood sampling from the inferior petrosal sinus in Cushingโ€™s disease: effects of CORTICOTROPIN โ€“RELEASING FACTOR and thyrotropin-RELEASING hormone on pituitary โ€ฆ
  1680. Acute intravenous CORTICOTROPIN โ€“RELEASING FACTOR administration: effects on insulin secretion in lean and genetically obese fa/fa rats.
  1681. The role of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin in brain mechanisms controlling feed intake of sheep
  1682. Effect of CORTICOTROPIN RELEASING FACTOR injected into the median eminence on growth hormone secretion in male rats
  1683. ฮฑ-Melanocyte Stimulating Hormone (MSH) antagonizes the anorexia by CORTICOTROPIN RELEASING FACTOR (CRF)
  1684. Interleukinโ€1ฮฑ induces CORTICOTROPIN โ€RELEASING FACTOR secretion and synthesis from NPLCโ€KC cells through various second messenger pathways
  1685. The distribution of radiolabeled CORTICOTROPIN โ€“RELEASING FACTOR in pregnant rats: an investigation of placental transfer to the fetuses
  1686. ROLE OF CORTICOTROPIN RELEASING FACTOR ๎€ƒ IN PRESSOR RESPONSE OF CENTRAL AMYGDALOID๎€ƒ NUCLEUS TO GLUTAMATE
  1687. Sublethal hypoxia up-regulates CORTICOTROPIN RELEASING FACTOR receptor type 1 in fetal hippocampal neurons
  1688. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and stress-related reproductive failure: the brain as a state of the art or the ovary as a novel clue?
  1689. Electrocortical power spectrum changes induced by microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR into the locus coeruleus in rats.
  1690. Increase of ฮฒ-endorphin serum levels by human CORTICOTROPIN โ€“RELEASING FACTOR does not affect beta-cell function in overweight women
  1691. Effects of corticosterone in vivo and in vitro on adrenocorticotropic hormone production by CORTICOTROPIN RELEASING FACTOR -stimulated leukocytes
  1692. Decreased expression of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein mRNA in ACTH-secreting pituitary adenomas
  1693. CORTICOTROPIN RELEASING FACTOR receptors in inflamed tissue: autoradiographic identification
  1694. CORTICOTROPIN โ€“RELEASING FACTOR -induced suppression of gastric emptying in the rat is blocked by cyclo (7-aminoheptanoyl-phe-D-TRP-LYS-THR [BZL]), an in vivo โ€ฆ
  1695. Stress, CORTICOTROPIN โ€“RELEASING FACTOR neurons, and the actions of benzodiazepines
  1696. Reduction of ischemic reperfusion edema with CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rat hind limb replantation.
  1697. Stress-induced alteration of gastrointestinal function: role of CORTICOTROPIN โ€“RELEASING FACTOR
  1698. The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with CORTICOTROPIN โ€“RELEASING FACTOR , down with acetylcholine
  1699. Mechanisms of norepinephrine mediated CORTICOTROPIN โ€“RELEASING FACTOR -41 release from cultured fetal hypothalamic cells
  1700. Novel highโ€affinity photoactivatable antagonists of CORTICOTROPIN โ€RELEASING FACTOR (CRF) Photoaffinity labeling studies on CRF receptor, type 1 (CRFR1)
  1701. CORTICOTROPIN RELEASING FACTOR -like immunoreactivity (CRF-LI) in horizontal cells of the developing rat retina
  1702. Treatment of periorbital edema with human CORTICOTROPIN โ€“RELEASING FACTOR after blepharoplasty.
  1703. Neuromodulation of CORTICOTROPIN RELEASING FACTOR -induced gastrointestinal motility alterations
  1704. The temporal and spatial development of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) binding sites and CRF afferents in the opossum cerebellum
  1705. Radioimmunocytochemical localization of CORTICOTROPIN โ€“RELEASING FACTOR and adrenoCORTICOTROPIN in the hypothalamo-hypophyseal system of the rat: effects of โ€ฆ
  1706. CORTICOTROPIN RELEASING FACTOR mRNA and peptide levels are differentially regulated in the developing ovine brain
  1707. โ€ฆ hormonal-and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and CORTICOTROPIN โ€“RELEASING FACTOR
  1708. CORTICOTROPIN RELEASING FACTOR stimulates growth hormone secretion in neonatal rats
  1709. Influence of CORTICOTROPIN โ€“RELEASING FACTOR on pancreatic and islet blood flow in different regions of the rat pancreas
  1710. Beneficial effect of intravenous bolus of CORTICOTROPIN โ€“RELEASING FACTOR on glucose intolerance of genetically obese (fa/fa) rats
  1711. Dexamethasone and aldosterone modulate CORTICOTROPIN โ€“RELEASING FACTOR -41 release from cultured rat fetal hypothalamic cells through type II and type I corticosteroid โ€ฆ
  1712. CORTICOTROPIN โ€“RELEASING FACTOR microinfused into the locus coeruleus produces electrocortical desynchronization and immunosuppression
  1713. CORTICOTROPIN โ€“RELEASING hormone and epidermal growth FACTOR : mitogens for anterior pituitary corticotropes
  1714. Inhibition of CORTICOTROPIN RELEASING FACTOR (CRF)-induced adrenoCORTICOTROPIN (ACTH) secretion in pituitary corticotropic cells by substance P.
  1715. Affinity purification of 61-and 65-kDa rat brain CORTICOTROPIN โ€“RELEASING FACTOR receptors and receptor-associated G proteins
  1716. CORTICOTROPIN โ€“RELEASING FACTOR is secreted in the BE (2)-C neuroblastoma cell and is responsive to forskolin
  1717. Characterization of [125I-Tyr0]-CORTICOTROPIN RELEASING FACTOR (CRF) binding to the CRF binding protein using a scintillation proximity assay
  1718. The use of CORTICOTROPIN RELEASING FACTOR (CRE) for the treatment of post-operative cerebral edema. A preliminary study.
  1719. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein concentrations in plasma of patients with hypothalamic-pituitary-adrenal disorders
  1720. Structures of ovine CORTICOTROPIN โ€“RELEASING FACTOR and its Ala32 mutant as studied by CD and NMR techniques
  1721. CORTICOTROPIN RELEASING FACTOR receptors and its binding protein: molecular, pharmacological and localization studies
  1722. Monoclonal antibodies directed against two different CORTICOTROPIN โ€“RELEASING FACTOR determinants
  1723. Expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in peritoneum and pericardium in the rat embryo by in situ hybridization histochemistry
  1724. Alpha-Melanocyte-Stimulating Hormone Inhibits CORTICOTROPIN RELEASING FACTOR Release by Blocking Protein Kinase C
  1725. Reduction of reperfusion injury edema with CORTICOTROPIN โ€RELEASING FACTOR (CRF): A pilot study
  1726. โ€ฆ of the pituitary pars distalis induces the corticotrophs to store melanocyte-stimulating hormone, an effect reversed by the administration of CORTICOTROPIN โ€“RELEASING FACTOR
  1727. The role of CORTICOTROPIN โ€“RELEASING FACTOR in the investigation of endocrine diseases
  1728. Metyrapone induced increase in plasma CORTICOTROPIN is not associated with changes in peripheral venous arginine vasopressin or CORTICOTROPIN RELEASING FACTOR
  1729. Effect of CORTICOTROPIN RELEASING FACTOR on acid-base alterations and bacterial translocation in a murine model of thermal injury
  1730. CORTICOTROPIN RELEASING FACTOR with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts
  1731. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on the pituitary-ovary axis in human luteal phase
  1732. Expression of Receptors for CORTICOTROPIN โ€“RELEASING FACTOR in Vasculature of Pregnant Rats.
  1733. Effects of glycyrrhizic acid and steroid treatment on CORTICOTROPIN RELEASING FACTOR and beta-endorphin containing neurons of the hypothalamus of the rat.
  1734. Stress-induced relapse to cocaine seeking in the rat: Contributions of central nervous system CORTICOTROPIN โ€“RELEASING FACTOR and noradrenaline
  1735. CORTICOTROPIN โ€“RELEASING hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid ฮฒ โ€ฆ
  1736. CORTICOTROPIN RELEASING hormone, interleukin-1ฮฑ, and tumor necrosis FACTOR -ฮฑ share characteristics of stress mediators
  1737. CORTICOTROPIN โ€“RELEASING FACTOR mediates lymphocyte proliferation suppression induced by hypoxia stress
  1738. Modulation of Prostaglandin Synthesis in Endothelial Cells and Fibroblasts by CORTICOTROPIN โ€“RELEASING FACTOR and Antagonists
  1739. CORTICOTROPIN โ€“RELEASING FACTOR and corticosterone modulate the anxiogenic-like effects of mCPP
  1740. CORTICOTROPIN โ€“RELEASING FACTOR and anxiety: Animal studies
  1741. Characterization of the N-linked glycan of recombinantly-expressed CORTICOTROPIN RELEASING FACTOR binding protein
  1742. 208. CORTICOTROPIN RELEASING FACTOR , stress and allostasis
  1743. Biphasic regulation of proopiomelanocortin messenger RNA concentrations by CORTICOTROPIN โ€“RELEASING FACTOR in primary cultures of rat hypothalamic neurons
  1744. CORTICOTROPIN RELEASING FACTOR dramatically reduces inflammation at the site of local doxorubicin chemomyectomy
  1745. Characterization of CORTICOTROPIN โ€RELEASING FACTOR (CRF) Receptors
  1746. The effect of dibenzofuran substitutions in CORTICOTROPIN โ€“RELEASING FACTOR
  1747. Effects of Cocaine and CORTICOTROPIN RELEASING FACTOR (CRF) on Pulsatile ACTH and Cortisol Release in Ovariectomized Rhesus Monkeys
  1748. โ€ฆ vasopressin plasma levels in young men is not associated with an enhanced response of adrenocorticotropic hormone (ACTH) to human CORTICOTROPIN RELEASING FACTOR โ€ฆ
  1749. Effects of CORTICOTROPIN โ€“RELEASING FACTOR , Arginine Vasopressin and Oxytocin on the Polymorphism of Plasma Adrenocorticotropic Hormone in the Rat Fetus in Late โ€ฆ
  1750. Effects of various stimuli on CORTICOTROPIN โ€“RELEASING FACTOR in the human neuroblastoma clones
  1751. Pheochromocytoma expressing adrenoCORTICOTROPIN and CORTICOTROPIN โ€“RELEASING hormone; regulation by glucocorticoids and nerve growth FACTOR
  1752. Sensitivity of the Fetal Rat Pituitary-Adrenal System to CORTICOTROPIN โ€“RELEASING FACTOR in Organ Culture
  1753. Immunohistochemical study of the distribution of CORTICOTROPIN RELEASING FACTOR and serotonin in the cerebellar nuclei of monkeys
  1754. CORTICOTROPIN โ€“RELEASING FACTOR modulation of serotonin release: Neurochemical and behavioral studies in the rat
  1755. Production and putative roles of inhibins and CORTICOTROPIN โ€“RELEASING FACTOR in human placenta and decidua
  1756. Vasopressin responses to CORTICOTROPIN โ€“RELEASING FACTOR and hypertonicity after truncal vagotomy in dogs
  1757. Tumor necrosis FACTOR -alpha increases after CORTICOTROPIN โ€“RELEASING hormone administration in Cushingโ€™s disease
  1758. Immunomodulating Properties of CORTICOTROPIN โ€“RELEASING FACTOR
  1759. Differential Effect of CORTICOTROPIN RELEASING FACTOR on Interleukin-1ฮฑ and Interleukin-1ฮฒ-Induced Prostaglandin Synthesis in Endothelial Cells and Fibroblasts
  1760. Design and Structure/Conformation-Activity Studies of a Prototypic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Antagonist: Multiple Alanine Substitutions of CRF12-41
  1761. The gene encoding for the novel transacting FACTOR proopiomelanocortin CORTICOTROPIN โ€“RELEASING hormone responsive element binding protein 1 (PCRH-REB-1) is โ€ฆ
  1762. Propofol inhibits nitrous oxide-induced activation of CORTICOTROPIN RELEASING FACTOR -containing neurons in rat paraventricular nucleus of hypothalamus
  1763. CORTICOTROPIN RELEASING FACTOR (CRF) induces longlasting depression of parallel fiber to Purkinje cell synaptic transmission in rat cerebellum
  1764. Studies on the metabolism of CORTICOTROPIN โ€“RELEASING FACTOR
  1765. Immunomodulatory role of CORTICOTROPIN โ€“RELEASING FACTOR .
  1766. CORTICOTROPIN RELEASING FACTOR receptor type II (CRF2) messenger ribonucleic acid levels in the hypothalamic ventromedial nucleus of the infant rat are reduced by โ€ฆ
  1767. Structural and functional characterization of the CORTICOTROPIN โ€“RELEASING FACTOR receptor
  1768. Vascular effects of CORTICOTROPIN โ€“RELEASING FACTOR in pregnant rats
  1769. Role of CORTICOTROPIN โ€“RELEASING FACTOR in Stress-Induced Changes in Gastrointestinal Transit
  1770. CORTICOTROPIN RELEASING FACTOR and Gastric Erosions
  1771. The characterization of the ovine CORTICOTROPIN โ€“RELEASING FACTOR binding protein
  1772. Prediction of mania in euthymic bipolar patients using CORTICOTROPIN โ€“RELEASING FACTOR challenge test
  1773. CORTICOTROPIN โ€“RELEASING FACTOR receptors in mouse spleen: Identification, localization, and characterization.
  1774. Spinal opioid mechanisms involved in the actions of CORTICOTROPIN โ€“RELEASING FACTOR .
  1775. CORTICOTROPIN โ€“RELEASING FACTOR receptors are downregulated in chronically stressed developing rats
  1776. Genetic animal models of depression: relationship with functional central and endocrine CORTICOTROPIN โ€“RELEASING FACTOR system
  1777. Study on the relationship between cadmium immunotoxicity and CORTICOTROPIN RELEASING FACTOR
  1778. A requirement for the POU transcription FACTOR , Brn-2, in CORTICOTROPIN โ€“RELEASING hormone expression in a neuronal cell line
  1779. Potential CORTICOTROPIN โ€RELEASING FACTOR Pathways in the Rat Brain as Determined by Bilateral Electrolytic Lesions of theโ€ฆ
  1780. CORTICOTROPIN โ€“RELEASING FACTOR gene regulation in the hypothalamus and neuronal cell lines
  1781. CORTICOTROPIN โ€“RELEASING FACTOR Increases Ca (2+) sub i via Receptor-Mediated Ca (2+) Channels in Human Epidermoid A-431 Cells
  1782. Neurotransmitter regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurons: In vitro and in vivo studies.
  1783. THE ROLE OF CORTICOTROPIN RELEASING FACTOR (CRF) IN THE PATHOGENESIS OF ANXIETY AND AFFECTIVE DISORDERS: PRECLINICAL AND CLINICAL โ€ฆ
  1784. Efficacy of Maternal Serum CORTICOTROPIN RELEASING FACTOR Levels in Diagnosis of Pregnancies Complicated by Preterm Labor
  1785. Physiological Function and Localization of a Short Isoform of the CORTICOTROPIN โ€“RELEASING FACTOR Receptor Subtype (CRF2ฮฑ-tr) in the Rat Brain
  1786. Antagonism by pivagabine of stress-induced changes in GABA A receptor function and CORTICOTROPIN โ€“RELEASING FACTOR concentrations in rat brain
  1787. Section Review: Central & Peripheral Nervous Systems: CORTICOTROPIN RELEASING FACTOR and Alzheimerโ€™s disease: recent developments with implications for more โ€ฆ
  1788. Glucocorticoid regulation of CORTICOTROPIN โ€“RELEASING FACTOR in the paraventricular nucleus of the hypothalamus.
  1789. Inhibition of CORTICOTROPIN โ€“RELEASING FACTOR CRH-R2 receptors in smooth muscle cells
  1790. Increased CORTICOTROPIN โ€“RELEASING FACTOR concentrations in the bed nucleus of the stria terminalis of anhedonicโ€ฆ
  1791. INVOLVEMENT OF CORTICOTROPIN โ€“RELEASING FACTOR AND UROTENSIN I IN MEDIATING THE APPETITE-SUPPRESSING EFFECTS OF STRESS IN โ€ฆ
  1792. Sleep deprivation induces changes in CORTICOTROPIN RELEASING FACTOR concentration and mRNA in the rat brain
  1793. Immunocytochemical Study on the Distribution Pattern of CORTICOTROPIN RELEASING FACTOR and Norepinephrine in the Middle Lobe of Monkey Cerebellum
  1794. CORTICOTROPIN โ€“RELEASING FACTOR receptors type 1 (CRF 1) in human neuroblastoma SH-SY5Y cells
  1795. CORTICOTROPIN RELEASING FACTOR modulates nitric oxide production and cell growth in a murine polyoma-transformed endothelioma cell line in vitro.
  1796. Time-course changes of nerve growth FACTOR , CORTICOTROPIN โ€“RELEASING hormone, and nitric oxide synthase isoforms and their possible role in the development of โ€ฆ
  1797. Central regulation of CORTICOTROPIN โ€“RELEASING FACTOR release in the median eminence of rat brain: An in vivo microdialysis study.
  1798. Electrocortical power spectrum changes induced by microinfusion of CORTICOTROPIN โ€“RELEASING FACTOR into the locus coeruleus in rats
  1799. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Induces Persistent Depression of Parallel Fiber to Purkinje Cell Synaptic Transmission
  1800. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and the interleukin-6 (IL-6) type cytokines as possible trophic FACTOR s in cerebellar development
  1801. Intravenous administration of tumor necrosis FACTOR -ฮฑ stimulates CORTICOTROPIN RELEASING hormone secretion in the push-pull cannulated median eminence of freely โ€ฆ
  1802. Immunocytochemical and biochemical studies with a CORTICOTROPIN โ€“RELEASING FACTOR anti-idiotypic antiserum which recognizes a NADPH-diaphorase activity in rat brain.
  1803. Interleukin-1, CORTICOTROPIN โ€“RELEASING FACTOR and resistant calcium currents in amygdala neurons
  1804. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory FACTOR and CORTICOTROPIN โ€“RELEASING hormone transcriptional synergy
  1805. Opposite dopaminergic regulation of neuropeptide Y and CORTICOTROPIN RELEASING FACTOR in the rat amygdala
  1806. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF (1) receptor expression in the postnatal mouse cerebellum
  1807. Nitrous Oxide Activates CORTICOTROPIN RELEASING FACTOR -Containing Neurons in Paraventricular Nucleus of Hypothalamus in Rats
  1808. The effects of benzodiazepine administration and withdrawal on CORTICOTROPIN โ€“RELEASING FACTOR and urocortin neuronal systems in the rat
  1809. Involvement of CORTICOTROPIN RELEASING FACTOR (CRF) and Vasopressin (AVP) in Stress-Induced Exacerbation of Experimental Colitis in Rats
  1810. Relationship of exercise-induced core temperature elevation to fever: Involvement of tumor necrosis FACTOR , prostaglandin, and CORTICOTROPIN RELEASING FACTOR
  1811. INDUCTION OF FOS ONCOPROTEIN AND CORTICOTROPIN RELEASING FACTOR IN THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS BY โ€ฆ
  1812. In vitro excitatory action of CORTICOTROPIN โ€“RELEASING FACTOR on rat colonic motility: a model of somatoform disease31. 3
  1813. Prior stress and arginine vasopressin potentiate the effect of CORTICOTROPIN โ€“RELEASING FACTOR on serotonin release in the rat brain
  1814. Role of Histamine, and Its Interaction With CORTICOTROPIN RELEASING FACTOR and Bombesin in Food Intake Regulation of Chickens
  1815. Matrix-assisted laser desorption analysis of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein and activin by means of immunoprecipitation
  1816. CORTICOTROPIN RELEASING FACTOR , UROCORTIN ANDTHEIR RECEPTORS AND BINDING PROTEIN: ROLE IN OBESITY AND INGESTIVE BEHAVIOR
  1817. CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive projections from barringtonโ€™s nucleus to the paraventricular thalamic nucleus and spinal cord in the rat.
  1818. Immunocytochemical Studies of CORTICOTROPIN RELEASING FACTOR -like Immunoreactive Innervation of Atrial Natriuretic Peptide Neurons in the Rat Diencephalon
  1819. โ€ฆ inhibition by catecholaminergic and opiatergic pathways of the electroencephalographic and vegetative pattern induced by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the โ€ฆ
  1820. Effects of nicotine on content of CORTICOTROPIN RELEASING FACTOR (CRF) in rat amygdala, hypothalamus and brain stem
  1821. Synaptic Interactions Between Atrial Natriuretic Peptide-and CORTICOTROPIN RELEASING FACTOR -Containing Neurons in the Paraventricular Nucleus of the Rat โ€ฆ
  1822. Central nervous mechanisms in restraint induced gastric erosions: Emphasis on the locus coeruleus noradrenergic system and CORTICOTROPIN โ€“RELEASING FACTOR .
  1823. An immunohistochemical study on CORTICOTROPIN โ€“RELEASING FACTOR immunoreactive neurons in the nucleus accumbens of the tree shrew (Tupaia belangeri) Chinese
  1824. The concept of stress and the role of hypothalamic and extra-hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the integration of the neuroendocrine and immune โ€ฆ
  1825. Role of CORTICOTROPIN โ€“RELEASING FACTOR , somatostatin and leptin in vagal nerve function and control of gastric emptying
  1826. CORTICOTROPIN โ€“RELEASING FACTOR , activin A and prostaglandins increase immunoreactive oxytocin release from cultured human placental cells.
  1827. Regulation of ACTH and ACTH precursor secretion in sheep fetuses by cortisol, CORTICOTROPIN โ€“RELEASING FACTOR , and arginine vasopressin.
  1828. Effects of prenatal stress on the development of CORTICOTROPIN RELEASING FACTOR (CRF) neurons of hypothalamic paraventricular nucleus (PVN) in the fetal rat brain.
  1829. Changes of immunoreactive neuropeptide Y, somatostatin and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the brain of a novel epileptic mutant rat, Iharaโ€™s genetically โ€ฆ
  1830. โ€ฆ situ-Hydridisierungs-histochemische Lokalisation der messenger-Ribonucleinsaeure (mRNA) von Galanin (GAL), CORTICOTROPIN โ€“RELEASING FACTOR (CRF) und Calcitonin โ€ฆ
  1831. CORTICOTROPIN RELEASING FACTOR (CRF) and leptin contributions to energy balance in genetically obese (lep-ob/lep-ob) mice, possible involvement of CRF in the leptin โ€ฆ
  1832. The effects of bilateral adrenalectomy and colchicine on vasopressin and CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in the paraventricular nucleus of female โ€ฆ
  1833. Ultrastructural study of phenylethanolamine-N-methyltransferase, CORTICOTROPIN โ€“RELEASING FACTOR and neurotensin immunoreactive neurons in the external cuneate โ€ฆ
  1834. Plasma atrial natriuretic FACTOR levels in the inferior petrosal sinus blood of patients with Cushingโ€™s disease before and after CORTICOTROPIN โ€“RELEASING hormone โ€ฆ
  1835. CORTICOTROPIN release-inhibiting FACTOR is preprothyrotropin-RELEASING hormone-(178-199)
  1836. Effect of ACTH on pain behavior and the level of brain-derived neurotrophic FACTOR and CORTICOTROPIN โ€“RELEASING hormone in the hippocampus of rats with chronic pain
  1837. Effect of ACTH on pain behavior and the level of brain-derived neurotrophic FACTOR and CORTICOTROPIN โ€“RELEASING hormone in the hippocampus of rats with chronic pain
  1838. CORTICOTROPIN โ€“RELEASING FACTOR receptors 1 and 2 in anxiety and depression
  1839. The role of CORTICOTROPIN โ€“RELEASING FACTOR in drug addiction
  1840. Progress in CORTICOTROPIN โ€“RELEASING FACTOR -1 antagonist development
  1841. The functional neuroanatomy of CORTICOTROPIN โ€RELEASING FACTOR
  1842. A key role for CORTICOTROPIN โ€“RELEASING FACTOR in alcohol dependence
  1843. Interaction between the CORTICOTROPIN โ€“RELEASING FACTOR system and hypocretins (orexins): a novel circuit mediating stress response
  1844. Regulation of behavioral responses by CORTICOTROPIN โ€“RELEASING FACTOR
  1845. Role of CORTICOTROPIN โ€“RELEASING hormone as a thyrotropin-RELEASING FACTOR in non-mammalian vertebrates
  1846. CORTICOTROPIN โ€“RELEASING FACTOR in brain: a role in activation, arousal, and affect regulation
  1847. Role of CORTICOTROPIN RELEASING FACTOR in anxiety disorders: a translational research perspective
  1848. The role of CORTICOTROPIN โ€RELEASING FACTOR in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies
  1849. Neurobiological mechanisms of addiction: focus on CORTICOTROPIN โ€“RELEASING FACTOR
  1850. Regulatory mechanisms underlying CORTICOTROPIN โ€“RELEASING FACTOR gene expression in the hypothalam
  1851. The central CORTICOTROPIN RELEASING FACTOR system during development and adulthood
  1852. Mast cells as targets of CORTICOTROPIN โ€“RELEASING FACTOR and related peptides
  1853. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for CORTICOTROPIN โ€“RELEASING FACTOR and their ligands
  1854. Ontogeny of the CORTICOTROPIN โ€“RELEASING FACTOR system in zebrafish
  1855. CORTICOTROPIN โ€“RELEASING FACTOR receptors and stress-related alterations of gut motor function
  1856. A role for CORTICOTROPIN โ€“RELEASING FACTOR in functional gastrointestinal disorders
  1857. Molecular recognition of CORTICOTROPIN โ€“RELEASING FACTOR by its G-protein-coupled receptor CRFR1
  1858. CORTICOTROPIN โ€“RELEASING FACTOR signaling and visceral response to stress
  1859. Long-term consequences of neonatal rearing on central CORTICOTROPIN โ€“RELEASING FACTOR systems in adult male rat offspring
  1860. CORTICOTROPIN RELEASING FACTOR (CRF) receptor signaling in the central nervous system: new molecular targets
  1861. III. Stress-related alterations of gut motor function: role of brain CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1862. โ€ฆ 1 CORTICOTROPIN โ€RELEASING FACTOR receptor expression reported in BAC transgenic mice: implications for reconciling ligandโ€receptor mismatch in the central CORTICOTROPIN โ€ฆ
  1863. Modulation of dendritic differentiation by CORTICOTROPIN โ€“RELEASING FACTOR in the developing hippocampus
  1864. Identification of urocortin III, an additional member of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family with high affinity for the CRF2 receptor
  1865. The dexamethasone/CORTICOTROPIN โ€“RELEASING FACTOR test in men with major depression: role of childhood trauma
  1866. CORTICOTROPIN RELEASING FACTOR signaling in colon and ileum: regulation by stress and pathophysiological implications
  1867. Brain circuits involved in CORTICOTROPIN โ€RELEASING FACTOR โ€norepinephrine interactions during stress
  1868. The CORTICOTROPIN โ€“RELEASING FACTOR system as a mediator of the appetite-suppressing effects of stress in fish
  1869. CORTICOTROPIN RELEASING FACTOR : a mediator of emotional influences on bladder function
  1870. Regulation of vertebrate CORTICOTROPIN โ€“RELEASING FACTOR genes
  1871. The role of CORTICOTROPIN โ€“RELEASING FACTOR and noradrenaline in stress-related responses, and the inter-relationships between the two systems
  1872. The role of CORTICOTROPIN โ€“RELEASING FACTOR receptors in stress and anxiety
  1873. Sexually dimorphic responses of the brain norepinephrine system to stress and CORTICOTROPIN โ€“RELEASING FACTOR
  1874. CORTICOTROPIN โ€“RELEASING FACTOR inhibits maternal aggression in mice.
  1875. Opposing regulation of the locus coeruleus by CORTICOTROPIN โ€“RELEASING FACTOR and opioids
  1876. The CORTICOTROPIN โ€“RELEASING FACTOR family of peptides and CRF receptors: their roles in the regulation of energy balance
  1877. Role of CORTICOTROPIN โ€“RELEASING FACTOR receptors type 1 and 2 in modulating the rat adrenoCORTICOTROPIN response to stressors
  1878. Negative regulation of CORTICOTROPIN RELEASING FACTOR expression and limitation of stress response
  1879. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and CORTICOTROPIN โ€“RELEASING FACTOR
  1880. Widespread tissue distribution and diverse functions of CORTICOTROPIN โ€“RELEASING FACTOR and related peptides
  1881. Behavioral and anatomical interactions between dopamine and CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  1882. Sex differences in CORTICOTROPIN โ€“RELEASING FACTOR receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology
  1883. MPZP: a novel small molecule CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor (CRF1) antagonist
  1884. Inhibitory effect of ghrelin on food intake is mediated by the CORTICOTROPIN โ€“RELEASING FACTOR system in neonatal chicks
  1885. Neuroendocrine control of the gut during stress: CORTICOTROPIN โ€“RELEASING FACTOR signaling pathways in the spotlight
  1886. CORTICOTROPIN โ€“RELEASING FACTOR 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
  1887. Phylogeny of the CORTICOTROPIN โ€“RELEASING FACTOR family of peptides in the metazoa
  1888. CORTICOTROPIN โ€“RELEASING FACTOR receptors differentially regulate stress-induced tau phosphorylation
  1889. Association of polymorphisms in genes regulating the CORTICOTROPIN โ€“RELEASING FACTOR system with antidepressant treatment response
  1890. CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin and receptor systems in depression and anxiety
  1891. Cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR and perceived early-life stress in depressed patients and healthy control subjects
  1892. Effects of the selective nonpeptide CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice
  1893. The role of CORTICOTROPIN โ€“RELEASING FACTOR in the median raphe nucleus in relapse to alcohol
  1894. Social stress-induced bladder dysfunction: potential role of CORTICOTROPIN โ€“RELEASING FACTOR
  1895. Mice deficient for both CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like โ€ฆ
  1896. CORTICOTROPIN โ€RELEASING FACTOR 1 receptorโ€mediated mechanisms inhibit colonic hypersensitivity in rats
  1897. CORTICOTROPIN RELEASING FACTOR โ€“induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence
  1898. Chronic peripheral administration of CORTICOTROPIN โ€“RELEASING FACTOR causes colonic barrier dysfunction similar to psychological stress
  1899. CORTICOTROPIN โ€“RELEASING FACTOR in the dorsal raphe nucleus: Linking stress coping and addiction
  1900. Expression of urocortin and CORTICOTROPIN โ€“RELEASING FACTOR receptor subtypes in the human heart
  1901. Increased depression-like behaviors in CORTICOTROPIN โ€“RELEASING FACTOR receptor-2-deficient mice: sexually dichotomous responses
  1902. Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of CORTICOTROPIN โ€“RELEASING FACTOR
  1903. Stress-induced redistribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtypes in the dorsal raphe nucleus
  1904. Evidence for regional heterogeneity in CORTICOTROPIN โ€RELEASING FACTOR interactions in the dorsal raphe nucleus
  1905. From Hans Selyeโ€™s Discovery of Biological Stress to the Identification of CORTICOTROPIN RELEASING FACTOR signaling pathways: Implication in Stress-Related โ€ฆ
  1906. CORTICOTROPIN โ€“RELEASING FACTOR and the psychobiology of early-life stress
  1907. CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism
  1908. Lack of effect of psychosocial stress on maternal CORTICOTROPIN โ€“RELEASING FACTOR and catecholamine levels at 28 weeksโ€™ gestation
  1909. Gender differences in CORTICOTROPIN and corticosterone secretion and CORTICOTROPIN โ€“RELEASING FACTOR mRNA expression in the paraventricular nucleus of the โ€ฆ
  1910. Urocortin, CORTICOTROPIN RELEASING FACTOR -2 receptors and energy balance
  1911. Urocortin II: a member of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
  1912. The effect of lateral septum CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 activation on anxiety is modulated by stress
  1913. Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.
  1914. CORTICOTROPIN โ€“RELEASING FACTOR within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats
  1915. The role of CORTICOTROPIN RELEASING FACTOR and its antagonist, astressin, on micturition in the rat
  1916. CORTICOTROPIN RELEASING FACTOR receptor antagonists: potential future therapy in gastroenterology?
  1917. Acute stress increases interstitial fluid amyloid-ฮฒ via CORTICOTROPIN โ€“RELEASING FACTOR and neuronal activity
  1918. The CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 pathway mediates the negative affective states of opiate withdrawal
  1919. Regulation of serotonin release in the lateral septum and striatum by CORTICOTROPIN โ€“RELEASING FACTOR
  1920. Cocaine experience establishes control of midbrain glutamate and dopamine by CORTICOTROPIN โ€“RELEASING FACTOR : a role in stress-induced relapse to drug seeking
  1921. Central and feedback regulation of hypothalamic CORTICOTROPIN โ€RELEASING FACTOR secretion
  1922. Characterization of three CORTICOTROPIN โ€“RELEASING FACTOR receptors in catfish: a novel third receptor is predominantly expressed in pituitary and urophysis
  1923. Sequences, expression patterns and regulation of the CORTICOTROPIN โ€“RELEASING FACTOR system in a teleost
  1924. โ€ฆ ethanol selfโ€administration and anxietyโ€like behavior during acute ethanol withdrawal and protracted abstinence: regulation by CORTICOTROPIN โ€RELEASING FACTOR
  1925. Multicenter, randomized, doubleโ€blind, active comparator and placeboโ€controlled trial of a CORTICOTROPIN โ€RELEASING FACTOR receptorโ€1 antagonist in generalized anxiety โ€ฆ
  1926. Continuous expression of CORTICOTROPIN โ€“RELEASING FACTOR in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes
  1927. CORTICOTROPIN โ€“RELEASING FACTOR in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects
  1928. Stress-induced intracellular trafficking of CORTICOTROPIN โ€“RELEASING FACTOR receptors in rat locus coeruleus neurons
  1929. โ€ฆ on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of CORTICOTROPIN โ€“RELEASING FACTOR and opioid mechanisms
  1930. Palatable foods, stress, and energy stores sculpt CORTICOTROPIN โ€“RELEASING FACTOR , adrenoCORTICOTROPIN , and corticosterone concentrations after restraint
  1931. Variable foraging demand rearing: sustained elevations in cisternal cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR concentrations in adult primates
  1932. CORTICOTROPIN โ€“RELEASING FACTOR requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons
  1933. CORTICOTROPIN RELEASING FACTOR (CRF) family of ligands and their receptors
  1934. Heteroatom-linked indanylpyrazines are CORTICOTROPIN RELEASING FACTOR type-1 receptor antagonists
  1935. Allostasis and dysregulation of CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y systems: implications for the development of alcoholism
  1936. The role of CORTICOTROPIN โ€“RELEASING FACTOR -like peptides in cannabis, nicotine, and alcohol dependence
  1937. CORTICOTROPIN โ€“RELEASING FACTOR projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area
  1938. Priming of long-term potentiation in mouse hippocampus by CORTICOTROPIN โ€“RELEASING FACTOR and acute stress: implications for hippocampus-dependent learning
  1939. Cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia
  1940. CORTICOTROPIN โ€“RELEASING FACTOR induces social preferences in male prairie voles
  1941. A comparison of ligand based virtual screening methods and application to CORTICOTROPIN RELEASING FACTOR 1 receptor
  1942. Common and divergent structural features of a series of CORTICOTROPIN RELEASING FACTOR -related peptides
  1943. CORTICOTROPIN โ€RELEASING FACTOR increases mouse ventral tegmental area dopamine neuron firing through a protein kinase Cโ€dependent enhancement of Ih
  1944. Biting suppresses stress-induced expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the rat hypothalamus
  1945. Angiotensin II AT1 receptor blockade prevents the hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR response to isolation stress
  1946. The bed nucleus is a neuroanatomical substrate for the anorectic effect of CORTICOTROPIN โ€“RELEASING FACTOR and for its reversal by nociceptin/orphanin FQ
  1947. Role of the CORTICOTROPIN โ€RELEASING FACTOR receptor type 2 in the control of food intake in mice: a meal pattern analysis
  1948. Do CORTICOTROPIN RELEASING FACTOR -1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
  1949. CORTICOTROPIN โ€“RELEASING FACTOR receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior
  1950. Strain differences in anxiety-like behavior: association with CORTICOTROPIN โ€“RELEASING FACTOR
  1951. CORTICOTROPIN โ€“RELEASING FACTOR and Urocortin I modulate excitatory glutamatergic synaptic transmission
  1952. Childhood trauma and personality disorder: positive correlation with adult CSF CORTICOTROPIN โ€“RELEASING FACTOR concentrations
  1953. In vitro and in vivo analysis of the Effects of CORTICOTROPIN RELEASING FACTOR on rat dorsal vagal complex
  1954. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  1955. CORTICOTROPIN โ€“RELEASING FACTOR receptors and urocortins, links between the brain and the heart
  1956. Potent and long-acting CORTICOTROPIN RELEASING FACTOR (CRF) receptor 2 selective peptide competitive antagonists
  1957. Nucleus accumbens CORTICOTROPIN โ€“RELEASING FACTOR increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress?
  1958. The central nucleus of the amygdala and CORTICOTROPIN โ€“RELEASING FACTOR : insights into contextual fear memory
  1959. Effects of cortisol on food intake, growth, and forebrain neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR gene expression in goldfish
  1960. Role of peripheral CORTICOTROPIN โ€“RELEASING FACTOR and urocortin II in intestinal inflammation and motility in terminal ileum
  1961. Effects of environmental and pharmacological stressors on c-fos and CORTICOTROPIN โ€“RELEASING FACTOR mRNA in rat brain: relationship to the reinstatement of alcohol โ€ฆ
  1962. CORTICOTROPIN โ€“RELEASING FACTOR
  1963. The CORTICOTROPIN โ€“RELEASING FACTOR system in inflammatory bowel disease: prospects for new therapeutic approaches
  1964. Increased anxietyโ€like behavior and ethanol selfโ€administration in dependent rats: reversal via CORTICOTROPIN โ€RELEASING FACTOR โ€2 receptor activation
  1965. Nociceptin/orphanin FQ acts as a functional antagonist of CORTICOTROPIN โ€“RELEASING FACTOR to inhibit its anorectic effect
  1966. Impairment of dopaminergic system function after chronic treatment with CORTICOTROPIN โ€“RELEASING FACTOR
  1967. CORTICOTROPIN โ€“RELEASING FACTOR : Physiology, pharmacology, and role in central nervous system disorders
  1968. CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y mRNA levels are elevated in the preoptic area of socially subordinate rainbow trout
  1969. Delayed stress-induced colonic hypersensitivity in male Wistar rats: role of neurokinin-1 and CORTICOTROPIN โ€“RELEASING FACTOR -1 receptors
  1970. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment
  1971. The CORTICOTROPIN RELEASING FACTOR system in cancer: expression and pathophysiological implications
  1972. CORTICOTROPIN โ€“RELEASING FACTOR receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal โ€ฆ
  1973. Activation of basolateral amygdala CORTICOTROPIN โ€“RELEASING FACTOR 1 receptors modulates the consolidation of contextual fear
  1974. Antidepressant-like activity of CORTICOTROPIN โ€“RELEASING FACTOR type-1 receptor antagonists in mice
  1975. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors 1 and 2ฮฒ by the CRF/urocortin โ€ฆ
  1976. CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse
  1977. Tissue plasminogen activator promotes the effects of CORTICOTROPIN โ€“RELEASING FACTOR on the amygdala and anxiety-like behavior
  1978. CORTICOTROPIN โ€RELEASING FACTOR neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress
  1979. Chronic stressโ€induced alterations in amygdala responsiveness and behaviorโ€“modulation by trait anxiety and CORTICOTROPIN โ€RELEASING FACTOR systems
  1980. Anxiogenic and aversive effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes
  1981. Selective activation of CORTICOTROPIN โ€“RELEASING FACTOR -2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions
  1982. Early life social isolation alters CORTICOTROPIN โ€“RELEASING FACTOR responses in adult rats
  1983. Medullary neurones regulate hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR cell responses to an emotional stressor
  1984. Region-specific onset of handling-induced changes in CORTICOTROPIN โ€“RELEASING FACTOR and glucocorticoid receptor expression
  1985. Expression and hypophysiotropic actions of CORTICOTROPIN โ€“RELEASING FACTOR in Xenopus laevis
  1986. Cortagine, a specific agonist of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 1, is anxiogenic and antidepressive in the mouse model
  1987. CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 is a tonic suppressor of vascularization
  1988. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  1989. Suppression of food intake induced by CORTICOTROPIN โ€“RELEASING FACTOR family in neonatal chicks
  1990. CORTICOTROPIN โ€“RELEASING FACTOR and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription FACTOR s PU. 1 and AP-1
  1991. Role of CORTICOTROPIN โ€“RELEASING FACTOR pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents
  1992. Effects of neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR on ethanol intake in Wistar rats: interaction with chronic ethanol exposure
  1993. Evidence supporting a role for CORTICOTROPIN โ€“RELEASING FACTOR type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons
  1994. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukinโ€1 and CORTICOTROPIN โ€RELEASING FACTOR release in rats
  1995. CORTICOTROPIN โ€“RELEASING FACTOR 1 and 2 receptors in the dorsal raphe differentially affect serotonin release in the nucleus accumbens
  1996. CORTICOTROPIN โ€“RELEASING FACTOR increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons
  1997. Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in mice
  1998. Blockade of the CORTICOTROPIN RELEASING FACTOR type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures
  1999. A novel transgenic mouse for gene-targeting within cells that express CORTICOTROPIN โ€“RELEASING FACTOR
  2000. The CORTICOTROPIN โ€“RELEASING FACTOR receptor: a novel target for the treatment of depression and anxiety-related disorders
  2001. Mechanism of CORTICOTROPIN โ€“RELEASING FACTOR type I receptor regulation by nonpeptide antagonists
  2002. Role of CORTICOTROPIN โ€“RELEASING FACTOR receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat
  2003. Neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis
  2004. CORTICOTROPIN โ€“RELEASING FACTOR testing reveals a dose-dependent difference in methadone maintained vs control subjects
  2005. The CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of neuropeptides in inflammation: potential therapeutic applications
  2006. Ontogeny of CORTICOTROPIN โ€“RELEASING FACTOR effects on locomotion and foraging in the Western spadefoot toad (Spea hammondii)
  2007. Molecular mechanisms of CORTICOTROPIN โ€“RELEASING FACTOR receptor-induced calcium signaling
  2008. Mouse CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฑ gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids
  2009. Peripheral CORTICOTROPIN โ€“RELEASING FACTOR induces diarrhea in rats: role of CRF1 receptor in fecal watery excretion
  2010. CORTICOTROPIN RELEASING FACTOR and neuroplasticity in cocaine addiction
  2011. PRECLINICAL STUDY: CORTICOTROPIN โ€RELEASING FACTOR โ€1 receptor antagonists decrease heroin selfโ€administration in longโ€but not shortโ€access rats
  2012. CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats
  2013. Pre-clinical evidence that CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism
  2014. CORTICOTROPIN โ€“RELEASING FACTOR type-1 receptor antagonists: the next class of antidepressants?
  2015. Pro-and anti-nociceptive effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in central amygdala neurons are mediated through different receptors
  2016. Dorsomedial hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR mediation of exercise-induced anorexia
  2017. CORTICOTROPIN โ€RELEASING FACTOR receptor 1โ€deficient mice show decreased anxiety and colonic sensitivity
  2018. Plasma CORTICOTROPIN โ€“RELEASING FACTOR in depressed patients before and after the dexamethasone suppression test
  2019. CORTICOTROPIN โ€“RELEASING FACTOR antagonists: recent advances and exciting prospects for the treatment of human diseases.
  2020. Urocortins and CORTICOTROPIN RELEASING FACTOR type 2 receptors in the hypothalamus and the cardiovascular system
  2021. โ€ฆ -evoked enhancement of hippocampal memory function and glucocorticoid receptor expression involves activation of the CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor
  2022. Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of CORTICOTROPIN โ€“RELEASING FACTOR
  2023. A role for CORTICOTROPIN RELEASING FACTOR (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice
  2024. Involvement of central amygdalar and bed nucleus of the stria terminalis CORTICOTROPIN โ€“RELEASING FACTOR in behavioral responses to social defeat.
  2025. CORTICOTROPIN โ€RELEASING FACTOR binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons
  2026. CORTICOTROPIN RELEASING FACTOR influences aggression and monoamines: modulation of attacks and retreats
  2027. Role of CORTICOTROPIN RELEASING FACTOR (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice
  2028. CORTICOTROPIN โ€“RELEASING FACTOR in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior
  2029. Synthesis and pharmacological characterization of novel druglike CORTICOTROPIN โ€“RELEASING FACTOR 1 antagonists
  2030. Restraint stress stimulates colonic motility via central CORTICOTROPIN โ€“RELEASING FACTOR and peripheral 5-HT3 receptors in conscious rats
  2031. Localization of CORTICOTROPIN โ€RELEASING FACTOR , urotensin I, and CRFโ€binding protein gene expression in the brain of the zebrafish, Danio rerio
  2032. Posttraining infusion of norepinephrine and CORTICOTROPIN RELEASING FACTOR into the bed nucleus of the stria terminalis enhanced retention in an inhibitory โ€ฆ
  2033. Central orexinโ€A activates hypothalamicโ€pituitaryโ€adrenal axis and stimulates hypothalamic CORTICOTROPIN RELEASING FACTOR and arginine vasopressin neurones in โ€ฆ
  2034. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local CORTICOTROPIN โ€“RELEASING FACTOR network
  2035. Mitogen-activated protein kinase signaling in the hippocampus and its modulation by CORTICOTROPIN โ€“RELEASING FACTOR receptor 2: a possible link between stress and fear โ€ฆ
  2036. Centrally administered orexin-A activates CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid โ€ฆ
  2037. โ€ฆ -and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a CORTICOTROPIN โ€“RELEASING FACTOR receptor-dependent mechanism
  2038. The CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with โ€ฆ
  2039. CORTICOTROPIN โ€“RELEASING FACTOR , interleukin-6, brain-derived neurotrophic FACTOR , insulin-like growth FACTOR -1, and substance P in the cerebrospinal fluid of civilians with โ€ฆ
  2040. Exposure to neonatal separation stress alters exploratory behavior and CORTICOTROPIN RELEASING FACTOR expression in neurons in the amygdala and hippocampus
  2041. Differential actions of peripheral CORTICOTROPIN โ€“RELEASING FACTOR (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor โ€ฆ
  2042. Ghrelin decreases food intake in juvenile rainbow trout (Oncorhynchus mykiss) through the central anorexigenic CORTICOTROPIN โ€“RELEASING FACTOR system
  2043. Vital functions of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) pathways in maintenance and regulation of energy homeostasis
  2044. Targeted mutations of the CORTICOTROPIN โ€“RELEASING FACTOR system: effects on physiology and behavior
  2045. CORTICOTROPIN โ€“RELEASING FACTOR receptor-1: a therapeutic target for cardiac autonomic disturbances
  2046. CORTICOTROPIN โ€“RELEASING FACTOR , corticosteroids, stress, and sugar: energy balance, the brain, and behavior
  2047. Effects of hypoxia on glucose, insulin, glucagon, and modulation by CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 in the rat
  2048. The CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of peptides as local modulators of adrenal function
  2049. Subtype-selective CORTICOTROPIN โ€“RELEASING FACTOR receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats
  2050. Expression of type 1 CORTICOTROPIN โ€RELEASING FACTOR receptor in the guinea pig enteric nervous system
  2051. Chronic morphine sensitizes the brain norepinephrine system to CORTICOTROPIN โ€“RELEASING FACTOR and stress
  2052. Characterization and regulation of CORTICOTROPIN โ€RELEASING FACTOR receptors in the central nervous, endocrine and immune systems
  2053. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats
  2054. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats
  2055. Effect of ethanol on the regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene expression
  2056. Species and sex differences in brain distribution of CORTICOTROPIN โ€RELEASING FACTOR receptor subtypes 1 and 2 in monogamous and promiscuous vole species
  2057. Evidence for CORTICOTROPIN โ€“RELEASING FACTOR regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming
  2058. The CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2a contains an N-terminal pseudo signal peptide
  2059. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule CORTICOTROPIN RELEASING FACTOR type I receptor selective antagonist
  2060. CORTICOTROPIN โ€“RELEASING FACTOR in the basolateral amygdala enhances memory consolidation via an interaction with the ฮฒ-adrenoceptorโ€“cAMP pathway: dependence on โ€ฆ
  2061. Molecular cloning and developmental expression of CORTICOTROPIN โ€“RELEASING FACTOR in the chicken
  2062. Pain is a salient โ€œstressorโ€ that is mediated by CORTICOTROPIN โ€“RELEASING FACTOR -1 receptors
  2063. Cloning and functional pharmacology of two CORTICOTROPIN โ€“RELEASING FACTOR receptors from a teleost fish
  2064. Roles of CORTICOTROPIN โ€RELEASING FACTOR , Neuropeptide Y and Corticosterone in the Regulation of Food Intake In Xenopus laevis
  2065. CORTICOTROPIN โ€“RELEASING FACTOR and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons
  2066. โ€ฆ urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for CORTICOTROPIN RELEASING FACTOR receptor type 2 in โ€ฆ
  2067. The role of neuropeptide Y in the amygdala on CORTICOTROPIN โ€“RELEASING FACTOR receptor-mediated behavioral stress responses in the rat
  2068. 2-aryloxy-4-alkylaminopyridines: discovery of novel CORTICOTROPIN โ€“RELEASING FACTOR 1 antagonists
  2069. Heads or tails? Stressor-specific expression of CORTICOTROPIN โ€“RELEASING FACTOR and urotensin I in the preoptic area and caudal neurosecretory system of rainbow โ€ฆ
  2070. CORTICOTROPIN RELEASING FACTOR promotes breast cancer cell motility and invasiveness
  2071. Dopamineโ€dependent responses to cocaine depend on CORTICOTROPIN โ€RELEASING FACTOR receptor subtypes
  2072. A soluble mouse brain splice variant of type 2ฮฑ CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor binds ligands and modulates their activity
  2073. Social environment regulates CORTICOTROPIN RELEASING FACTOR , corticosterone and vasopressin in juvenile prairie voles
  2074. CORTICOTROPIN RELEASING FACTOR -induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2
  2075. Pharmacology and biology of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors
  2076. Social defeat stress activates medial amygdala cells that express type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor mRNA
  2077. Evolutionarily conserved glucocorticoid regulation of CORTICOTROPIN โ€“RELEASING FACTOR expression
  2078. The potential role of a CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonist in psychiatric disorders
  2079. Differing concentrations of CORTICOTROPIN โ€“RELEASING FACTOR and oxytocin in the cerebrospinal fluid of bonnet and pigtail macaques
  2080. Heart rate dynamics and behavioral responses during acute emotional challenge in CORTICOTROPIN โ€“RELEASING FACTOR receptor 1-deficient and CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  2081. Arylamidrazones as novel CORTICOTROPIN RELEASING FACTOR receptor antagonists
  2082. Identification and characterization of multiple CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor isoforms in the rat esophagus
  2083. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein, stress and major depression
  2084. Effects of CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonists on the brain stress system responses to morphine withdrawal
  2085. Urocortin and CORTICOTROPIN โ€“RELEASING FACTOR receptor expression in normal cycling human ovaries
  2086. Synapses between CORTICOTROPIN โ€RELEASING FACTOR โ€containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic
  2087. Attenuation of fear conditioning by antisense inhibition of brain CORTICOTROPIN RELEASING FACTOR -2 receptor
  2088. Stress elevates CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein mRNA levels in rainbow trout (Oncorhynchus mykiss)
  2089. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1-deficient mice do not develop postoperative gastric ileus
  2090. The binding protein of CORTICOTROPIN โ€“RELEASING FACTOR : ligand-binding site and subunit structure
  2091. Agonistโ€induced internalization of CORTICOTROPIN โ€RELEASING FACTOR receptors in noradrenergic neurons of the rat locus coeruleus
  2092. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel CORTICOTROPIN โ€“RELEASING FACTOR related peptide
  2093. Combined dexamethasone/CORTICOTROPIN โ€“RELEASING FACTOR test in chronic fatigue syndrome
  2094. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation
  2095. Region-specific effects of brain CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 blockade on footshock-stress-or drug-priming-induced reinstatement of morphine โ€ฆ
  2096. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 CORTICOTROPIN โ€“RELEASING FACTOR agonist in rats: intra-hypothalamic urocortin โ€ฆ
  2097. Stressin1-A, a Potent CORTICOTROPIN RELEASING FACTOR Receptor 1 (CRF1)-Selective Peptide Agonist
  2098. Brain pharmacokinetics of a nonpeptidic CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonist
  2099. Effects of naltrexone, duloxetine, and a CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor antagonist on binge-like alcohol drinking in rats
  2100. CORTICOTROPIN RELEASING FACTOR (CRF) activation of NF-ฮบB-directed transcription in leukocytes
  2101. CORTICOTROPIN โ€RELEASING FACTOR in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity
  2102. Stressor-and CORTICOTROPIN RELEASING FACTOR -induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self โ€ฆ
  2103. CORTICOTROPIN โ€“RELEASING FACTOR receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold
  2104. Activation of raphe efferents to the medial prefrontal cortex by CORTICOTROPIN โ€“RELEASING FACTOR : correlation with anxiety-like behavior
  2105. Sucrose ingestion normalizes central expression of CORTICOTROPIN โ€“RELEASING โ€“FACTOR messenger ribonucleic acid and energy balance in adrenalectomized rats: a โ€ฆ
  2106. Ligand affinity for amino-terminal and juxtamembrane domains of the CORTICOTROPIN RELEASING FACTOR type I receptor: regulation by G-protein and nonpeptide antagonists
  2107. Peripheral antiโ€inflammatory actions of CORTICOTROPIN โ€RELEASING FACTOR
  2108. Structural evolution of urotensin-I: reflections of life before CORTICOTROPIN RELEASING FACTOR
  2109. CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y mRNA levels are modified by glucocorticoids in rainbow trout, Oncorhynchus mykiss
  2110. Influence of sex and CORTICOTROPIN โ€“RELEASING FACTOR pathways as determinants in serotonin sensitivity
  2111. Design and synthesis of tricyclic CORTICOTROPIN โ€“RELEASING FACTOR -1 antagonists
  2112. Intracerebroventricular CORTICOTROPIN โ€“RELEASING FACTOR increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates
  2113. Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR levels in rat brains
  2114. Dimerization of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 is not coupled to ligand binding
  2115. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 and type 2 โ€ฆ
  2116. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 selectively inhibits CaV3. 2 T-type calcium channels
  2117. Recent advances in CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonists
  2118. Effects of electro-acupuncture on CORTICOTROPIN โ€“RELEASING FACTOR in rats with experimentally-induced polycystic ovaries
  2119. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation โ€ฆ
  2120. Both CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats
  2121. Elevated stress sensitivity in CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 deficient mice decreases maternal, but not intermale aggression
  2122. Effects of chronic footshock, restraint and CORTICOTROPIN โ€“RELEASING FACTOR on freezing, ultrasonic vocalization and forced swim behavior in rats
  2123. Differential regulation of CORTICOTROPIN RELEASING FACTOR 1ฮฑ receptor endocytosis and trafficking by ฮฒโ€arrestins and Rab GTPases
  2124. Human urocortin II, a selective agonist for the type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor, decreases feeding and drinking in the rat
  2125. Selective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced CORTICOTROPIN โ€“RELEASING FACTOR function
  2126. โ€ฆ of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic FACTOR is enhanced by CORTICOTROPIN RELEASING FACTOR through the activation of a cAMP โ€ฆ
  2127. Chronic cocaine enhances CORTICOTROPIN โ€“RELEASING FACTOR -dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons
  2128. Regulation of hypoxia-induced release of CORTICOTROPIN โ€“RELEASING FACTOR in the rat hypothalamus by norepinephrine
  2129. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  2130. CORTICOTROPIN โ€“RELEASING FACTOR within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine โ€ฆ
  2131. Deletion of CORTICOTROPIN โ€“RELEASING FACTOR binding protein selectively impairs maternal, but not intermale aggression
  2132. Footshock-induced urinary bladder hypersensitivity: role of spinal CORTICOTROPIN โ€“RELEASING FACTOR receptors
  2133. Functional and protein chemical characterization of the Nโ€terminal domain of the rat CORTICOTROPIN โ€RELEASING FACTOR receptor 1
  2134. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and related peptides confer neuroprotection via type 1 CRF receptors
  2135. Effects of sodium valproate on CORTICOTROPIN โ€“RELEASING FACTOR systems in rat brain
  2136. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on CORTICOTROPIN โ€“RELEASING FACTOR , nociceptin/orphanin FQ, and โ€ฆ
  2137. Immunohistochemical visualization of CORTICOTROPIN โ€RELEASING FACTOR type 1 (CRF1) receptors in monkey brain
  2138. CORTICOTROPIN โ€“RELEASING FACTOR -1 receptors in the basolateral amygdala mediate stress-induced anorexia.
  2139. CORTICOTROPIN RELEASING FACTOR in the rat colon: expression, localization and upregulation by endotoxin
  2140. Human urocortin 2, a CORTICOTROPIN โ€“RELEASING FACTOR (CRF) 2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity
  2141. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 in lateral septum negatively regulates maternal defense.
  2142. In Vitro Intrinsic Clearance-Based Optimization of N3-Phenylpyrazinones as CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) Receptor Antagonists
  2143. Activity of the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in hippocampus and CORTICOTROPIN โ€“RELEASING FACTOR in hypothalamus in SPS rats
  2144. Distribution and chemical coding of CORTICOTROPIN โ€RELEASING FACTOR โ€immunoreactive neurons in the guinea pig enteric nervous system
  2145. Determinants of CORTICOTROPIN RELEASING FACTOR . Receptor selectivity of CORTICOTROPIN RELEASING FACTOR related peptides
  2146. A soluble form of the first extracellular domain of mouse type 2ฮฒ CORTICOTROPIN โ€“RELEASING FACTOR receptor reveals differential ligand specificity
  2147. Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 CORTICOTROPIN RELEASING FACTOR receptor
  2148. CORTICOTROPIN โ€RELEASING FACTOR (CRF) receptor type 2 in the human stomach: Protective biological role by inhibition of apoptosis
  2149. Immunomodulatory role of the CORTICOTROPIN โ€“RELEASING FACTOR .
  2150. CORTICOTROPIN RELEASING FACTOR induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity
  2151. Acute and chronic CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity
  2152. โ€ฆ โ€histidin tag position influences disulfide structure but not binding behavior of in vitro folded Nโ€terminal domain of rat CORTICOTROPIN โ€RELEASING FACTOR receptor type 2a
  2153. Single exposure to social defeat increases CORTICOTROPIN โ€“RELEASING FACTOR and glucocorticoid receptor mRNA expression in rat hippocampus
  2154. Role of CORTICOTROPIN โ€“RELEASING FACTOR and its receptor in nociceptive modulation in the central nucleus of amygdala in rats
  2155. The signal peptide of the rat CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 promotes receptor expression but is not essential for establishing a functional receptor
  2156. Recent advances in small molecule antagonists of the CORTICOTROPIN โ€“RELEASING FACTOR type-1 receptor-focus on pharmacology and pharmacokinetics
  2157. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 1 in the vole brain
  2158. A role for CORTICOTROPIN โ€“RELEASING FACTOR , but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats
  2159. Transcriptional response to CORTICOTROPIN โ€“RELEASING FACTOR in AtT-20 cells
  2160. Sauvagine cross-links to the second extracellular loop of the CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor
  2161. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic CORTICOTROPIN โ€RELEASING FACTOR cell responses to systemic โ€ฆ
  2162. Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the rat brain: evidence for involvement of the bed nucleus โ€ฆ
  2163. CORTICOTROPIN RELEASING FACTOR receptor 1 (CRF1) and CRF2 agonists exert an antiโ€inflammatory effect during the early phase of inflammation suppressing LPSโ€induced TNFโ€ฮฑ โ€ฆ
  2164. Discovery of NBI-77860/GSK561679, a potent CORTICOTROPIN โ€“RELEASING FACTOR (CRF1) receptor antagonist with improved pharmacokinetic properties
  2165. CORTICOTROPIN โ€RELEASING FACTOR triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways
  2166. The CORTICOTROPIN โ€RELEASING FACTOR /urocortin system and alcohol
  2167. CORTICOTROPIN โ€RELEASING FACTOR receptor type 2โ€deficient mice display impaired coping behaviors during stress
  2168. โ€ฆ ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the CORTICOTROPIN RELEASING FACTOR 2 โ€ฆ
  2169. Distinct conformations of the CORTICOTROPIN RELEASING FACTOR type 1 receptor adopted following agonist and antagonist binding are differentially regulated
  2170. โ€ฆ -yl-thiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl-imidazo [1, 2-b] pyridazine: a novel brain-penetrant, orally available CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist โ€ฆ
  2171. Subtype-specific differences in CORTICOTROPIN โ€“RELEASING FACTOR receptor complexes detected by fluorescence spectroscopy
  2172. Differential regulation of CREB and ERK phosphorylation through CORTICOTROPIN โ€“RELEASING FACTOR receptors type 1 and 2 in AtT-20 and A7r5 cells
  2173. Differential stressโ€induced alterations of colonic CORTICOTROPIN โ€RELEASING FACTOR receptors in the Wistar Kyoto rat
  2174. Teneurin C-terminal associated peptides: an enigmatic family of neuropeptides with structural similarity to the CORTICOTROPIN โ€“RELEASING FACTOR and calcitonin families of โ€ฆ
  2175. CORTICOTROPIN โ€“RELEASING FACTOR as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats
  2176. CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 is involved in the stressโ€induced exacerbation of chronic contact dermatitis in rats
  2177. CORTICOTROPIN RELEASING FACTOR receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin
  2178. Long-term expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation
  2179. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonists in affective disorders and drug dependence-an update
  2180. Altered maternal profiles in CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 deficient mice
  2181. CORTICOTROPIN โ€RELEASING FACTOR (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases
  2182. Modulation of social learning in rats by brain CORTICOTROPIN โ€“RELEASING FACTOR
  2183. Progesterone attenuates CORTICOTROPIN โ€“RELEASING FACTOR -enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone
  2184. Ultrastructural evidence for a role of ฮณโ€aminobutyric acid in mediating the effects of CORTICOTROPIN โ€RELEASING FACTOR on the rat dorsal raphe serotonin system
  2185. Differential increase in forebrain and caudal neurosecretory system CORTICOTROPIN โ€“RELEASING FACTOR and urotensin I gene expression associated with seawater transfer in โ€ฆ
  2186. Intermale aggression in CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 deficient mice
  2187. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 CORTICOTROPIN โ€“RELEASING FACTOR agonist
  2188. CORTICOTROPIN โ€“RELEASING FACTOR regulates TLR4 expression in the colon and protects mice from colitis
  2189. CORTICOTROPIN โ€“RELEASING FACTOR binding protein-A ligand trap?
  2190. CORTICOTROPIN โ€“RELEASING FACTOR mediates the antinociceptive action of nitrous oxide in rats
  2191. Dissection of hypothalamicโ€pituitaryโ€adrenal axis pathology in 1โ€monthโ€abstinent alcoholโ€dependent men, part 2: response to ovine CORTICOTROPIN โ€RELEASING FACTOR โ€ฆ
  2192. CORTICOTROPIN โ€“RELEASING FACTOR is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region
  2193. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific โ€ฆ
  2194. CORTICOTROPIN โ€RELEASING FACTOR decreases ILโ€18 in the monocyteโ€derived dendritic cell
  2195. Possible involvement of CORTICOTROPIN โ€“RELEASING FACTOR receptor signaling on vascular inflammation
  2196. CORTICOTROPIN โ€RELEASING FACTOR , urocortin 1, and their receptors in the mouse spinal cord
  2197. The Threeโ€Dimensional Structure of the Nโ€Terminal Domain of CORTICOTROPIN โ€RELEASING FACTOR Receptors: Sushi Domains and the B1 Family of G Proteinโ€“Coupled โ€ฆ
  2198. Role of CORTICOTROPIN RELEASING FACTOR receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
  2199. CORTICOTROPIN โ€“RELEASING FACTOR mediates the dysphoria-like state associated with alcohol withdrawal in rats
  2200. Amygdala protein kinase C epsilon regulates CORTICOTROPIN โ€RELEASING FACTOR and anxietyโ€like behavior
  2201. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on prepulse inhibition of the acoustic startle response in two rat strains
  2202. Blocking CORTICOTROPIN โ€“RELEASING FACTOR -2 receptors, but not CORTICOTROPIN โ€“RELEASING FACTOR -1 receptors or glucocorticoid feedback, disrupts the development of โ€ฆ
  2203. N-Phenylphenylglycines as Novel CORTICOTROPIN RELEASING FACTOR Receptor Antagonists
  2204. Hippocampal serotonergic system is involved in anxiety-like behavior induced by CORTICOTROPIN โ€“RELEASING FACTOR
  2205. Rapid changes in monoamine levels following administration of CORTICOTROPIN โ€“RELEASING FACTOR or corticosterone are localized in the dorsomedial hypothalamus
  2206. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in CORTICOTROPIN โ€“RELEASING FACTOR receptor (CRFR) 1-and โ€ฆ
  2207. CORTICOTROPIN RELEASING FACTOR antagonist, ฮฑ-helical CRF 9โ€“41, reverses nicotine-induced conditioned, but not unconditioned, anxiety
  2208. A new role for CORTICOTROPIN โ€“RELEASING FACTOR receptor-2: suppression of vascularization
  2209. Serotonin modifies CORTICOTROPIN โ€“RELEASING FACTOR -induced behaviors of chicks
  2210. Chronic stimulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 enhances the anxiogenic response of the cholecystokinin system
  2211. NMR structure of the first extracellular domain of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist
  2212. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptors
  2213. Cocaine withdrawal enhances longโ€term potentiation induced by CORTICOTROPIN โ€RELEASING FACTOR at central amygdala glutamatergic synapses via CRF1, NMDA โ€ฆ
  2214. Local ฮณโ€aminobutyric acid and glutamate circuit control of hypophyseotrophic CORTICOTROPIN โ€RELEASING FACTOR neuron activity in the paraventricular nucleus of the โ€ฆ
  2215. Receptor occupancy of nonpeptide CORTICOTROPIN โ€“RELEASING FACTOR 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacy
  2216. Structural and functional conservation of vertebrate CORTICOTROPIN โ€“RELEASING FACTOR genes: evidence for a critical role for a conserved cyclic AMP response element
  2217. Alterations in colonic CORTICOTROPIN โ€“RELEASING FACTOR receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute โ€ฆ
  2218. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the CORTICOTROPIN โ€“RELEASING FACTOR receptor pathways
  2219. Regulation of the coupling to different G proteins of rat CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 in human embryonic kidney 293 cells
  2220. CORTICOTROPIN โ€“RELEASING FACTOR receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters
  2221. Corticosterone differentially modulates expression of CORTICOTROPIN RELEASING FACTOR and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus โ€ฆ
  2222. Repeated restraint stress-induced increase in baroreceptor reflex sensitivity: role of CORTICOTROPIN โ€“RELEASING FACTOR
  2223. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1)
  2224. Ontogeny of CORTICOTROPIN โ€“RELEASING FACTOR and of hypothalamicโ€“pituitaryโ€“interrenal axis responsiveness to stress in tilapia (Oreochromis mossambicus; Teleostei)
  2225. CORTICOTROPIN โ€“RELEASING FACTOR induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans
  2226. A single amino acid serves as an affinity switch between the receptor and the binding protein of CORTICOTROPIN โ€“RELEASING FACTOR : implications for the design of agonists โ€ฆ
  2227. Evidence that CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 couples to Gsโ€and Giโ€proteins through different conformations of its Jโ€domain
  2228. Effect of pharmacological manipulations of neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR neurotransmission on incubation of conditioned fear
  2229. Alanine scanning mutagenesis of the second extracellular loop of type 1 CORTICOTROPIN โ€“RELEASING FACTOR receptor revealed residues critical for peptide binding
  2230. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on CORTICOTROPIN โ€“RELEASING FACTOR neuronal systems
  2231. Chronic anabolic androgenic steroid exposure alters CORTICOTROPIN RELEASING FACTOR expression and anxiety-like behaviors in the female mouse
  2232. The involvement of altered CORTICOTROPIN RELEASING FACTOR receptor 2 expression in prostate cancer due to alteration of antiโ€angiogenic signaling pathways
  2233. The pseudo signal peptide of the CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl โ€ฆ
  2234. Peripheral CORTICOTROPIN RELEASING FACTOR (CRF) and a novel CRF1 receptor agonist, stressin1โ€A activate CRF1 receptor expressing cholinergic and nitrergic โ€ฆ
  2235. CSF CORTICOTROPIN โ€“RELEASING FACTOR in personality disorder: relationship with self-reported parental care
  2236. Expression of CORTICOTROPIN โ€“RELEASING FACTOR and CRF receptors in micturition pathways after cyclophosphamide-induced cystitis
  2237. Distribution of CORTICOTROPIN โ€RELEASING FACTOR โ€immunoreactive neurons in the central nervous system of the domestic chicken and Japanese quail
  2238. Differences in response to CORTICOTROPIN โ€“RELEASING FACTOR after short-and long-term consumption of a high-fat diet
  2239. CORTICOTROPIN RELEASING FACTOR in urineโ€”A possible biochemical marker of fibromyalgia: Responses to massage and guided relaxation
  2240. Urocortin shares the memory modulating effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF): mediation by CRF1 receptors
  2241. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor type 1-dependent modulation of synaptic plasticity
  2242. Chronically elevated corticosterone in the amygdala increases CORTICOTROPIN RELEASING FACTOR mRNA in the dorsolateral bed nucleus of stria terminalis following duress
  2243. Type 1 CORTICOTROPIN โ€“RELEASING FACTOR receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation
  2244. โ€ฆ teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rat models of โ€ฆ
  2245. CORTICOTROPIN โ€RELEASING FACTOR promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat
  2246. CORTICOTROPIN โ€“RELEASING FACTOR family and its receptors: tumor therapeutic targets?
  2247. CORTICOTROPIN RELEASING FACTOR enhances attentional function as assessed by the five-choice serial reaction time task in rats
  2248. Interaction of neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR signaling pathways in AR-5 amygdalar cells
  2249. Neonatal gastric suctioning results in chronic visceral and somatic hyperalgesia: role of CORTICOTROPIN RELEASING FACTOR
  2250. CORTICOTROPIN โ€“RELEASING FACTOR overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol
  2251. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonists
  2252. Different binding modes of amphibian and human CORTICOTROPIN โ€“RELEASING FACTOR type 1 and type 2 receptors: evidence for evolutionary differences
  2253. A role for CORTICOTROPIN โ€“RELEASING FACTOR in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice
  2254. The CORTICOTROPIN โ€“RELEASING FACTOR -hypocretin connection: implications in stress response and addiction
  2255. Allosteric ligands for the CORTICOTROPIN RELEASING FACTOR type 1 receptor modulate conformational states involved in receptor activation
  2256. Synthesis and structureโ€“activity relationships of N3-pyridylpyrazinones as CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) receptor antagonists
  2257. Involvement of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland
  2258. Promoter analysis of human CORTICOTROPIN โ€“RELEASING FACTOR (CRF) type 1 receptor and regulation by CRF and urocortin
  2259. Differential effects of stress and amphetamine administration on Fosโ€like protein expression in CORTICOTROPIN RELEASING FACTOR โ€neurons of the rat brain
  2260. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and โ€ฆ
  2261. Evolution of Complementary Peptide Systems: Teneurin Cโ€terminalโ€associated Peptides and CORTICOTROPIN โ€RELEASING FACTOR Superfamilies
  2262. CORTICOTROPIN โ€“RELEASING FACTOR test in melancholic patients in depressed state versus recovery: a comparative study
  2263. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 and central heart rate regulation in mice during expression of conditioned fear
  2264. Rational Design, Synthesis, and Structureโˆ’ Activity Relationships of Aryltriazoles as Novel CORTICOTROPIN โ€“RELEASING FACTOR -1 Receptor Antagonists
  2265. Achieving signalling selectivity of ligands for the CORTICOTROPIN โ€RELEASING FACTOR type 1 receptor by modifying the agonistโ€™s signalling domain
  2266. Mice deficient in CORTICOTROPIN โ€RELEASING FACTOR receptor type 2 exhibit normal ethanolโ€associated behaviors
  2267. CORTICOTROPIN โ€“RELEASING FACTOR in the rat amygdala differentially influences sensory-discriminative and emotional-like pain response in peripheral neuropathy
  2268. CORTICOTROPIN โ€“RELEASING FACTOR , neuroplasticity (sensitization), and alcoholism
  2269. Residues of CORTICOTROPIN RELEASING FACTOR -binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1
  2270. Spatial distribution of CORTICOTROPIN โ€“RELEASING FACTOR immunopositive climbing fibers in the mouse cerebellum: analysis by whole mount immunohistochemistry
  2271. Conformational states of the CORTICOTROPIN RELEASING FACTOR 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands
  2272. Evidence for ฮฒ 1-Adrenergic Receptor Involvement in Amygdalar CORTICOTROPIN โ€“RELEASING FACTOR Gene Expression: Implications for Cocaine Withdrawal
  2273. CORTICOTROPIN โ€“RELEASING FACTOR in the dorsal raphe nucleus regulates activity of lateral septal neurons
  2274. Frequency-dependent expression of CORTICOTROPIN RELEASING FACTOR in the ratโ€™s cerebellum
  2275. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) is involved in the acute anorexic effect of ฮฑ-melanocyte-stimulating hormone: a study using CRF-deficient mice
  2276. Antagonists of the CORTICOTROPIN RELEASING FACTOR receptor
  2277. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 and 2 mRNA expression in the rat anterior pituitary is modulated by intermittent hypoxia, cold and restraint
  2278. Teneurin C-terminal associated peptide (TCAP)-1 attenuates CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced c-Fos expression in the limbic system and modulates โ€ฆ
  2279. Mediation of CORTICOTROPIN RELEASING FACTOR type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation
  2280. NBI 30775 (R121919), an orally active antagonist of the CORTICOTROPIN โ€RELEASING FACTOR (CRF) typeโ€1 receptor for the treatment of anxiety and depression
  2281. โ€ฆ from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor
  2282. Monoaminergic activity in subregions of raphรฉ nuclei elicited by prior stress and the neuropeptide CORTICOTROPIN โ€RELEASING FACTOR
  2283. CORTICOTROPIN RELEASING FACTOR increases in brown adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus and medullary raphe pallidus
  2284. Interaction of CORTICOTROPIN โ€“RELEASING FACTOR and glucagon-like peptide-1 on behaviors in chicks
  2285. Ultrastructural evidence for co-localization of CORTICOTROPIN โ€“RELEASING FACTOR receptor and ฮผ-opioid receptor in the rat nucleus locus coeruleus
  2286. Antidepressant-like effects of the CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in โ€ฆ
  2287. Intracellular calcium measurements of single human skin cells after stimulation with CORTICOTROPIN โ€“RELEASING FACTOR and urocortin using confocal laser scanning โ€ฆ
  2288. CORTICOTROPIN โ€“RELEASING FACTOR : putative neurotransmitter actions of a neurohormone
  2289. Deciphering the interaction of the CORTICOTROPIN โ€“RELEASING FACTOR and serotonin brain systems in anxiety-related disorders
  2290. Reversal of startle gating deficits in transgenic mice overexpressing CORTICOTROPIN โ€“RELEASING FACTOR by antipsychotic drugs
  2291. The CORTICOTROPIN โ€“RELEASING FACTOR system as a potential target for antiobesity drugs.
  2292. Activation of CORTICOTROPIN โ€RELEASING FACTOR receptorโ€2 causes bronchorelaxation and inhibits pulmonary inflammation in mice
  2293. Pharmacological characterization of recombinant rat CORTICOTROPIN RELEASING FACTOR binding protein using different sauvagine analogs
  2294. A novel CORTICOTROPIN โ€RELEASING FACTOR receptor splice variant exhibits dominant negative activity: a putative link to stressโ€induced heart disease
  2295. Transcriptional regulation of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR gene
  2296. Intrahypothalamic Neuroendocrine Actions of CORTICOTROPIN โ€RELEASING FACTOR
  2297. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal CORTICOTROPIN โ€“RELEASING FACTOR
  2298. Synthesis and structureโ€“activity relationship of imidazo [1, 2-a] benzimidazoles as CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists
  2299. โ€ฆ variable foraging demand in nonhuman primates: Effects of timing of stressor on cerebrospinal fluid CORTICOTROPIN โ€RELEASING FACTOR and circulating glucocorticoid โ€ฆ
  2300. CORTICOTROPIN โ€“RELEASING FACTOR : effect on cerebral blood flow in physiologic and ischaemic conditions
  2301. Dopamine and CORTICOTROPIN โ€“RELEASING FACTOR synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic โ€ฆ
  2302. Thyrotropin-RELEASING hormone increased heat production without the involvement of CORTICOTROPIN โ€“RELEASING FACTOR in neonatal chicks
  2303. The effects of CRA 1000, a non-peptide antagonist of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1, on adaptive behaviour in therat
  2304. Synthesis, Structureโˆ’Activity Relationships, and In Vivo Evaluation of N3-Phenylpyrazinones as Novel CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) Receptor โ€ฆ
  2305. Molecular genetic approaches to the neuropharmacology of CORTICOTROPIN โ€“RELEASING FACTOR
  2306. Juxtamembrane region of the amino terminus of the CORTICOTROPIN RELEASING FACTOR receptor type 1 is important for ligand interaction
  2307. Cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple โ€ฆ
  2308. CORTICOTROPIN โ€“RELEASING FACTOR gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a โ€ฆ
  2309. Peptide ligand binding properties of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling โ€ฆ
  2310. Close juxtapositions between luteinizing hormone-RELEASING hormone-immunoreactive neurons and CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive axons in the human โ€ฆ
  2311. Gene expression profiles highlight adaptive brain mechanisms in CORTICOTROPIN RELEASING FACTOR overexpressing mice
  2312. CORTICOTROPIN โ€RELEASING FACTOR and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro
  2313. Interrelations between monoaminergic afferents and CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive neurons in the rat central amygdaloid nucleus: ultrastructural โ€ฆ
  2314. Cerebrospinal fluid concentrations of biogenic amines and CORTICOTROPIN โ€“RELEASING FACTOR in adolescent non-human primates as a function of the timing of adverse early โ€ฆ
  2315. Levels of maternal plasma CORTICOTROPIN โ€“RELEASING FACTOR and urocortin during labor
  2316. Structureโ€“Activity Studies on the CORTICOTROPIN RELEASING FACTOR Antagonist Astressin, leading to a Minimal Sequence necessary for Antagonistic Activity
  2317. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in stress and disease: a review of literature and treatment perspectives with special emphasis on psychiatric disorders
  2318. Urocortin and CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
  2319. Fluoxetine inhibits CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced behavioural responses in rats
  2320. New developments in the study of CORTICOTROPIN RELEASING FACTOR
  2321. Characterization of a CORTICOTROPIN โ€“RELEASING FACTOR (CRF)/diuretic hormone-like peptide from tunicates: insight into the origins of the vertebrate CRF family
  2322. Cardiac dynamics in CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype-2 deficient mice
  2323. Action of three ectopeptidases on CORTICOTROPIN โ€“RELEASING FACTOR : metabolism and functional aspects
  2324. Regional hemodynamic actions of selective CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor ligands in conscious rats
  2325. Isolation and Characterisation of the CORTICOTROPIN RELEASING FACTOR Receptor 1 (CRFR1) Gene in a Teleost Fish, Fugu rubripes
  2326. Abuse and ACTH response to CORTICOTROPIN RELEASING FACTOR .
  2327. Acoustic stimulation in vivo and CORTICOTROPIN โ€“RELEASING FACTOR in vitro increase tryptophan hydroxylase activity in the rat caudal dorsal raphe nucleus
  2328. CORTICOTROPIN โ€“RELEASING FACTOR regulates the development in the direct developing frog, Eleutherodactylus coqui
  2329. Cellular interactions between axon terminals containing endogenous opioid peptides or CORTICOTROPIN โ€RELEASING FACTOR in the rat locus coeruleus and surrounding โ€ฆ
  2330. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR subtype 1 receptor in the acquisition phase of learned helplessness in rats
  2331. CORTICOTROPIN โ€“RELEASING FACTOR 2 receptor localization in skeletal muscle
  2332. Comparison of basal neuropeptide Y and CORTICOTROPIN RELEASING FACTOR levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred โ€ฆ
  2333. Amphetamine treatment increases CORTICOTROPIN โ€“RELEASING FACTOR receptors in the dorsal raphe nucleus
  2334. Mice overexpressing CORTICOTROPIN โ€“RELEASING FACTOR show brain atrophy and motor dysfunctions
  2335. Nonโ€invasive, quantitative assessment of the anatomical phenotype of CORTICOTROPIN โ€RELEASING FACTOR โ€overexpressing mice by MRI
  2336. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) type-1 receptor gene expression by CRF in the hypothalamus
  2337. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) can directly affect brain microvessel endothelial cells
  2338. Comparative biotransformation of pyrazinone-containing CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonists: minimizing the reactive metabolite formation
  2339. Dissociation of arousal-like from anxiogenic-like actions of brain CORTICOTROPIN โ€“RELEASING FACTOR receptor ligands in rats
  2340. Electron microscopic localization of CORTICOTROPIN โ€RELEASING FACTOR (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala
  2341. The CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist CP-154,526 reverses stress-induced learning deficits in mice
  2342. Long-term losses of amygdala CORTICOTROPIN โ€“RELEASING FACTOR neurons are associated with behavioural outcomes following neonatal hypoxia-ischemia
  2343. Chronic psychosocial stress affects CORTICOTROPIN โ€“RELEASING FACTOR in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non โ€ฆ
  2344. CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1ฮฒ are involved in the electroacupuncture-induced analgesic effect on inflammatory pain elicited by carrageenan
  2345. Distinct distribution of CORTICOTROPIN RELEASING FACTOR receptors in human breast cancer
  2346. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress
  2347. Antagonism of specific CORTICOTROPIN โ€“RELEASING FACTOR receptor subtypes selectively modifies weight loss in restrained rats
  2348. The roles of CORTICOTROPIN RELEASING FACTOR (CRF) in responses to emotional stress: is CRF release a cause or result of fear/anxiety?
  2349. Stress, CORTICOTROPIN โ€“RELEASING FACTOR and serotonergic neurotransmission
  2350. โ€ฆ of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of CORTICOTROPIN โ€“RELEASING FACTOR
  2351. Central endothelin ETB receptors mediate IL-1-dependent fever induced by preformed pyrogenic FACTOR and CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  2352. CORTICOTROPIN โ€“RELEASING FACTOR Is Cytoprotective in Xenopus Tadpole Tail: Coordination of Ligand, Receptor, and Binding Protein in Tail Muscle Cell Survival
  2353. Centrally administered norepinephrine modifies the behavior induced by CORTICOTROPIN โ€RELEASING FACTOR in neonatal chicks
  2354. Effects of estradiol on regulation of CORTICOTROPIN โ€“RELEASING FACTOR gene and interleukin-6 production via estrogen receptor type ฮฒ in hypothalamic 4B cells
  2355. Substance P induces expression of the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 by activation of the neurokinin-1 receptor
  2356. Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists
  2357. Mu-opioid and CORTICOTROPIN โ€“RELEASING โ€“FACTOR receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central โ€ฆ
  2358. Preparation of a CORTICOTROPIN โ€“RELEASING FACTOR antagonist by nucleophilic aromatic substitution and copper-mediated ether formation
  2359. Chronic fluoxetine differentially affects 5-hydroxytryptamine2A receptor signaling in frontal cortex, oxytocin-and CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in rat โ€ฆ
  2360. A role for CORTICOTROPIN โ€“RELEASING FACTOR in the long-term expression of behavioral sensitization to cocaine
  2361. Dopamine receptor mechanisms mediate CORTICOTROPIN โ€RELEASING FACTOR โ€induced longโ€term potentiation in the rat amygdala following cocaine withdrawal
  2362. Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rats
  2363. Evidence for the presence of the type 2 CORTICOTROPIN RELEASING FACTOR receptor in the rodent cerebellum
  2364. Chronic amphetamine treatment enhances CORTICOTROPIN โ€“RELEASING FACTOR -induced serotonin release in the amygdala
  2365. Role of CORTICOTROPIN โ€“RELEASING FACTOR family peptides and receptors in stress-related psychiatric disorders.
  2366. Small molecule CORTICOTROPIN โ€“RELEASING FACTOR antagonists
  2367. CORTICOTROPIN โ€“RELEASING FACTOR is a downstream mediator of the beta-melanocyte-stimulating hormone-induced anorexigenic pathway in chicks
  2368. Membrane and synaptic effects of CORTICOTROPIN โ€“RELEASING FACTOR on periaqueductal gray neurons of the rat
  2369. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of CORTICOTROPIN โ€“RELEASING FACTOR receptor-2 pathway
  2370. Small molecule antagonists of the CORTICOTROPIN RELEASING FACTOR (CRF) receptor: recent medicinal chemistry developments
  2371. Proโ€opiomelanocortin colocalizes with CORTICOTROPIN โ€RELEASING FACTOR in axon terminals of the noradrenergic nucleus locus coeruleus
  2372. Localization and characterization of a short isoform of the CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฑ (CRF2ฮฑ-tr) in the rat brain
  2373. Increased cerebrospinal fluid CORTICOTROPIN โ€“RELEASING FACTOR concentrations during tryptophan depletion in healthy adults
  2374. Longitudinal brain CORTICOTROPIN RELEASING FACTOR and somatostatin in a transgenic mouse (TG2576) model of Alzheimerโ€™s disease
  2375. NPY Y1 receptors exert opposite effects on CORTICOTROPIN RELEASING FACTOR and noradrenaline overflow from the rat hypothalamus in vitro
  2376. Potent, orally active CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core
  2377. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1ฮฒ by a selective non-peptide antagonist of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  2378. Pituitary adenylate cyclase-activating polypeptide stimulates CORTICOTROPIN โ€“RELEASING FACTOR , vasopressin and interleukin-6 gene transcription in hypothalamic โ€ฆ
  2379. Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical CORTICOTROPIN โ€“RELEASING FACTOR mRNA expression
  2380. CORTICOTROPIN โ€“RELEASING FACTOR type II (CRFโ‚‚) receptors in the bed nucleus of the stria terminalis modulate conditioned defeat in Syrian hamsters (Mesocricetus auratus โ€ฆ
  2381. Selective stimulatory actions of CORTICOTROPIN โ€“RELEASING FACTOR ligands on correlates of energy balance
  2382. โ€ฆ in neonatal chicks exposed to low environmental temperature with or without intracerebroventricular administration of CORTICOTROPIN โ€“RELEASING FACTOR
  2383. Localized increases in CORTICOTROPIN โ€“RELEASING FACTOR receptors in pulp after dental injury
  2384. Postnatal handling does not normalize hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR mRNA levels in animals prenatally exposed to ethanol
  2385. Gastric electrical stimulation modulates hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR โ€“producing neurons during post-operative ileus in rat
  2386. Impact of N-terminal domains for CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptorโˆ’ ligand interactions
  2387. Shunt related changes in somatostatin, neuropeptide Y, and CORTICOTROPIN RELEASING FACTOR concentrations in patients with normal pressure hydrocephalus
  2388. Central ฮฑ-adrenergic receptors and CORTICOTROPIN RELEASING FACTOR mediate hemodynamic responses to acute cold stress
  2389. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system
  2390. The roles of CORTICOTROPIN โ€“RELEASING FACTOR -related peptides and their receptors in the cardiovascular system
  2391. Dihydropyridopyrazinones and Dihydropteridinones as CORTICOTROPIN โ€“RELEASING FACTOR -1 Receptor Antagonists: Structureโˆ’ Activity Relationships and Computational โ€ฆ
  2392. Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with CORTICOTROPIN RELEASING FACTOR test
  2393. The measurement of maternal plasma CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein improves the early prediction of preeclampsia
  2394. Cell-type specific calcium signaling by CORTICOTROPIN โ€“RELEASING FACTOR type 1 (CRF1) and 2a (CRF2 (a)) receptors: phospholipase C-mediated responses in human โ€ฆ
  2395. CORTICOTROPIN โ€RELEASING FACTOR receptor types 1 and 2 are differentially expressed in preโ€and postโ€synaptic elements in the postโ€natal developing rat cerebellum
  2396. Urocortin 1, urocortin 3/stresscopin, and CORTICOTROPIN โ€“RELEASING FACTOR receptors in human adrenal and its disorders
  2397. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of CORTICOTROPIN RELEASING FACTOR
  2398. Effect of blockade of CORTICOTROPIN โ€“RELEASING FACTOR receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain
  2399. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฒ mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells
  2400. Possible inhibitory roles of endogenous 2-arachidonoylglycerol during CORTICOTROPIN โ€“RELEASING FACTOR -induced activation of central sympatho-adrenomedullary outflow โ€ฆ
  2401. Nicotine suppresses energy storage through activation of sympathetic outflow to brown adipose tissue via CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor
  2402. Participation of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats
  2403. CORTICOTROPIN โ€RELEASING FACTOR typeโ€1 receptor mRNA is not induced in mouse hypothalamus by either stress or osmotic stimulation
  2404. Fractal dynamics in circadian cardiac time series of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype-2 deficient mice
  2405. Increase of core temperature induced by CORTICOTROPIN โ€“RELEASING FACTOR and urocortin: a comparative study
  2406. The neuropeptide CORTICOTROPIN โ€RELEASING FACTOR regulates excitatory transmission and plasticity at the climbing fibreโ€Purkinje cell synapse
  2407. CORTICOTROPIN โ€“RELEASING FACTOR -overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting
  2408. CORTICOTROPIN โ€“RELEASING FACTOR from the rat brain measured by protein immunoblot
  2409. Role and action in the pituitary corticotroph of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the hypothalamus
  2410. Molecular cloning of bullfrog CORTICOTROPIN โ€“RELEASING FACTOR (CRF): effect of homologous CRF on the release of TSH from pituitary cells in vitro
  2411. โ€ฆ of Neuropeptide YY5 Receptor Activates Hypothalamo-Pituitary-Adrenal Axis in Conscious Rats via both CORTICOTROPIN โ€“RELEASING FACTOR โ€“ and Arginine Vasopressin โ€ฆ
  2412. Single nucleotide polymorphism analysis of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein gene in recurrent major depressive disorder
  2413. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of CORTICOTROPIN RELEASING FACTOR
  2414. Paracrine regulation of endometrial function: interaction between progesterone and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and activin A
  2415. A CORTICOTROPIN โ€“RELEASING FACTOR system expressed in the cochlea modulates hearing sensitivity and protects against noise-induced hearing loss
  2416. Brain Regionโ€“Specific regulation of urocortin 1 innervation and CORTICOTROPIN โ€RELEASING FACTOR receptor type 2 binding by ethanol exposure
  2417. Central oxytocin, vasopressin, and CORTICOTROPIN โ€“RELEASING FACTOR receptor densities in the basal forebrain predict isolation potentiated startle in rats
  2418. Thyroid hormones inhibit frog CORTICOTROPIN โ€“RELEASING FACTOR -induced thyrotropin release from the bullfrog pituitary in vitro
  2419. Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 2
  2420. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) expression in postnatal and adult rat sacral parasympathetic nucleus (SPN)
  2421. Mice that lack CORTICOTROPIN โ€RELEASING FACTOR (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite upโ€regulated constitutive hypothalamic โ€ฆ
  2422. Modulation of T-type Ca2+ channels by CORTICOTROPIN โ€“RELEASING FACTOR through protein kinase C pathway in MN9D dopaminergic cells
  2423. Distribution and origin of CORTICOTROPIN โ€RELEASING FACTOR โ€immunoreactive axons in the female rat lumbosacral spinal cord
  2424. Expression of CORTICOTROPIN RELEASING FACTOR (CRF), urocortin and CRF type 1 receptors in hypothalamicโ€hypophyseal systems under osmotic stimulation
  2425. Valproic acid inhibits CORTICOTROPIN โ€“RELEASING FACTOR synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic โ€ฆ
  2426. Neonatal thyroxine treatment: changes in the number of CORTICOTROPIN โ€“RELEASING โ€“FACTOR (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine โ€ฆ
  2427. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats
  2428. CORTICOTROPIN RELEASING FACTOR (CRF) modulates fear-induced alterations in sleep in mice
  2429. Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by CORTICOTROPIN โ€“RELEASING FACTOR and by rat strain.
  2430. G protein-coupled receptor kinase 2 involvement in desensitization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor type 1 by CRF in murine corticotrophs
  2431. Distinct structural and functional roles of conserved residues in the first extracellular domain of receptors for CORTICOTROPIN โ€“RELEASING FACTOR and related G-protein โ€ฆ
  2432. Photoaffinity cross-linking of the CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 with photoreactive urocortin analogues
  2433. CORTICOTROPIN โ€“RELEASING FACTOR modulates maternal separation-induced ultrasonic vocalization in rat pups via activation of CRF1 receptor
  2434. The expression of CORTICOTROPIN โ€“RELEASING FACTOR in the central nucleus of the amygdala, induced by colorectal distension, is attenuated by general anesthesia
  2435. Increased colocalization of CORTICOTROPIN โ€RELEASING FACTOR and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: Evidence from โ€ฆ
  2436. Stressโ€mediated heart rate dynamics after deletion of the gene encoding CORTICOTROPIN โ€RELEASING FACTOR receptor 2
  2437. Effect of central CORTICOTROPIN RELEASING FACTOR on hepatic circulation in rats: the role of the CRF2 receptor in the brain
  2438. Fecal pellet output does not always correlate with colonic transit in response to restraint stress and CORTICOTROPIN โ€“RELEASING FACTOR in rats
  2439. CORTICOTROPIN RELEASING FACTOR -1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice
  2440. Activation of CORTICOTROPIN โ€“RELEASING FACTOR 2 receptor inhibits Purkinje neuron P-type calcium currents via Goฮฑ-dependent PKC epsilon pathway
  2441. Maternal separation affects male rat copulatory behaviour and hypothalamic CORTICOTROPIN RELEASING FACTOR in concert
  2442. Prenatal ethanol exposure alters sensitivity to the effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on behavior in the elevated plus-maze
  2443. CORTICOTROPIN RELEASING FACTOR in the median raphe nucleus is involved in the retrieval of fear memory in rats
  2444. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the CORTICOTROPIN โ€“RELEASING FACTOR receptor
  2445. Effect of serotonin depletion on the neuronal, endocrine and behavioural responses to CORTICOTROPIN โ€“RELEASING FACTOR in the rat
  2446. Presynaptic localization of a truncated isoform of the type 2 CORTICOTROPIN RELEASING FACTOR receptor in the cerebellum
  2447. Chronic low dose ovine CORTICOTROPIN RELEASING FACTOR or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in โ€ฆ
  2448. Brainstem reticulospinal neurons are targets for CORTICOTROPIN โ€“RELEASING FACTOR -Induced locomotion in roughskin newts
  2449. Antisocial and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain CORTICOTROPIN โ€“RELEASING FACTOR
  2450. Ovarian steroid regulation of the midbrain CORTICOTROPIN RELEASING FACTOR and urocortin systems in macaques
  2451. Involvement of regulatory elements on CORTICOTROPIN โ€“RELEASING FACTOR gene promoter in nypothalamic 4B cells
  2452. CORTICOTROPIN โ€“RELEASING FACTOR neurons in the hypothalamic paraventricular nucleus are involved in arousal/yawning response of rats
  2453. Role of CORTICOTROPIN RELEASING FACTOR Receptor Type 2ฮฒ in Urocortin-Induced Vasodilation of Rat Aortas
  2454. New class of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) antagonists: small peptides having high binding affinity for CRF receptor
  2455. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein expression in and release from the head kidney of common carp: evolutionary conservation of โ€ฆ
  2456. Optimization of 3-phenylpyrazolo [1, 5-a] pyrimidines as potent CORTICOTROPIN โ€“RELEASING FACTOR -1 antagonists with adequate lipophilicity and water solubility
  2457. Imidazo [4, 5-b] pyridines as CORTICOTROPIN RELEASING FACTOR receptor ligands
  2458. Decreased CORTICOTROPIN โ€RELEASING FACTOR Receptor Expression and Adrenocorticotropic Hormone Responsiveness in Anterior Pituitary Cells of Wistarโ€Kyoto Rats
  2459. mRNA expression of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 1 after restraint and foot shock together with alprazolam administration
  2460. Influence of urocortin and CORTICOTROPIN RELEASING FACTOR on venous tone in conscious rats
  2461. โ€ฆ [1,5-a]pyrimidine (NBI 30775/R121919) and Structureโˆ’Activity Relationships of a Series of Potent and Orally Active CORTICOTROPIN โ€“RELEASING FACTOR Receptor โ€ฆ
  2462. Nicotine self-administration differentially regulates hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR and arginine vasopressin mRNAs and facilitates stress-induced โ€ฆ
  2463. Expression patterns of CORTICOTROPIN โ€RELEASING FACTOR , arginine vasopressin, histidine decarboxylase, melaninโ€concentrating hormone, and orexin genes in the human โ€ฆ
  2464. Pioglitazone reduces the adrenal androgen response to CORTICOTROPIN โ€“RELEASING FACTOR without changes in ACTH release in hyperinsulinemic women with polycystic โ€ฆ
  2465. โ€ฆ of CORTICOTROPIN โ€RELEASING FACTOR Binding Proteinโ€Immunoreactivity in the Rat Hypothalamus: Association With CORTICOTROPIN โ€RELEASING FACTOR โ€, Urocortin 1โ€and โ€ฆ
  2466. Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of CORTICOTROPIN โ€“RELEASING FACTOR on adrenoCORTICOTROPIN secretion
  2467. Residue 17 of sauvagine cross-links to the first transmembrane domain of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (CRFR1)
  2468. Central hyperventilatory action of the stress-related neurohormonal peptides, CORTICOTROPIN โ€“RELEASING FACTOR and urotensin-I in the trout Oncorhynchus mykiss
  2469. โ€ฆ -containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered CORTICOTROPIN โ€“RELEASING FACTOR and arginineโ€“vasopressin in rats
  2470. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and CORTICOTROPIN RELEASING FACTOR in rat brain amygdala
  2471. Synthesis of benzoylpyrimidines as antagonists of the CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor
  2472. Fractal rigidity by enhanced sympatho-vagal antagonism in heartbeat interval dynamics elicited by central application of CORTICOTROPIN โ€“RELEASING FACTOR in mice
  2473. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR and adrenocorticotropic hormone in the ovarian maturation, seawater acclimation, and induced spawning of Liza ramada
  2474. Involvement of cAMPโ€Response Element Binding Protein in CORTICOTROPIN โ€RELEASING FACTOR (CRF)โ€Induced Downโ€Regulation of CRF Receptor 1 Gene Expression in โ€ฆ
  2475. Genetic analysis of the hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR system
  2476. Changes in the distribution of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-like immunoreactivity in the larval bullfrog brain and the involvement of CRF in the cessation of food โ€ฆ
  2477. Cardiovascular actions of the stress-related neurohormonal peptides, CORTICOTROPIN โ€“RELEASING FACTOR and urotensin-I in the trout Oncorhynchus mykiss
  2478. Sauvagine analogs selective for CORTICOTROPIN RELEASING FACTOR 2 receptor: effect of substitutions at positions 35 and 39 on CRF2R selectivity
  2479. CORTICOTROPIN RELEASING FACTOR 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal โ€ฆ
  2480. Intraperitoneal CORTICOTROPIN โ€“RELEASING FACTOR and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in โ€ฆ
  2481. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 inhibits the growth of human small cell lung carcinoma cells
  2482. โ€ฆ of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for CORTICOTROPIN โ€“RELEASING FACTOR in sustained elevation
  2483. Central administration of CORTICOTROPIN โ€“RELEASING FACTOR induces thermogenesis by changes in mitochondrial bioenergetics in neonatal chicks
  2484. CORTICOTROPIN โ€“RELEASING FACTOR receptor subtypes mediating nutritional suppression of estrous behavior in Syrian hamsters
  2485. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on plasticity of optically recorded neuronal activity in the substantia gelatinosa of rat spinal cord slices
  2486. Both CORTICOTROPIN โ€“RELEASING FACTOR and apomorphine reduce prepulse inhibition following repeated central infusion of CORTICOTROPIN โ€“RELEASING FACTOR
  2487. 2-Arylaminothiazoles as high-affinity CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy
  2488. Increased expression of CORTICOTROPIN โ€“RELEASING FACTOR receptor mRNA in the locus coeruleus of stress-induced rat model of depression
  2489. โ€ฆ white seabream Diplodus sargus: immunocytochemical identification of arginine-vasotocin, isotocin, melanin-concentrating hormone and CORTICOTROPIN โ€“RELEASING FACTOR
  2490. Activation of phosphatidylinositol 3-kinase/protein kinase B by CORTICOTROPIN โ€“RELEASING FACTOR in human monocytes
  2491. Subcellular plasticity of the CORTICOTROPIN โ€“RELEASING FACTOR receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure
  2492. Cardiovascular effects of long-term central and peripheral administration of urocortin, CORTICOTROPIN โ€“RELEASING FACTOR , and adrenoCORTICOTROPIN in sheep
  2493. 3D-QSAR study of CORTICOTROPIN โ€“RELEASING FACTOR 1 antagonists and pharmacophore-based drug design
  2494. A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing CORTICOTROPIN โ€“RELEASING FACTOR and โ€ฆ
  2495. Modulation of CORTICOTROPIN RELEASING FACTOR (CRF) signaling through receptor splicing in mouse pituitary cell line AtT-20โ€“emerging role of soluble isoforms
  2496. Neonatal REM sleep is regulated by CORTICOTROPIN RELEASING FACTOR
  2497. Involvement of the hypothalamusโ€“pituitaryโ€“adrenal axis in antidepressant activity of CORTICOTROPIN โ€“RELEASING FACTOR subtype 1 receptor antagonists in the rat learned โ€ฆ
  2498. Regulation of somatodendritic dopamine release by CORTICOTROPIN โ€“RELEASING FACTOR via the inhibition of voltage-operated Ca2+ channels
  2499. Design and Synthesis of Tricyclic Imidazo[4,5-b]pyridin-2-ones as CORTICOTROPIN โ€“RELEASING FACTOR -1 Antagonists
  2500. Analgesic actions of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on somatic pain sensitivity: involvement of glucocorticoid and CRF-2 receptors
  2501. CORTICOTROPIN โ€“RELEASING FACTOR receptors induce calcium mobilization through cross-talk with Gq-coupled receptors
  2502. Central administration of CORTICOTROPIN โ€“RELEASING FACTOR induces tissue specific oxidative damage in chicks
  2503. Interactions of CORTICOTROPIN โ€“RELEASING FACTOR , urocortin and citalopram in a primate model of stress-induced amenorrhea
  2504. HIV-1 Gp120 protein modulates CORTICOTROPIN RELEASING FACTOR synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of โ€ฆ
  2505. Evidence for an axonal localization of the type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor during postnatal development of the mouse cerebellum
  2506. Effect of neuropeptide B on feeding behavior is influenced by endogenous CORTICOTROPIN โ€“RELEASING FACTOR activities
  2507. Nociceptin/orphanin FQโ€induced delay in gastric emptying: role of central CORTICOTROPIN โ€RELEASING FACTOR and glucocorticoid receptors
  2508. The differential expression of CORTICOTROPIN RELEASING FACTOR and its binding protein in the gerbil hippocampal complex following seizure
  2509. Anxiogenic-like effect of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 antisense oligonucleotides infused into rat brain
  2510. Five amino acids of the Xenopus laevis CRF (CORTICOTROPIN โ€“RELEASING FACTOR ) type 2 receptor mediate differential binding of CRF ligands in comparison with its human โ€ฆ
  2511. Effects of chlordiazepoxide on footshock-and CORTICOTROPIN โ€“RELEASING FACTOR -induced increases in cortical and hypothalamic norepinephrine secretion in rats
  2512. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonists: Potential novel therapies for human disease
  2513. CORTICOTROPIN โ€RELEASING FACTOR โ€2 activation prevents gentamicinโ€induced oxidative stress in cells derived from the inner ear
  2514. CORTICOTROPIN โ€“RELEASING FACTOR decreases meal size by decreasing cluster number in Koletsky (LA/N) rats with and without a null mutation of the leptin receptor
  2515. Discovery of CORTICOTROPIN RELEASING FACTOR 2 receptor selective sauvagine analogues for treatment of skeletal muscle atrophy
  2516. Exploring the binding site crevice of a family BG protein-coupled receptor, the type 1 CORTICOTROPIN RELEASING FACTOR receptor
  2517. Circulating human CORTICOTROPIN โ€“RELEASING FACTOR -binding protein levels following cortisol infusions
  2518. Co-localization of CORTICOTROPIN โ€“RELEASING FACTOR and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus
  2519. CORTICOTROPIN RELEASING FACTOR -Binding Protein
  2520. Synthesis, structureโ€“activity relationships, and anxiolytic activity of 7-aryl-6, 7-dihydroimidazoimidazole CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists
  2521. Central CORTICOTROPIN RELEASING FACTOR (CRF) and adrenergic receptors mediate hemodynamic responses to cocaine
  2522. Behavioral consequences of altered CORTICOTROPIN โ€“RELEASING FACTOR activation in brain: a functionalist view of affective neuroscience
  2523. Altered CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor immunoreactivity in the gerbil hippocampal complex following spontaneous seizure
  2524. The effect of restraint stress on prepulse inhibition and on CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF receptor gene expression in Wistarโ€“Kyoto and Brown Norway โ€ฆ
  2525. Region specific gene expression profile in mouse brain after chronic CORTICOTROPIN RELEASING FACTOR receptor 1 activation: the novel role for diazepam binding inhibitor in โ€ฆ
  2526. CORTICOTROPIN โ€“RELEASING FACTOR , urocortin and endothelin-1 stimulate activin A release from cultured human placental cells
  2527. CORTICOTROPIN โ€“RELEASING FACTOR mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus โ€ฆ
  2528. Pyrazolo-[1, 5-a]-1, 3, 5-triazine CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor ligands
  2529. CORTICOTROPIN โ€“RELEASING FACTOR (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein
  2530. Selective activation of the sympathetic ganglia by centrally administered CORTICOTROPIN โ€“RELEASING FACTOR in rats
  2531. Characterization of the effects of CORTICOTROPIN โ€“RELEASING FACTOR on prepulse inhibition of the acoustic startle response in Brown Norway and Wistar-Kyoto rats
  2532. Acute effects of acephate and methamidophos and interleukin-1 on CORTICOTROPIN โ€“RELEASING FACTOR (CRF) synthesis in and release from the hypothalamus in vitro
  2533. Differential regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 (CRF1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in โ€ฆ
  2534. Amniotic fluid and umbilical cord plasma CORTICOTROPIN โ€“RELEASING FACTOR (CRF), CRF-binding protein, adrenoCORTICOTROPIN , and cortisol concentrations in intraamniotic โ€ฆ
  2535. Extinction of cocaine self-administration produces alterations in CORTICOTROPIN RELEASING FACTOR gene expression in the paraventricular nucleus of the hypothalamus
  2536. Cloning and distribution of the bullfrog type 1 and type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptors
  2537. CORTICOTROPIN RELEASING FACTOR enhances survival of cultured GABAergic cerebellar neurons after exposure to a neurotoxin
  2538. Bacterial lipopolysaccharide-induced coordinate downregulation of arginine vasopressin receptor V3 and CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 messenger โ€ฆ
  2539. CORTICOTROPIN โ€“RELEASING FACTOR and its receptors in the brain of rats with insulin and corticosterone deficits
  2540. โ€ฆ and Structureโˆ’ Activity Relationships of 8-(Pyrid-3-yl) pyrazolo [1, 5-a]-1, 3, 5-triazines: Potent, Orally Bioavailable CORTICOTROPIN RELEASING FACTOR Receptor-1 (CRF1) โ€ฆ
  2541. Development of a CORTICOTROPIN โ€“RELEASING FACTOR -mediated effect on the firing rate of Purkinje cells in the postnatal mouse cerebellum
  2542. โ€ฆ -[1, 2, 4] triazoles: novel synthesis via cyclization of N-Acyl-S-methylisothioureas with alkylhydrazines and their potent CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) receptor โ€ฆ
  2543. The dynamic developmental localization of the fullโ€length CORTICOTROPIN โ€RELEASING FACTOR receptor type 2 in rat cerebellum
  2544. Implications of CORTICOTROPIN RELEASING FACTOR in targeted anticancer therapy
  2545. Maternal profiling of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 deficient mice in association with restraint stress
  2546. โ€ฆ )-2, 5-dimethylpyridin-3-ylamino]-5-oxo-4, 5-dihydropyrazine-2-carbonitrile as a potent, orally bioavailable CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonist
  2547. Stimulation of the inferior olivary complex alters the distribution of the type 1 CORTICOTROPIN RELEASING FACTOR receptor in the adult rat cerebellar cortex
  2548. Cytokines induce NF-ฤธB, Nurr1 and CORTICOTROPIN โ€“RELEASING FACTOR gene transcription in hypothalamic 4B cells
  2549. CORTICOTROPIN โ€“RELEASING FACTOR inhibition of sheep fetal colonic contractility: mechanisms to prevent meconium passage in utero
  2550. Effects of exogenous CORTICOTROPIN โ€“RELEASING FACTOR on antropyloroduodenal motility and appetite in humans
  2551. An oxidation resistant radioligand for CORTICOTROPIN โ€“RELEASING FACTOR receptors
  2552. โ€ฆ 8-tetrachlorodibenzo-p-dioxin that produces reduced food and water intake induces long-lasting expression of CORTICOTROPIN โ€“RELEASING FACTOR , arginine vasopressin, and โ€ฆ
  2553. Endogenous CORTICOTROPIN RELEASING FACTOR regulates adrenergic and opioid receptors
  2554. Chronic CORTICOTROPIN โ€RELEASING FACTOR type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawnโ€Hooded rats
  2555. Cellular localization of the fullโ€length isoform of the type 2 CORTICOTROPIN RELEASING FACTOR receptor in the postnatal mouse cerebellar cortex
  2556. Regulation of pituitary CORTICOTROPIN RELEASING FACTOR typeโ€1 receptor mRNA binding proteins by modulation of the hypothalamicโ€pituitaryโ€adrenal axis
  2557. OlFACTOR y neophobia and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain CORTICOTROPIN RELEASING FACTOR
  2558. Regulation and role of p21-activated kinase 3 by CORTICOTROPIN โ€“RELEASING FACTOR in mouse pituitary
  2559. Actions of endothelin and CORTICOTROPIN RELEASING FACTOR in the guinea-pig ileum: no evidence for an interaction with capsaicin-sensitive neurons
  2560. Altered responsivity to central administrations of CORTICOTROPIN โ€“RELEASING FACTOR in rats with a history of opiate exposures.
  2561. Cyclopenta[d]pyrimidines and Dihydropyrrolo[2,3โ€d]pyrimidines as Potent and Selective CORTICOTROPIN โ€RELEASING FACTOR โ€…1 Receptor Antagonists
  2562. Postnatal expression of CORTICOTROPIN RELEASING FACTOR (CRF) in rat urinary bladder
  2563. Synthesis of 3-phenylpyrazolo [4, 3-b] pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of CORTICOTROPIN โ€“RELEASING FACTOR receptor type-1 โ€ฆ
  2564. Topological relationship between CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive cerebellar afferents and tyrosine hydroxylase-immunoreactive Purkinje cells in a โ€ฆ
  2565. Fractal dynamics of heart beat interval fluctuations in CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 2 deficient mice
  2566. Inflammatory response to cold injury in remote organs is reduced by CORTICOTROPIN โ€“RELEASING FACTOR
  2567. Effects of repeated stress on expression of CORTICOTROPIN RELEASING FACTOR type I and II receptors
  2568. Localization of CORTICOTROPIN โ€“RELEASING FACTOR -immunoreactive nervous tissue and colocalization with neuropeptide Y-like substance in the optic lobe and peduncle โ€ฆ
  2569. Expression of CORTICOTROPIN RELEASING FACTOR , but not its binding protein, in CA1 pyramidal cells of gerbil hippocampus following transient ischemia
  2570. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist, SSR125543, on FG 7142-induced โ€ฆ
  2571. The effects of CORTICOTROPIN โ€“RELEASING FACTOR on the cortical EEG are reduced following adolescent nicotine exposure
  2572. Molecular cloning and initial characterization of African green monkey (Cercopithecus aethiops) CORTICOTROPIN RELEASING FACTOR receptor type 1 (CRF1) from COS-7 cells
  2573. Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of CORTICOTROPIN RELEASING FACTOR in rabbit eyelid
  2574. Fluoxetine potentiates the effects of CORTICOTROPIN โ€“RELEASING FACTOR on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa
  2575. Quetiapine regulates the stress-induced increase in CORTICOTROPIN โ€“RELEASING FACTOR mRNA expression in the rat hypothalamus
  2576. Maternal plasma CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration
  2577. Homeostasis within the CORTICOTROPIN โ€RELEASING FACTOR system via CRF2 receptor activation: a novel approach for the treatment of anxiety
  2578. Modulation of Ca2+ influx by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of peptides via CRF receptors in rat pancreatic ฮฒ-cells
  2579. CORTICOTROPIN โ€RELEASING FACTOR Modulates Cardiovascular and Pupillary Autonomic Reflexes in Man: Is there a Link to Inflammationโ€Induced Autonomic Nervous โ€ฆ
  2580. โ€ฆ solid phase synthesis strategyโ€”including onโ€resin lactamizationโ€”of astressin, its retroโ€, inversoโ€, and retroโ€“inverso isomers as CORTICOTROPIN RELEASING FACTOR โ€ฆ
  2581. Effect of non-peptide CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 antagonist on adrenocorticotropic hormone release and interleukin-1 receptors followed by stress
  2582. Interplay of the Endocannabinoid System with Neuropeptide Y and CORTICOTROPIN โ€RELEASING FACTOR in the Goldfish Forebrain
  2583. Decreased proopiomelanocortin mRNA in lymphocytes of chronic alcoholics after intravenous human CORTICOTROPIN RELEASING FACTOR injection
  2584. Localization of the type 1 CORTICOTROPIN RELEASING FACTOR receptor (CRF-R1) in the embryonic mouse cerebellum
  2585. Putative neuroprotective role of centrally administered CORTICOTROPIN โ€“RELEASING FACTOR in low-temperature-exposed neonatal chicks
  2586. The CORTICOTROPIN โ€“RELEASING FACTOR (CRF) 1 receptor antagonists CP154, 526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms
  2587. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: Selective and Centrally Active CORTICOTROPIN โ€“RELEASING FACTOR Receptor-1 (CRF1) Antagonists
  2588. NOTE Expression of prolactin receptors and regulation of cell proliferation by prolactin, CORTICOTROPIN โ€“RELEASING FACTOR , and corticosterone in a neuroblastoma cell line
  2589. Role of brain nicotinic acetylcholine receptor in centrally administered CORTICOTROPIN โ€“RELEASING FACTOR -induced elevation of plasma corticosterone in rats
  2590. Dihydropyrrole[2,3-d]pyridine Derivatives as Novel CORTICOTROPIN โ€“RELEASING FACTOR -1 Antagonists: Mapping of the Receptor Binding Pocket by in Silico Docking โ€ฆ
  2591. An orally active CORTICOTROPIN RELEASING FACTOR 1 receptor antagonist from 8-aryl-1, 3a, 7, 8-tetraaza-cyclopenta [a] indenes
  2592. Over-expression of CORTICOTROPIN โ€“RELEASING FACTOR mRNA in inferior olivary neurons of rolling mouse Nagoya
  2593. Binding differences of human and amphibian CORTICOTROPIN โ€“RELEASING FACTOR type 1 (CRF1) receptors: identification of amino acids mediating high-affinity astressin โ€ฆ
  2594. Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor (CRF1R)
  2595. Topochemical model for prediction of CORTICOTROPIN RELEASING FACTOR antagonizing activity of N-phenylphenylglycines
  2596. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and urocortin promote the survival of cultured cerebellar GABAergic neurons through the type 1 CRF receptor
  2597. Alphaโ€melanocyteโ€stimulating hormone attenuates behavioral effects of CORTICOTROPIN โ€RELEASING FACTOR in isolated guinea pig pups
  2598. Effects of infusion of CORTICOTROPIN โ€“RELEASING FACTOR antagonist into the locus cocruleus on freezing behavior and brain catecholamines in rats
  2599. Effects of urocortin, CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleepโ€“wake pattern: analysis by โ€ฆ
  2600. Identification of brain target neurons using a fluorescent conjugate of CORTICOTROPIN โ€“RELEASING FACTOR
  2601. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats
  2602. CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 1 and somatostatin modulating hypoxia-caused downregulated mRNA of pituitary growth hormone and upregulated โ€ฆ
  2603. CORTICOTROPIN โ€RELEASING FACTOR Immunoreactivity Increases in the Cerebellar Climbing Fibers in the Novel Ataxic Mutant Mouse, Pogo
  2604. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฒ messenger ribonucleic acid by interleukin-1ฮฒ in rat vascular smooth muscle cells
  2605. Localization and functional roles of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 in the cerebellum
  2606. Effects of electroacupuncture on the expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family and CRF receptor 1 in traumatic injury rats
  2607. Doxapram increases CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity and mRNA expression in the rat central nucleus of the amygdala
  2608. Human mast cells express CORTICOTROPIN โ€“RELEASING hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth FACTOR
  2609. Intracerebroventricular administration of CORTICOTROPIN โ€“RELEASING FACTOR antagonist attenuates arousal response accompanied by yawning behavior in rats
  2610. Stimulation of rat pancreatic exocrine secretion by urocortin and CORTICOTROPIN RELEASING FACTOR
  2611. Impaired uterine artery blood flow at mid gestation and low levels of maternal plasma CORTICOTROPIN โ€“RELEASING FACTOR
  2612. Corticorelin acetate, a synthetic CORTICOTROPIN โ€“RELEASING FACTOR with preclinical antitumor activity, alone and with bevacizumab, against human brain tumor models
  2613. Time-and dose-dependent effects of CORTICOTROPIN RELEASING FACTOR on cerebral glucose metabolism in rats
  2614. Quantitative Analysis of CORTICOTROPIN โ€RELEASING FACTOR and Arginine Vasopressin mRNA in the Hypothalamus During Chronic Morphine Treatment in Rats: An In Situ โ€ฆ
  2615. High-priority communication I Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR attenuates the enhanced responsiveness to stress observed during protracted ethanol โ€ฆ
  2616. CORTICOTROPIN โ€RELEASING FACTOR (CRF) and CRFโ€Related Peptidesโ€“a Linkage Between Stress and Anxiety
  2617. Stress Neurobiology and CORTICOTROPIN โ€“RELEASING FACTOR
  2618. Acute stress ameliorates colitis via central CORTICOTROPIN โ€“RELEASING FACTOR and serotonin (5-HT)-3 receptors
  2619. The role of CORTICOTROPIN โ€“RELEASING FACTOR in the pathophysiology of depression: Implications for antidepressant mechanisms of action
  2620. The effect of CORTICOTROPIN โ€“RELEASING FACTOR on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats
  2621. Brain nuclear FACTOR kappa B is involved in the CORTICOTROPIN โ€“RELEASING FACTOR -induced central activation of sympatho-adrenomedullary outflow in rats
  2622. General anesthetics inhibit the nitrous-oxide-induced activation of CORTICOTROPIN RELEASING FACTOR containing neurons in rats
  2623. Human placental CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the adaptive response to pregnancy
  2624. Effects of the traditional Japanese medicine Unkei-to on the CORTICOTROPIN โ€“RELEASING FACTOR โ€“induced increase in locomotor activity
  2625. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฒ mRNA by mitogen-activated protein kinases in aortic smooth muscle cells
  2626. Onโ€column refolding of CORTICOTROPIN โ€RELEASING FACTOR receptor 1 extracellular domain by size exclusion chromatography
  2627. An inhibitory effect of cytokine-induced neutrophil chemoattractant on CORTICOTROPIN โ€“RELEASING FACTOR -induced increase in locomotor activity
  2628. Discovery of 6-chloro-2-trifluoromethyl-7-aryl-7H-imidazo [1, 2-a] imidazol-3-ylmethylamines, a novel class of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 (CRF1R) โ€ฆ
  2629. Water deprivation increases Fos expression in hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR neurons induced by right atrial distension in awake rats
  2630. Interaction between the effects of CORTICOTROPIN โ€“RELEASING FACTOR and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a โ€ฆ
  2631. Vasodilation of retinal arteriole mediated by CORTICOTROPIN โ€“RELEASING FACTOR receptor is impaired in streptozotocin-induced diabetic rats
  2632. CORTICOTROPIN โ€“RELEASING FACTOR Circuitry in the Brain-Relevance for Affective Disorders and Anxiety
  2633. Focal cerebral ischaemia induces CORTICOTROPIN RELEASING FACTOR (CRF) vascular immunoreactivity in rat occluded hemisphere
  2634. 372 Silencing of Gene Expression for CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in the Colon Attenuates Stress-Induced Acceleration of Colonic Transit in Rats
  2635. Single nucleotide polymorphism analysis of CORTICOTROPIN โ€“RELEASING FACTOR -binding protein gene in bipolar disorder
  2636. CORTICOTROPIN โ€“RELEASING FACTOR antagonist attenuates stress-induced inhibition of seasonal ovarian recrudescence in the lizard Mabuya carinata
  2637. โ€ฆ of Naloxoneโ€Induced Luteinising Hormone Secretion Is Accompanied by Increases in CORTICOTROPIN โ€RELEASING FACTOR Immunoreactivity in Hypothalamic โ€ฆ
  2638. Regulation of nuclear FACTOR -ฮบB by CORTICOTROPIN โ€“RELEASING hormone in mouse thymocytes
  2639. Interactions between neuropeptide S and CORTICOTROPIN RELEASING FACTOR in the control of palatable food intake in rats.
  2640. โ€ฆ , Structureโˆ’Activity Relationships, and in Vivo Properties of 3,4-Dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as CORTICOTROPIN โ€“RELEASING FACTOR -1 Receptor Antagonists
  2641. Development of a selective photoactivatable antagonist for CORTICOTROPIN โ€RELEASING FACTOR receptor, type 2 (CRF2)
  2642. Degradation pathways of a CORTICOTROPIN โ€“RELEASING FACTOR antagonist in solution and solid states
  2643. Mechanisms of CORTICOTROPIN โ€“RELEASING FACTOR -induced analgesic effect in conscious rats
  2644. Social isolation modulates CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor, urocortin 1 and urocortin 2 mRNAs expression in the cardiovascular system of prairie voles
  2645. The alteration of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor immunoreactivity in the gerbil hippocampus and neocortex following ischemic insults
  2646. โ€ฆ -deficient juvenile visceral steatosis (JVS) mice: involvement of defective acyl-ghrelin secretion and enhanced CORTICOTROPIN โ€“RELEASING FACTOR signaling in the โ€ฆ
  2647. โ€ฆ in the water-maze: differential expression of CORTICOTROPIN โ€“RELEASING hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic FACTOR in limbic regions
  2648. Effects of infusion of CORTICOTROPIN โ€“RELEASING FACTOR antagonist into the locus coeruleus on freezing behavior and brain catecholamines in rats.
  2649. Regional difference in CORTICOTROPIN โ€“RELEASING FACTOR immunoreactivity in mossy fiber terminals innervating calretinin-immunoreactive unipolar brush cells in โ€ฆ
  2650. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as CORTICOTROPIN RELEASING FACTOR antagonists
  2651. Corticorelin, a synthetic human CORTICOTROPIN โ€“RELEASING FACTOR analog, for the treatment of peritumoral brain edema.
  2652. CORTICOTROPIN โ€“RELEASING FACTOR , Serotonin, and Sex: Keys to the Castle of Depressive Illness
  2653. CORTICOTROPIN โ€RELEASING hormoneโ€receptor 2 is required for acute stressโ€induced bladder vascular permeability and release of vascular endothelial growth FACTOR
  2654. CORTICOTROPIN โ€“RELEASING hormone induces vascular endothelial growth FACTOR release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated โ€ฆ
  2655. Reduction in touch sensitivity and hyperinnervation in vesicant-injured rabbit eyelid by direct injection of CORTICOTROPIN RELEASING FACTOR
  2656. CORTICOTROPIN โ€“RELEASING FACTOR
  2657. Effects of Moutan Cortex on CORTICOTROPIN โ€“RELEASING FACTOR , c-Fos and Tyrosine Hydroxylase in Forced Swimming Test
  2658. The phenotypic differentiation of locus coeruleus noradrenergic neurons mediated by BDNF is enhanced by CORTICOTROPIN RELEASING FACTOR through the activation โ€ฆ
  2659. Effects of Gardeniae Fructus on CORTICOTROPIN โ€“RELEASING FACTOR , c-fos and Tyrosine Hydroxylase in Forced Swimming Test
  2660. Morphology, size and distribution of CORTICOTROPIN RELEASING FACTOR (CRF) immunoreactive neurons in the central nucleus of the rat amygdaloid complex
  2661. Epileptogenic activity of tripeptide CORTICOTROPIN โ€“RELEASING FACTOR fragment (CRF (4-6))
  2662. โ€ฆ [4, 3-b] pyridines via a methylation of 4-phthalimino-3-phenylpyrazoles and optimization toward highly potent CORTICOTROPIN โ€“RELEASING FACTOR type-1 antagonists
  2663. The effects of CORTICOTROPIN โ€“RELEASING FACTOR on anoxia-induced changes in evoked potentials in living slices of rat olFACTOR y cortex
  2664. Competitive antagonists of the CORTICOTROPIN RELEASING FACTOR (CRF) scanned with a i-(i+ 3) Glu Lys Bridge
  2665. โ€ฆ 4โ€(1Hโ€pyrazolโ€1โ€yl)โ€5,6โ€dihydroโ€1Hโ€pyrrolo[2,3โ€d]pyrimidine Derivatives as Potent and Selective CORTICOTROPIN โ€RELEASING FACTOR Receptorโ€1 Antagonists
  2666. 500 Involvement of CORTICOTROPIN โ€“RELEASING FACTOR (CRF)/CRF2 Receptors in Pathogenesis of Ischemia/Reperfusion-Induced Intestinal Lesions in Rats
  2667. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR Receptor 2ฮฒ in Differentiation of Dopaminergic MN9D Cells.
  2668. Acute stress and intravesical CORTICOTROPIN โ€“RELEASING hormone induces mast cell dependent vascular endothelial growth FACTOR release from mouse bladder explants
  2669. Human CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor analysis with white blood cells mRNAs and DNA
  2670. CORTICOTROPIN RELEASING FACTOR (CRF) peptide family and their receptors: Divergent actions influencing human physiology
  2671. CORTICOTROPIN RELEASING FACTOR receptors and agonistic behavior in Syrian hamsters
  2672. Peripheral plasma CORTICOTROPIN โ€“RELEASING FACTOR concentration does not correlate with augmented colonic motility in response to restraint stress in rats.
  2673. Neurophysiological effects of CORTICOTROPIN โ€“RELEASING FACTOR in living slices of the olFACTOR y area of the rat cortex
  2674. Role of CORTICOTROPIN RELEASING FACTOR receptor 2 antisense oligodeoxynucleotide of hypothalamus in hypermetabolism in rats with severe burn
  2675. Influence of Chinese herbal extract complex on expression of CORTICOTROPIN โ€“RELEASING FACTOR and protein kinasec protein in hippocampus of middle cerebral artery โ€ฆ
  2676. CORTICOTROPIN โ€“RELEASING FACTOR and the
  2677. The excitatory actions of CORTICOTROPIN โ€“RELEASING FACTOR on ventral tegmental area dopamine neurons
  2678. Changes of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and neuropeptide Y (NPY) of rats in response to footshock or reexposure to conditions previously paired with โ€ฆ
  2679. Effects of total flavone of Abelmoschus Manihot L. Medic on the expression of CORTICOTROPIN RELEASING FACTOR in rats with post stroke depression [J]
  2680. COMPARATIVE BIOTRANSFORMATION OF PYRAZINONE-CONTAINING CORTICOTROPIN โ€“RELEASING FACTOR RECEPTOR-1 (CRF-R1) ANTAGONISTS โ€ฆ
  2681. CRH haplotype as a FACTOR influencing cerebrospinal fluid levels of CORTICOTROPIN โ€“RELEASING hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and โ€ฆ
  2682. Endogenous pain modulation: Magnitude and direction of effect of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on inflammatory pain in rats depend on sex and pain measure
  2683. Identification and characterization of a novel family of CORTICOTROPIN RELEASING FACTOR (CRF)-like peptides, the teneurin C-terminal associated peptides (TCAP).
  2684. CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus
  2685. โ€ฆ sensitization of CORTICOTROPIN โ€“RELEASING hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis FACTOR -ฮฑ
  2686. Intracerebroventricular injection of CORTICOTROPIN โ€“RELEASING FACTOR does not alter monoamine content of the paraventricular nucleus of the hypothalamus in neonatal โ€ฆ
  2687. Isoflurane suppresses the nitrous oxide-induced activation of CORTICOTROPIN RELEASING FACTOR -containing neurons in rat paraventricular nucleus of hypothalamus
  2688. โ€ฆ , Corticoliberin, Corticotrophin-RELEASING Hormone, CORTICOTROPIN โ€“RELEASING FACTOR , Human CORTICOTROPIN โ€“RELEASING Hormone, Ovine Corticotrophin-RELEASING FACTOR โ€ฆ
  2689. 36. Overview of CORTICOTROPIN โ€“RELEASING FACTOR Receptors and Binding Protein
  2690. CORTICOTROPIN โ€“RELEASING FACTOR Receptors
  2691. Synthesis of a CORTICOTROPIN โ€“RELEASING FACTOR Antagonist
  2692. Immunomodulatory Role of the CORTICOTROPIN โ€“RELEASING FACTOR
  2693. CORTICOTROPIN โ€“RELEASING FACTOR and its receptor in gastrointestinal disease
  2694. Characterization and regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptors in the central nervous, endocrine and
  2695. Emerging Anxiolytics: CORTICOTROPIN โ€RELEASING FACTOR Receptor Antagonists
  2696. The role of CORTICOTROPIN โ€“RELEASING FACTOR in anxiety disorders
  2697. CORTICOTROPIN โ€“RELEASING hormone inhibits nuclear FACTOR -ฮบB pathway in human HaCaT keratinocytes
  2698. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  2699. CORTICOTROPIN RELEASING FACTOR Receptor Deficiency in Mice
  2700. The roles of the CORTICOTROPIN โ€“RELEASING FACTOR system in amphibians
  2701. CORTICOTROPIN โ€“RELEASING FACTOR and hypoxic-ischemic brain damage
  2702. Supporting Information Dihydropyridopyrazinones and Dihydropteridinones as CORTICOTROPIN โ€“RELEASING FACTOR -1 Receptor Antagonists: Structure Activity โ€ฆ
  2703. The Impact of Stress on Tumor Growth; the Significance of Peripheral CORTICOTROPIN RELEASING FACTOR
  2704. Sex differences in the CORTICOTROPIN โ€RELEASING FACTOR receptor and its regulation by stress
  2705. Interleukin-1 and CORTICOTROPIN โ€“RELEASING FACTOR Receptors in the Hypothalamicโ€“Pituitaryโ€“Adrenal Axis
  2706. CORTICOTROPIN โ€“RELEASING hormone attenuates vascular endothelial growth FACTOR release from human HaCaT keratinocytes
  2707. The teleost CORTICOTROPIN โ€“RELEASING FACTOR system: distribution, regulation, and developmental role
  2708. The role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in preclinical models of depression.
  2709. CORTICOTROPIN RELEASING FACTOR receptors in functional and inflammatory gastrointestinal disorders
  2710. Modulation of dendritic differentiation by CORTICOTROPIN โ€“RELEASING FACTOR in the developing hippocampus
  2711. Effects of exogenous CORTICOTROPIN โ€“RELEASING FACTOR on antropyloroduodenal motility and appetite in humans.
  2712. Pharmacology and Biology of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptors
  2713. EFFECTS OF CORTICOTROPIN RELEASING FACTOR ON LEARNING AND MEMORY IN THE NUCLEUS BASALIS OF MEYNERT IN RATS
  2714. Structure-Activity Studies on the CORTICOTROPIN RELEASING FACTOR Antagonist Astressin, Minimal Sequence Necessary for Antagonistic Activity: Implications for a New โ€ฆ
  2715. Role of CORTICOTROPIN โ€“RELEASING FACTOR in stress-related visceral hyperalgesia
  2716. (649): Functional knockout of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) R1 receptors affects mechanical nociception but not mechanical sensitivity or thermal and acute โ€ฆ
  2717. CORTICOTROPIN โ€“RELEASING FACTOR and acute post-operative gut function in truamatic abdominal injury and elective abdominal surgery
  2718. CORTICOTROPIN โ€“RELEASING FACTOR mediates the suppressing but not the facilitating effects of footshock on progressive-ratio cocaine self-administration.
  2719. The functional role of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) system in the amygdala: Molecular, behavioral, and anatomical studies
  2720. Neuromodulatory effects of CORTICOTROPIN RELEASING FACTOR on anxiety, social dominance, stress coping and learning strategies
  2721. The pharmacology of CORTICOTROPIN โ€“RELEASING FACTOR (CRF). Effects on sensorimotor gating in the rat
  2722. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF-Related Peptidesโ€“a Linkage Between Stress and Anxiety
  2723. Social isolation alters anxiety-like behavior and CORTICOTROPIN โ€“RELEASING FACTOR interactions with serotonin
  2724. Effect of curcumin on CORTICOTROPIN โ€“RELEASING FACTOR mRNA expression in brain regions of chronic stress-exposed rats
  2725. Association of CORTICOTROPIN RELEASING FACTOR receptorโ€2 variants with response to inhaled glucocorticoids in asthma
  2726. CORTICOTROPIN RELEASING FACTOR (CRF) Mediates the Antinociceptive Effect of Nitrous Oxide in Rats
  2727. Roles of CORTICOTROPIN โ€“RELEASING FACTOR -related peptides in the development of Purkinje cells and their extracerebellar afferents
  2728. Ultrastructural localisation and functional implications of CORTICOTROPIN RELEASING FACTOR , Urocortin and their receptors in cerebellar neuronal development
  2729. Functional and anatomical basis for CORTICOTROPIN RELEASING FACTOR mediated analgesia: Convergence of parallel pathways on the periaqueductal gray
  2730. Intestinal CORTICOTROPIN โ€“RELEASING FACTOR is decreased in shocked trauma patients and may affect gut function
  2731. CORTICOTROPIN โ€“RELEASING FACTOR receptors: oligomerization and lateral mobility studied by fluorescence spectroscopy
  2732. CORTICOTROPIN โ€“RELEASING hormone activates connexin 43 via activator protein-1 transcription FACTOR in human myometrial smooth muscle cells
  2733. CORTICOTROPIN โ€“RELEASING FACTOR overexpression in the central amygdala: Gene expression, HPA axis function, and behavior
  2734. Role of leptin in modulation of CORTICOTROPIN โ€“RELEASING FACTOR neurons in the brain of Xenopus laevis
  2735. Mechanisms of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Gene Regulation in the Frog Xenopus laevis.
  2736. The Effects of CORTICOTROPIN โ€“RELEASING FACTOR and Restraint Stress on Prepulse Inhibition of the Acoustic Startle Response in Rats
  2737. Effect of CORTICOTROPIN โ€“RELEASING FACTOR on anoxia-induced changes in evoked potentials in cultured tissue of the rat olFACTOR y cortex
  2738. Antagonism of Specific CORTICOTROPIN RELEASING FACTOR Receptor Subtypes Selectively Modifies Weight Loss in Restrained Rats
  2739. The neuroanatomical and neurophysiological mechanisms for CORTICOTROPIN โ€“RELEASING FACTOR induced enhancement of locomotion in roughskin newts
  2740. Participation of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats
  2741. Retroviral gene transfer of CORTICOTROPIN RELEASING FACTOR (CRF) into adult and neonatal rat brain: Functional and neurobiological evidence of action
  2742. Regulation of the dorsal raphe nucleus serotonin system by the stress related peptide CORTICOTROPIN โ€“RELEASING FACTOR
  2743. The regulation of amygdala CORTICOTROPIN โ€“RELEASING FACTOR -binding protein (CRF-BP) in stress and psychopathology
  2744. An artificial peptide with CORTICOTROPIN โ€RELEASING FACTOR receptorโ€2 (CRFโ€R2) selective properties: the role of primary structure in the induction of signal transduction โ€ฆ
  2745. Detrimental role of CORTICOTROPIN โ€“RELEASING FACTOR on the decrease of CA1 field potential induced by in vitro ischemia in rat hippocampal slices
  2746. The role of estrogen in basal and CORTICOTROPIN RELEASING FACTOR -induced colonic motility: Implications for irritable bowel syndrome
  2747. The CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor selective ligand Urocortin 3 suppresses angiogenesis in vitro and in vivo
  2748. Corticorelin acetate, a synthetic CORTICOTROPIN RELEASING FACTOR , demonstrates antiangiogenic and antitumor activity alone and enhances bevacizumab activity in human โ€ฆ
  2749. The expression of the CORTICOTROPIN RELEASING FACTOR (CRF) system of neuropeptides and receptors in mouse microglia cells
  2750. โ€ฆ element silencing transcription FACTOR /neuron-restrictive silencing FACTOR (REST/NRSF) can act as an enhancer as well as a repressor of CORTICOTROPIN โ€“RELEASING โ€ฆ
  2751. Endothelinโ€converting enzymeโ€1 (ECEโ€1)โ€dependent trafficking of CORTICOTROPIN โ€RELEASING FACTOR receptor 1 (CRFโ€R1).
  2752. CORTICOTROPIN โ€“RELEASING FACTOR Regulates Somatodendritic Dopamine Release By Inhibiting Voltage-dependent Ca2+ Channels
  2753. Intra-Accumbens CORTICOTROPIN โ€“RELEASING FACTOR Increases the Conditioned Incentive Salience of Sucrose Reward
  2754. Increased density and stabilization of climbing fiber-Purkinje cell synapses in mice overexpressing CORTICOTROPIN โ€“RELEASING FACTOR
  2755. CORTICOTROPIN RELEASING FACTOR and Urocortin modulate Purkinje cell dendritic outgrowth and differentiation in vitro
  2756. Analgesic effect of CORTICOTROPIN RELEASING FACTOR (CRF) on somatic pain sensitivity: participation of glucocorticoid and CRF-2 receptors
  2757. The effects of intracerebroventricular CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on the behaviour and cerebral glucose metabolism of non-human primates
  2758. Enduring Effects Of Traumatic Stress On Brain Neuropeptide Y (NPY) and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Systems: Molecular and Neuropharmacologic Studies
  2759. โ€ฆ exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory FACTOR (LIF) and CORTICOTROPIN โ€“RELEASING hormone (CRH) gene expression โ€ฆ
  2760. The Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptor-1 in Brain Suppress Stress-Induced Propofol Self-administration in Rats
  2761. An investigation of two animal models of anxiety: central administration of CORTICOTROPIN โ€“RELEASING FACTOR on the behaviour and neurochemistry of rats, and the โ€ฆ
  2762. Behavioral/Systems/Cognitive CORTICOTROPIN โ€“RELEASING FACTOR Receptors CRF 1 and CRF 2 Exert Both Additive and Opposing Influences on Defensive Startle โ€ฆ
  2763. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and neuropeptide Y (NPY) mRNA levels are modified by stress and glucocorticoids in rainbow trout (Oncorhynchus mykiss)
  2764. Expression of CORTICOTROPIN RELEASING FACTOR (CRF), Urocortin and CRF Type 1 Receptors in Hypothalamic-Hypophyseal Systems Under Osmotic Stimulation
  2765. โ€ฆ AND SOMATIC HYPERALGESIA IN ADULT RATS FOLLOWING NEONATAL GASTRIC SUCTIONING IS MEDIATED BY CORTICOTROPIN RELEASING FACTOR
  2766. Cerebrospinal fluid levels of orexin-A and CORTICOTROPIN โ€“RELEASING FACTOR suggest their involvement in the negative motivational state that driverโ€ drug dependenceโ€ in โ€ฆ
  2767. Functional neuroanatomy of neuropeptide Y (NPY) and CORTICOTROPIN RELEASING FACTOR (CRF) receptors in the rat basolateral amygdala (BLA)
  2768. Centrally administered orexin-A activates CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid โ€ฆ
  2769. Coordinate regulation of CORTICOTROPIN RELEASING FACTOR receptor 1 and arginine vasopressin receptor V3 messenger ribonucleic acids in the anterior pituitary of โ€ฆ
  2770. Effects of CORTICOTROPIN โ€“RELEASING hormone and stresscopin on vascular endothelial growth FACTOR mRNA expression in cultured early human extravillous trophoblasts
  2771. Synergistic signaling by CORTICOTROPIN โ€“RELEASING hormone and leukemia inhibitory FACTOR bridged by phosphorylated 3โ€ฒ, 5โ€ฒ-cyclic adenosine monophosphate โ€ฆ
  2772. Association between serum tumor necrosis FACTOR โ€ฮฑ and CORTICOTROPIN โ€RELEASING hormone levels in women with preterm labor
  2773. PIโ€5: Intravesical CORTICOTROPIN โ€RELEASING hormone (CRH) induces mast cellโ€dependent vascular endothelial growth FACTOR (VEGF) release from mouse bladder โ€ฆ
  2774. The CORTICOTROPIN โ€“RELEASING FACTOR family: physiology of the stress response
  2775. CORTICOTROPIN RELEASING FACTOR : a key role in the neurobiology of addiction
  2776. Role of CORTICOTROPIN โ€“RELEASING FACTOR in drug addiction
  2777. Role of CORTICOTROPIN โ€“RELEASING FACTOR in gastrointestinal permeability
  2778. Structure of class B GPCR CORTICOTROPIN โ€“RELEASING FACTOR receptor 1
  2779. Sex differences in stress responses: a critical role for CORTICOTROPIN โ€“RELEASING FACTOR
  2780. Region-specific roles of the CORTICOTROPIN โ€“RELEASING FACTOR โ€“urocortin system in stress
  2781. CORTICOTROPIN RELEASING FACTOR in neuroplasticity
  2782. Evidence for the role of CORTICOTROPIN โ€“RELEASING FACTOR in major depressive disorder
  2783. Molecular basis for hormone recognition and activation of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  2784. A CORTICOTROPIN RELEASING FACTOR network in the extended amygdala for anxiety
  2785. Central CORTICOTROPIN RELEASING FACTOR and social stress
  2786. Sex-specific cell signaling: the CORTICOTROPIN โ€“RELEASING FACTOR receptor model
  2787. The bladderโ€“brain connection: putative role of CORTICOTROPIN โ€“RELEASING FACTOR
  2788. Update on CORTICOTROPIN โ€“RELEASING FACTOR pharmacotherapy for psychiatric disorders: a revisionist view.
  2789. Allostasis and addiction: role of the dopamine and CORTICOTROPIN โ€“RELEASING FACTOR systems
  2790. Local CORTICOTROPIN โ€“RELEASING FACTOR signaling in the hypothalamic paraventricular nucleus
  2791. โ€ฆ stress to female rats alters CORTICOTROPIN RELEASING FACTOR type 1 expression in ova and behavior and brain CORTICOTROPIN RELEASING FACTOR type 1 expression in offspring
  2792. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) circuit modulation of cognition and motivation
  2793. Sex differences in circuits activated by CORTICOTROPIN RELEASING FACTOR in rats
  2794. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonism is ineffective for women with posttraumatic stress disorder
  2795. Increased vulnerability of the brain norepinephrine system of females to CORTICOTROPIN โ€“RELEASING FACTOR overexpression
  2796. CORTICOTROPIN โ€“RELEASING FACTOR -related peptides, serotonergic systems, and emotional behavior
  2797. Prefrontal cortex CORTICOTROPIN โ€“RELEASING FACTOR neurons control behavioral style selection under challenging situations
  2798. CORTICOTROPIN โ€RELEASING FACTOR acting on CORTICOTROPIN โ€RELEASING FACTOR receptor type 1 is critical for binge alcohol drinking in mice
  2799. Sex-biased stress signaling: the CORTICOTROPIN โ€“RELEASING FACTOR receptor as a model
  2800. Striatal cholinergic interneurons are a novel target of CORTICOTROPIN RELEASING FACTOR
  2801. Chronic stress induces sex-specific alterations in methylation and expression of CORTICOTROPIN โ€“RELEASING FACTOR gene in the rat
  2802. Is it really a matter of simple dualism? CORTICOTROPIN โ€“RELEASING FACTOR receptors in body and mental health
  2803. CORTICOTROPIN RELEASING FACTOR receptor antagonists for major depressive disorder
  2804. Sex differences in CORTICOTROPIN RELEASING FACTOR peptide regulation of inhibitory control and excitability in central amygdala CORTICOTROPIN RELEASING FACTOR receptor 1 โ€ฆ
  2805. Site-specific genetic manipulation of amygdala CORTICOTROPIN โ€“RELEASING FACTOR reveals its imperative role in mediating behavioral response to challenge
  2806. CORTICOTROPIN โ€“RELEASING FACTOR overexpression gives rise to sex differences in Alzheimerโ€™s disease-related signaling
  2807. Preclinical evidence implicating CORTICOTROPIN โ€RELEASING FACTOR signaling in ethanol consumption and neuroadaptation
  2808. Role of CORTICOTROPIN โ€“RELEASING FACTOR signaling in stress-related alterations of colonic motility and hyperalgesia
  2809. The organization and possible function of amygdaloid CORTICOTROPIN โ€“RELEASING FACTOR pathways
  2810. Impaired emotional learning and involvement of the CORTICOTROPIN โ€“RELEASING FACTOR signaling system in patients with irritable bowel syndrome
  2811. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a CORTICOTROPIN โ€“RELEASING FACTOR receptor-dependent mechanism in a โ€ฆ
  2812. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR neurons in the mouse brain: a study using CORTICOTROPIN โ€“RELEASING FACTOR -modified yellow fluorescent protein knock-in โ€ฆ
  2813. Prolonged and site-specific over-expression of CORTICOTROPIN โ€“RELEASING FACTOR reveals differential roles for extended amygdala nuclei in emotional regulation
  2814. Amygdalar CORTICOTROPIN โ€“RELEASING FACTOR mediates stress-induced anxiety
  2815. Adolescent binge drinking leads to changes in alcohol drinking, anxiety, and amygdalar CORTICOTROPIN RELEASING FACTOR cells in adulthood in male rats
  2816. Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for CORTICOTROPIN โ€“RELEASING FACTOR
  2817. CORTICOTROPIN โ€“RELEASING FACTOR in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility
  2818. CORTICOTROPIN โ€“RELEASING FACTOR receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation
  2819. Defining the role of CORTICOTROPIN RELEASING FACTOR binding protein in alcohol consumption
  2820. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 and type 2 interaction in irritable bowel syndrome
  2821. CORTICOTROPIN RELEASING FACTOR signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice
  2822. Interaction of stress, CORTICOTROPIN โ€“RELEASING FACTOR , arginine vasopressin and behaviour
  2823. Binding kinetics redefine the antagonist pharmacology of the CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor
  2824. Perturbations in effort-related decision-making driven by acute stress and CORTICOTROPIN โ€“RELEASING FACTOR
  2825. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and addictive behaviors
  2826. Prefrontal cortex CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 conveys acute stress-induced executive dysfunction
  2827. A CORTICOTROPIN RELEASING FACTOR pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis
  2828. Glutamine enhances tight junction protein expression and modulates CORTICOTROPIN โ€“RELEASING FACTOR signaling in the jejunum of weanling piglets
  2829. MicroRNA 375 mediates the signaling pathway of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen โ€ฆ
  2830. Sex differences in CORTICOTROPIN RELEASING FACTOR -evoked behavior and activated networks
  2831. Sexโ€and regionโ€specific pubertal maturation of the CORTICOTROPIN โ€RELEASING FACTOR receptor system in the rat
  2832. Role of CORTICOTROPIN โ€“RELEASING FACTOR in cerebellar motor control and ataxia
  2833. Sex differences in CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 action within the dorsal raphe nucleus in stress responsivity
  2834. Stress and glucocorticoids regulated CORTICOTROPIN RELEASING FACTOR in rat prefrontal cortex
  2835. Effects of continuously enhanced CORTICOTROPIN RELEASING FACTOR expression within the bed nucleus of the stria terminalis on conditioned and unconditioned โ€ฆ
  2836. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR and receptors in immune cells in irritable bowel syndrome
  2837. Emerging role for CORTICOTROPIN RELEASING FACTOR signaling in the bed nucleus of the stria terminalis at the intersection of stress and reward
  2838. Overexpressing CORTICOTROPIN โ€“RELEASING FACTOR in the primate amygdala increases anxious temperament and alters its neural circuit
  2839. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist alters regional activation and effective connectivity in an emotionalโ€“arousal circuit during expectation of abdominal โ€ฆ
  2840. The CORTICOTROPIN RELEASING FACTOR receptor 1 in alcohol use disorder: still a valid drug target?
  2841. CORTICOTROPIN RELEASING FACTOR -binding protein (CRF-BP) as a potential new therapeutic target in Alzheimerโ€™s disease and stress disorders
  2842. Distribution of urocortins and CORTICOTROPIN โ€“RELEASING FACTOR receptors in the cardiovascular system
  2843. Stress and addiction: contribution of the CORTICOTROPIN RELEASING FACTOR (CRF) system in neuroplasticity
  2844. CORTICOTROPIN โ€“RELEASING FACTOR family: a stress hormone-receptor systemโ€™s emerging role in mediating sex-specific signaling
  2845. Neonatal maternal separation in the rat impacts on the stress responsivity of central CORTICOTROPIN โ€“RELEASING FACTOR receptors in adulthood
  2846. Role of CORTICOTROPIN RELEASING FACTOR in the neuroimmune mechanisms of depression: Examination of current pharmaceutical and herbal therapies
  2847. Extended amygdala to ventral tegmental area CORTICOTROPIN โ€“RELEASING FACTOR circuit controls binge ethanol intake
  2848. Differential responses of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 1 to acute pain stress in the rat brain
  2849. Susceptibility to PTSD-like behavior is mediated by CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 levels in the bed nucleus of the stria terminalis
  2850. CORTICOTROPIN RELEASING FACTOR impairs sustained attention in male and female rats
  2851. Single-dose study of a CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonist in women with 21-hydroxylase deficiency
  2852. Working memory impairing actions of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurotransmission in the prefrontal cortex
  2853. Predator stress engages CORTICOTROPIN โ€“RELEASING FACTOR and opioid systems to alter the operating mode of locus coeruleus norepinephrine neurons
  2854. Cell-type specific deletion of GABA (A) ฮฑ1 in CORTICOTROPIN โ€“RELEASING FACTOR -containing neurons enhances anxiety and disrupts fear extinction
  2855. Frontline Science: CORTICOTROPIN โ€RELEASING FACTOR receptor subtype 1 is a critical modulator of mast cell degranulation and stressโ€induced pathophysiology
  2856. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurocircuitry and neuropharmacology in alcohol drinking
  2857. Orexinโ€“CORTICOTROPIN โ€“RELEASING FACTOR receptor heteromers in the ventral tegmental area as targets for cocaine
  2858. Regulation of gonadotropins by CORTICOTROPIN โ€“RELEASING FACTOR and urocortin
  2859. Molecular signaling and translational significance of the CORTICOTROPIN RELEASING FACTOR system
  2860. CORTICOTROPIN โ€“RELEASING FACTOR : basic and clinical studies of a neuropeptide
  2861. Early-life stress, CORTICOTROPIN โ€“RELEASING FACTOR , and serotonin transporter gene: a pilot study
  2862. Expression of CORTICOTROPIN RELEASING FACTOR receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with โ€ฆ
  2863. Behavioral effects of CORTICOTROPIN โ€“RELEASING FACTOR
  2864. Constitutive increases in amygdalar CORTICOTROPIN โ€“RELEASING FACTOR and fatty acid amide hydrolase drive an anxious phenotype
  2865. Eosinophils express muscarinic receptors and CORTICOTROPIN โ€“RELEASING FACTOR to disrupt the mucosal barrier in ulcerative colitis
  2866. Sex differences in activated CORTICOTROPIN โ€“RELEASING FACTOR neurons within stress-related neurocircuitry and hypothalamicโ€“pituitaryโ€“adrenocortical axis hormones โ€ฆ
  2867. Cognitive disruptions in stress-related psychiatric disorders: a role for CORTICOTROPIN RELEASING FACTOR (CRF)
  2868. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 mediates the colonic motor coping response to acute stress in rodents
  2869. Posttraumatic stress disorder-like induction elevates ฮฒ-amyloid levels, which directly activates CORTICOTROPIN โ€“RELEASING FACTOR neurons to exacerbate stress responses
  2870. Biological intersection of sex, age, and environment in the CORTICOTROPIN RELEASING FACTOR (CRF) system and alcohol
  2871. CORTICOTROPIN โ€“RELEASING FACTOR peptide antagonists: design, characterization and potential clinical relevance
  2872. Evolution and phylogeny of the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of peptides: expansion and specialization in the vertebrates
  2873. Modulation of enteric neurons by interleukinโ€6 and CORTICOTROPIN โ€RELEASING FACTOR contributes to visceral hypersensitivity and altered colonic motility in a rat model of โ€ฆ
  2874. Predator odor stress alters CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor (CRF1R)-dependent behaviors in rats
  2875. Conformational thermostabilisation of CORTICOTROPIN RELEASING FACTOR receptor 1
  2876. CORTICOTROPIN RELEASING FACTOR and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala
  2877. Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing CORTICOTROPIN โ€“RELEASING FACTOR
  2878. Ghrelin activates hypophysiotropic CORTICOTROPIN โ€“RELEASING FACTOR neurons independently of the arcuate nucleus
  2879. Increased mesocorticolimbic dopamine during acute and repeated social defeat stress: modulation by CORTICOTROPIN RELEASING FACTOR receptors in the ventral tegmental โ€ฆ
  2880. Chronic overexpression of CORTICOTROPIN โ€“RELEASING FACTOR from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene โ€ฆ
  2881. Prefrontal CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurons act locally to modulate frontostriatal cognition and circuit function
  2882. The specific monomer/dimer equilibrium of the CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 is established in the endoplasmic reticulum
  2883. CORTICOTROPIN โ€“RELEASING FACTOR acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses
  2884. Overactivation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema
  2885. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety-& alcohol-related behaviors
  2886. The effect of acute or repeated stress on the CORTICOTROPIN RELEASING FACTOR system in the CRH-IRES-Cre mouse: a validation study
  2887. Novel insights in the role of peripheral CORTICOTROPIN โ€RELEASING FACTOR and mast cells in stressโ€induced visceral hypersensitivity
  2888. CORTICOTROPIN โ€RELEASING FACTOR typeโ€2 receptor and CORTICOTROPIN โ€RELEASING FACTOR โ€binding protein coexist in rat ventral tegmental area nerve terminals originated in the โ€ฆ
  2889. Effects of acute treadmill running at different intensities on activities of serotonin and CORTICOTROPIN โ€“RELEASING FACTOR neurons, and anxiety-and depressive-like behaviors โ€ฆ
  2890. CORTICOTROPIN โ€“RELEASING FACTOR receptor binding in the amygdala changes across puberty in a sex-specific manner
  2891. CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced disruption of attention in rats is blocked by the ฮบ-opioid receptor antagonist JDTic
  2892. Chronic psychosocial stress induces reversible mitochondrial damage and CORTICOTROPIN โ€“RELEASING FACTOR receptor type-1 upregulation in the rat intestine and IBS-like โ€ฆ
  2893. Sex-specific effects of relaxin-3 on food intake and brain expression of CORTICOTROPIN โ€“RELEASING FACTOR in rats
  2894. CORTICOTROPIN โ€“RELEASING FACTOR in ventromedial prefrontal cortex mediates avoidance of a traumatic stress-paired context
  2895. Role of CORTICOTROPIN โ€“RELEASING FACTOR in alcohol and nicotine addiction
  2896. Predator odor increases avoidance and glutamatergic synaptic transmission in the prelimbic cortex via CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 signaling
  2897. Regulation of the autonomic nervous system by CORTICOTROPIN โ€“RELEASING FACTOR
  2898. Gastric CORTICOTROPIN โ€“RELEASING FACTOR influences mast cell infiltration in a rat model of functional dyspepsia
  2899. Opposing roles of CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of โ€ฆ
  2900. Role of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR in mediating alcohol-induced activation of the rat hypothalamicโ€“pituitaryโ€“adrenal axis
  2901. The upside of stress: a mechanism for the positive motivational role of CORTICOTROPIN RELEASING FACTOR
  2902. Negative consequences of early-life adversity on substance use as mediated by CORTICOTROPIN โ€“RELEASING FACTOR modulation of serotonin activity
  2903. Stress and the stomach: CORTICOTROPIN โ€“RELEASING FACTOR may protect the gastric mucosa in stress through involvement of glucocorticoids
  2904. Knockdown of CORTICOTROPIN โ€“RELEASING FACTOR in the central amygdala reverses persistent viscerosomatic hyperalgesia
  2905. Stress-derived CORTICOTROPIN RELEASING FACTOR breaches epithelial endotoxin tolerance
  2906. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the CORTICOTROPIN โ€“RELEASING FACTOR system
  2907. The role of central amygdala CORTICOTROPIN โ€“RELEASING FACTOR in predator odor stress-induced avoidance behavior and escalated alcohol drinking in rats
  2908. Sex-dependent effects of chronic variable stress on discrete CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 cell populations
  2909. CORTICOTROPIN โ€“RELEASING FACTOR critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol
  2910. The realization of the brain-gut interactions with CORTICOTROPIN โ€“RELEASING FACTOR and glucocorticoids
  2911. Nicotine dependence produces hyperalgesia: role of CORTICOTROPIN โ€“RELEASING FACTOR -1 receptors (CRF1Rs) in the central amygdala (CeA)
  2912. Adolescent drinking targets CORTICOTROPIN โ€“RELEASING FACTOR peptide-labeled cells in the central amygdala of male and female rats
  2913. CORTICOTROPIN โ€“RELEASING FACTOR receptor densities vary with photoperiod and sociality
  2914. Traumatic stress promotes hyperalgesia via CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor (CRFR1) signaling in central amygdala
  2915. Angiotensin type 1a receptors on CORTICOTROPIN โ€RELEASING FACTOR neurons contribute to the expression of conditioned fear1
  2916. CORTICOTROPIN RELEASING FACTOR Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice
  2917. A sexually dimorphic distribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the paraventricular hypothalamus
  2918. CORTICOTROPIN โ€“RELEASING FACTOR in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine โ€ฆ
  2919. Cyclotides isolated from an ipecac root extract antagonize the CORTICOTROPIN RELEASING FACTOR type 1 receptor
  2920. Differential effects of CORTICOTROPIN โ€“RELEASING FACTOR and acute stress on different forms of risk/reward decision-making
  2921. Decoding CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 crystal structures
  2922. Effect of early life social adversity on drug abuse vulnerability: Focus on CORTICOTROPIN โ€“RELEASING FACTOR and oxytocin
  2923. Long-term effects of early adolescent stress: dysregulation of hypothalamicโ€“pituitaryโ€“adrenal axis and central CORTICOTROPIN RELEASING FACTOR receptor 1 expression in โ€ฆ
  2924. Optogenetic silencing of a CORTICOTROPIN โ€“RELEASING FACTOR pathway from the central amygdala to the bed nucleus of the stria terminalis disrupts sustained fear
  2925. Episodic social stress-escalated cocaine self-administration: role of phasic and tonic CORTICOTROPIN RELEASING FACTOR in the anterior and posterior ventral tegmental area
  2926. Effects of intracerebroventricular CORTICOTROPIN RELEASING FACTOR on sensory-evoked responses in the rat visual thalamus
  2927. CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimerโ€™s disease
  2928. Nociceptin/orphanin FQ blockade of CORTICOTROPIN โ€“RELEASING FACTOR -induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol โ€ฆ
  2929. Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for CORTICOTROPIN โ€“RELEASING FACTOR 1 receptors
  2930. Characterization and gonadal hormone regulation of a sexually dimorphic CORTICOTROPIN โ€RELEASING FACTOR receptor 1 cell group
  2931. Sexโ€dependent and differential responses to acute restraint stress of CORTICOTROPIN โ€RELEASING FACTOR โ€“producing neurons in the rat paraventricular nucleus, central โ€ฆ
  2932. A functional switch in tonic GABA currents alters the output of central amygdala CORTICOTROPIN RELEASING FACTOR receptor-1 neurons following chronic ethanol exposure
  2933. Activation of neuropeptide Sโ€expressing neurons in the locus coeruleus by CORTICOTROPIN โ€RELEASING FACTOR
  2934. Lithium, but not fluoxetine or the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus
  2935. The Pseudo signal peptide of the CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2A prevents receptor oligomerization
  2936. Appetite-suppressing effects and interactions of centrally administered CORTICOTROPIN โ€“RELEASING FACTOR , urotensin I and serotonin in rainbow trout (Oncorhynchus โ€ฆ
  2937. Urocortin 3 expression at baseline and during inflammation in the colon: CORTICOTROPIN RELEASING FACTOR receptors cross-talk
  2938. CORTICOTROPIN โ€RELEASING FACTOR neurogenesis during midlife development in salmon: genetic, environmental and thyroid hormone regulation
  2939. Actin cytoskeletonโ€“dependent regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor heteromers
  2940. Ethanol and CORTICOTROPIN RELEASING FACTOR receptor modulation of central amygdala neurocircuitry: an update and future directions
  2941. CORTICOTROPIN โ€“RELEASING FACTOR receptors and their interacting proteins: functional consequences
  2942. Crosstalk between interleukin-6 and CORTICOTROPIN โ€“RELEASING FACTOR modulate submucosal plexus activity and colonic secretion
  2943. The CORTICOTROPIN โ€“RELEASING FACTOR -like diuretic hormone 44 (DH44) and kinin neuropeptides modulate desiccation and starvation tolerance in Drosophila โ€ฆ
  2944. Tonic suppression of the mesolimbic dopaminergic system by enhanced CORTICOTROPIN โ€“RELEASING FACTOR signaling within the bed nucleus of the stria terminalis in chronic โ€ฆ
  2945. Activating CORTICOTROPIN โ€“RELEASING FACTOR systems in the nucleus accumbens, amygdala, and bed nucleus of stria terminalis: Incentive motivation or aversive motivation?
  2946. Enduring sensorimotor gating abnormalities following predator exposure or CORTICOTROPIN โ€“RELEASING FACTOR in rats: a model for PTSD-like information-processing deficits โ€ฆ
  2947. Female-biased sexual dimorphism of CORTICOTROPIN โ€“RELEASING FACTOR neurons in the bed nucleus of the stria terminalis
  2948. Identification of substances which regulate activity of CORTICOTROPIN โ€“RELEASING FACTOR -producing neurons in the paraventricular nucleus of the hypothalamus
  2949. Interactions between anandamide and CORTICOTROPIN โ€“RELEASING FACTOR signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics โ€ฆ
  2950. Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR CRF1 receptors blocks the enhanced response to cocaine after social stress
  2951. Mast cell CORTICOTROPIN โ€“RELEASING FACTOR subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability
  2952. Urocortin 1 modulates immunosignaling in a rat model of colitis via CORTICOTROPIN โ€“RELEASING FACTOR receptor 2
  2953. Reduced brain CORTICOTROPIN โ€RELEASING FACTOR receptor activation is required for adequate maternal care and maternal aggression in lactating rats
  2954. CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor antagonists for stress-related disorders: time to call it quits?
  2955. CORTICOTROPIN RELEASING FACTOR โ€”distribution in rat intestine and role in neuroprotection
  2956. Lipopolysaccharideโ€induced tau phosphorylation and kinase activityโ€“modulation, but not mediation, by CORTICOTROPIN โ€RELEASING FACTOR receptors
  2957. Receptors for CORTICOTROPIN โ€“RELEASING FACTOR
  2958. Binge Ethanolโ€Drinking Potentiates CORTICOTROPIN RELEASING FACTOR R 1 Receptor Activity in the Ventral Tegmental Area
  2959. Overexpression of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 in the bed nucleus of stria terminalis improves posttraumatic stress disorder-like symptoms in a model โ€ฆ
  2960. CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis
  2961. Activation of CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor: insights from molecular dynamics simulations
  2962. Ontogeny of the CORTICOTROPIN โ€“RELEASING FACTOR system in rainbow trout and differential effects of hypoxia on the endocrine and cellular stress responses during โ€ฆ
  2963. Role of a genetic polymorphism in the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian โ€ฆ
  2964. Activation of CORTICOTROPIN โ€“RELEASING FACTOR neurons and microglia in paraventricular nucleus precipitates visceral hypersensitivity induced by colorectal distension in โ€ฆ
  2965. Molecular, morphological, and functional characterization of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1-expressing neurons in the central nucleus of the โ€ฆ
  2966. Regulation of maternal care by CORTICOTROPIN โ€“RELEASING FACTOR receptors in the dorsal raphe nucleus in mice.
  2967. Epigenetic regulation of nociceptin/orphanin FQ and CORTICOTROPIN โ€RELEASING FACTOR system genes in frustration stressโ€induced bingeโ€like palatable food consumption
  2968. Psychophysiological treatment outcomes: CORTICOTROPIN โ€RELEASING FACTOR type 1 receptor antagonist increases inhibition of fearโ€potentiated startle in PTSD patients
  2969. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and ฮฑ2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats
  2970. CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor haplotype and cognitive features of major depression
  2971. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of CORTICOTROPIN โ€“RELEASING FACTOR from the central amygdala
  2972. Targeting CORTICOTROPIN โ€RELEASING FACTOR Projections from the Oval Nucleus of the Bed Nucleus of the Stria Terminalis Using Cellโ€Type Specific Neuronal Tracing โ€ฆ
  2973. Activation of CORTICOTROPIN RELEASING FACTOR -containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different โ€ฆ
  2974. Functional impact of CORTICOTROPIN โ€“RELEASING FACTOR exposure on tau phosphorylation and axon transport
  2975. Plasticity in the brainstem vagal circuits controlling gastric motor function triggered by CORTICOTROPIN RELEASING FACTOR
  2976. CORTICOTROPIN โ€“RELEASING FACTOR and noradrenergic signalling exert reciprocal control over startle reactivity
  2977. CORTICOTROPIN RELEASING FACTOR , but not alcohol, modulates norepinephrine release in the rat central nucleus of the amygdala
  2978. CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists: a patent review
  2979. CORTICOTROPIN โ€“RELEASING FACTOR in the brain and blocking spinal descending signals induce hyperalgesia in the latent sensitization model of chronic pain
  2980. Exploration of the antagonist CP-376395 escape pathway for the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 by random acceleration molecular dynamics simulations
  2981. Anxiogenic and antinociceptive effects induced by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) injections into the periaqueductal gray are modulated by CRF1 โ€ฆ
  2982. Comparison of CORTICOTROPIN โ€“RELEASING FACTOR , dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas
  2983. Tonic modulation of anxiety-like behavior by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role โ€ฆ
  2984. CORTICOTROPIN โ€“RELEASING FACTOR receptor signaling and modulation: implications for stress response and resilience
  2985. CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 mediates sex-specific cellular stress responses
  2986. Electroacupuncture regulates disorders of gut-brain interaction by decreasing CORTICOTROPIN โ€“RELEASING FACTOR in a rat model of IBS
  2987. CORTICOTROPIN โ€“RELEASING FACTOR neurotransmission in the lateral hypothalamus modulates the tachycardiac response during acute emotional stress in rats
  2988. CORTICOTROPIN RELEASING FACTOR in the bed nucleus of the stria terminalis in socially defeated and non-stressed mice with a history of chronic alcohol intake
  2989. Type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue
  2990. CORTICOTROPIN โ€“RELEASING FACTOR receptors modulate oxytocin release in the dorsolateral bed nucleus of the stria terminalis (BNST) in male rats
  2991. Overexpression of CORTICOTROPIN โ€“RELEASING FACTOR in the nucleus accumbens enhances the reinforcing effects of nicotine in intact female versus male and โ€ฆ
  2992. โ€ฆ mechanisms regulate visceral hypersensitivity in adult females following early life stress: importance of the glucocorticoid receptor and CORTICOTROPIN โ€“RELEASING FACTOR
  2993. Crossโ€talk between dopamine D1 and CORTICOTROPIN RELEASING FACTOR type 2 receptors leads to occlusion of their ERK1/2 signaling
  2994. Basolateral amygdala and the regulation of fear-conditioned changes in sleep: role of CORTICOTROPIN โ€“RELEASING FACTOR
  2995. Signal transduction in the hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR system and its clinical implications
  2996. Plasma CORTICOTROPIN โ€“RELEASING FACTOR receptors and B7-2+ extracellular vesicles in blood correlate with irritable bowel syndrome disease severity
  2997. Different effects of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 2 on apoptosis of prostate cancer cells in vitro.
  2998. Role of SAP97 protein in the regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling
  2999. Identification of members of the gonadotropin-RELEASING hormone (GnRH), CORTICOTROPIN โ€“RELEASING FACTOR (CRF) families in the genome of the holocephalan โ€ฆ
  3000. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptors in the rostral ventrolateral medulla is required for glucose-induced sympathoexcitation
  3001. Sex-and CORTICOTROPIN โ€“RELEASING FACTOR receptor 2-dependent actions of urocortin 1 during inflammation
  3002. Inhibition of CORTICOTROPIN RELEASING FACTOR expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses
  3003. The CORTICOTROPIN RELEASING FACTOR system in the liver: expression, actions and possible implications in hepatic physiology and pathology
  3004. Altered expression of glucocorticoid receptor and CORTICOTROPIN โ€“RELEASING FACTOR in the central amygdala in response to elevated corticosterone
  3005. Overexpression of CORTICOTROPIN โ€RELEASING FACTOR in Barringtonโ€™s nucleus neurons by adenoโ€associated viral transduction: effects on bladder function and behavior
  3006. Role of CORTICOTROPIN โ€RELEASING FACTOR in the median raphe nucleus in yohimbineโ€induced reinstatement of alcohol seeking in rats
  3007. Sex differences in CORTICOTROPIN RELEASING FACTOR regulation of medial septum-mediated memory formation
  3008. Peripheral activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 inhibits food intake and alters meal structures in mice
  3009. Orexigenic response to tail pinch: role of brain NPY1 and CORTICOTROPIN RELEASING FACTOR receptors
  3010. Pyrazolo [1, 5-a] pyrimidines, triazolo [1, 5-a] pyrimidines and their tricyclic derivatives as CORTICOTROPIN โ€“RELEASING FACTOR 1 (CRF1) receptor antagonists
  3011. โ€ฆ adaptive fear and attenuates anxiety responses in animal models and human studiesโ€”potential interaction with the CORTICOTROPIN โ€“RELEASING FACTOR (CRF) system in the โ€ฆ
  3012. Topographical distribution of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan โ€ฆ
  3013. Localization of the delta opioid receptor and CORTICOTROPIN โ€“RELEASING FACTOR in the amygdalar complex: role in anxiety
  3014. Ethanol concentration-dependent effects and the role of stress on ethanol drinking in CORTICOTROPIN โ€“RELEASING FACTOR type 1 and double type 1 and 2 receptor knockout โ€ฆ
  3015. Hypothalamic mechanisms associated with CORTICOTROPIN โ€“RELEASING FACTOR -induced anorexia in chicks
  3016. CORTICOTROPIN โ€“RELEASING FACTOR infusion in the bed nucleus of the stria terminalis of lactating mice alters maternal care and induces behavioural phenotypes in โ€ฆ
  3017. Selective lesioning of nucleus incertus with CORTICOTROPIN RELEASING FACTOR -saporin conjugate
  3018. Functional antagonism between nociceptin/orphanin FQ and CORTICOTROPIN โ€“RELEASING FACTOR in rat anxiety-related behaviors: involvement of the serotonergic system
  3019. Visualization of CORTICOTROPIN โ€“RELEASING FACTOR neurons by fluorescent proteins in the mouse brain and characterization of labeled neurons in the paraventricular โ€ฆ
  3020. CORTICOTROPIN โ€“RELEASING FACTOR family peptide signaling in feline bladder urothelial cells
  3021. Alterations in effort-related decision-making induced by stimulation of dopamine D 1, D 2, D 3, and CORTICOTROPIN โ€“RELEASING FACTOR receptors in nucleus accumbens โ€ฆ
  3022. Extended access cocaine selfโ€administration differentially activates dorsal raphe and amygdala CORTICOTROPIN โ€RELEASING FACTOR systems in rats
  3023. Chronic activation of CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and โ€ฆ
  3024. Sex differences in the subcellular distribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the rat hippocampus following chronic immobilization stress
  3025. A balance theory of peripheral CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats
  3026. Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleusโ€norepinephrine neurons and CORTICOTROPIN RELEASING FACTOR โ€mediated โ€ฆ
  3027. CORTICOTROPIN RELEASING FACTOR -induced CREB activation in striatal neurons occurs via a novel Gฮฒฮณ signaling pathway
  3028. Binge drinking decreases CORTICOTROPIN โ€RELEASING FACTOR โ€binding protein expression in the medial prefrontal cortex of mice
  3029. Contrasting effects of pretraining, posttraining, and pretesting infusions of CORTICOTROPIN โ€“RELEASING FACTOR into the lateral amygdala: attenuation of fear memory formation โ€ฆ
  3030. PDZK1/NHERF3 differentially regulates CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 and serotonin 2A receptor signaling and endocytosis
  3031. Influence of transgenic CORTICOTROPIN โ€“RELEASING FACTOR (CRF) over-expression on social recognition memory in mice
  3032. CORTICOTROPIN โ€“RELEASING FACTOR -binding protein (CRF-BP) inhibits CRF-and urotensin-I-mediated activation of CRF receptor-1 and-2 in common carp
  3033. Central blockage of nesfatin-1 has anxiolytic effects but does not prevent CORTICOTROPIN โ€“RELEASING FACTOR -induced anxiety in male rats
  3034. Sex-dependent effects of mild blast-induced traumatic brain injury on CORTICOTROPIN โ€“RELEASING FACTOR receptor gene expression: potential link to anxiety-like behaviors
  3035. CORTICOTROPIN โ€“RELEASING FACTOR in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as โ€ฆ
  3036. Local repeated CORTICOTROPIN โ€“RELEASING FACTOR infusion exacerbates anxiety-and fear-related behavior: differential involvement of the basolateral amygdala and medial โ€ฆ
  3037. Role of CORTICOTROPIN โ€“RELEASING FACTOR on bladder function in rats with psychological stress
  3038. CORTICOTROPIN โ€“RELEASING FACTOR : a possible key to gut dysfunction in the critically ill
  3039. Polymorphism in the CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol โ€ฆ
  3040. Expression and regulation of CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2ฮฒ in developing and mature mouse skeletal muscle
  3041. CORTICOTROPIN โ€“RELEASING FACTOR family and its receptors: pro-inflammatory or anti-inflammatory targets in the periphery?
  3042. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the developing mouse forebrain: a novel sex difference revealed in the rostral periventricular hypothalamus
  3043. Expression and Functional Characterization of Membrane-Integrated Mammalian CORTICOTROPIN RELEASING FACTOR Receptors 1 and 2 in Escherichia coli
  3044. Corticosterone and CORTICOTROPIN โ€RELEASING FACTOR acutely facilitate gamma oscillations in the hippocampus in vitro
  3045. The blockade of CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor attenuates anxiety-related symptoms and hypothalamusโ€“pituitaryโ€“adrenal axis reactivity in mice with mild โ€ฆ
  3046. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of CORTICOTROPIN โ€“RELEASING FACTOR and cocaine withdrawal
  3047. Endothelin-converting enzyme-1 actions determine differential trafficking and signaling of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 at high agonist concentrations
  3048. Differential effect of amphetamine over the CORTICOTROPIN โ€“RELEASING FACTOR CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex
  3049. Synthesis and evaluation of candidate PET radioligands for CORTICOTROPIN โ€“RELEASING FACTOR type-1 receptors
  3050. CORTICOTROPIN โ€“RELEASING FACTOR and toll-like receptor gene expression is associated with low-grade inflammation in irritable bowel syndrome patients with โ€ฆ
  3051. Amygdaloid CORTICOTROPIN โ€“RELEASING FACTOR is involved in the anxiolytic effect of acupuncture during ethanol withdrawal in rats
  3052. The central amygdala nucleus via CORTICOTROPIN โ€“RELEASING FACTOR is necessary for time-limited consolidation processing but not storage of contextual fear memory
  3053. CORTICOTROPIN RELEASING FACTOR type 1 and 2 receptor signaling in the medial prefrontal cortex modulates Binge-like ethanol consumption in C57BL/6J mice
  3054. Residues remote from the binding pocket control the antagonist selectivity towards the CORTICOTROPIN โ€“RELEASING FACTOR receptor-1
  3055. Peripheral CORTICOTROPIN โ€“RELEASING FACTOR triggers jejunal mast cell activation and abdominal pain in patients with diarrhea-predominant irritable bowel syndrome
  3056. Teneurin C-terminal associated peptides (TCAP): modulators of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) physiology and behavior
  3057. Vagus nerve stimulation suppresses CORTICOTROPIN โ€“RELEASING FACTOR -induced adrenocorticotropic hormone release in rats
  3058. Pharmacophore Modelling and 3D-QSAR Studies on N๐Ÿ‘-Phenylpyrazinones as CORTICOTROPIN โ€“RELEASING FACTOR 1 Receptor Antagonists
  3059. Ovarian hormones influence CORTICOTROPIN RELEASING FACTOR receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites
  3060. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR receptors type 2, located in periaquaductal gray matter, in central and peripheral CRF-induced analgesic effect on โ€ฆ
  3061. Role of CORTICOTROPIN โ€“RELEASING FACTOR and corticosterone in behavioral sensitization to ethanol
  3062. CORTICOTROPIN โ€“RELEASING FACTOR neurons in the bed nucleus of the stria terminalis exhibit sex-specific pain encoding in mice
  3063. Overexpression of CORTICOTROPIN RELEASING FACTOR in the central nucleus of the amygdala advances puberty and disrupts reproductive cycles in female rats
  3064. Imaging CORTICOTROPIN โ€“RELEASING โ€“FACTOR and nociceptin in addiction and PTSD models
  3065. Expression of genes encoding cytokines and CORTICOTROPIN RELEASING FACTOR are altered by citalopram in the hypothalamus of post-stroke depression rats
  3066. Abandoned prairie vole mothers show normal maternal care but altered emotionality: Potential influence of the brain CORTICOTROPIN โ€“RELEASING FACTOR system
  3067. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in CORTICOTROPIN RELEASING FACTOR overexpressing male and female mice
  3068. Delta opioid receptors colocalize with CORTICOTROPIN RELEASING FACTOR in hippocampal interneurons
  3069. CORTICOTROPIN RELEASING FACTOR doseโ€dependently modulates excitatory synaptic transmission in the noradrenergic nucleus locus coeruleus
  3070. CORTICOTROPIN โ€“RELEASING FACTOR modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the โ€ฆ
  3071. Increased protein and mRNA expression of CORTICOTROPIN โ€“RELEASING FACTOR (CRF), decreased CRF receptors and CRF binding protein in specific postmortem brain areas โ€ฆ
  3072. CORTICOTROPIN โ€“RELEASING FACTOR mediates pain-induced anxiety through the ERK1/2 signaling cascade in locus coeruleus neurons
  3073. Production of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine
  3074. The brain oxytocin and CORTICOTROPIN โ€“RELEASING FACTOR systems in grieving mothers: What we know and what we need to learn
  3075. Ghrelin stimulates CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin gene expression in rat hypothalamic 4B cells
  3076. CORTICOTROPIN โ€“RELEASING FACTOR and ingestive behaviors
  3077. โ€ฆ behavior in juvenile and adult rats are associated with monoaminergic neurotransmission and with the expression of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the โ€ฆ
  3078. Age-related changes in central effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) suggest a role for this mediator in aging anorexia and cachexia
  3079. Teneurin Cโ€terminal associated peptideโ€1 blocks the effects of CORTICOTROPIN โ€RELEASING FACTOR on reinstatement of cocaine seeking and on cocaineโ€induced โ€ฆ
  3080. The role of peripheral CORTICOTROPIN โ€“RELEASING FACTOR signaling in a rat model of stress-induced gastric hyperalgesia
  3081. CORTICOTROPIN โ€RELEASING FACTOR infusion into nucleus incertus suppresses medial prefrontal cortical activity and hippocampoโ€medial prefrontal cortical longโ€term โ€ฆ
  3082. Effects of voluntary alcohol drinking on CORTICOTROPIN โ€“RELEASING FACTOR and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats
  3083. Stress differentially regulates brain expression of CORTICOTROPIN โ€“RELEASING FACTOR in binge-like eating prone and resistant female rats
  3084. Peripheral CORTICOTROPIN RELEASING FACTOR signaling inhibits gastric emptying: mechanisms of action and role in stress-related gastric alterations of motor function
  3085. CORTICOTROPIN โ€“RELEASING FACTOR -producing cells in the paraventricular nucleus of the hypothalamus and extended amygdala show age-dependent FOS and โ€ฆ
  3086. Dissection of CORTICOTROPIN โ€RELEASING FACTOR system involvement in locomotor sensitivity to methamphetamine
  3087. Differential activation of neuronal cell types in the basolateral amygdala by CORTICOTROPIN RELEASING FACTOR
  3088. CORTICOTROPIN โ€“RELEASING FACTOR increases ascending colon volume after a fructose test meal in healthy humans: a randomized controlled trial
  3089. A medial prefrontal cortex-nucleus acumens CORTICOTROPIN โ€“RELEASING FACTOR circuitry for neuropathic pain-increased susceptibility to opioid reward
  3090. Overexpression of CORTICOTROPIN โ€“RELEASING FACTOR in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel โ€ฆ
  3091. Distribution of CORTICOTROPIN โ€RELEASING FACTOR (CRF) receptor binding in the mouse brain using a new, highโ€affinity radioligand, [125I]โ€PDโ€Sauvagine
  3092. CORTICOTROPIN โ€“RELEASING FACTOR binding protein enters the regulated secretory pathway in neuroendocrine cells and cortical neurons
  3093. CORTICOTROPIN โ€“RELEASING FACTOR in the rat dorsal raphe nucleus promotes different forms of behavioral flexibility depending on social stress history
  3094. Modulation of neuroplastic changes and CORTICOTROPIN โ€“RELEASING FACTOR -associated behavior by a phylogenetically ancient and conserved peptide family
  3095. The CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive โ€ฆ
  3096. Design and synthesis of benzimidazoles as novel CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists
  3097. Biochemical and functional analysis of CORTICOTROPIN RELEASING FACTOR purified from an aqueous extract of human placenta used as wound healer
  3098. Structural-functional analysis of the third transmembrane domain of the CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor: role in activation and allosteric antagonism
  3099. CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference
  3100. โ€ฆ administrations of teneurin-C terminal associated peptide (TCAP)-1 attenuates reinstatement of cocaine seeking by CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in rats
  3101. Prolonged chronic ethanol exposure alters neuropeptide Y and CORTICOTROPIN โ€“RELEASING FACTOR levels in the brain of adult Wistar rats
  3102. Using high resolution imaging to determine trafficking of CORTICOTROPIN โ€“RELEASING FACTOR receptors in noradrenergic neurons of the rat locus coeruleus
  3103. CORTICOTROPIN โ€“RELEASING FACTOR protects against ammonia neurotoxicity in isolated larval zebrafish brains
  3104. Antidepressive effect of sodium valproate involving suppression of CORTICOTROPIN โ€“RELEASING FACTOR expression and elevation of BDNF expression in rats exposed to โ€ฆ
  3105. CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 modulates biomarkers of DNA oxidation in Alzheimerโ€™s disease mice
  3106. Reinstatement of cocaine seeking in rats by the pharmacological stressors, CORTICOTROPIN โ€“RELEASING FACTOR and yohimbine: role for D1/5 dopamine receptors
  3107. Impact of gender on CORTICOTROPIN โ€RELEASING FACTOR and noradrenergic sensitivity in cocaine use disorder
  3108. Hypothalamic Regulation of CORTICOTROPIN โ€“RELEASING FACTOR under Stress and Stress Resilience
  3109. CORTICOTROPIN RELEASING FACTOR type-1 receptor antagonism in the dorsolateral bed nucleus of the stria terminalis disrupts contextually conditioned fear, but not โ€ฆ
  3110. Suppression of piriform cortex activity in rat by CORTICOTROPIN โ€“RELEASING FACTOR 1 and serotonin 2A/C receptors
  3111. Effect of Central CORTICOTROPIN โ€“RELEASING FACTOR on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats
  3112. Antagonizing CORTICOTROPIN โ€“RELEASING FACTOR in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing
  3113. Activation of CORTICOTROPIN RELEASING FACTOR receptor type 2 in the heart by CORTICOTROPIN RELEASING FACTOR offers cytoprotection against ischemic injury via PKA and PKC โ€ฆ
  3114. CORTICOTROPIN โ€“RELEASING FACTOR mediates bone cancer induced pain through neuronal activation in rat spinal cord
  3115. โ€ฆ effects of urocortin1 against intracerebral hemorrhage by activating JNK1/2 and p38 phosphorylation and further increasing VEGF via CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  3116. Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)
  3117. CORTICOTROPIN โ€“RELEASING FACTOR overexpression in mice abrogates sex differences in body weight, visceral fat, and food intake response to a fast and alters โ€ฆ
  3118. Inhibitory effect of CORTICOTROPIN โ€“RELEASING FACTOR on food intake in the bullfrog, Aquarana catesbeiana
  3119. โ€ฆ area or intracerebroventricular orexinโ€A increases the intraโ€cranial selfโ€stimulation threshold via activation of the CORTICOTROPIN โ€RELEASING FACTOR system in rats
  3120. CORTICOTROPIN โ€“RELEASING FACTOR in the hippocampus: eustress or distress?
  3121. Central urocortin 3 and type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor in the regulation of energy homeostasis: critical involvement of the ventromedial โ€ฆ
  3122. Distribution of CORTICOTROPIN โ€“RELEASING FACTOR in the tree shrew brain
  3123. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and CORTICOTROPIN RELEASING FACTOR
  3124. Alterations in CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 in the preoptic area and hypothalamus in mice during the postpartum period
  3125. CORTICOTROPIN โ€“RELEASING FACTOR and urocortin regulate spine and synapse formation: structural basis for stress-induced neuronal remodeling and pathology
  3126. Peripheral CORTICOTROPIN โ€RELEASING FACTOR (CRF) induces stimulation of gastric contractions in freely moving conscious rats: role of CRF receptor types 1 and 2
  3127. Methylation Status of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptor Genes in Colorectal Cancer
  3128. Crowding stress inhibits serotonin 1A receptor-mediated increases in CORTICOTROPIN โ€“RELEASING FACTOR mRNA expression and adrenoCORTICOTROPIN hormone secretion in โ€ฆ
  3129. Computational investigation of binding mechanism of substituted pyrazinones targeting CORTICOTROPIN RELEASING FACTOR -1 receptor deliberated for anti-depressant drug โ€ฆ
  3130. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in the rat central nervous system: autoradiographic localization studies
  3131. CB1 receptors in CORTICOTROPIN โ€RELEASING FACTOR neurons selectively control the acoustic startle response in male mice
  3132. Early Life Stress Associated With Increased Striatal N-Acetyl-Aspartate: Cerebrospinal Fluid CORTICOTROPIN โ€“RELEASING FACTOR Concentrations, Hippocampal Volume โ€ฆ
  3133. CORTICOTROPIN โ€“RELEASING FACTOR regulates caspase-3 and may protect developing zebrafish from stress-induced apoptosis
  3134. Increased anxiety in CORTICOTROPIN โ€“RELEASING FACTOR type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated โ€ฆ
  3135. Stress and CORTICOTROPIN RELEASING FACTOR (CRF) promote necrotizing enterocolitis in a formula-fed neonatal rat model
  3136. Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing CORTICOTROPIN โ€“RELEASING FACTOR type 1 receptor following slow-pressor โ€ฆ
  3137. Brain CORTICOTROPIN โ€RELEASING FACTOR signaling: Involvement in acute stressโ€induced visceral analgesia in male rats
  3138. L-ornithine attenuates CORTICOTROPIN โ€“RELEASING FACTOR -induced stress responses acting at GABAA receptors in neonatal chicks
  3139. Behavioral effects of peripheral CORTICOTROPIN โ€“RELEASING FACTOR during maternal separation may be mediated by proinflammatory activity
  3140. The mouse cochlea expresses a local hypothalamic-pituitary-adrenal equivalent signaling system and requires CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 to establish โ€ฆ
  3141. The CORTICOTROPIN RELEASING FACTOR system in the kidney: perspectives for novel therapeutic intervention in nephrology
  3142. A CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonist improves urodynamic dysfunction produced by social stress or partial bladder outlet obstruction in male rats
  3143. Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of CORTICOTROPIN RELEASING FACTOR receptors
  3144. The expression of CORTICOTROPIN โ€“RELEASING FACTOR and its receptors in the spinal cord and dorsal root ganglion in a rat model of neuropathic pain
  3145. โ€ฆ mechanism of neuropeptide S-induced satiety in Japanese quail (Coturnix japonica) involves the paraventricular nucleus and CORTICOTROPIN โ€“RELEASING FACTOR
  3146. The CORTICOTROPIN โ€“RELEASING FACTOR receptor-2 mediates the motivational effect of opiate withdrawal
  3147. CORTICOTROPIN โ€RELEASING FACTOR receptor 2โ€deficiency eliminates social behaviour deficits and vulnerability induced by cocaine
  3148. CORTICOTROPIN โ€“RELEASING FACTOR enhances inhibitory synaptic transmission to type III neurons in the bed nucleus of the stria terminalis
  3149. Repeated binge ethanol drinking enhances electrical activity of central amygdala CORTICOTROPIN RELEASING FACTOR neurons in vivo
  3150. Isolation and characterization of the CORTICOTROPIN โ€“RELEASING FACTOR -related diuretic hormone receptor in Rhodnius prolixus
  3151. CORTICOTROPIN โ€“RELEASING FACTOR : innocent until proven guilty
  3152. CORTICOTROPIN โ€“RELEASING FACTOR Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure
  3153. CORTICOTROPIN โ€“RELEASING FACTOR secretion from dendritic cells stimulated by commensal bacteria
  3154. Electrophysiology of CORTICOTROPIN โ€“RELEASING FACTOR in nervous tissue
  3155. Potential regulatory effects of CORTICOTROPIN โ€“RELEASING FACTOR on tight junction-related intestinal epithelial permeability are partially mediated by CK8 upregulation
  3156. Activation of adenylate cyclaseโ€cyclic AMPโ€protein kinase A signaling by CORTICOTROPIN โ€RELEASING FACTOR within the dorsolateral bed nucleus of the stria terminalis is โ€ฆ
  3157. In silico binding mechanism prediction of benzimidazole based CORTICOTROPIN RELEASING FACTOR -1 receptor antagonists by quantitative structure activity relationship โ€ฆ
  3158. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral CORTICOTROPIN โ€“RELEASING FACTOR in rats
  3159. Cannabinoid CB1 receptors mediate the effects of CORTICOTROPIN โ€RELEASING FACTOR on the reinstatement of cocaine seeking and expression of cocaineโ€induced โ€ฆ
  3160. Microinjection of different doses of CORTICOTROPIN โ€“RELEASING FACTOR into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats
  3161. Pharmacotherapy in smoking cessation: CORTICOTROPIN RELEASING FACTOR receptors as emerging intervention targets
  3162. Regulation of adrenocorticotropic hormone (ACTH) secretion by CORTICOTROPIN โ€“RELEASING FACTOR (CRF)
  3163. CORTICOTROPIN RELEASING FACTOR Receptors in breast cancer: Expression and activity in hormone-dependent growth in vitro
  3164. โ€ฆ Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and CORTICOTROPIN RELEASING FACTOR mRNA levels in the โ€ฆ
  3165. Brainโ€derived neurotrophic FACTOR , CORTICOTROPIN โ€RELEASING FACTOR , and hypothalamic neuronal histamine interact to regulate feeding behavior
  3166. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptors from the basolateral or central amygdala increases the tonic immobility response in guinea pigs: an innate fear โ€ฆ
  3167. Effect of lamotrigine and carbamazepine on CORTICOTROPIN โ€“RELEASING FACTOR -associated serotonergic transmission in rat dorsal raphe nucleus
  3168. Effects of chronic noise on the CORTICOTROPIN โ€“RELEASING FACTOR system in the rat hippocampus: relevance to Alzheimerโ€™s disease-like tau hyperphosphorylation
  3169. Changes in CORTICOTROPIN RELEASING FACTOR system transcript levels in relation to feeding condition in Acipenser dabryanus
  3170. FACTOR s of sex and age dictate the regulation of GABAergic activity by CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the medial sub-nucleus of the central amygdala
  3171. Targeting CORTICOTROPIN โ€“RELEASING FACTOR (CRF) projections from the oval nucleus of the BNST using cell-type specific neuronal tracing studies in mouse and rat โ€ฆ
  3172. Exposure of male mice to perfluorooctanoic acid induces anxiety-like behaviors by increasing CORTICOTROPIN โ€“RELEASING FACTOR in the basolateral amygdala complex
  3173. CORTICOTROPIN โ€“RELEASING FACTOR : An ancient peptide family related to the Secretin peptide superfamily
  3174. Roles of CORTICOTROPIN โ€“RELEASING FACTOR signaling in the lateral habenula in anxiety-like and alcohol drinking behaviors in male rats
  3175. CORTICOTROPIN RELEASING FACTOR and norepinephrine related circuitry changes in the bed nucleus of the stria terminalis in stress and alcohol and substance use disorders
  3176. Inhibitory effect of ramosetron on CORTICOTROPIN RELEASING FACTOR โ€and soybean oilโ€induced delays in gastric emptying in rats
  3177. Multi-facets of CORTICOTROPIN โ€“RELEASING FACTOR in modulating inflammation and angiogenesis
  3178. [76Br]BMKโ€152, a nonpeptide analogue, with high affinity and low nonspecific binding for the CORTICOTROPIN โ€RELEASING FACTOR type 1 receptor
  3179. Contribution of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (CRF1) to serotonin receptor 5-HT2CR function in amygdala neurons in a neuropathic pain model
  3180. CORTICOTROPIN โ€“RELEASING FACTOR increases Purkinje neuron excitability by modulating sodium, potassium, and Ih currents
  3181. Hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR is centrally involved in learning under moderate stress
  3182. Roles for CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 in energy homeostasis in mice
  3183. Contrasting effects of nitric oxide and CORTICOTROPIN โ€“RELEASING FACTOR within the dorsal periaqueductal gray on defensive behavior and nociception in mice
  3184. CORTICOTROPIN RELEASING FACTOR -overexpressing mouse is a model of chronic stress-induced muscle atrophy
  3185. Effects of CORTICOTROPIN RELEASING FACTOR (CRF) on sleep and temperature following predictable controllable and uncontrollable stress in mice
  3186. Reduction of ethanol intake by CORTICOTROPIN โ€“RELEASING FACTOR receptor-1 antagonist in โ€œheavy-drinkingโ€ mice in a free-choice paradigm
  3187. Basolateral amygdala CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 regulates context-cocaine memory strength during reconsolidation in a sex-dependent manner
  3188. Water avoidance stress induces visceral hyposensitivity through peripheral CORTICOTROPIN RELEASING FACTOR receptor type 2 and central dopamine D2 receptor in rats
  3189. Behavioral and physiological responses to central administration of CORTICOTROPIN โ€“RELEASING FACTOR in the bluebanded goby (Lythrypnus dalli)
  3190. Abnormalities in CORTICOTROPIN โ€“RELEASING FACTOR (CRF) in neurodegenerative diseases
  3191. Spexin as an anxiety regulator in mouse hippocampus: Mechanisms for transcriptional regulation of spexin gene expression by CORTICOTROPIN RELEASING FACTOR
  3192. Co-localization of the cannabinoid type 1 receptor with CORTICOTROPIN โ€“RELEASING FACTOR -containing afferents in the noradrenergic nucleus locus coeruleus โ€ฆ
  3193. Neuropeptide S Increases locomotion activity through CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in substantia nigra of mice
  3194. Ethanol produces CORTICOTROPIN โ€RELEASING FACTOR receptorโ€dependent enhancement of spontaneous glutamatergic transmission in the mouse central amygdala
  3195. The CORTICOTROPIN RELEASING FACTOR binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system?
  3196. High-altitude hypoxia induces disorders of the brain-endocrine-immune network through activation of CORTICOTROPIN โ€“RELEASING FACTOR and its type-1 receptors
  3197. Dopamine D2 receptor desensitization by dopamine or CORTICOTROPIN RELEASING FACTOR in ventral tegmental area neurons is associated with increased glutamate release
  3198. CORTICOTROPIN โ€RELEASING FACTOR and urocortin I activate CREB through functionally selective Gฮฒฮณ signaling in hippocampal pyramidal neurons
  3199. Differential regulation of gonadotropin-RELEASING hormone by CORTICOTROPIN โ€“RELEASING FACTOR family peptides in hypothalamic N39 cells
  3200. Prefrontal CORTICOTROPIN โ€RELEASING FACTOR neurons impair sustained attention via distal transmitter release
  3201. The effect of short moderate stress on the midbrain CORTICOTROPIN โ€“RELEASING FACTOR system in a macaque model of functional hypothalamic amenorrhea
  3202. CORTICOTROPIN โ€“RELEASING FACTOR and catecholamines: a study on their role in stress-induced immunomodulation
  3203. CORTICOTROPIN RELEASING FACTOR receptor 1 antagonist differentially inhibits freezing behavior and changes gamma-aminobutyric acidergic activity in the amygdala โ€ฆ
  3204. Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in CORTICOTROPIN โ€“RELEASING FACTOR -induced sympatho-adrenomedullary outflow in โ€ฆ
  3205. Antagonism of CORTICOTROPIN RELEASING FACTOR in the basolateral amygdala of resilient and vulnerable rats: Effects on fear-conditioned sleep, temperature and freezing
  3206. Selective CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist E2508 reduces restraint stress-induced defecation and visceral pain in rat models
  3207. Serotonin mediated changes in CORTICOTROPIN RELEASING FACTOR mRNA expression and feeding behavior isolated to the hypothalamic paraventricular nuclei
  3208. Role of CORTICOTROPIN RELEASING FACTOR 1 signaling in cocaine seeking during early extinction in female and male rats
  3209. โ€ฆ AND THE STRESS RESPONSE: FROMโ€ THE FIRST MEDIATORโ€ TO THE IDENTIFICATION OF THE HYPOTHALAMIC CORTICOTROPIN โ€“RELEASING FACTOR .
  3210. Action of glucagon-like peptide 1 and glucose levels on CORTICOTROPIN โ€“RELEASING FACTOR and vasopressin gene expression in rat hypothalamic 4B cells
  3211. (3ฮฑ, 5ฮฑ) 3-hydroxypregnan-20-one (3ฮฑ, 5ฮฑ-THP) regulation of hypothalamic and extrahypothalamic CORTICOTROPIN RELEASING FACTOR (CRF): Sexual dimorphism and brain โ€ฆ
  3212. Synthesis and Structureโ€“Activity Relationships of Pyrazolo[1,5-a]pyridine Derivatives: Potent and Orally Active Antagonists of CORTICOTROPIN โ€“RELEASING FACTOR 1 โ€ฆ
  3213. Relevance of both type-1 and type-2 CORTICOTROPIN RELEASING FACTOR receptors in stress-induced relapse to cocaine seeking behaviour
  3214. Dissociation of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine
  3215. 6, 7-Dihydro-5H-cyclopenta [d] pyrazolo [1, 5-a] pyrimidines and their derivatives as novel CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists
  3216. CORTICOTROPIN โ€“RELEASING FACTOR augments LPS-induced immune/inflammatory responses in JAWSII cells
  3217. The stress response in Atlantic salmon (Salmo salar L.): identification and functional characterization of the CORTICOTROPIN โ€“RELEASING FACTOR (crf) paralogs
  3218. Amygdalar CORTICOTROPIN โ€“RELEASING FACTOR Signaling Is Required for Later-Life Behavioral Dysfunction Following Neonatal Pain
  3219. CORTICOTROPIN โ€“RELEASING FACTOR Facilitates Epileptiform Activity in the Entorhinal Cortex: Roles of CRF2 Receptors and PKA Pathway
  3220. Interactions between CORTICOTROPIN โ€“RELEASING FACTOR and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in โ€ฆ
  3221. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress โ€ฆ
  3222. CORTICOTROPIN RELEASING FACTOR -1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1ฮฒ administration
  3223. Knockdown of CORTICOTROPIN โ€“RELEASING FACTOR 1 receptors in the ventral tegmental area enhances conditioned fear
  3224. Peripheral Guanylate Cyclaseโ€C modulation of corticolimbic activation and CORTICOTROPIN โ€RELEASING FACTOR signaling in a rat model of stressโ€induced colonic โ€ฆ
  3225. Distribution of type I CORTICOTROPIN โ€RELEASING FACTOR (CRF1) receptors on GABAergic neurons within the basolateral amygdala
  3226. MicroRNA-34 contributes to the stress-related behavior and affects 5-HT prefrontal/GABA amygdalar system through regulation of CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  3227. Effects of CORTICOTROPIN RELEASING FACTOR (CRF) on sleep and body temperature following controllable footshock stress in mice
  3228. CORTICOTROPIN โ€RELEASING FACTOR (CRF) receptorโ€1 is involved in cardiac noradrenergic activity observed during naloxoneโ€precipitated morphine withdrawal
  3229. CORTICOTROPIN RELEASING FACTOR excites neurons of posterior hypothalamic nucleus to produce tachycardia in rats
  3230. Ghrelin, via CORTICOTROPIN โ€RELEASING FACTOR receptors, reduces glucose uptake and increases lipid content in mouse myoblasts cells
  3231. Immunolocalization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CORTICOTROPIN โ€“RELEASING FACTOR receptor 2 (CRF-R2) in the developing gut of the sea bass (Dicentrarchus โ€ฆ
  3232. CORTICOTROPIN โ€“RELEASING FACTOR from rodents to primates: translational hope expresses itself, pun intended
  3233. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 (CRF-R1) antagonists: promising agents to prevent visceral hypersensitivity in irritable bowel syndrome
  3234. An insight into antagonist binding and induced conformational dynamics of class B GPCR CORTICOTROPIN โ€“RELEASING FACTOR receptor 1
  3235. Quantum Chemical Study of the Relationships between Electronic Structure and CORTICOTROPIN โ€“RELEASING FACTOR 1 Receptor Binding Inhibition by a Group of โ€ฆ
  3236. Assessment of serum level of CORTICOTROPIN โ€“RELEASING FACTOR in primary nocturnal enuresis
  3237. Cell type-specific modifications of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating
  3238. Acute central effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on energy balance: Effects of age and gender
  3239. Regulation of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells
  3240. Involvement of CORTICOTROPIN โ€“RELEASING FACTOR and CORTICOTROPIN โ€“RELEASING FACTOR 2 receptors in pathogenesis of ischemia/reperfusion-induced enteritis in rats
  3241. CORTICOTROPIN โ€“RELEASING FACTOR : cerebrospinal fluid studies
  3242. Acute ether stress differentially affects CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 1 in the Brattleboro rat
  3243. The peripheral CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-induced analgesic effect on somatic pain sensitivity in conscious rats: Involving CRF, opioid and glucocorticoid โ€ฆ
  3244. Inhibitory CORTICOTROPIN โ€“RELEASING FACTOR neurons in the dorsomedial prefrontal cortex promote stress-resilient behavior in male rodents
  3245. โ€ฆ Properties and Pharmacological Evaluation of Novel & Potent Thiazolo [4, 5-d] pyrimidine CORTICOTROPIN RELEASING FACTOR (CRF) Receptor Antagonists
  3246. MAGI proteins regulate the trafficking and signaling of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 via a compensatory mechanism
  3247. Blockade of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the central amygdala prevents cocaine-seeking behaviour induced by orexin-A administered to the โ€ฆ
  3248. Repeated water avoidance stress induces visceral hypersensitivity; role of IL-1, IL-6 and peripheral CORTICOTROPIN โ€“RELEASING FACTOR .
  3249. CORTICOTROPIN โ€RELEASING FACTOR induces inflammatory cytokines via the NLRP6โ€inflammatory cytokine axis in a murine model of irritable bowel syndrome
  3250. CORTICOTROPIN โ€“RELEASING FACTOR receptor type 1 colocalizes with type 2 in CORTICOTROPIN โ€“RELEASING FACTOR -containing cellular profiles in rat brain
  3251. CORTICOTROPIN โ€“RELEASING FACTOR depolarizes rat lateral vestibular nuclear neurons through activation of CRF receptors 1 and 2
  3252. CORTICOTROPIN โ€“RELEASING FACTOR Receptor-1 antagonism reduces oxidative damage in an Alzheimerโ€™s disease transgenic mouse model
  3253. The calcineurinโ€”nuclear FACTOR of activated T cells signaling pathway mediates the effect of CORTICOTROPIN RELEASING FACTOR and urocortins on catecholamine synthesis
  3254. Effects of CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonism on the hypothalamic-pituitary-adrenal axis of rodents
  3255. CORTICOTROPIN RELEASING FACTOR upโ€regulates the expression and function of norepinephrine transporter in SKโ€Nโ€BE (2) M17 cells
  3256. CORTICOTROPIN RELEASING FACTOR (CRF) and obesity
  3257. CORTICOTROPIN โ€“RELEASING FACTOR antagonist reduces activation of noradrenalin and serotonin neurons in the locus coeruleus and dorsal raphe in the arousal response โ€ฆ
  3258. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 activation during exposure to novelty stress protects against Alzheimerโ€™s disease-like cognitive decline in AฮฒPP/PS1 mice
  3259. CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 in the anterior cingulate cortex mediates maternal absence-induced attenuation of transport response in mouse pups
  3260. Role of cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) in regulating the trafficking and signaling of CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  3261. Love it or Leave it: Differential Modulation of Incentive Motivation by CORTICOTROPIN โ€“RELEASING FACTOR Neurons
  3262. Synthesis of substituted pyrimidines as CORTICOTROPIN RELEASING FACTOR (CRF) receptor ligands
  3263. Stimulation of CORTICOTROPIN โ€“RELEASING FACTOR gene expression by FosB in rat hypothalamic 4B cells
  3264. Cellular signaling protective against noise-induced hearing lossโ€“A role for novel intrinsic cochlear signaling involving CORTICOTROPIN โ€“RELEASING FACTOR ?
  3265. In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonist
  3266. Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral CORTICOTROPIN โ€“RELEASING FACTOR and interleukin-1 in rats
  3267. CORTICOTROPIN โ€“RELEASING FACTOR neurons in the bed nucleus of the stria terminalis differentially influence pain processing and modulation in male and female mice
  3268. Nicotine, CORTICOTROPIN โ€“RELEASING FACTOR , and Anxiety-Like Behavior
  3269. Age-dependent changes in the mRNA levels of neuropeptide Y, proopiomelanocortin, and CORTICOTROPIN โ€“RELEASING FACTOR in the hypothalamus in growing broiler chicks
  3270. Chronic traumatic stress impairs memory in mice: potential roles of acetylcholine, neuroinflammation and CORTICOTROPIN RELEASING FACTOR expression in the hippocampus
  3271. CORTICOTROPIN โ€“RELEASING FACTOR is present in intestinal tissue of patients with gastrointestinal dysfunction following shock and abdominal surgery
  3272. Expression of mRNAs of urocortin and CORTICOTROPIN โ€“RELEASING FACTOR receptors in malignant glioma cell lines
  3273. CORTICOTROPIN โ€“RELEASING FACTOR receptor type-2 is involved in the cocaine-primed reinstatement of cocaine conditioned place preference in rats
  3274. CORTICOTROPIN RELEASING FACTOR (CRF) in the hippocampus of the mouse pilocarpine model of status epilepticus
  3275. Assessment of serum levels of copeptin and CORTICOTROPIN โ€“RELEASING FACTOR in children with monosymptomatic and non-monosymptomatic nocturnal enuresis
  3276. Prostaglandin E2 receptor EP3 subtype in the paraventricular hypothalamic nucleus mediates CORTICOTROPIN โ€“RELEASING FACTOR -induced elevation of plasma โ€ฆ
  3277. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in brain: characterization and regulation studies
  3278. Regulation of the expression of CORTICOTROPIN โ€“RELEASING FACTOR gene by pyroglutamylated RFamide peptide in rat hypothalamic 4B cells
  3279. Functional significance of the signal peptides of CORTICOTROPIN โ€“RELEASING FACTOR receptors
  3280. Characterization of second messengers coupled to CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptors in brain
  3281. Chiral separation of potent CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonists by supercritical fluid chromatography
  3282. The effects of CORTICOTROPIN โ€“RELEASING FACTOR and the urocortins on hypothalamic gamma-amino butyric acid releaseโ€“The impacts on the hypothalamicโ€“pituitaryโ€“adrenal โ€ฆ
  3283. Expression of CORTICOTROPIN โ€“RELEASING FACTOR and urocortins in the normal and Schistosoma mansoni-infected mouse ileum
  3284. Lifelong, central CORTICOTROPIN โ€“RELEASING FACTOR (CRF) overexpression is associated with individual differences in cocaine-induced conditioned place preference
  3285. CORTICOTROPIN RELEASING FACTOR modulates excitatory synaptic transmission
  3286. The use of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) as a marker of agonic stress in abused dogs: Preliminary results
  3287. The activation of type 1 CORTICOTROPIN RELEASING FACTOR receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 โ€ฆ
  3288. Mechanisms of the analgesic effect of CORTICOTROPIN โ€“RELEASING FACTOR in conscious rats
  3289. Characterization of multisubstituted CORTICOTROPIN RELEASING FACTOR (CRF) peptide antagonists (astressins)
  3290. CORTICOTROPIN โ€“RELEASING FACTOR changes the phenotype and function of dendritic cells in mouse mesenteric lymph nodes
  3291. Selective CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonist E2508 has potent antidepressant-like and anxiolytic-like properties in rodent models
  3292. Cannabinoid CB1 receptor restrains accentuated activity of hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR and brainstem tyrosine hydroxylase neurons in endotoxemia โ€ฆ
  3293. Regulation of Cued Fear Expression via CORTICOTROPIN โ€“RELEASING โ€“FACTOR Neurons in the Ventral Anteromedial Thalamic Nucleus
  3294. Expression and actions of CORTICOTROPIN โ€“RELEASING FACTOR /diuretic hormone-like peptide (CDLP) and teneurin C-terminal associated peptide (TCAP) in the vase tunicate โ€ฆ
  3295. Energy metabolism and behavior in the CORTICOTROPIN โ€“RELEASING FACTOR family of peptides
  3296. Sex differences in morphine-induced trafficking of mu-opioid and CORTICOTROPIN โ€“RELEASING FACTOR receptors in locus coeruleus neurons
  3297. Neuropathic pain and the brain. Differential involvement of CORTICOTROPIN โ€“RELEASING FACTOR and urocortin 1 in acute and chronic pain processing
  3298. โ€ฆ , and Structureโ€“Activity Relationships of Novel Pyrazolo[5,1-b]thiazole Derivatives as Potent and Orally Active CORTICOTROPIN โ€“RELEASING FACTOR 1 Receptor Antagonists
  3299. Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 test cases
  3300. Toxicity of Pexacerfont, a CORTICOTROPIN โ€“RELEASING FACTOR Type 1 Receptor Antagonist, in Rats and Dogs
  3301. Effect of CORTICOTROPIN โ€RELEASING FACTOR receptor antagonist on psychologically suppressed masculine sexual behavior in rats
  3302. Valproate improves prepulse inhibition deficits induced by CORTICOTROPIN โ€“RELEASING FACTOR independent of GABAA and GABAB receptor activation
  3303. Effects of voluntary running in the female mice lateral septum on BDNF and CORTICOTROPIN โ€“RELEASING FACTOR receptor 2
  3304. Cytokines, but not CORTICOTROPIN โ€“RELEASING FACTOR and endothelin-1, participate centrally in the febrile response in zymosan-induced arthritis in rats
  3305. Pharmacological evaluation of a novel CORTICOTROPIN โ€RELEASING FACTOR 1 receptor antagonist Tโ€3047928 in stressโ€induced animal models in a comparison with โ€ฆ
  3306. Predictive QSAR modeling of substituted Phenylpyrazinones as CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) receptor antagonists: computational approach
  3307. Involvement of Nurr-1/Nur77 in CORTICOTROPIN โ€“RELEASING FACTOR /urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells
  3308. The multi-faceted profile of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) family of neuropeptides and of their receptors on the paracrine/local regulation of the inflammatory โ€ฆ
  3309. The effects of viable and non-viable Lactobacillus gasseri CP2305 cells on colonic ion transport and CORTICOTROPIN RELEASING FACTOR -induced diarrhea
  3310. Repeated norepinephrine receptor stimulation in the BNST induces sensorimotor gating deficits via CORTICOTROPIN RELEASING FACTOR
  3311. The effect of a CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist on the fear conditioning response in low-and high-anxiety rats after chronic corticosterone โ€ฆ
  3312. Peripheral CORTICOTROPIN โ€“RELEASING FACTOR receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats
  3313. Pyrrolo [1, 2-b] pyridazines, pyrrolo [2, 1-f] triazin-4 (3H)-ones, and related compounds as novel CORTICOTROPIN โ€“RELEASING FACTOR 1 (CRF1) receptor antagonists
  3314. Hypothalamic expression of urocortin 3 and the type 2 CORTICOTROPIN โ€“RELEASING FACTOR receptor is regulated according to feeding state in lean but not obese Zucker rats
  3315. CORTICOTROPIN โ€“RELEASING FACTOR induces immune escape of cervical cancer cells by downregulation of NKG2D
  3316. Ultrastructural characterization of CORTICOTROPIN โ€“RELEASING FACTOR and neuropeptide Y in the rat locus coeruleus: anatomical evidence for putative interactions
  3317. The Antagonism of CORTICOTROPIN โ€“RELEASING FACTOR Receptor-1 in Brain Suppress Stress-Induced Propofol Self-Administration in Rats
  3318. CORTICOTROPIN โ€“RELEASING FACTOR suppresses glioma progression by upregulation of long non-coding RNA-p21
  3319. โ€ฆ holocephalans in understanding peptide evolution in the vertebrates: lessons learned from gonadotropin RELEASING hormone (GnRH) and CORTICOTROPIN RELEASING FACTOR โ€ฆ
  3320. Tectal CORTICOTROPIN โ€“RELEASING FACTOR (CRF) neurons respond to fasting and a reactive stressor in the African Clawed Frog, Xenopus laevis
  3321. Neuroplasticity of central CORTICOTROPIN โ€“RELEASING FACTOR and serotonergic systems in anxiety-related behavior
  3322. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) 1 receptor
  3323. PD-sauvagine: a novel sauvagine/CORTICOTROPIN RELEASING FACTOR analogue from the skin secretion of the Mexican giant leaf frog, Pachymedusa dacnicolor
  3324. Effects of CORTICOTROPIN RELEASING FACTOR on spontaneous burst activity in the piriformโ€“amygdala complex of in vitro brain preparations from newborn rats
  3325. Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukinโ€1, interleukinโ€6, and peripheral CORTICOTROPIN โ€RELEASING FACTOR
  3326. Role of Hypothalamic-Pituitary-Adrenal axis and CORTICOTROPIN โ€“RELEASING FACTOR stress system on cue-induced relapse to alcohol seeking
  3327. Early-Life Stress Induced Epigenetic Changes of CORTICOTROPIN โ€“RELEASING FACTOR Gene in Anorexic Low Body Weightโ€“Selected Chicks
  3328. Understanding CORTICOTROPIN RELEASING FACTOR receptor (CRFR) activation using structural models
  3329. Chemogenetic stimulation of mouse central amygdala CORTICOTROPIN โ€“RELEASING FACTOR neurons: Effects on cellular and behavioral correlates of alcohol dependence
  3330. Synthesis and structureโ€“activity relationships of pyrido [3, 2-b] pyrazin-3 (4H)-ones and pteridin-7 (8H)-ones as CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonists
  3331. Synthesis and structureโ€“activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonists
  3332. Enhanced dendritic availability of ฮผโ€opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the CORTICOTROPIN โ€RELEASING FACTOR โ€1 receptor
  3333. ACTH response to desmopressin in a patient with acromegaly; expression of CORTICOTROPIN โ€“RELEASING FACTOR , urocortins and vasopressin V1b receptor in GH-producing โ€ฆ
  3334. 109 Chemogenetic silencing of CORTICOTROPIN RELEASING FACTOR neurons in the paraventricular nucleus: the effect on post-stress sleep
  3335. The effect of antagonizing CORTICOTROPIN RELEASING FACTOR receptor 1/activating CORTICOTROPIN RELEASING FACTOR receptor 2 on visceral sensitivity and colonic motility of โ€ฆ
  3336. Effects of mixture of lycii radicis cortex and moutan cortex on CORTICOTROPIN โ€“RELEASING FACTOR , c-Fos, and tyrosine hydroxylase in forced swimming test
  3337. A possible solution for hair loss by inhibiting CORTICOTROPIN โ€“RELEASING FACTOR (CRF) receptor from traditional Chinese medicine
  3338. Neurobiology of CORTICOTROPIN โ€“RELEASING FACTOR in the enteric nervous system during stress
  3339. Characterization of a Pachymedusa dacnicolorโ€“Sauvagine Analog as a New High-Affinity Radioligand for CORTICOTROPIN โ€“RELEASING FACTOR Receptor Studies
  3340. Galanin is Coโ€Expressed with Substance P, Calbindin and CORTICOTROPIN โ€RELEASING FACTOR (CRF) in The Enteric Nervous System of the Wild Boar (Sus scrofa) Small โ€ฆ
  3341. CORTICOTROPIN โ€“RELEASING FACTOR Receptors in the Locus Coeruleus Modulate the Enhancement of Active Coping Behaviors Induced by Chronic Predator Odor โ€ฆ
  3342. Gastroprotective action of CORTICOTROPIN โ€“RELEASING FACTOR (CRF): involvement of glucocorticoids and CRF receptors type 2
  3343. โ€ฆ ) aniline and its application to the synthesis of BMS-665053, a potent and selective pyrazinone-containing CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonist
  3344. Discovery of pyrrolo [2, 3-d] pyrimidin-4-ones as CORTICOTROPIN โ€“RELEASING FACTOR 1 receptor antagonists with a carbonyl-based hydrogen bonding acceptor
  3345. Synthesis of new thiazolo [4, 5-d] pyrimidines as CORTICOTROPIN RELEASING FACTOR modulators
  3346. Molecular modeling of structures and interaction of human CORTICOTROPIN โ€“RELEASING FACTOR (CRF) binding protein and CRF Type-2 receptor
  3347. Synthesis of 2-imino and 2-hydrazono thiazolo [4, 5-d] pyrimidines as CORTICOTROPIN RELEASING FACTOR (CRF) antagonists
  3348. Activation of CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 aggravates dextran sodium sulphate-induced colitis in mice by promoting M1 macrophage polarization
  3349. Effect of electroacupuncture intervention on expression of pain sensory and affection processing related CORTICOTROPIN โ€“RELEASING FACTOR receptor mRNA, etc. in the โ€ฆ
  3350. CORTICOTROPIN โ€“RELEASING FACTOR may protect the gastric mucosa in stress through involvement of glucocorticoids
  3351. Insular cortex CORTICOTROPIN โ€“RELEASING FACTOR integrates stress signaling with social decision making.
  3352. A complete CORTICOTROPIN RELEASING FACTOR system localized in human fetal lung
  3353. CORTICOTROPIN RELEASING FACTOR receptor expression in painful human dental pulp
  3354. Corticorelin acetate, a synthetic CORTICOTROPIN โ€“RELEASING FACTOR with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models
  3355. CORTICOTROPIN โ€“RELEASING FACTOR stimulates colonic motility via muscarinic receptors in the rat
  3356. Discovery of 1, 2, 3, 4-tetrahydropyrimido [1, 2-a] benzimidazoles as novel class of CORTICOTROPIN RELEASING FACTOR 1 receptor antagonists
  3357. CORTICOTROPIN โ€“RELEASING FACTOR Induces Functional And Structural Synaptic Remodelling In Acute Stress
  3358. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on intermediolateral cell column neurons of newborn rats
  3359. The Implication of the CORTICOTROPIN RELEASING FACTOR in Nicotine Dependence and Significance for Pharmacotherapy in Smoking Cessation
  3360. The tale of a person and a peptide: Wylie W. Vale Jr. and the role of CORTICOTROPIN โ€“RELEASING FACTOR in the stress response
  3361. Cardiovascular functions of central CORTICOTROPIN โ€“RELEASING FACTOR related peptides system
  3362. Suppression of preoptic sleep-regulatory neuronal activity during CORTICOTROPIN โ€“RELEASING FACTOR -induced sleep disturbance
  3363. Influence of adrenalectomy on protective effects of urocortin I, a CORTICOTROPIN โ€“RELEASING FACTOR , against indomethacin-induced enteropathy in rats
  3364. Metyrapone effect on gastroprotective action of CORTICOTROPIN โ€“RELEASING FACTOR administered centrally against indomethacin-induced gastric injury
  3365. Acyloxyacyl Hydrolase Modulates the Gut Microbiome Through Transcriptional Regulators of CORTICOTROPIN โ€“RELEASING FACTOR
  3366. Pituitary adenylate cyclase-activating peptide-27 (PACAP-27) is co-stored with galanin, substance P and CORTICOTROPIN RELEASING FACTOR (CRF) in intrapancreatic ganglia โ€ฆ
  3367. 3D-QSAR studies of 8-substituted-2-aryl-5-alkylaminoquinolines as CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonists
  3368. Development of an aequorin-based assay for the screening of CORTICOTROPIN โ€“RELEASING FACTOR receptor antagonists
  3369. CORTICOTROPIN RELEASING FACTOR (CRF) and its Receptors: From Structure to Function in Health and Disease (Part I)
  3370. Neural circuitry of stress, fear, and anxiety: focus on extended amygdala CORTICOTROPIN โ€“RELEASING FACTOR systems
  3371. R278995/CRA0450, a CORTICOTROPIN โ€“RELEASING FACTOR (CRF1) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication
  3372. โ€ฆ )-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl] amine 59 (NGD 98โˆ’ 2): An Orally Active CORTICOTROPIN RELEASING FACTOR -1 (CRF-1) โ€ฆ
  3373. Depression and immunity: Central CORTICOTROPIN โ€“RELEASING FACTOR activates the autonomic nervous system and reduces natural killer cell activity
  3374. Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as CORTICOTROPIN RELEASING FACTOR -1 (CRF1) receptor antagonists
  3375. CORTICOTROPIN โ€“RELEASING FACTOR reduces tumor volume, halts further growth, and enhances the effect of chemotherapy in 4T1 mammary carcinoma in mice
  3376. โ€ฆ on โ€œSex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleusโ€norepinephrine neurons and CORTICOTROPIN RELEASING FACTOR โ€ฆ
  3377. CORTICOTROPIN โ€“RELEASING FACTOR -like peptide modifies the AMPA-, NMDA-dependent and GABAB-ergic properties of synaptic transmissions in vitro
  3378. Effects of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) on somatic pain sensitivity in conscious rats: Involvement of types 1 and 2 CRF receptors
  3379. Altered responses to cold environment in urocortin 1 and CORTICOTROPIN โ€“RELEASING FACTOR deficient mice
  3380. Components of the CORTICOTROPIN โ€“RELEASING โ€“FACTOR (CRF) Signaling System in Snail Atria
  3381. Comparative molecular similarity indices analysis (CoMSIA) of 8-substituted-2-aryl-5-alkylaminoquinolines as CORTICOTROPIN โ€“RELEASING FACTOR -1 receptor antagonists
  3382. CORTICOTROPIN โ€“RELEASING FACTOR in the locus coeruleus as a modulator of ventilation in rats
  3383. Blast-induced mild traumatic brain injury alterations of CORTICOTROPIN โ€“RELEASING FACTOR neuronal activity in the mouse hypothalamic paraventricular nucleus
  3384. CORTICOTROPIN โ€“RELEASING FACTOR distribution in the brain of the brown anole lizard
  3385. Mast cell-specific receptor/CORTICOTROPIN โ€“RELEASING FACTOR axis regulates alcohol withdrawal-associated headache
  3386. โ€ฆ gray matter of the midbrain in regulation of somatic pain sensitivity during stress: participation of CORTICOTROPIN โ€“RELEASING FACTOR and glucocorticoid hormones
  3387. Anti-ictogenic effects of the CORTICOTROPIN โ€“RELEASING FACTOR -like peptide in the pentylenetetrazole model of seizure in brain slices
  3388. 0005 The Effect Of Chemogenetic Silencing Of CORTICOTROPIN RELEASING FACTOR Neurons In The Paraventricular Nucleus On Post-stress Sleep In Mice
  3389. Effects of early trauma and CORTICOTROPIN โ€RELEASING FACTOR receptor 1 gene polymorphism on adult visual spatial memory
  3390. Gastroprotective effect of CORTICOTROPIN โ€“RELEASING FACTOR in streptozotocin-induced diabetic rats
  3391. Negative Feedback of the Hypothalamic Pituitary Adrenal (HPA) Axis as Assessed by the Dexamethasone-CORTICOTROPIN RELEASING FACTOR (CRF) Test in Irritable Bowel โ€ฆ
  3392. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) system localization in human fetal heart
  3393. Adult glucocorticoid receptor mRNA expression volatility in response to an acute stressor and juvenile CSF CORTICOTROPIN โ€“RELEASING FACTOR : A pilot neurodevelopmental โ€ฆ
  3394. The analgesic effect of CORTICOTROPIN โ€“RELEASING FACTOR given into the periaqueductal gray matter of the midbrain
  3395. Functional and anatomical characterization of CORTICOTROPIN โ€“RELEASING FACTOR receptor subtypes of the rat spinal cord involved in somatic pain relief
  3396. Exploring the Effects of a CORTICOTROPIN RELEASING FACTOR (CRF) Receptor Antagonist on Habit Expression
  3397. Synthesis and evaluation of prodrugs of CORTICOTROPIN โ€“RELEASING FACTOR -1 (CRF1) receptor antagonist BMS-665053 leading to improved oral bioavailability
  3398. P7, a novel antagonist of CORTICOTROPIN RELEASING FACTOR receptor type 1 (CRFR1) screened from phage display library
  3399. Effects of footshocks on anxiety-like behavior and mRNA levels of precursor peptides for CORTICOTROPIN RELEASING FACTOR and opioids in the forebrain of the rat
  3400. Docking Study of CORTICOTROPIN โ€“RELEASING FACTOR -1 Receptor with Its Antagonists
  3401. Effect of electroacupuncture intervention on expression of CORTICOTROPIN โ€“RELEASING FACTOR protein in hypothalamus and hippocampus of traumatized rats
  3402. Preclinical metabolism and pharmacokinetics of NVS-CRF38, a potent and orally bioavailable CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 antagonist
  3403. Somatosensory regulation of serotonin release in the central nucleus of the amygdala is mediated via CORTICOTROPIN RELEASING FACTOR and gamma-aminobutyric โ€ฆ
  3404. Cloning and distribution of expression of the rat CORTICOTROPIN โ€“RELEASING FACTOR (CRF) gene
  3405. CORTICOTROPIN โ€“RELEASING FACTOR activates different circuits in male and female rats
  3406. CORTICOTROPIN RELEASING FACTOR Signaling in the Mammalian Cochlea: An Integrative Niche for Cochlear Homeostatic Balance Against Noise
  3407. โ€ฆ of the Stria Terminalisโ€“Derived CORTICOTROPIN โ€“RELEASING FACTOR Controls Binge Alcohol Drinking Via Interacting With CORTICOTROPIN โ€“RELEASING FACTOR Receptors 1 and 2 โ€ฆ
  3408. Activation of the CORTICOTROPIN โ€“RELEASING FACTOR receptor from the basolateral or central amygdala modulates nociception in guinea pigs
  3409. Effects of Alcohol and Fecal Microbiota Transplantation on CORTICOTROPIN โ€“RELEASING FACTOR
  3410. Identification and Characterization of the CORTICOTROPIN โ€RELEASING FACTOR (CRF) System in Atlantic Salmon (Salmo salar)
  3411. CORTICOTROPIN RELEASING FACTOR receptor 2 exerts global suppression of mast cell degranulation and associated pathophysiology.
  3412. Novel Hippocampal Interaction between Spexin and CORTICOTROPIN RELEASING FACTOR
  3413. Relaxin-3 regulates CORTICOTROPIN โ€“RELEASING FACTOR gene expression in cultured rat hypothalamic 4B cells
  3414. 154 Evaluating the effects of prophylactic antibiotics on intestinal health in pigs given a CORTICOTROPIN โ€“RELEASING FACTOR antagonist during weaning and transport
  3415. CORTICOTROPIN RELEASING FACTOR -Producing Neurons in the Central Amygdala Induces Experience-Dependent Influences on Behavior
  3416. CORTICOTROPIN โ€“RELEASING FACTOR
  3417. Effect of glucocorticoid receptor blockade on analgesic effect of CORTICOTROPIN โ€“RELEASING FACTOR .
  3418. CORTICOTROPIN RELEASING hormone and urocortin 3 stimulate vascular endothelial growth FACTOR expression through the cAMP/CREB pathway
  3419. 0004 Sleep Disruption By Chemo-genetic Activation Of CORTICOTROPIN RELEASING FACTOR neurons In The Hypothalamic Paraventricular Nucleus Of Mice
  3420. Gonadotropin-RELEASING Hormone (GnRH) and CORTICOTROPIN โ€“RELEASING FACTOR (CRF): An Evolutionary History of Interaction
  3421. โ€ฆ -4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3, 4-dihydropyrido [2, 3-b] pyrazin-2 (1H)-ones as ligands for brain CORTICOTROPIN โ€“RELEASING FACTOR type-1 (CRF1) โ€ฆ
  3422. Localization of CORTICOTROPIN RELEASING FACTOR receptor 2 (CRFR2) in the nucleus tractus solitarii (nTS)
  3423. Teneurin C-Terminal Associated Peptide (TCAP)-1 and CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Interactions in the Modulation of Cocaine-Related Behavior
  3424. Brain CORTICOTROPIN โ€“RELEASING FACTOR and Development
  3425. Effect of CORTICOTROPIN RELEASING FACTOR (CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors
  3426. Expression of CORTICOTROPIN RELEASING FACTOR (CRF) in the enteric nervous system of the jejunum of sheep
  3427. CORTICOTROPIN โ€“RELEASING FACTOR down-regulates hair growth-related cytokines in cultured human dermal papilla cells
  3428. Alterations in CORTICOTROPIN โ€“RELEASING FACTOR Receptor Type 1 in the Hypothalamus and Preoptic Area During the Postpartum Period
  3429. โ€ฆ of 3-(2, 4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2, 5-dimethylpyrazolo [1, 5-a] pyrimidin-7-amines as ligands of the CORTICOTROPIN โ€“RELEASING FACTOR type-1 (CRF1) โ€ฆ
  3430. CORTICOTROPIN RELEASING FACTOR (CRF) and Its Receptors: From Structure to Function in Health and Disease (Part II)
  3431. Correction to: Effect of lamotrigine and carbamazepine on CORTICOTROPIN โ€“RELEASING FACTOR -associated serotonergic transmission in rat dorsal raphe nucleus
  3432. Activation of CORTICOTROPIN RELEASING FACTOR receptors up regulates collagen production by hepatic stellate cells via promoting p300 expression
  3433. Sex-Specific Regulation of Pain: A Novel Role for Dopamine and CORTICOTROPIN โ€“RELEASING FACTOR Signaling in the Midbrain and Extended Amygdala
  3434. PHASE I INDIVIDUAL DOSE TITRATION TRIAL OF THE HUMAN CORTICOTROPIN โ€“RELEASING FACTOR (HCRF), CORTICORELIN ACETATE INJECTION โ€ฆ
  3435. Acute CORTICOTROPIN โ€“RELEASING FACTOR Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue โ€ฆ
  3436. The Contribution of CORTICOTROPIN โ€“RELEASING FACTOR to Gastroprotection
  3437. Probing the Interactome of CORTICOTROPIN โ€“RELEASING FACTOR Receptor Heteromers Using Mass Spectrometry.
  3438. Effects of Bifidobacteria Use After Gastric Cancer Surgery on Intestinal Flora and Serum CORTICOTROPIN โ€“RELEASING FACTOR .
  3439. CORTICOTROPIN RELEASING FACTOR and dopamine interactions in a heterogeneous ventral tegmental area: How can aversive experiences heighten cocaine self โ€ฆ
  3440. The effect of magnesium sulfate on the placental CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and CRF binding protein mRNA expression in perfused human placental โ€ฆ
  3441. CORTICOTROPIN RELEASING FACTOR in the Medial Septum and Its Effects on Cognition
  3442. The effect of the CORTICOTROPIN RELEASING FACTOR -like diuretic hormone, Manse-DH, on the molecular mechanism of activation of vacuolar-ATPase in Manduca โ€ฆ
  3443. An in Silico Study of G Protein-Coupled-Receptor Activation, Specifically in the CORTICOTROPIN RELEASING FACTOR Receptor and the Glucagon-Like Peptide โ€ฆ
  3444. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Modulation of Cognition and Frontostriatal Neural Function
  3445. MP82-04 TRANSCRIPTIONAL REGULATION OF CORTICOTROPIN RELEASING FACTOR
  3446. The Role of Androgens on Sexually Dimorphic Distributions of Key CORTICOTROPIN โ€“RELEASING FACTOR Receptor 1 Populations and Stress Responses within the Brain
  3447. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) processes in acute and chronic anxiety
  3448. MP75-06 TRANSCRIPTIONAL REGULATION OF CORTICOTROPIN RELEASING FACTOR GENE EXPRESSION
  3449. Differential effect of amphetamine over the CORTICOTROPIN โ€“RELEASING FACTOR CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex
  3450. Influence of CORTICOTROPIN โ€“RELEASING FACTOR fragment CRF4-6 on metabolism in rats
  3451. MP12-02 TRANSCRIPTIONAL REGULATION OF CORTICOTROPIN RELEASING FACTOR GENE EXPRESSION
  3452. Intersections of Sex and CORTICOTROPIN โ€“RELEASING FACTOR
  3453. S&T-31 TRANSCRIPTIONAL REGULATION OF CORTICOTROPIN RELEASING FACTOR
  3454. Investigations of CORTICOTROPIN โ€“RELEASING FACTOR : Assessment of Its Role in Depressive Disorders
  3455. The CORTICOTROPIN RELEASING FACTOR System and Alcohol Consumption
  3456. Gamma-melanotropin response to ovine CORTICOTROPIN RELEASING FACTOR in normal humans
  3457. CORTICOTROPIN โ€“RELEASING FACTOR -like peptide
  3458. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) and Somatic Pain Sensitivity: the Contribution of CRF Receptors of Subtypes 1 and 2
  3459. The role of CORTICOTROPIN โ€“RELEASING FACTOR receptors in mediating stress-induced bladder sensitivity in female mice
  3460. CORTICOTROPIN โ€“RELEASING FACTOR and Autonomicโ€”Cardiovascular
  3461. The role of CORTICOTROPIN RELEASING FACTOR in the pathophysiology of schizophrenia
  3462. CORTICOTROPIN โ€“RELEASING FACTOR and irritable bowel syndrome
  3463. MP11-13 CENTRALLY ADMINISTERED BOMBESIN INDUCES FREQUENT URINATION VIA BRAIN CORTICOTROPIN โ€“RELEASING FACTOR RECEPTOR TYPE 1 IN โ€ฆ
  3464. Stress, CORTICOTROPIN โ€RELEASING FACTOR and cognitive flexibility
  3465. โ€ฆ of CORTICOTROPIN โ€“RELEASING hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic FACTOR
  3466. Developmental Changes in CORTICOTROPIN RELEASING FACTOR Receptor 1 in the Postnatal Dentate Gyrus
  3467. Intravenous Ovine CORTICOTROPIN โ€“RELEASING FACTOR and Human Growth Hormone-RELEASING
  3468. AB 43. The CORTICOTROPIN RELEASING FACTOR system in lung cancer: expression and pathophysiological implications
  3469. Effects of CORTICOTROPIN โ€“RELEASING FACTOR on appetite regulation of broilers.
  3470. CORTICOTROPIN โ€“RELEASING FACTOR receptors and their interacting proteins: functional consequences
  3471. Evolution and Phylogeny of the CORTICOTROPIN โ€“RELEASING FACTOR Family of Peptides
  3472. CORTICOTROPIN RELEASING FACTOR : suppression effects on fish feed intake.
  3473. SUN-479 Role of ฮฒ-arrestin2 in ERK 1/2 Activation Mediated by CORTICOTROPIN โ€“RELEASING FACTOR Receptor Type 1
  3474. CORTICOTROPIN โ€“RELEASING FACTOR : Basic and Clinical Studies of a Neuropeptide: Basic and Clinical Studies of a Neuropeptide
  3475. 284 EFFECTS OF CORTICOTROPIN โ€“RELEASING FACTOR ON INTERMEDIOLATERAL CELL COLUMN NEURONS
  3476. Predator odor increases glutamatergic synaptic transmission in the prelimbic cortex via CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 signaling
  3477. Molecular Modeling of structures and interaction of human CORTICOTROPIN โ€“RELEASING FACTOR (crF) Binding Protein and crF Type-2 receptor
  3478. Comparison of Calcium and cAMP Measurements for the Screening of CORTICOTROPIN RELEASING FACTOR Receptor Antagonists
  3479. The possible link between CORTICOTROPIN RELEASING FACTOR and post-traumatic stress disorder
  3480. PD50-11 THE ROLE OF CORTICOTROPIN โ€“RELEASING FACTOR RECEPTORS SUBTYPES ON THE CLINICAL SYMPTOMS AND TREATMENT OUTCOME OF โ€ฆ
  3481. Overexpression of CORTICOTROPIN โ€“RELEASING FACTOR in the nucleus accumbens enhances the reinforcing effects of nicotine in female versus male rats
  3482. Effects of CORTICOTROPIN RELEASING FACTOR on dendritic development of hippocampal neurons
  3483. CORTICOTROPIN โ€“RELEASING FACTOR Receptors as a Potential Target in the Developments of Antidepressant Drugs
  3484. CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Actions on Adenohypophyseal Hormone Secretion by Direct Effects on the Pituitary and by Indirect Effects on the Hypothalamus
  3485. CORTICOTROPIN โ€“RELEASING FACTOR and Urocortin Receptors
  3486. Prefrontal Cortex CORTICOTROPIN โ€“RELEASING FACTOR Neurons Motivate Behavioral Coping Strategies During Various Challenging Situations
  3487. The supposition of the mechanism of escitalopram makes a dopamine nerve activity rise by inhibiting CORTICOTROPIN โ€“RELEASING FACTOR to the non-organic-pain~ A โ€ฆ
  3488. Influence of adrenalectomy on protective effects of urocortin I, a CORTICOTROPIN โ€“RELEASING FACTOR (CRF)-related peptide, against indomethacin-induced โ€ฆ
  3489. Signalling and agonist-selective antagonism at CORTICOTROPIN โ€“RELEASING FACTOR receptors
  3490. Signalling and agonist-selective antagonism at CORTICOTROPIN โ€“RELEASING FACTOR receptors
  3491. Characterization of CORTICOTROPIN โ€“RELEASING FACTOR Cells in the Medial Prefrontal Cortex of Rats
  3492. CORTICOTROPIN RELEASING FACTOR Affects the Expression of TLR4 Receptor in Adipocytes
  3493. Identification, Characterization and Physiological Function of CORTICOTROPIN โ€“RELEASING FACTOR Type 1 Receptor Within the Paraventricular Nucleus of the Hypothalamus
  3494. Changes of hypothalamus CORTICOTROPIN RELEASING FACTOR levels in children with acute brain injury
  3495. Immunolocalization of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) andCORTICOTROPIN โ€“RELEASING FACTOR receptor 2 (CRF-R2) in the developinggut of the sea bass (Dicentrarchus โ€ฆ
  3496. The role of copeptin and CORTICOTROPIN โ€“RELEASING FACTOR in children with monosymptomatic and nonmonosymptomatic nocturnal enuresis
  3497. Cerebellar CORTICOTROPIN โ€“RELEASING FACTOR and Its Type 1 Receptor: Behavioral and Physiological Functions
  3498. Interleukin-Stimulates the Secretion of Hypothalamic CORTICOTROPIN โ€“RELEASING FACTOR
  3499. CORTICOTROPIN RELEASING FACTOR and irritable bowel syndromeโ€”โ€”from bench to bedside
  3500. Role of CORTICOTROPIN โ€“RELEASING FACTOR and Corticosterone in Behavioral Sensitization to Ethanol
  3501. Characterization of the Ovarian CORTICOTROPIN โ€“RELEASING FACTOR System and its anti-steroidogenic effects in Zebrafish
  3502. CORTICOTROPIN RELEASING FACTOR Invigorates Cocaineโ€Seeking via CRFโ€R2 in the Nucleus Accumbens Core
  3503. Reciprocal Interaction between Hypothalamic Orexinโ€A and CORTICOTROPIN โ€RELEASING FACTOR under Stressed Condition
  3504. The role of CORTICOTROPIN โ€“RELEASING FACTOR in binge-like ethanol consumption
  3505. The Role of CORTICOTROPIN โ€“RELEASING FACTOR in the Behavior and Proinflammatory Activity of Separated Guinea Pig Pups
  3506. The role of CORTICOTROPIN โ€“RELEASING FACTOR in mediating the effect of acute stress on effort-based decision-making
  3507. CORTICOTROPIN โ€“RELEASING FACTOR Receptors in the Brainโ€”Pituitaryโ€”Immune Axis
  3508. Mechanisms of analgesic action of CORTICOTROPIN โ€“RELEASING FACTOR on somatic pain sensitivity in rats
  3509. CORTICOTROPIN โ€RELEASING FACTOR receptor crosstalk pivotal to ligandโ€specific signaling and trafficking (795.3)
  3510. Structural-Functional Analysis of the Third Transmembrane Domain of the CORTICOTROPIN โ€“RELEASING FACTOR Type 1 Receptor
  3511. CORTICOTROPIN โ€“RELEASING FACTOR Signaling at the Intersection of Pain and Opioid Addiction
  3512. Ganglionic blockade alters behavioral and cerebral metabolic responses to CORTICOTROPIN RELEASING FACTOR in the rat
  3513. Differential expression of CORTICOTROPIN RELEASING FACTOR and urocortins in the Schistosoma mansoniโ€infected mouse ileum (214.2)
  3514. Multiple Players Vying for One Target: Regulation of Differential Signaling Fate of CORTICOTROPIN โ€RELEASING FACTOR Receptor 1 (CRF1)
  3515. The Role of Angiotensin Receptor Type 1 on CORTICOTROPIN RELEASING FACTOR Expressing Neurons in Auditory Fear Conditioning
  3516. CORTICOTROPIN RELEASING FACTOR receptor type 1 signaling in epilepsy and traumatic brain injury
  3517. Experimental neuropathy increases limbic forebrain CORTICOTROPIN โ€“RELEASING FACTOR
  3518. Involvement of brain CORTICOTROPIN โ€“RELEASING FACTOR in the responses of arterial pressure and heart rate to noxious cutaneous stimulation in rats
  3519. CORTICOTROPIN RELEASING FACTOR Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research
  3520. Effect of early psychological traumatic stress and CORTICOTROPIN โ€“RELEASING FACTOR receptor 1 gene polymorphism on visual spatial memory
  3521. EAE (Experimental Autoimmune Encephalomyelitis), CORTICOTROPIN โ€“RELEASING FACTOR and the Blood Brain Barrier
  3522. The CORTICOTROPIN โ€“RELEASING FACTOR system in lactating rats: implications in the regulation of maternal behavior with special focus on the BNST
  3523. Sexโ€and CORTICOTROPIN โ€RELEASING FACTOR Receptor 2โ€dependent Actions of Urocortin 1 During Colitis
  3524. CORTICOTROPIN RELEASING FACTOR (CRF) Impairs Sustained Attention in Male and Female Rats
  3525. Chemogenetic Activation of Parasubthalamic nucleus CORTICOTROPIN โ€RELEASING FACTOR Neurons recapitulates Alcohol Withdrawalโ€Related Behavioral Symptomatology
  3526. 13 CORTICOTROPIN โ€“RELEASING FACTOR and Hypothalamicโ€“-Pituitaryโ€“Adrenal Axis Regulation of Behavioral Stress Response and Depression
  3527. Polytherapy for Alzheimerโ€™s Disease: Combining Gamma Secretase Modulation and CORTICOTROPIN โ€“RELEASING FACTOR Receptor 1 Antagonism
  3528. Characterization of a PD-Sauvagine Analog as a New High-Affinity Radioligand for CORTICOTROPIN โ€“RELEASING FACTOR Receptor Studies
  3529. Sensitivity and Resilience to Stressโ€Induced Alcohol Intake Enhancement Produces Sex Differences in the CORTICOTROPIN RELEASING FACTOR System in Male and Female โ€ฆ
  3530. CORTICOTROPIN โ€RELEASING FACTOR involves in promotive effect of restraint on neuronal activation by methamphetamine
  3531. Acceleration of DNCB-induced Early-apoptosis via Activation of CORTICOTROPIN RELEASING FACTOR in the Hair Root of NC/Nga Mice
  3532. Amygdaloid CORTICOTROPIN RELEASING FACTOR as the Key Mediator of Chronic Visceral Pain in Females with a History of Early Life Stress
  3533. Analgesic effect of CORTICOTROPIN โ€“RELEASING FACTOR administered into midbrain periaqueductal grey matter
  3534. The Expression of CORTICOTROPIN โ€“RELEASING FACTOR in Ratโ€™s Hippocampus Involves in the Pathology of Salicylate Induced Tinnitus [J]
  3535. Re: Assessment of Serum Levels of Copeptin and CORTICOTROPIN โ€“RELEASING FACTOR in Children with Monosymptomatic and Non-Monosymptomatic Nocturnal Enuresis
  3536. Corrigendum to โ€œSelective lesioning of nucleus incertus with CORTICOTROPIN RELEASING FACTOR -saporin conjugateโ€[Brain Res. 1543 (2014) 179โ€“190]
  3537. Coโ€expression of Orexinโ€B and CORTICOTROPIN โ€RELEASING FACTOR in Hypothalamic Neurons of the Ovariectomized Female on a High Fat Diet
  3538. Traumatic Stress Promotes Hyperalgesia via CORTICOTROPIN โ€RELEASING FACTOR Signaling in Central Amygdala
  3539. MP28-16 BRAIN SEROTONIN AND CORTICOTROPIN โ€“RELEASING FACTOR ARE INVOLVED IN BOMBESIN-INDUCED FREQUENT URINATION IN RATS
  3540. Investigation of the role of CORTICOTROPIN โ€RELEASING FACTOR receptors and alphaโ€adrenergic receptors within the amygdala during nicotine withdrawal
  3541. Mechanisms of gastroprotective action of CORTICOTROPIN โ€“RELEASING FACTOR (CRF): involvement of CRF receptor subtypes 1 and 2
  3542. Quantitative comparison of mRNA level of CORTICOTROPIN โ€“RELEASING FACTOR peptide family in normal kidney and corresponding clear cell renal cell carcinoma specimens.
  3543. The amygdala, a relay station for switching on and off pain Role of limbic CORTICOTROPIN โ€“RELEASING FACTOR in neuropathic pain
  3544. Mast Cell CORTICOTROPIN โ€“RELEASING FACTOR Receptor Subtypes, CRF1 and CRF2, Differentially Modulate Stress-induced Intestinal Permeability
  3545. CORTICOTROPIN โ€“RELEASING FACTOR facilitates epileptiform activity in the entorhinal cortex via CRF2 signaling mechanisms
  3546. A Study of CORTICOTROPIN โ€“RELEASING FACTOR -Catecholamine Interactions in the Reinstatement of Cocaine Seeking in Rats
  3547. CORTICOTROPIN โ€“RELEASING FACTOR facilitates epileptiform activity in the entorhinal cortex via activation of [CRF. sub. 2] receptors and H-channels
  3548. Effects of electroacupuncture at meridian point on the mRNA expressions of CORTICOTROPIN โ€“RELEASING FACTOR and corticosteroid in the hippocampus after cerebral โ€ฆ
  3549. Mast Cell CORTICOTROPIN RELEASING FACTOR Receptor Subtypes Play Opposing Roles in Mediating Stressโ€Induced Colonic Barrier Dysfunction
  3550. Orexin-CORTICOTROPIN โ€“RELEASING FACTOR receptor heteromers in the ventral tegmental area as targets for cocaine
  3551. The Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Signaling in the Ventral Tegmental Area in the Regulation of Binge-Like Alcohol Consumption
  3552. CORTICOTROPIN โ€“RELEASING hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth FACTOR release, which is โ€ฆ
  3553. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via CORTICOTROPIN โ€“RELEASING FACTOR receptor 2
  3554. PT632. Alteration of the effects of CORTICOTROPIN โ€“RELEASING FACTOR on synaptic transmission in the dorsolateral bed nucleus of the stria terminalis of chronic pain model โ€ฆ
  3555. Effects of Bifidobacterium infantis on intestinal CORTICOTROPIN RELEASING FACTOR receptors and mast cells activation in a murine model of irritable bowel syndrome
  3556. Stress exposure produces a switch from appetitive to aversive signaling by CORTICOTROPIN โ€“RELEASING FACTOR in the nucleus accumbens
  3557. CORTICOTROPIN โ€RELEASING FACTOR (CRF) and Glucocorticoids as Gastroprotective Components of Brainโ€Gut Interactions in Stress
  3558. Manipulation of CORTICOTROPIN โ€“RELEASING FACTOR Signaling Using DREADDs Reduces Binge-Like Ethanol Consumption of CRF-Cre Transgenic Mice
  3559. โ€ฆ in Rats Subjected to Repeated Alcohol Administration by Modulating the Brain-Derived Neurotrophic FACTOR /CORTICOTROPIN โ€“RELEASING Hormone Signaling Pathway
  3560. Antagonism of CORTICOTROPIN RELEASING FACTOR (CRF) in the locus coeruleus (LC) increase respiratory response to hypercapnia
  3561. Central nervous system CORTICOTROPIN RELEASING FACTOR (CRF) systems contribute to increased anxiety-like behavior during opioid withdrawal: an analysis of โ€ฆ
  3562. Elucidating Mechanisms that Lead to Persistent Anxiety-like Behavior in Rats Following Repeated Activation of CORTICOTROPIN โ€“RELEASING FACTOR Receptors in the โ€ฆ
  3563. Interactions of TCAP-1 and Endocannabinoids with CORTICOTROPIN โ€“RELEASING FACTOR in Mediating Cocaine-and Anxiety-Related Behaviour
  3564. The Effects Of Adolescent Binge Drinking On CORTICOTROPIN โ€“RELEASING FACTOR Cells In The Amygdala And Social Predictors Of Alcohol Intake In Male And Female Rats
  3565. Investigation of the role of CORTICOTROPIN โ€RELEASING FACTOR receptors within the central amygdala and basolateral amygdala during nicotine withdrawal in rats
  3566. โ€ฆ and Biological Evaluation of Substituted Thiazolo (4, 5-d) Pyrimidines and Substituted Pyrimidines as CORTICOTROPIN RELEASING FACTOR (CRF) Receptor Antagonists
  3567. CORTICOTROPIN โ€“RELEASING FACTOR mediated epileptiform activity in the entorhinal cortex: roles of [CRF. sub. 2] receptors, PKA pathway & cation channels
  3568. Stochastic Clearing System For Nicotine Self Administration Differentially Regulates CORTICOTROPIN RELEASING FACTOR And Arginine Vasopressin Due To Stress
  3569. โ€ฆ Responses in the Paraventricular Nucleus of the Hypothalamus: Backgrounds and Future Perspectives of CORTICOTROPIN โ€“RELEASING FACTOR -Modified Yellow Fluorescent โ€ฆ
  3570. A CORTICOTROPIN โ€RELEASING FACTOR (CRF) receptor antagonist prevents bladder pathology associated with either social stress or partial bladder outlet obstruction (pBOO)
  3571. CORTICOTROPIN โ€“RELEASING FACTOR and urocortin I activate CREB through functionally selective Gbc signaling in hippocampal pyramidal neurons
  3572. โ€ฆ of 3-(2, 4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2, 5-dimethylpyrazolo [1, 5-a] pyrimidin-7-amines as ligands of the CORTICOTROPIN โ€“RELEASING FACTOR type-1 (CRF1) โ€ฆ
  3573. Changes in immunoreactive terminals containing serotonin, substance P, vesicular glutamate transporter 2 and CORTICOTROPIN โ€“RELEASING FACTOR in the lumbosacral spinal โ€ฆ
  3574. Correction: Role of CORTICOTROPIN โ€“RELEASING FACTOR (CRF) Receptor-1 on the Catecholaminergic Response to Morphine Withdrawal in the Nucleus Accumbens (NAc)
  3575. CORTICOTROPIN RELEASING FACTOR type-1 receptor antagonism in the dorsolateral bed nucleus of the stria terminalis disrupts contextually conditioned fear, but not โ€ฆ
  3576. Episodic Social Stress-Escalated Cocaine Self-Administration: Role of Phasic and Tonic CORTICOTROPIN RELEASING FACTOR in the Anterior and Posterior Ventral โ€ฆ
  3577. โ€ฆ in carnitine-deficient juvenile visceral steatosis (JVS) mice: Involvement of defective acyl-ghrelin secretion and enhanced CORTICOTROPIN โ€“RELEASING FACTOR signaling in the โ€ฆ
  3578. Leukemia inhibitory FACTOR induces CORTICOTROPIN โ€“RELEASING hormone in mouse trophoblast stem cells
  3579. โ€ฆ to: MicroRNA-34 Contributes to the Stress-related Behavior and Affects 5-HT Prefrontal/GABA Amygdalar System through Regulation of CORTICOTROPIN โ€“RELEASING FACTOR โ€ฆ
  3580. โ€ฆ Glutamate, GABA, Endogenous Opioids, Endocannabinoids, Noradrenaline, Arginine Vasopressin, Neuropeptide Y, MAO, CREB, and CORTICOTROPIN โ€“RELEASING FACTOR
  3581. The importance of specific amino acid residues in transmembrane domains 3 and 5 of a CORTICOTROPIN RELEASING โ€“FACTOR receptor for functional activity of a CRF-R1 โ€ฆ
  3582. CORTICOTROPIN โ€RELEASING hormoneโ€binding protein is upโ€regulated by brainโ€derived neurotrophic FACTOR and is secreted in an activityโ€dependent manner in rat cerebral โ€ฆ
  3583. Perturbations of Neuron-Restrictive Silencing FACTOR Modulate CORTICOTROPIN โ€“RELEASING Hormone Gene Expression in the Human Cell Line BeWo
  3584. Comparative Immunohistochemistry of Placental CORTICOTROPIN โ€“RELEASING Hormone and the Transcription FACTOR RelBโ€“NFฮบB2 Between Humans and Nonhuman โ€ฆ
  3585. Proteinaseโ€activated receptor 2 modulates CORTICOTROPIN RELEASING hormoneโ€induced brainโ€derived neurotrophic FACTOR release from microglial cells
  3586. Possible roles of brain derived neurotrophic FACTOR and CORTICOTROPIN RELEASING hormone neurons in the nucleus of hippocampal commissure functioning within the โ€ฆ
  3587. Brain-derived neurotrophic FACTOR in neurons expressing CORTICOTROPIN โ€“RELEASING hormone mediates the response to chronic stress
  3588. Comparative Immunohistochemistry of Placental CORTICOTROPIN โ€“RELEASING Hormone and the Transcription FACTOR RelB-โ€ฆ
Related Posts

Pyrazines

Lipotoxicity

Cold-inducible Rna-binding Protein (Cirbp) & Dna Repair

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping